ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count,Ontology
GO:0007059,chromosome segregation,88/262,373/12185,3.89E-69,7.16E-66,5.99E-66,CDCA8/CDC20/KIF2C/STIL/SASS6/GPSM2/PSRC1/NUF2/FIRRM/CENPL/ASPM/KIF14/NEK2/CENPF/ZWINT/CDK1/KIF11/MKI67/KIF18A/INCENP/CDCA5/NCAPD2/RACGAP1/ESPL1/KNTC1/SKA3/CENPJ/DLGAP5/BUB1B/KNSTRN/KNL1/OIP5/NUSAP1/CCNB2/ZWILCH/KIF23/PRC1/RMI2/PLK1/CDT1/AURKB/SPAG5/CDC6/TOP2A/BRCA1/KIF18B/BRIP1/BIRC5/NDC80/SKA1/SPC24/CENPO/NCAPH/BUB1/SPC25/SGO2/HJURP/TPX2/DSN1/FAM83D/MYBL2/UBE2C/AURKA/CENPM/FANCD2/SGO1/SMC4/ECT2/TACC3/NCAPG/CENPE/MAD2L1/MND1/CENPU/TRIP13/CENPK/CCNB1/CENPH/PTTG1/SPDL1/KIFC1/TTK/CENPW/NCAPG2/CDCA2/ESCO2/KIF4A/CENPI,88,BP
GO:0000280,nuclear division,80/262,350/12185,3.05E-61,2.81E-58,2.35E-58,CDCA8/CDC20/KIF2C/RAD54L/PSRC1/NUF2/ASPM/KIF14/NEK2/CENPF/ZWINT/CDK1/KIF20B/KIF11/MKI67/KIF18A/INCENP/CDCA5/CHEK1/RAD51AP1/NCAPD2/RACGAP1/ESPL1/KNTC1/BRCA2/BORA/DLGAP5/BUB1B/KNSTRN/KNL1/RAD51/NUSAP1/CCNB2/ZWILCH/KIF23/PRC1/PKMYT1/PLK1/CDT1/FANCA/AURKB/SPAG5/TOP2A/KIF18B/EME1/BRIP1/BIRC5/NDC80/SPC24/UBE2S/NCAPH/BUB1/SPC25/TPX2/DSN1/MYBL2/UBE2C/AURKA/FANCD2/SGO1/SMC4/NCAPG/CENPE/MAD2L1/MND1/TRIP13/CENPK/CCNB1/CDC25C/PTTG1/SPDL1/KIFC1/TTK/ANLN/FIGNL1/NCAPG2/CDCA2/RAD54B/KIF4A/CENPI,80,BP
GO:0048285,organelle fission,80/262,393/12185,5.33E-57,3.27E-54,2.74E-54,CDCA8/CDC20/KIF2C/RAD54L/PSRC1/NUF2/ASPM/KIF14/NEK2/CENPF/ZWINT/CDK1/KIF20B/KIF11/MKI67/KIF18A/INCENP/CDCA5/CHEK1/RAD51AP1/NCAPD2/RACGAP1/ESPL1/KNTC1/BRCA2/BORA/DLGAP5/BUB1B/KNSTRN/KNL1/RAD51/NUSAP1/CCNB2/ZWILCH/KIF23/PRC1/PKMYT1/PLK1/CDT1/FANCA/AURKB/SPAG5/TOP2A/KIF18B/EME1/BRIP1/BIRC5/NDC80/SPC24/UBE2S/NCAPH/BUB1/SPC25/TPX2/DSN1/MYBL2/UBE2C/AURKA/FANCD2/SGO1/SMC4/NCAPG/CENPE/MAD2L1/MND1/TRIP13/CENPK/CCNB1/CDC25C/PTTG1/SPDL1/KIFC1/TTK/ANLN/FIGNL1/NCAPG2/CDCA2/RAD54B/KIF4A/CENPI,80,BP
GO:0098813,nuclear chromosome segregation,68/262,268/12185,6.59E-55,3.03E-52,2.54E-52,CDCA8/CDC20/KIF2C/PSRC1/NUF2/ASPM/KIF14/NEK2/CENPF/ZWINT/CDK1/KIF11/KIF18A/INCENP/CDCA5/NCAPD2/RACGAP1/ESPL1/KNTC1/DLGAP5/BUB1B/KNSTRN/KNL1/NUSAP1/CCNB2/ZWILCH/KIF23/PRC1/RMI2/PLK1/CDT1/AURKB/SPAG5/CDC6/TOP2A/KIF18B/BRIP1/BIRC5/NDC80/SPC24/NCAPH/BUB1/SPC25/TPX2/DSN1/FAM83D/MYBL2/UBE2C/AURKA/FANCD2/SGO1/SMC4/ECT2/TACC3/NCAPG/CENPE/MAD2L1/MND1/TRIP13/CENPK/CCNB1/PTTG1/SPDL1/KIFC1/TTK/NCAPG2/KIF4A/CENPI,68,BP
GO:0140014,mitotic nuclear division,64/262,250/12185,7.99E-52,2.94E-49,2.46E-49,CDCA8/CDC20/KIF2C/PSRC1/NUF2/KIF14/NEK2/CENPF/ZWINT/CDK1/KIF20B/KIF11/MKI67/KIF18A/INCENP/CDCA5/CHEK1/NCAPD2/RACGAP1/ESPL1/KNTC1/BORA/DLGAP5/BUB1B/KNSTRN/KNL1/NUSAP1/ZWILCH/KIF23/PRC1/PKMYT1/PLK1/CDT1/AURKB/SPAG5/KIF18B/BIRC5/NDC80/SPC24/UBE2S/NCAPH/BUB1/SPC25/TPX2/DSN1/MYBL2/UBE2C/AURKA/SMC4/NCAPG/CENPE/MAD2L1/TRIP13/CENPK/CCNB1/CDC25C/SPDL1/KIFC1/TTK/ANLN/NCAPG2/CDCA2/KIF4A/CENPI,64,BP
GO:0044770,cell cycle phase transition,81/262,496/12185,7.25E-50,2.23E-47,1.86E-47,E2F2/CLSPN/CDCA8/CDC20/STIL/CDKN2C/ORC1/CDC7/SASS6/IQGAP3/NUF2/KIF14/DTL/CENPF/ZWINT/CDK1/DNA2/RRM1/INCENP/CDCA5/H2AX/CHEK1/FOXM1/ESPL1/TIMELESS/KNTC1/POLE/CENPJ/BRCA2/CDKN3/DLGAP5/BUB1B/KNL1/RAD51/WDR76/CCNB2/RPS27L/TIPIN/ZWILCH/TICRR/BLM/CCNF/PKMYT1/PLK1/CDT1/AURKB/CDC6/BRCA1/EME1/BRIP1/BIRC5/NDC80/RBBP8/SPC24/UBE2S/RRM2/MSH2/BUB1/SPC25/E2F1/RBL1/FAM83D/UBE2C/AURKA/CDC45/GTSE1/FANCD2/TOPBP1/TACC3/CENPE/MAD2L1/CCNA2/TRIP13/CCNB1/CDC25C/SPDL1/CDKN1A/TTK/ANLN/DBF4/MELK,81,BP
GO:0000819,sister chromatid segregation,58/262,215/12185,2.88E-48,7.07E-46,5.91E-46,CDCA8/CDC20/KIF2C/PSRC1/NUF2/KIF14/NEK2/CENPF/ZWINT/CDK1/KIF11/KIF18A/INCENP/CDCA5/NCAPD2/RACGAP1/ESPL1/KNTC1/DLGAP5/BUB1B/KNSTRN/KNL1/NUSAP1/ZWILCH/KIF23/PRC1/RMI2/PLK1/CDT1/AURKB/SPAG5/CDC6/TOP2A/KIF18B/BIRC5/NDC80/SPC24/NCAPH/BUB1/SPC25/TPX2/DSN1/MYBL2/UBE2C/SMC4/TACC3/NCAPG/CENPE/MAD2L1/TRIP13/CENPK/CCNB1/SPDL1/KIFC1/TTK/NCAPG2/KIF4A/CENPI,58,BP
GO:0000070,mitotic sister chromatid segregation,54/262,176/12185,3.07E-48,7.07E-46,5.91E-46,CDCA8/CDC20/KIF2C/PSRC1/NUF2/KIF14/NEK2/CENPF/ZWINT/CDK1/KIF11/KIF18A/INCENP/CDCA5/NCAPD2/RACGAP1/ESPL1/KNTC1/DLGAP5/BUB1B/KNSTRN/KNL1/NUSAP1/ZWILCH/KIF23/PRC1/PLK1/CDT1/AURKB/SPAG5/KIF18B/BIRC5/NDC80/SPC24/NCAPH/BUB1/SPC25/TPX2/DSN1/MYBL2/UBE2C/SMC4/NCAPG/CENPE/MAD2L1/TRIP13/CENPK/CCNB1/SPDL1/KIFC1/TTK/NCAPG2/KIF4A/CENPI,54,BP
GO:1901987,regulation of cell cycle phase transition,70/262,388/12185,1.01E-45,2.06E-43,1.72E-43,CLSPN/CDCA8/CDC20/STIL/CDKN2C/ORC1/CDC7/SASS6/NUF2/KIF14/DTL/CENPF/ZWINT/CDK1/DNA2/RRM1/INCENP/CDCA5/H2AX/CHEK1/ESPL1/TIMELESS/KNTC1/CENPJ/BRCA2/DLGAP5/BUB1B/KNL1/RAD51/WDR76/RPS27L/TIPIN/ZWILCH/TICRR/BLM/PKMYT1/PLK1/CDT1/AURKB/CDC6/BRCA1/EME1/BRIP1/BIRC5/NDC80/RBBP8/SPC24/RRM2/MSH2/BUB1/SPC25/E2F1/RBL1/FAM83D/UBE2C/AURKA/CDC45/GTSE1/FANCD2/TOPBP1/CENPE/MAD2L1/TRIP13/CCNB1/CDC25C/SPDL1/CDKN1A/TTK/ANLN/DBF4,70,BP
GO:0006260,DNA replication,58/262,260/12185,4.07E-43,7.49E-41,6.26E-41,NASP/ORC1/CDC7/DTL/MCM10/CDK1/DNA2/RRM1/FAM111B/POLA2/POLD3/CHEK1/DDX11/TIMELESS/PRIM1/RFC5/POLE/BRCA2/RFC3/POLE2/WDHD1/RAD51/PCLAF/PIF1/TIPIN/TICRR/BLM/CHTF18/RMI2/GINS2/CDT1/CDC6/BRCA1/EME1/TK1/RBBP8/CHAF1A/RRM2/MCM6/GINS1/CHAF1B/CDC45/MCM5/TRAIP/POLQ/MCM2/TOPBP1/RFC4/CCNA2/GMNN/MCM3/MMS22L/RFC2/DBF4/MCM7/ESCO2/MCM4/DSCC1,58,BP
GO:0000075,cell cycle checkpoint signaling,50/262,185/12185,1.51E-41,2.53E-39,2.12E-39,CLSPN/CDCA8/CDC20/ORC1/NUF2/DTL/CENPF/ZWINT/CDK1/DNA2/INCENP/H2AX/CHEK1/TIMELESS/KNTC1/BRCA2/BUB1B/KNL1/RAD51/WDR76/RPS27L/TIPIN/ZWILCH/TICRR/BLM/PLK1/CDT1/AURKB/CDC6/BRCA1/EME1/BRIP1/BIRC5/NDC80/RBBP8/SPC24/MSH2/BUB1/SPC25/E2F1/CDC45/GTSE1/FANCD2/TOPBP1/MAD2L1/TRIP13/CCNB1/SPDL1/CDKN1A/TTK,50,BP
GO:0044772,mitotic cell cycle phase transition,67/262,409/12185,7.31E-41,1.12E-38,9.39E-39,E2F2/CLSPN/CDCA8/CDC20/STIL/CDKN2C/ORC1/CDC7/SASS6/IQGAP3/NUF2/KIF14/DTL/CENPF/ZWINT/CDK1/RRM1/INCENP/CDCA5/CHEK1/FOXM1/ESPL1/KNTC1/POLE/CENPJ/CDKN3/DLGAP5/BUB1B/KNL1/CCNB2/RPS27L/ZWILCH/TICRR/BLM/CCNF/PKMYT1/PLK1/AURKB/CDC6/BRCA1/BIRC5/NDC80/RBBP8/SPC24/UBE2S/RRM2/BUB1/SPC25/E2F1/RBL1/UBE2C/AURKA/GTSE1/TOPBP1/TACC3/CENPE/MAD2L1/CCNA2/TRIP13/CCNB1/CDC25C/SPDL1/CDKN1A/TTK/ANLN/DBF4/MELK,67,BP
GO:0006261,DNA-templated DNA replication,45/262,153/12185,3.36E-39,4.76E-37,3.98E-37,ORC1/CDC7/MCM10/DNA2/RRM1/POLA2/POLD3/DDX11/TIMELESS/PRIM1/RFC5/POLE/BRCA2/RFC3/POLE2/WDHD1/RAD51/TIPIN/TICRR/BLM/CHTF18/GINS2/CDT1/CDC6/BRCA1/EME1/TK1/RBBP8/MCM6/GINS1/CDC45/MCM5/TRAIP/POLQ/MCM2/TOPBP1/RFC4/GMNN/MCM3/MMS22L/RFC2/DBF4/MCM7/MCM4/DSCC1,45,BP
GO:0007346,regulation of mitotic cell cycle,67/262,439/12185,7.75E-39,1.02E-36,8.52E-37,CLSPN/CDCA8/CDC20/STIL/CDKN2C/ORC1/CDC7/SASS6/NUF2/KIF14/NEK2/DTL/CENPF/ZWINT/CDK1/KIF20B/MKI67/RRM1/INCENP/CDCA5/CHEK1/ESPL1/KNTC1/CENPJ/BRCA2/BORA/DLGAP5/BUB1B/KNL1/NUSAP1/RPS27L/TIPIN/ZWILCH/TICRR/BLM/PKMYT1/PLK1/AURKB/CDC6/BRCA1/EME1/BIRC5/NDC80/RBBP8/SPC24/RRM2/MSH2/BUB1/SPC25/E2F1/RBL1/UBE2C/AURKA/GTSE1/FANCD2/TOPBP1/CENPE/MAD2L1/TRIP13/CCNB1/CDC25C/SPDL1/GMNN/CDKN1A/TTK/ANLN/CDCA2,67,BP
GO:0010948,negative regulation of cell cycle process,55/262,273/12185,2.64E-38,3.20E-36,2.68E-36,CLSPN/CDCA8/CDC20/ORC1/NUF2/NEK2/DTL/CENPF/ZWINT/CDK1/DNA2/INCENP/H2AX/CHEK1/ESPL1/TIMELESS/KNTC1/BRCA2/BUB1B/KNL1/RAD51/WDR76/RPS27L/TIPIN/ZWILCH/TICRR/BLM/CCNF/PKMYT1/PLK1/CDT1/AURKB/CDC6/BRCA1/EME1/BRIP1/BIRC5/NDC80/RBBP8/SPC24/MSH2/BUB1/SPC25/E2F1/RBL1/CDC45/GTSE1/FANCD2/TOPBP1/MAD2L1/TRIP13/CCNB1/SPDL1/CDKN1A/TTK,55,BP
GO:1901988,negative regulation of cell cycle phase transition,52/262,236/12185,2.78E-38,3.20E-36,2.68E-36,CLSPN/CDCA8/CDC20/ORC1/NUF2/DTL/CENPF/ZWINT/CDK1/DNA2/INCENP/H2AX/CHEK1/TIMELESS/KNTC1/BRCA2/BUB1B/KNL1/RAD51/WDR76/RPS27L/TIPIN/ZWILCH/TICRR/BLM/PKMYT1/PLK1/CDT1/AURKB/CDC6/BRCA1/EME1/BRIP1/BIRC5/NDC80/RBBP8/SPC24/MSH2/BUB1/SPC25/E2F1/RBL1/CDC45/GTSE1/FANCD2/TOPBP1/MAD2L1/TRIP13/CCNB1/SPDL1/CDKN1A/TTK,52,BP
GO:1901990,regulation of mitotic cell cycle phase transition,54/262,303/12185,1.12E-34,1.22E-32,1.02E-32,CLSPN/CDCA8/CDC20/STIL/CDKN2C/ORC1/CDC7/SASS6/NUF2/KIF14/DTL/CENPF/ZWINT/CDK1/RRM1/INCENP/CDCA5/CHEK1/ESPL1/KNTC1/CENPJ/DLGAP5/BUB1B/KNL1/RPS27L/ZWILCH/TICRR/BLM/PLK1/AURKB/CDC6/BRCA1/BIRC5/NDC80/RBBP8/SPC24/RRM2/BUB1/SPC25/E2F1/RBL1/UBE2C/AURKA/GTSE1/TOPBP1/CENPE/MAD2L1/TRIP13/CCNB1/CDC25C/SPDL1/CDKN1A/TTK/ANLN,54,BP
GO:0007093,mitotic cell cycle checkpoint signaling,40/262,138/12185,1.41E-34,1.44E-32,1.21E-32,CLSPN/CDCA8/CDC20/ORC1/NUF2/DTL/CENPF/ZWINT/CDK1/INCENP/CHEK1/KNTC1/BUB1B/KNL1/RPS27L/TIPIN/ZWILCH/TICRR/BLM/PLK1/AURKB/CDC6/BRCA1/EME1/BIRC5/NDC80/RBBP8/SPC24/MSH2/BUB1/SPC25/GTSE1/FANCD2/TOPBP1/MAD2L1/TRIP13/CCNB1/SPDL1/CDKN1A/TTK,40,BP
GO:0045786,negative regulation of cell cycle,56/262,334/12185,1.66E-34,1.61E-32,1.34E-32,CLSPN/CDCA8/CDC20/ORC1/NUF2/NEK2/DTL/CENPF/ZWINT/CDK1/DNA2/INCENP/H2AX/CHEK1/ESPL1/TIMELESS/KNTC1/BRCA2/BUB1B/KNL1/RAD51/WDR76/RPS27L/TIPIN/ZWILCH/TICRR/BLM/CCNF/PKMYT1/PLK1/CDT1/AURKB/CDC6/BRCA1/EME1/BRIP1/BIRC5/NDC80/RBBP8/SPC24/MSH2/BUB1/SPC25/E2F1/RBL1/CDC45/GTSE1/FANCD2/TOPBP1/MAD2L1/TRIP13/CCNB1/SPDL1/GMNN/CDKN1A/TTK,56,BP
GO:0051983,regulation of chromosome segregation,38/262,122/12185,3.36E-34,3.09E-32,2.59E-32,CDCA8/CDC20/KIF2C/NUF2/CENPF/ZWINT/CDK1/MKI67/INCENP/NCAPD2/ESPL1/KNTC1/DLGAP5/BUB1B/KNL1/ZWILCH/RMI2/PLK1/AURKB/CDC6/BIRC5/NDC80/SPC24/NCAPH/BUB1/SPC25/UBE2C/SMC4/TACC3/NCAPG/CENPE/MAD2L1/TRIP13/CCNB1/SPDL1/TTK/NCAPG2/CDCA2,38,BP
GO:0007088,regulation of mitotic nuclear division,35/262,102/12185,3.14E-33,2.76E-31,2.31E-31,CDCA8/CDC20/NUF2/NEK2/CENPF/ZWINT/KIF20B/MKI67/INCENP/CHEK1/ESPL1/KNTC1/BORA/DLGAP5/BUB1B/KNL1/NUSAP1/ZWILCH/PKMYT1/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/UBE2C/AURKA/MAD2L1/TRIP13/CCNB1/CDC25C/SPDL1/TTK/CDCA2,35,BP
GO:0051783,regulation of nuclear division,36/262,118/12185,4.65E-32,3.89E-30,3.26E-30,CDCA8/CDC20/NUF2/NEK2/CENPF/ZWINT/KIF20B/MKI67/INCENP/CHEK1/RAD51AP1/ESPL1/KNTC1/BORA/DLGAP5/BUB1B/KNL1/NUSAP1/ZWILCH/PKMYT1/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/UBE2C/AURKA/MAD2L1/TRIP13/CCNB1/CDC25C/SPDL1/TTK/CDCA2,36,BP
GO:1905818,regulation of chromosome separation,30/262,71/12185,7.75E-32,6.21E-30,5.19E-30,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/NCAPD2/ESPL1/KNTC1/DLGAP5/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/NCAPH/BUB1/SPC25/UBE2C/SMC4/NCAPG/MAD2L1/TRIP13/CCNB1/SPDL1/TTK/NCAPG2,30,BP
GO:1902850,microtubule cytoskeleton organization involved in mitosis,39/262,154/12185,3.22E-31,2.47E-29,2.07E-29,CDCA8/CDC20/STIL/SASS6/GPSM2/PSRC1/NUF2/NEK2/CDK1/KIF11/INCENP/RACGAP1/ESPL1/CENPJ/BORA/DLGAP5/NUSAP1/KIF23/PRC1/PLK1/AURKB/BIRC5/NDC80/WDR62/CENPA/SPC25/TPX2/MYBL2/AURKA/TACC3/CENPE/MAD2L1/CCNB1/CENPH/SPDL1/KIFC1/TTK/SAPCD2/KIF4A,39,BP
GO:0051304,chromosome separation,30/262,77/12185,1.53E-30,1.13E-28,9.42E-29,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/NCAPD2/ESPL1/KNTC1/DLGAP5/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/NCAPH/BUB1/SPC25/UBE2C/SMC4/NCAPG/MAD2L1/TRIP13/CCNB1/SPDL1/TTK/NCAPG2,30,BP
GO:0090068,positive regulation of cell cycle process,43/262,208/12185,2.13E-30,1.51E-28,1.26E-28,CDCA8/CDC20/STIL/CDC7/SASS6/GPSM2/KIF14/DTL/CDK1/KIF20B/RRM1/INCENP/CDCA5/RAD51AP1/NCAPD2/DDX11/RACGAP1/ESPL1/CIT/CENPJ/DLGAP5/NUSAP1/KIF23/AURKB/SPAG5/CDC6/BIRC5/NDC80/RRM2/NCAPH/BUB1/FAM83D/UBE2C/AURKA/SMC4/ECT2/NCAPG/MAD2L1/PLK4/CCNB1/CDC25C/DBF4/NCAPG2,43,BP
GO:0045787,positive regulation of cell cycle,46/262,265/12185,5.60E-29,3.82E-27,3.19E-27,CDCA8/CDC20/STIL/CDC7/SASS6/GPSM2/PSRC1/KIF14/DTL/CDK1/KIF20B/RRM1/INCENP/CDCA5/CHEK1/RAD51AP1/NCAPD2/DDX11/RACGAP1/ESPL1/CIT/CENPJ/BRCA2/DLGAP5/NUSAP1/KIF23/AURKB/SPAG5/CDC6/BIRC5/NDC80/RRM2/NCAPH/BUB1/FAM83D/UBE2C/AURKA/SMC4/ECT2/NCAPG/MAD2L1/PLK4/CCNB1/CDC25C/DBF4/NCAPG2,46,BP
GO:0045930,negative regulation of mitotic cell cycle,41/262,209/12185,4.85E-28,3.19E-26,2.67E-26,CLSPN/CDCA8/CDC20/ORC1/NUF2/DTL/CENPF/ZWINT/CDK1/INCENP/CHEK1/KNTC1/BUB1B/KNL1/RPS27L/TIPIN/ZWILCH/TICRR/BLM/PLK1/AURKB/CDC6/BRCA1/EME1/BIRC5/NDC80/RBBP8/SPC24/MSH2/BUB1/SPC25/RBL1/GTSE1/FANCD2/TOPBP1/MAD2L1/TRIP13/CCNB1/SPDL1/CDKN1A/TTK,41,BP
GO:0051310,metaphase chromosome alignment,30/262,92/12185,8.13E-28,5.17E-26,4.32E-26,CDCA8/KIF2C/PSRC1/NUF2/KIF14/NEK2/CENPF/KIF18A/INCENP/CDCA5/RACGAP1/KNTC1/KNSTRN/KNL1/ZWILCH/CDT1/AURKB/SPAG5/BIRC5/NDC80/SPC24/SPC25/DSN1/FAM83D/SGO1/ECT2/CENPE/CCNB1/SPDL1/KIFC1,30,BP
GO:1901991,negative regulation of mitotic cell cycle phase transition,37/262,165/12185,1.44E-27,8.87E-26,7.41E-26,CLSPN/CDCA8/CDC20/ORC1/NUF2/DTL/CENPF/ZWINT/CDK1/INCENP/CHEK1/KNTC1/BUB1B/KNL1/RPS27L/ZWILCH/TICRR/BLM/PLK1/AURKB/CDC6/BRCA1/BIRC5/NDC80/RBBP8/SPC24/BUB1/SPC25/RBL1/GTSE1/TOPBP1/MAD2L1/TRIP13/CCNB1/SPDL1/CDKN1A/TTK,37,BP
GO:0010965,regulation of mitotic sister chromatid separation,25/262,57/12185,3.49E-27,2.07E-25,1.73E-25,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/ESPL1/KNTC1/DLGAP5/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/UBE2C/MAD2L1/TRIP13/CCNB1/SPDL1/TTK,25,BP
GO:0050000,chromosome localization,31/262,106/12185,4.61E-27,2.65E-25,2.22E-25,CDCA8/KIF2C/PSRC1/NUF2/KIF14/NEK2/CENPF/KIF18A/INCENP/CDCA5/RACGAP1/KNTC1/DLGAP5/KNSTRN/KNL1/ZWILCH/CDT1/AURKB/SPAG5/BIRC5/NDC80/SPC24/SPC25/DSN1/FAM83D/SGO1/ECT2/CENPE/CCNB1/SPDL1/KIFC1,31,BP
GO:0051303,establishment of chromosome localization,30/262,98/12185,6.99E-27,3.90E-25,3.26E-25,CDCA8/KIF2C/PSRC1/NUF2/KIF14/NEK2/CENPF/KIF18A/INCENP/CDCA5/RACGAP1/KNTC1/KNSTRN/KNL1/ZWILCH/CDT1/AURKB/SPAG5/BIRC5/NDC80/SPC24/SPC25/DSN1/FAM83D/SGO1/ECT2/CENPE/CCNB1/SPDL1/KIFC1,30,BP
GO:0033045,regulation of sister chromatid segregation,30/262,100/12185,1.38E-26,7.48E-25,6.25E-25,CDCA8/CDC20/NUF2/CENPF/ZWINT/CDK1/INCENP/ESPL1/KNTC1/DLGAP5/BUB1B/KNL1/ZWILCH/RMI2/PLK1/AURKB/CDC6/BIRC5/NDC80/SPC24/BUB1/SPC25/UBE2C/TACC3/CENPE/MAD2L1/TRIP13/CCNB1/SPDL1/TTK,30,BP
GO:0051306,mitotic sister chromatid separation,25/262,60/12185,1.72E-26,9.07E-25,7.59E-25,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/ESPL1/KNTC1/DLGAP5/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/UBE2C/MAD2L1/TRIP13/CCNB1/SPDL1/TTK,25,BP
GO:0007051,spindle organization,38/262,189/12185,1.96E-26,1.00E-24,8.37E-25,AUNIP/CDCA8/CDC20/STIL/SASS6/GPSM2/PSRC1/NUF2/ASPM/NEK2/KIF11/INCENP/RACGAP1/ESPL1/CENPJ/BORA/DLGAP5/KNSTRN/CCNB2/KIF23/PRC1/PLK1/AURKB/SPAG5/BIRC5/NDC80/WDR62/SPC25/TPX2/MYBL2/AURKA/TACC3/CENPE/CCNB1/CENPH/KIFC1/TTK/KIF4A,38,BP
GO:0007052,mitotic spindle organization,32/262,125/12185,6.93E-26,3.45E-24,2.88E-24,CDCA8/CDC20/STIL/SASS6/GPSM2/PSRC1/NUF2/NEK2/KIF11/INCENP/RACGAP1/CENPJ/BORA/DLGAP5/KIF23/PRC1/PLK1/AURKB/BIRC5/NDC80/WDR62/SPC25/TPX2/MYBL2/AURKA/TACC3/CENPE/CCNB1/CENPH/KIFC1/TTK/KIF4A,32,BP
GO:0007094,mitotic spindle assembly checkpoint signaling,22/262,44/12185,1.17E-25,5.41E-24,4.52E-24,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/KNTC1/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/SPDL1/TTK,22,BP
GO:0071173,spindle assembly checkpoint signaling,22/262,44/12185,1.17E-25,5.41E-24,4.52E-24,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/KNTC1/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/SPDL1/TTK,22,BP
GO:0071174,mitotic spindle checkpoint signaling,22/262,44/12185,1.17E-25,5.41E-24,4.52E-24,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/KNTC1/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/SPDL1/TTK,22,BP
GO:0031577,spindle checkpoint signaling,22/262,45/12185,2.25E-25,1.01E-23,8.47E-24,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/KNTC1/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/SPDL1/TTK,22,BP
GO:0051321,meiotic cell cycle,37/262,189/12185,2.57E-25,1.13E-23,9.41E-24,CDC20/RAD54L/NUF2/ASPM/NEK2/EXO1/KIF18A/INCENP/H2AX/RAD51AP1/NCAPD2/ESPL1/BRCA2/RAD51/CCNB2/PKMYT1/PLK1/FANCA/TOP2A/EME1/BRIP1/NDC80/RBBP8/NCAPH/SGO2/AURKA/FANCD2/SGO1/SMC4/MND1/TRIP13/CDC25C/PTTG1/TTK/FIGNL1/XRCC2/RAD54B,37,BP
GO:0007091,metaphase/anaphase transition of mitotic cell cycle,28/262,91/12185,3.22E-25,1.38E-23,1.15E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/ESPL1/KNTC1/DLGAP5/BUB1B/KNL1/ZWILCH/PLK1/AURKB/CDC6/BIRC5/NDC80/SPC24/BUB1/SPC25/UBE2C/TACC3/CENPE/MAD2L1/TRIP13/CCNB1/SPDL1/TTK,28,BP
GO:0033047,regulation of mitotic sister chromatid segregation,23/262,52/12185,3.40E-25,1.43E-23,1.19E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/CDK1/INCENP/KNTC1/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/SPDL1/TTK,23,BP
GO:0033046,negative regulation of sister chromatid segregation,22/262,46/12185,4.24E-25,1.63E-23,1.36E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/KNTC1/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/SPDL1/TTK,22,BP
GO:0033048,negative regulation of mitotic sister chromatid segregation,22/262,46/12185,4.24E-25,1.63E-23,1.36E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/KNTC1/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/SPDL1/TTK,22,BP
GO:0045841,negative regulation of mitotic metaphase/anaphase transition,22/262,46/12185,4.24E-25,1.63E-23,1.36E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/KNTC1/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/SPDL1/TTK,22,BP
GO:2000816,negative regulation of mitotic sister chromatid separation,22/262,46/12185,4.24E-25,1.63E-23,1.36E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/KNTC1/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/SPDL1/TTK,22,BP
GO:0044784,metaphase/anaphase transition of cell cycle,28/262,93/12185,6.39E-25,2.40E-23,2.01E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/ESPL1/KNTC1/DLGAP5/BUB1B/KNL1/ZWILCH/PLK1/AURKB/CDC6/BIRC5/NDC80/SPC24/BUB1/SPC25/UBE2C/TACC3/CENPE/MAD2L1/TRIP13/CCNB1/SPDL1/TTK,28,BP
GO:0051985,negative regulation of chromosome segregation,22/262,47/12185,7.82E-25,2.77E-23,2.32E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/KNTC1/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/SPDL1/TTK,22,BP
GO:1902100,negative regulation of metaphase/anaphase transition of cell cycle,22/262,47/12185,7.82E-25,2.77E-23,2.32E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/KNTC1/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/SPDL1/TTK,22,BP
GO:1905819,negative regulation of chromosome separation,22/262,47/12185,7.82E-25,2.77E-23,2.32E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/KNTC1/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/SPDL1/TTK,22,BP
GO:0045839,negative regulation of mitotic nuclear division,23/262,54/12185,1.01E-24,3.51E-23,2.93E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/CHEK1/KNTC1/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/SPDL1/TTK,23,BP
GO:0008608,attachment of spindle microtubules to kinetochore,22/262,48/12185,1.42E-24,4.83E-23,4.04E-23,CDCA8/KIF2C/NUF2/NEK2/INCENP/RACGAP1/KNTC1/KNSTRN/KNL1/ZWILCH/CDT1/AURKB/SPAG5/BIRC5/NDC80/SPC24/SPC25/DSN1/SGO1/ECT2/CENPE/CCNB1,22,BP
GO:0030071,regulation of mitotic metaphase/anaphase transition,27/262,87/12185,1.83E-24,6.13E-23,5.12E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/ESPL1/KNTC1/DLGAP5/BUB1B/KNL1/ZWILCH/PLK1/AURKB/CDC6/BIRC5/NDC80/SPC24/BUB1/SPC25/UBE2C/CENPE/MAD2L1/TRIP13/CCNB1/SPDL1/TTK,27,BP
GO:1902099,regulation of metaphase/anaphase transition of cell cycle,27/262,89/12185,3.65E-24,1.20E-22,1.00E-22,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/ESPL1/KNTC1/DLGAP5/BUB1B/KNL1/ZWILCH/PLK1/AURKB/CDC6/BIRC5/NDC80/SPC24/BUB1/SPC25/UBE2C/CENPE/MAD2L1/TRIP13/CCNB1/SPDL1/TTK,27,BP
GO:0051784,negative regulation of nuclear division,23/262,57/12185,4.66E-24,1.51E-22,1.26E-22,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/CHEK1/KNTC1/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/SPDL1/TTK,23,BP
GO:0006302,double-strand break repair,42/262,278/12185,5.31E-24,1.69E-22,1.41E-22,AUNIP/RAD54L/CDC7/DNA2/CDCA5/H2AX/CHEK1/FOXM1/RAD51AP1/DDX11/TIMELESS/PARPBP/BRCA2/RAD51/BLM/RMI2/GINS2/BRCA1/EME1/BRIP1/RBBP8/UHRF1/MSH2/MCM6/CDC45/MCM5/FANCD2/POLQ/MCM2/NSD2/ZGRF1/HMGB2/TRIP13/DEK/MCM3/MMS22L/FIGNL1/MCM7/XRCC2/ESCO2/MCM4/RAD54B,42,BP
GO:0033044,regulation of chromosome organization,39/262,237/12185,1.01E-23,3.15E-22,2.63E-22,CDCA8/CDC20/NUF2/NEK2/CENPF/ZWINT/CDK1/INCENP/NCAPD2/DDX11/ESPL1/KNTC1/DLGAP5/BUB1B/KNL1/PIF1/ZWILCH/RMI2/PLK1/AURKB/CDC6/TOP2A/BIRC5/NDC80/SPC24/NCAPH/BUB1/SPC25/UBE2C/SMC4/TACC3/NCAPG/CENPE/MAD2L1/TRIP13/CCNB1/SPDL1/TTK/NCAPG2,39,BP
GO:0006310,DNA recombination,41/262,268/12185,1.18E-23,3.62E-22,3.03E-22,AUNIP/RAD54L/CDC7/EXO1/H2AX/CHEK1/RAD51AP1/TIMELESS/PARPBP/BRCA2/RAD51/PIF1/BLM/RMI2/GINS2/TOP2A/BRCA1/EME1/BRIP1/KPNA2/RBBP8/UHRF1/MSH2/MCM6/CDC45/MCM5/FANCD2/POLQ/MCM2/TOPBP1/NSD2/MND1/HMGB2/TRIP13/MCM3/MMS22L/FIGNL1/MCM7/XRCC2/MCM4/RAD54B,41,BP
GO:1903046,meiotic cell cycle process,31/262,138/12185,3.09E-23,9.35E-22,7.81E-22,CDC20/RAD54L/NUF2/ASPM/KIF18A/INCENP/RAD51AP1/NCAPD2/ESPL1/BRCA2/RAD51/CCNB2/PKMYT1/PLK1/FANCA/TOP2A/EME1/BRIP1/NDC80/NCAPH/AURKA/FANCD2/SGO1/SMC4/MND1/TRIP13/CDC25C/PTTG1/TTK/FIGNL1/RAD54B,31,BP
GO:0090329,regulation of DNA-templated DNA replication,20/262,43/12185,1.33E-22,3.96E-21,3.31E-21,CDC7/TIMELESS/RFC5/RFC3/TIPIN/TICRR/BLM/CHTF18/CDT1/MCM6/MCM5/MCM2/RFC4/GMNN/MCM3/RFC2/DBF4/MCM7/MCM4/DSCC1,20,BP
GO:0032392,DNA geometric change,25/262,83/12185,2.32E-22,6.79E-21,5.68E-21,DNA2/DDX11/RFC5/RFC3/RAD51/PIF1/BLM/CHTF18/GINS2/TOP2A/BRIP1/MCM6/GINS1/CDC45/MCM5/POLQ/MCM2/RFC4/HMGB2/MCM3/RFC2/MCM7/MCM4/RAD54B/DSCC1,25,BP
GO:0032508,DNA duplex unwinding,24/262,77/12185,6.59E-22,1.90E-20,1.58E-20,DNA2/DDX11/RFC5/RFC3/RAD51/PIF1/BLM/CHTF18/GINS2/TOP2A/BRIP1/MCM6/GINS1/CDC45/MCM5/POLQ/MCM2/RFC4/MCM3/RFC2/MCM7/MCM4/RAD54B/DSCC1,24,BP
GO:0071103,DNA conformation change,25/262,89/12185,1.61E-21,4.55E-20,3.81E-20,DNA2/DDX11/RFC5/RFC3/RAD51/PIF1/BLM/CHTF18/GINS2/TOP2A/BRIP1/MCM6/GINS1/CDC45/MCM5/POLQ/MCM2/RFC4/HMGB2/MCM3/RFC2/MCM7/MCM4/RAD54B/DSCC1,25,BP
GO:2001251,negative regulation of chromosome organization,25/262,90/12185,2.18E-21,6.09E-20,5.09E-20,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/ESPL1/KNTC1/BUB1B/KNL1/PIF1/ZWILCH/PLK1/AURKB/TOP2A/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/SPDL1/TTK,25,BP
GO:0140013,meiotic nuclear division,28/262,123/12185,3.04E-21,8.36E-20,6.99E-20,CDC20/RAD54L/NUF2/ASPM/KIF18A/INCENP/RAD51AP1/ESPL1/BRCA2/RAD51/CCNB2/PLK1/FANCA/TOP2A/EME1/BRIP1/NDC80/NCAPH/AURKA/FANCD2/SGO1/SMC4/MND1/TRIP13/PTTG1/TTK/FIGNL1/RAD54B,28,BP
GO:0031570,DNA integrity checkpoint signaling,28/262,130/12185,1.53E-20,4.13E-19,3.45E-19,CLSPN/ORC1/DTL/CDK1/DNA2/H2AX/CHEK1/TIMELESS/BRCA2/RAD51/WDR76/RPS27L/TIPIN/TICRR/BLM/PLK1/CDT1/CDC6/BRCA1/EME1/BRIP1/MSH2/E2F1/CDC45/GTSE1/FANCD2/TOPBP1/CDKN1A,28,BP
GO:0006275,regulation of DNA replication,25/262,111/12185,5.92E-19,1.58E-17,1.32E-17,CDC7/CDK1/DNA2/TIMELESS/RFC5/RFC3/TIPIN/TICRR/BLM/CHTF18/CDT1/CDC6/MCM6/MCM5/MCM2/RFC4/CCNA2/GMNN/MCM3/RFC2/DBF4/MCM7/ESCO2/MCM4/DSCC1,25,BP
GO:0000724,double-strand break repair via homologous recombination,28/262,157/12185,3.21E-18,8.37E-17,7.00E-17,AUNIP/RAD54L/CDC7/H2AX/CHEK1/RAD51AP1/TIMELESS/PARPBP/BRCA2/RAD51/BLM/RMI2/GINS2/BRCA1/RBBP8/UHRF1/MCM6/CDC45/MCM5/POLQ/MCM2/MCM3/MMS22L/FIGNL1/MCM7/XRCC2/MCM4/RAD54B,28,BP
GO:0051052,regulation of DNA metabolic process,45/262,452/12185,3.23E-18,8.37E-17,7.00E-17,AUNIP/CDC7/NEK2/CDK1/DNA2/H2AX/CHEK1/FOXM1/RAD51AP1/DDX11/TIMELESS/PARPBP/RFC5/RFC3/RAD51/PIF1/TIPIN/TICRR/BLM/CHTF18/RMI2/CDT1/AURKB/CDC6/BRCA1/KPNA2/MSH2/MCM6/MCM5/POLQ/MCM2/RFC4/NSD2/CCNA2/DEK/GMNN/CDKN1A/MCM3/FIGNL1/RFC2/DBF4/MCM7/ESCO2/MCM4/DSCC1,45,BP
GO:0006270,DNA replication initiation,16/262,35/12185,3.72E-18,9.53E-17,7.96E-17,ORC1/MCM10/POLA2/PRIM1/TICRR/CDT1/CDC6/MCM6/CDC45/MCM5/MCM2/TOPBP1/GMNN/MCM3/MCM7/MCM4,16,BP
GO:0044839,cell cycle G2/M phase transition,27/262,146/12185,4.99E-18,1.26E-16,1.05E-16,CLSPN/ORC1/CDC7/KIF14/DTL/CENPF/CDK1/RRM1/CHEK1/FOXM1/CCNB2/TICRR/BLM/PKMYT1/PLK1/AURKB/CDC6/BRCA1/NDC80/RBBP8/AURKA/TOPBP1/CCNA2/CCNB1/CDC25C/CDKN1A/MELK,27,BP
GO:0000725,recombinational repair,28/262,161/12185,6.45E-18,1.60E-16,1.34E-16,AUNIP/RAD54L/CDC7/H2AX/CHEK1/RAD51AP1/TIMELESS/PARPBP/BRCA2/RAD51/BLM/RMI2/GINS2/BRCA1/RBBP8/UHRF1/MCM6/CDC45/MCM5/POLQ/MCM2/MCM3/MMS22L/FIGNL1/MCM7/XRCC2/MCM4/RAD54B,28,BP
GO:0033260,nuclear DNA replication,16/262,38/12185,1.93E-17,4.73E-16,3.95E-16,CDC7/DNA2/BRCA2/RAD51/TIPIN/BLM/CDT1/TK1/MCM6/GINS1/CDC45/MCM2/GMNN/MCM3/DBF4/MCM4,16,BP
GO:0000086,G2/M transition of mitotic cell cycle,25/262,132/12185,4.98E-17,1.21E-15,1.01E-15,CLSPN/ORC1/CDC7/KIF14/DTL/CENPF/CDK1/RRM1/CHEK1/FOXM1/TICRR/BLM/PKMYT1/PLK1/AURKB/CDC6/BRCA1/RBBP8/AURKA/TOPBP1/CCNA2/CCNB1/CDC25C/CDKN1A/MELK,25,BP
GO:0051225,spindle assembly,24/262,123/12185,1.05E-16,2.52E-15,2.10E-15,CDCA8/CDC20/STIL/SASS6/GPSM2/ASPM/NEK2/KIF11/INCENP/RACGAP1/CENPJ/CCNB2/KIF23/PRC1/PLK1/AURKB/SPAG5/BIRC5/NDC80/TPX2/MYBL2/AURKA/KIFC1/KIF4A,24,BP
GO:0044786,cell cycle DNA replication,16/262,42/12185,1.33E-16,3.15E-15,2.64E-15,CDC7/DNA2/BRCA2/RAD51/TIPIN/BLM/CDT1/TK1/MCM6/GINS1/CDC45/MCM2/GMNN/MCM3/DBF4/MCM4,16,BP
GO:0140694,non-membrane-bounded organelle assembly,39/262,375/12185,1.67E-16,3.89E-15,3.25E-15,CDCA8/CDC20/STIL/SASS6/GPSM2/ASPM/NEK2/CENPF/KIF11/INCENP/RACGAP1/KNTC1/CENPJ/DLGAP5/CEP152/CCNB2/RPS27L/KIF23/PRC1/PLK1/AURKB/SPAG5/BRCA1/BIRC5/NDC80/RTTN/WDR62/CENPA/TPX2/MYBL2/AURKA/CENPE/PLK4/CENPK/CENPH/KIFC1/CENPW/ANLN/KIF4A,39,BP
GO:0061982,meiosis I cell cycle process,20/262,81/12185,3.14E-16,7.24E-15,6.05E-15,CDC20/RAD54L/RAD51AP1/ESPL1/BRCA2/RAD51/CCNB2/PKMYT1/PLK1/TOP2A/EME1/BRIP1/NDC80/AURKA/FANCD2/MND1/TRIP13/CDC25C/PTTG1/RAD54B,20,BP
GO:1902749,regulation of cell cycle G2/M phase transition,22/262,107/12185,6.49E-16,1.48E-14,1.23E-14,CLSPN/ORC1/CDC7/KIF14/DTL/CENPF/CDK1/RRM1/CHEK1/TICRR/BLM/PKMYT1/PLK1/AURKB/CDC6/BRCA1/RBBP8/AURKA/TOPBP1/CCNB1/CDC25C/CDKN1A,22,BP
GO:0010389,regulation of G2/M transition of mitotic cell cycle,21/262,96/12185,7.99E-16,1.79E-14,1.50E-14,CLSPN/ORC1/CDC7/KIF14/DTL/CENPF/CDK1/RRM1/CHEK1/TICRR/BLM/PLK1/AURKB/CDC6/BRCA1/RBBP8/AURKA/TOPBP1/CCNB1/CDC25C/CDKN1A,21,BP
GO:0051656,establishment of organelle localization,39/262,402/12185,1.76E-15,3.90E-14,3.26E-14,CDCA8/KIF2C/GPSM2/PSRC1/NUF2/KIF14/NEK2/CENPF/KIF18A/INCENP/CDCA5/RACGAP1/ESPL1/KNTC1/KNSTRN/KNL1/NUSAP1/ZWILCH/PLK1/CDT1/AURKB/SPAG5/BIRC5/NDC80/LMNB2/SPC24/CENPA/SPC25/DSN1/FAM83D/SGO1/ECT2/CENPE/MAD2L1/CCNB1/LMNB1/SPDL1/KIFC1/SAPCD2,39,BP
GO:0051988,regulation of attachment of spindle microtubules to kinetochore,12/262,21/12185,1.88E-15,4.13E-14,3.45E-14,CDCA8/NEK2/INCENP/RACGAP1/KNTC1/KNSTRN/ZWILCH/AURKB/SPAG5/BIRC5/ECT2/CCNB1,12,BP
GO:1905820,positive regulation of chromosome separation,13/262,28/12185,4.39E-15,9.50E-14,7.95E-14,CDCA8/CDC20/INCENP/NCAPD2/ESPL1/DLGAP5/AURKB/BIRC5/NCAPH/UBE2C/SMC4/NCAPG/NCAPG2,13,BP
GO:0000077,DNA damage checkpoint signaling,22/262,121/12185,9.89E-15,2.12E-13,1.77E-13,CLSPN/DTL/CDK1/H2AX/CHEK1/BRCA2/RAD51/WDR76/RPS27L/TIPIN/TICRR/BLM/PLK1/BRCA1/EME1/BRIP1/MSH2/E2F1/GTSE1/FANCD2/TOPBP1/CDKN1A,22,BP
GO:0034508,centromere complex assembly,13/262,30/12185,1.35E-14,2.86E-13,2.39E-13,NASP/CENPF/KNTC1/DLGAP5/OIP5/CENPO/CENPA/HJURP/CENPE/CENPK/CENPH/CENPW/CENPI,13,BP
GO:0007080,mitotic metaphase chromosome alignment,16/262,55/12185,1.86E-14,3.89E-13,3.25E-13,CDCA8/KIF2C/PSRC1/NUF2/KIF14/KIF18A/INCENP/CDCA5/CDT1/AURKB/BIRC5/NDC80/CENPE/CCNB1/SPDL1/KIFC1,16,BP
GO:0045132,meiotic chromosome segregation,16/262,57/12185,3.48E-14,7.20E-13,6.02E-13,NUF2/ASPM/ESPL1/CCNB2/PLK1/BRIP1/NDC80/NCAPH/AURKA/FANCD2/SGO1/SMC4/MND1/TRIP13/PTTG1/TTK,16,BP
GO:0000727,double-strand break repair via break-induced replication,9/262,11/12185,4.54E-14,9.29E-13,7.77E-13,CDC7/GINS2/MCM6/CDC45/MCM5/MCM2/MCM3/MCM7/MCM4,9,BP
GO:0051984,positive regulation of chromosome segregation,12/262,26/12185,5.62E-14,1.14E-12,9.51E-13,CDCA8/CDK1/INCENP/NCAPD2/AURKB/CDC6/BIRC5/NCAPH/SMC4/NCAPG/CCNB1/NCAPG2,12,BP
GO:0006268,DNA unwinding involved in DNA replication,11/262,21/12185,1.07E-13,2.13E-12,1.78E-12,RAD51/BLM/GINS2/MCM6/GINS1/CDC45/MCM5/MCM2/MCM3/MCM7/MCM4,11,BP
GO:0051383,kinetochore organization,11/262,21/12185,1.07E-13,2.13E-12,1.78E-12,NUF2/CENPF/KNTC1/DLGAP5/NDC80/CENPA/SMC4/CENPE/CENPK/CENPH/CENPW,11,BP
GO:0000281,mitotic cytokinesis,18/262,84/12185,1.44E-13,2.79E-12,2.34E-12,CDCA8/IQGAP3/KIF20B/CEP55/INCENP/RACGAP1/ESPL1/CIT/NUSAP1/KIF23/PLK1/AURKB/BIRC5/CENPA/ECT2/KIF20A/ANLN/KIF4A,18,BP
GO:0044774,mitotic DNA integrity checkpoint signaling,18/262,84/12185,1.44E-13,2.79E-12,2.34E-12,CLSPN/ORC1/DTL/CDK1/CHEK1/RPS27L/TIPIN/TICRR/BLM/PLK1/CDC6/BRCA1/EME1/MSH2/GTSE1/FANCD2/TOPBP1/CDKN1A,18,BP
GO:0051231,spindle elongation,9/262,12/12185,1.78E-13,3.42E-12,2.86E-12,CDCA8/KIF11/INCENP/RACGAP1/KIF23/PRC1/AURKB/BIRC5/KIF4A,9,BP
GO:0007127,meiosis I,17/262,75/12185,2.60E-13,4.94E-12,4.13E-12,RAD54L/RAD51AP1/ESPL1/BRCA2/RAD51/CCNB2/PLK1/TOP2A/EME1/BRIP1/NDC80/AURKA/FANCD2/MND1/TRIP13/PTTG1/RAD54B,17,BP
GO:0035825,homologous recombination,14/262,45/12185,2.94E-13,5.53E-12,4.62E-12,RAD54L/RAD51AP1/RAD51/TOP2A/BRCA1/EME1/BRIP1/RBBP8/UHRF1/FANCD2/TOPBP1/MND1/TRIP13/RAD54B,14,BP
GO:0000076,DNA replication checkpoint signaling,10/262,17/12185,3.03E-13,5.64E-12,4.72E-12,CLSPN/ORC1/DNA2/TIMELESS/TIPIN/TICRR/CDT1/CDC6/CDC45/TOPBP1,10,BP
GO:0007098,centrosome cycle,21/262,128/12185,3.40E-13,6.27E-12,5.24E-12,STIL/SASS6/NEK2/CDK1/KIF11/CHEK1/CENPJ/BRCA2/CEP152/PCLAF/CCNF/PLK1/BRCA1/NDC80/RTTN/WDR62/CEP250/AURKA/SGO1/PLK4/XRCC2,21,BP
GO:0000910,cytokinesis,23/262,166/12185,9.90E-13,1.81E-11,1.51E-11,CDCA8/IQGAP3/KIF14/KIF20B/CEP55/INCENP/RACGAP1/ESPL1/CIT/BRCA2/NUSAP1/KIF23/PRC1/PLK1/AURKB/CDC6/BIRC5/CENPA/AURKA/ECT2/KIF20A/ANLN/KIF4A,23,BP
GO:0030174,regulation of DNA-templated DNA replication initiation,9/262,14/12185,1.56E-12,2.82E-11,2.36E-11,TICRR/CDT1/MCM6/MCM5/MCM2/GMNN/MCM3/MCM7/MCM4,9,BP
GO:0000022,mitotic spindle elongation,8/262,10/12185,1.78E-12,3.19E-11,2.66E-11,CDCA8/INCENP/RACGAP1/KIF23/PRC1/AURKB/BIRC5/KIF4A,8,BP
GO:0031023,microtubule organizing center organization,21/262,140/12185,2.08E-12,3.68E-11,3.08E-11,STIL/SASS6/NEK2/CDK1/KIF11/CHEK1/CENPJ/BRCA2/CEP152/PCLAF/CCNF/PLK1/BRCA1/NDC80/RTTN/WDR62/CEP250/AURKA/SGO1/PLK4/XRCC2,21,BP
GO:0006271,DNA strand elongation involved in DNA replication,9/262,15/12185,3.83E-12,6.72E-11,5.62E-11,DNA2/POLD3/POLE/RFC3/GINS1/RFC4/MCM3/MCM7/MCM4,9,BP
GO:0042770,signal transduction in response to DNA damage,23/262,179/12185,4.94E-12,8.58E-11,7.17E-11,CLSPN/DTL/CDK1/H2AX/CHEK1/FOXM1/BRCA2/RAD51/WDR76/RPS27L/TIPIN/TICRR/BLM/PLK1/BRCA1/EME1/BRIP1/MSH2/E2F1/GTSE1/FANCD2/TOPBP1/CDKN1A,23,BP
GO:1902750,negative regulation of cell cycle G2/M phase transition,15/262,65/12185,5.17E-12,8.89E-11,7.44E-11,CLSPN/ORC1/DTL/CDK1/CHEK1/TICRR/BLM/PKMYT1/PLK1/AURKB/CDC6/BRCA1/RBBP8/TOPBP1/CDKN1A,15,BP
GO:0010639,negative regulation of organelle organization,30/262,314/12185,6.09E-12,1.04E-10,8.68E-11,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/CHEK1/ESPL1/KNTC1/BUB1B/KNL1/PIF1/ZWILCH/CCNF/PLK1/AURKB/TOP2A/BRCA1/BIRC5/NDC80/SPC24/BUB1/SPC25/TPX2/MAD2L1/TRIP13/CCNB1/SPDL1/TTK/KIF24,30,BP
GO:0032465,regulation of cytokinesis,16/262,78/12185,6.90E-12,1.17E-10,9.75E-11,CDCA8/KIF14/KIF20B/INCENP/RACGAP1/CIT/BRCA2/KIF23/PRC1/PLK1/AURKB/CDC6/BIRC5/AURKA/ECT2/KIF20A,16,BP
GO:0090307,mitotic spindle assembly,15/262,67/12185,8.29E-12,1.39E-10,1.16E-10,CDCA8/CDC20/NEK2/KIF11/INCENP/RACGAP1/KIF23/PRC1/PLK1/AURKB/BIRC5/TPX2/MYBL2/KIFC1/KIF4A,15,BP
GO:1902969,mitotic DNA replication,9/262,16/12185,8.60E-12,1.43E-10,1.19E-10,BRCA2/RAD51/TK1/MCM6/GINS1/CDC45/MCM2/MCM3/MCM4,9,BP
GO:0044773,mitotic DNA damage checkpoint signaling,16/262,80/12185,1.04E-11,1.71E-10,1.43E-10,CLSPN/DTL/CDK1/CHEK1/RPS27L/TIPIN/TICRR/BLM/PLK1/BRCA1/EME1/MSH2/GTSE1/FANCD2/TOPBP1/CDKN1A,16,BP
GO:0061640,cytoskeleton-dependent cytokinesis,18/262,108/12185,1.33E-11,2.17E-10,1.81E-10,CDCA8/IQGAP3/KIF20B/CEP55/INCENP/RACGAP1/ESPL1/CIT/NUSAP1/KIF23/PLK1/AURKB/BIRC5/CENPA/ECT2/KIF20A/ANLN/KIF4A,18,BP
GO:1901992,positive regulation of mitotic cell cycle phase transition,16/262,82/12185,1.55E-11,2.50E-10,2.09E-10,CDC20/STIL/CDC7/SASS6/DTL/CDK1/RRM1/CDCA5/ESPL1/CENPJ/DLGAP5/CDC6/RRM2/UBE2C/CCNB1/CDC25C,16,BP
GO:0045931,positive regulation of mitotic cell cycle,18/262,109/12185,1.56E-11,2.50E-10,2.09E-10,CDC20/STIL/CDC7/SASS6/DTL/CDK1/RRM1/CDCA5/ESPL1/CENPJ/BRCA2/DLGAP5/CDC6/RRM2/UBE2C/AURKA/CCNB1/CDC25C,18,BP
GO:0065004,protein-DNA complex assembly,22/262,172/12185,1.61E-11,2.55E-10,2.13E-10,NASP/CENPF/H2AX/KNTC1/DLGAP5/RAD51/OIP5/CDT1/CHAF1A/CENPO/CENPA/HJURP/CHAF1B/CDC45/MCM2/CENPE/HMGB2/CENPK/CENPH/GMNN/CENPW/CENPI,22,BP
GO:0051255,spindle midzone assembly,8/262,12/12185,1.89E-11,2.97E-10,2.49E-10,CDCA8/INCENP/RACGAP1/KIF23/PRC1/AURKB/BIRC5/KIF4A,8,BP
GO:1901989,positive regulation of cell cycle phase transition,17/262,99/12185,3.05E-11,4.76E-10,3.98E-10,CDC20/STIL/CDC7/SASS6/DTL/CDK1/RRM1/CDCA5/ESPL1/CENPJ/DLGAP5/CDC6/RRM2/FAM83D/UBE2C/CCNB1/CDC25C,17,BP
GO:0010972,negative regulation of G2/M transition of mitotic cell cycle,14/262,62/12185,3.70E-11,5.72E-10,4.78E-10,CLSPN/ORC1/DTL/CDK1/CHEK1/TICRR/BLM/PLK1/AURKB/CDC6/BRCA1/RBBP8/TOPBP1/CDKN1A,14,BP
GO:0044818,mitotic G2/M transition checkpoint,13/262,52/12185,4.70E-11,7.15E-10,5.98E-10,CLSPN/ORC1/DTL/CDK1/CHEK1/TICRR/BLM/PLK1/CDC6/BRCA1/RBBP8/TOPBP1/CDKN1A,13,BP
GO:0045005,DNA-templated DNA replication maintenance of fidelity,13/262,52/12185,4.70E-11,7.15E-10,5.98E-10,DNA2/DDX11/TIMELESS/POLE/BRCA2/RAD51/TIPIN/BLM/BRCA1/EME1/RBBP8/TRAIP/MMS22L,13,BP
GO:1901976,regulation of cell cycle checkpoint,12/262,43/12185,6.45E-11,9.73E-10,8.14E-10,CDCA8/INCENP/BRCA2/KNL1/RAD51/WDR76/AURKB/BRCA1/BIRC5/NDC80/MAD2L1/CCNB1,12,BP
GO:0032467,positive regulation of cytokinesis,11/262,34/12185,6.81E-11,1.02E-09,8.52E-10,CDCA8/KIF14/KIF20B/INCENP/RACGAP1/CIT/KIF23/AURKB/CDC6/BIRC5/ECT2,11,BP
GO:0071897,DNA biosynthetic process,21/262,174/12185,1.44E-10,2.13E-09,1.78E-09,NEK2/DTL/CENPF/RRM1/POLD3/CHEK1/RFC5/POLE/RFC3/POLE2/PCLAF/PIF1/CHTF18/AURKB/TK1/POLQ/RFC4/CCNA2/CDKN1A/RFC2/DSCC1,21,BP
GO:0051302,regulation of cell division,19/262,141/12185,1.64E-10,2.42E-09,2.02E-09,CDCA8/ASPM/KIF14/KIF20B/INCENP/RACGAP1/CIT/BRCA2/KIF23/BLM/PRC1/PLK1/AURKB/CDC6/KIF18B/BIRC5/AURKA/ECT2/KIF20A,19,BP
GO:0051315,attachment of mitotic spindle microtubules to kinetochore,9/262,21/12185,2.01E-10,2.94E-09,2.46E-09,CDCA8/KIF2C/NUF2/INCENP/CDT1/AURKB/BIRC5/NDC80/CENPE,9,BP
GO:0044843,cell cycle G1/S phase transition,23/262,223/12185,4.51E-10,6.54E-09,5.47E-09,E2F2/STIL/CDKN2C/CDC7/SASS6/IQGAP3/KIF14/CDK1/RRM1/POLE/CENPJ/CDKN3/RPS27L/CDC6/RBBP8/RRM2/E2F1/RBL1/FAM83D/GTSE1/CCNA2/CDKN1A/DBF4,23,BP
GO:0000082,G1/S transition of mitotic cell cycle,22/262,205/12185,5.12E-10,7.37E-09,6.16E-09,E2F2/STIL/CDKN2C/CDC7/SASS6/IQGAP3/KIF14/CDK1/RRM1/POLE/CENPJ/CDKN3/RPS27L/CDC6/RBBP8/RRM2/E2F1/RBL1/GTSE1/CCNA2/CDKN1A/DBF4,22,BP
GO:0051382,kinetochore assembly,8/262,17/12185,8.45E-10,1.20E-08,1.00E-08,CENPF/KNTC1/DLGAP5/CENPA/CENPE/CENPK/CENPH/CENPW,8,BP
GO:1901970,positive regulation of mitotic sister chromatid separation,8/262,17/12185,8.45E-10,1.20E-08,1.00E-08,CDCA8/CDC20/INCENP/ESPL1/DLGAP5/AURKB/BIRC5/UBE2C,8,BP
GO:0010212,response to ionizing radiation,17/262,128/12185,1.95E-09,2.74E-08,2.29E-08,RAD54L/RRM1/H2AX/RAD51AP1/BRCA2/RAD51/TICRR/BLM/BRCA1/MSH2/FANCD2/TOPBP1/ECT2/CDKN1A/FIGNL1/XRCC2/RAD54B,17,BP
GO:0030261,chromosome condensation,10/262,35/12185,2.04E-09,2.84E-08,2.37E-08,CDK1/CDCA5/NCAPD2/NUSAP1/PLK1/TOP2A/NCAPH/SMC4/NCAPG/NCAPG2,10,BP
GO:0031297,replication fork processing,11/262,46/12185,2.52E-09,3.43E-08,2.86E-08,DNA2/DDX11/BRCA2/RAD51/TIPIN/BLM/BRCA1/EME1/RBBP8/TRAIP/MMS22L,11,BP
GO:0090231,regulation of spindle checkpoint,8/262,19/12185,2.53E-09,3.43E-08,2.86E-08,CDCA8/INCENP/KNL1/AURKB/BIRC5/NDC80/MAD2L1/CCNB1,8,BP
GO:0090266,regulation of mitotic cell cycle spindle assembly checkpoint,8/262,19/12185,2.53E-09,3.43E-08,2.86E-08,CDCA8/INCENP/KNL1/AURKB/BIRC5/NDC80/MAD2L1/CCNB1,8,BP
GO:1903504,regulation of mitotic spindle checkpoint,8/262,19/12185,2.53E-09,3.43E-08,2.86E-08,CDCA8/INCENP/KNL1/AURKB/BIRC5/NDC80/MAD2L1/CCNB1,8,BP
GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,13/262,72/12185,3.57E-09,4.81E-08,4.02E-08,CDKN2C/PSRC1/CDKN3/CCNB2/BLM/CCNF/PKMYT1/PLK1/CDC6/CCNA2/CCNB1/CDC25C/CDKN1A,13,BP
GO:0007095,mitotic G2 DNA damage checkpoint signaling,10/262,37/12185,3.72E-09,4.89E-08,4.09E-08,CLSPN/DTL/CDK1/CHEK1/TICRR/BLM/PLK1/BRCA1/TOPBP1/CDKN1A,10,BP
GO:0007131,reciprocal meiotic recombination,10/262,37/12185,3.72E-09,4.89E-08,4.09E-08,RAD54L/RAD51AP1/RAD51/TOP2A/EME1/BRIP1/FANCD2/MND1/TRIP13/RAD54B,10,BP
GO:0140527,reciprocal homologous recombination,10/262,37/12185,3.72E-09,4.89E-08,4.09E-08,RAD54L/RAD51AP1/RAD51/TOP2A/EME1/BRIP1/FANCD2/MND1/TRIP13/RAD54B,10,BP
GO:1904029,regulation of cyclin-dependent protein kinase activity,13/262,74/12185,5.08E-09,6.63E-08,5.55E-08,CDKN2C/PSRC1/CDKN3/CCNB2/BLM/CCNF/PKMYT1/PLK1/CDC6/CCNA2/CCNB1/CDC25C/CDKN1A,13,BP
GO:0071459,"protein localization to chromosome, centromeric region",9/262,29/12185,5.89E-09,7.64E-08,6.39E-08,CDK1/KNTC1/BUB1B/KNL1/ZWILCH/AURKB/CENPA/SPDL1/TTK,9,BP
GO:0051653,spindle localization,11/262,51/12185,8.20E-09,1.06E-07,8.83E-08,GPSM2/ASPM/ESPL1/NUSAP1/PLK1/SPAG5/NDC80/CENPA/MAD2L1/SPDL1/SAPCD2,11,BP
GO:0034501,protein localization to kinetochore,7/262,15/12185,1.09E-08,1.38E-07,1.16E-07,CDK1/KNTC1/KNL1/ZWILCH/AURKB/SPDL1/TTK,7,BP
GO:1903083,protein localization to condensed chromosome,7/262,15/12185,1.09E-08,1.38E-07,1.16E-07,CDK1/KNTC1/KNL1/ZWILCH/AURKB/SPDL1/TTK,7,BP
GO:0051054,positive regulation of DNA metabolic process,23/262,263/12185,1.12E-08,1.41E-07,1.18E-07,CDC7/NEK2/CDK1/DNA2/H2AX/FOXM1/RAD51AP1/DDX11/TIMELESS/RFC5/RFC3/RAD51/CHTF18/CDT1/AURKB/BRCA1/MSH2/RFC4/NSD2/CCNA2/RFC2/DBF4/DSCC1,23,BP
GO:0007062,sister chromatid cohesion,11/262,53/12185,1.26E-08,1.58E-07,1.32E-07,CDC20/CDCA5/DDX11/ESPL1/BUB1B/PLK1/BUB1/SGO2/SGO1/ESCO2/DSCC1,11,BP
GO:0031055,chromatin remodeling at centromere,6/262,10/12185,1.82E-08,2.24E-07,1.87E-07,NASP/OIP5/CENPA/HJURP/CENPW/CENPI,6,BP
GO:0034080,CENP-A containing chromatin assembly,6/262,10/12185,1.82E-08,2.24E-07,1.87E-07,NASP/OIP5/CENPA/HJURP/CENPW/CENPI,6,BP
GO:0044771,meiotic cell cycle phase transition,6/262,10/12185,1.82E-08,2.24E-07,1.87E-07,CDC20/CCNB2/PKMYT1/NDC80/CDC25C/TTK,6,BP
GO:0090224,regulation of spindle organization,10/262,44/12185,2.32E-08,2.83E-07,2.37E-07,STIL/SASS6/GPSM2/PSRC1/CENPJ/BORA/PLK1/SPAG5/TPX2/TACC3,10,BP
GO:0034502,protein localization to chromosome,14/262,99/12185,2.38E-08,2.88E-07,2.41E-07,CDK1/KNTC1/BRCA2/BUB1B/KNL1/ZWILCH/PLK1/AURKB/CENPA/MSH2/SPDL1/TTK/MMS22L/ESCO2,14,BP
GO:0022616,DNA strand elongation,9/262,35/12185,3.71E-08,4.44E-07,3.71E-07,DNA2/POLD3/POLE/RFC3/GINS1/RFC4/MCM3/MCM7/MCM4,9,BP
GO:0040001,establishment of mitotic spindle localization,9/262,35/12185,3.71E-08,4.44E-07,3.71E-07,GPSM2/ESPL1/NUSAP1/PLK1/NDC80/CENPA/MAD2L1/SPDL1/SAPCD2,9,BP
GO:0051293,establishment of spindle localization,10/262,47/12185,4.57E-08,5.44E-07,4.54E-07,GPSM2/ESPL1/NUSAP1/PLK1/SPAG5/NDC80/CENPA/MAD2L1/SPDL1/SAPCD2,10,BP
GO:0090232,positive regulation of spindle checkpoint,6/262,12/12185,7.74E-08,9.08E-07,7.59E-07,CDCA8/INCENP/AURKB/BIRC5/NDC80/MAD2L1,6,BP
GO:0090267,positive regulation of mitotic cell cycle spindle assembly checkpoint,6/262,12/12185,7.74E-08,9.08E-07,7.59E-07,CDCA8/INCENP/AURKB/BIRC5/NDC80/MAD2L1,6,BP
GO:0007076,mitotic chromosome condensation,7/262,19/12185,7.93E-08,9.24E-07,7.73E-07,CDCA5/NCAPD2/NUSAP1/PLK1/NCAPH/SMC4/NCAPG,7,BP
GO:0036297,interstrand cross-link repair,9/262,38/12185,8.09E-08,9.38E-07,7.84E-07,FIRRM/RAD51AP1/RAD51/FANCI/FANCA/FANCD2/NEIL3/FANCE/FANCG,9,BP
GO:0007143,female meiotic nuclear division,8/262,28/12185,8.79E-08,1.01E-06,8.46E-07,CCNB2/PLK1/TOP2A/NDC80/NCAPH/AURKA/TRIP13/TTK,8,BP
GO:0009314,response to radiation,25/262,343/12185,9.54E-08,1.09E-06,9.13E-07,RAD54L/DTL/RRM1/POLD3/H2AX/RAD51AP1/BRCA2/RAD51/PCLAF/TIPIN/TICRR/BLM/AURKB/BRCA1/MSH2/CEP250/FANCD2/TOPBP1/ECT2/CDKN1A/FIGNL1/XRCC2/PBK/RAD54B/FANCG,25,BP
GO:0051781,positive regulation of cell division,11/262,64/12185,9.99E-08,1.14E-06,9.50E-07,CDCA8/KIF14/KIF20B/INCENP/RACGAP1/CIT/KIF23/AURKB/CDC6/BIRC5/ECT2,11,BP
GO:0060236,regulation of mitotic spindle organization,9/262,40/12185,1.31E-07,1.48E-06,1.24E-06,STIL/SASS6/GPSM2/PSRC1/CENPJ/BORA/PLK1/TPX2/TACC3,9,BP
GO:0051053,negative regulation of DNA metabolic process,14/262,114/12185,1.47E-07,1.65E-06,1.38E-06,AUNIP/CHEK1/TIMELESS/PARPBP/PIF1/TIPIN/BLM/RMI2/CDT1/CDC6/MSH2/POLQ/GMNN/CDKN1A,14,BP
GO:0051298,centrosome duplication,11/262,70/12185,2.59E-07,2.90E-06,2.42E-06,STIL/SASS6/CENPJ/BRCA2/CEP152/CCNF/BRCA1/NDC80/RTTN/WDR62/PLK4,11,BP
GO:0051294,establishment of spindle orientation,8/262,35/12185,5.84E-07,6.48E-06,5.42E-06,GPSM2/PLK1/SPAG5/NDC80/CENPA/MAD2L1/SPDL1/SAPCD2,8,BP
GO:0070192,chromosome organization involved in meiotic cell cycle,8/262,37/12185,9.24E-07,1.02E-05,8.52E-06,NCAPD2/RAD51/BRIP1/NCAPH/FANCD2/SMC4/MND1/TRIP13,8,BP
GO:1901978,positive regulation of cell cycle checkpoint,6/262,18/12185,1.39E-06,1.53E-05,1.28E-05,CDCA8/INCENP/AURKB/BIRC5/NDC80/MAD2L1,6,BP
GO:0007099,centriole replication,8/262,39/12185,1.42E-06,1.55E-05,1.29E-05,STIL/SASS6/CENPJ/CEP152/BRCA1/RTTN/WDR62/PLK4,8,BP
GO:0032886,regulation of microtubule-based process,18/262,223/12185,1.50E-06,1.63E-05,1.36E-05,STIL/SASS6/GPSM2/PSRC1/KIF18A/SKA3/CENPJ/BORA/CCNF/PLK1/SPAG5/BRCA1/SKA1/WDR62/TPX2/AURKA/TACC3/PLK4,18,BP
GO:0051987,positive regulation of attachment of spindle microtubules to kinetochore,5/262,11/12185,1.84E-06,1.98E-05,1.66E-05,CDCA8/INCENP/AURKB/BIRC5/CCNB1,5,BP
GO:2000779,regulation of double-strand break repair,13/262,122/12185,2.13E-06,2.28E-05,1.91E-05,AUNIP/CHEK1/FOXM1/RAD51AP1/DDX11/TIMELESS/PARPBP/RAD51/RMI2/POLQ/NSD2/DEK/FIGNL1,13,BP
GO:0032506,cytokinetic process,8/262,42/12185,2.57E-06,2.72E-05,2.28E-05,IQGAP3/KIF20B/CEP55/RACGAP1/AURKB/ECT2/KIF20A/ANLN,8,BP
GO:0098534,centriole assembly,8/262,42/12185,2.57E-06,2.72E-05,2.28E-05,STIL/SASS6/CENPJ/CEP152/BRCA1/RTTN/WDR62/PLK4,8,BP
GO:0000132,establishment of mitotic spindle orientation,7/262,30/12185,2.62E-06,2.75E-05,2.30E-05,GPSM2/PLK1/NDC80/CENPA/MAD2L1/SPDL1/SAPCD2,7,BP
GO:0000018,regulation of DNA recombination,12/262,106/12185,2.78E-06,2.91E-05,2.43E-05,CHEK1/RAD51AP1/TIMELESS/PARPBP/RAD51/BLM/RMI2/KPNA2/MSH2/POLQ/NSD2/FIGNL1,12,BP
GO:2000278,regulation of DNA biosynthetic process,12/262,108/12185,3.39E-06,3.53E-05,2.95E-05,NEK2/CHEK1/RFC5/RFC3/PIF1/CHTF18/AURKB/RFC4/CCNA2/CDKN1A/RFC2/DSCC1,12,BP
GO:0022412,cellular process involved in reproduction in multicellular organism,19/262,263/12185,4.00E-06,4.14E-05,3.46E-05,ASPM/KIF18A/BRCA2/KNL1/CCNB2/PLK1/FANCA/TOP2A/BRIP1/NDC80/MSH2/NCAPH/AURKA/HMGB2/TRIP13/TTK/FIGNL1/DPY19L2P2/FANCG,19,BP
GO:0060623,regulation of chromosome condensation,5/262,13/12185,4.94E-06,5.06E-05,4.23E-05,NCAPD2/NCAPH/SMC4/NCAPG/NCAPG2,5,BP
GO:0090235,regulation of metaphase plate congression,5/262,13/12185,4.94E-06,5.06E-05,4.23E-05,CDCA8/INCENP/AURKB/SPAG5/BIRC5,5,BP
GO:0045143,homologous chromosome segregation,7/262,34/12185,6.42E-06,6.53E-05,5.46E-05,ESPL1/PLK1/BRIP1/FANCD2/MND1/TRIP13/PTTG1,7,BP
GO:1902806,regulation of cell cycle G1/S phase transition,14/262,160/12185,8.95E-06,9.06E-05,7.57E-05,STIL/CDKN2C/SASS6/KIF14/RRM1/CENPJ/RPS27L/CDC6/RRM2/E2F1/RBL1/FAM83D/GTSE1/CDKN1A,14,BP
GO:0071479,cellular response to ionizing radiation,9/262,65/12185,9.56E-06,9.57E-05,8.00E-05,H2AX/RAD51AP1/BRCA2/RAD51/BLM/BRCA1/ECT2/CDKN1A/FIGNL1,9,BP
GO:2000573,positive regulation of DNA biosynthetic process,9/262,65/12185,9.56E-06,9.57E-05,8.00E-05,NEK2/RFC5/RFC3/CHTF18/AURKB/RFC4/CCNA2/RFC2/DSCC1,9,BP
GO:0010638,positive regulation of organelle organization,25/262,443/12185,1.03E-05,0.000102556,8.57E-05,CDC20/STIL/SASS6/GPSM2/PSRC1/NEK2/CDK1/RAD51AP1/NCAPD2/DDX11/ESPL1/CENPJ/DLGAP5/NUSAP1/AURKB/SPAG5/NCAPH/BUB1/UBE2C/AURKA/SMC4/NCAPG/PLK4/NCAPG2/WDR45,25,BP
GO:0000731,DNA synthesis involved in DNA repair,7/262,37/12185,1.16E-05,0.000115158,9.63E-05,DTL/RRM1/POLD3/POLE/RFC3/POLE2/PCLAF,7,BP
GO:0046605,regulation of centrosome cycle,8/262,51/12185,1.17E-05,0.000115651,9.67E-05,STIL/SASS6/CENPJ/CCNF/BRCA1/WDR62/AURKA/PLK4,8,BP
GO:2000045,regulation of G1/S transition of mitotic cell cycle,13/262,143/12185,1.24E-05,0.000121717,0.000101761,STIL/CDKN2C/SASS6/KIF14/RRM1/CENPJ/RPS27L/CDC6/RRM2/E2F1/RBL1/GTSE1/CDKN1A,13,BP
GO:0051347,positive regulation of transferase activity,20/262,314/12185,1.47E-05,0.00014282,0.000119404,CLSPN/CDC20/PSRC1/KIF14/NEK2/RFC5/RFC3/BORA/CHTF18/PLK1/AURKB/UBE2S/TPX2/UBE2C/ECT2/RFC4/CENPE/CDKN1A/RFC2/DSCC1,20,BP
GO:0051785,positive regulation of nuclear division,7/262,39/12185,1.67E-05,0.000162349,0.000135731,CDC20/RAD51AP1/ESPL1/DLGAP5/NUSAP1/UBE2C/AURKA,7,BP
GO:0000212,meiotic spindle organization,5/262,17/12185,2.22E-05,0.00021251,0.000177669,ASPM/ESPL1/CCNB2/NDC80/AURKA,5,BP
GO:1904666,regulation of ubiquitin protein ligase activity,5/262,17/12185,2.22E-05,0.00021251,0.000177669,CDC20/PLK1/UBE2S/UBE2C/MAD2L1,5,BP
GO:0010971,positive regulation of G2/M transition of mitotic cell cycle,6/262,28/12185,2.36E-05,0.000225424,0.000188465,CDC7/DTL/CDK1/RRM1/CCNB1/CDC25C,6,BP
GO:0070507,regulation of microtubule cytoskeleton organization,13/262,152/12185,2.39E-05,0.000227325,0.000190055,STIL/SASS6/GPSM2/PSRC1/KIF18A/SKA3/CENPJ/BORA/PLK1/SPAG5/SKA1/TPX2/TACC3,13,BP
GO:0006282,regulation of DNA repair,15/262,200/12185,2.73E-05,0.000258309,0.000215959,AUNIP/H2AX/CHEK1/FOXM1/RAD51AP1/DDX11/TIMELESS/PARPBP/RAD51/RMI2/BRCA1/POLQ/NSD2/DEK/FIGNL1,15,BP
GO:0045840,positive regulation of mitotic nuclear division,6/262,30/12185,3.59E-05,0.000337448,0.000282123,CDC20/ESPL1/DLGAP5/NUSAP1/UBE2C/AURKA,6,BP
GO:0044837,actomyosin contractile ring organization,4/262,10/12185,3.96E-05,0.000368563,0.000308137,IQGAP3/RACGAP1/ECT2/ANLN,4,BP
GO:0072711,cellular response to hydroxyurea,4/262,10/12185,3.96E-05,0.000368563,0.000308137,DDX11/TIMELESS/RAD51/BLM,4,BP
GO:0007064,mitotic sister chromatid cohesion,6/262,31/12185,4.37E-05,0.000400733,0.000335032,CDC20/CDCA5/BUB1/SGO1/ESCO2/DSCC1,6,BP
GO:0090169,regulation of spindle assembly,6/262,31/12185,4.37E-05,0.000400733,0.000335032,STIL/SASS6/GPSM2/CENPJ/PLK1/SPAG5,6,BP
GO:1902751,positive regulation of cell cycle G2/M phase transition,6/262,31/12185,4.37E-05,0.000400733,0.000335032,CDC7/DTL/CDK1/RRM1/CCNB1/CDC25C,6,BP
GO:0008156,negative regulation of DNA replication,5/262,20/12185,5.26E-05,0.000480007,0.000401309,TIMELESS/TIPIN/CDT1/CDC6/GMNN,5,BP
GO:0051445,regulation of meiotic cell cycle,7/262,47/12185,5.91E-05,0.000536569,0.000448597,CDC20/ASPM/RAD51AP1/PKMYT1/TRIP13/CDC25C/TTK,7,BP
GO:0033262,regulation of nuclear cell cycle DNA replication,4/262,11/12185,6.12E-05,0.000547284,0.000457555,CDC7/TIPIN/CDT1/DBF4,4,BP
GO:0072710,response to hydroxyurea,4/262,11/12185,6.12E-05,0.000547284,0.000457555,DDX11/TIMELESS/RAD51/BLM,4,BP
GO:0090306,meiotic spindle assembly,4/262,11/12185,6.12E-05,0.000547284,0.000457555,ASPM/CCNB2/NDC80/AURKA,4,BP
GO:0046599,regulation of centriole replication,5/262,21/12185,6.79E-05,0.000604055,0.000505019,STIL/SASS6/CENPJ/BRCA1/PLK4,5,BP
GO:0010569,regulation of double-strand break repair via homologous recombination,8/262,65/12185,7.18E-05,0.00063572,0.000531492,CHEK1/RAD51AP1/TIMELESS/PARPBP/RAD51/RMI2/POLQ/FIGNL1,8,BP
GO:0006301,postreplication repair,6/262,34/12185,7.57E-05,0.000666913,0.000557571,DTL/POLD3/POLE2/PCLAF/BRCA1/MSH2,6,BP
GO:1902808,positive regulation of cell cycle G1/S phase transition,7/262,49/12185,7.79E-05,0.000682977,0.000571001,STIL/SASS6/RRM1/CENPJ/CDC6/RRM2/FAM83D,7,BP
GO:0007292,female gamete generation,10/262,104/12185,7.86E-05,0.000683356,0.000571318,ASPM/BRCA2/CCNB2/PLK1/TOP2A/NDC80/NCAPH/AURKA/TRIP13/TTK,10,BP
GO:2001252,positive regulation of chromosome organization,10/262,104/12185,7.86E-05,0.000683356,0.000571318,NEK2/CDK1/NCAPD2/DDX11/AURKB/NCAPH/BUB1/SMC4/NCAPG/NCAPG2,10,BP
GO:0007276,gamete generation,24/262,472/12185,8.28E-05,0.000716141,0.000598728,ASPM/KIF18A/H2AX/RACGAP1/BRCA2/KNL1/CCNB2/PLK1/FANCA/TOP2A/BRIP1/NDC80/MSH2/NCAPH/AURKA/FANCD2/HMGB2/TRIP13/CDC25C/PTTG1/TTK/FIGNL1/DPY19L2P2/FANCG,24,BP
GO:0071478,cellular response to radiation,12/262,151/12185,0.000100598,0.000865898,0.000723932,POLD3/H2AX/RAD51AP1/BRCA2/RAD51/BLM/AURKB/BRCA1/ECT2/CDKN1A/FIGNL1/PBK,12,BP
GO:0007100,mitotic centrosome separation,4/262,13/12185,0.000128178,0.001093071,0.000913859,NEK2/KIF11/CHEK1/AURKA,4,BP
GO:0045842,positive regulation of mitotic metaphase/anaphase transition,4/262,13/12185,0.000128178,0.001093071,0.000913859,CDC20/ESPL1/DLGAP5/UBE2C,4,BP
GO:0072698,protein localization to microtubule cytoskeleton,7/262,53/12185,0.000129864,0.001102346,0.000921614,STIL/KIF20B/SPAG5/CEP250/FAM83D/AURKA/TTK,7,BP
GO:0072331,signal transduction by p53 class mediator,12/262,158/12185,0.000154867,0.001308552,0.001094012,E2F2/CHEK1/FOXM1/BRCA2/RPS27L/AURKB/MSH2/E2F1/AURKA/GTSE1/CDKN1A/EDA2R,12,BP
GO:1900087,positive regulation of G1/S transition of mitotic cell cycle,6/262,39/12185,0.000167772,0.00141112,0.001179763,STIL/SASS6/RRM1/CENPJ/CDC6/RRM2,6,BP
GO:0001833,inner cell mass cell proliferation,4/262,14/12185,0.000176426,0.001457296,0.001218369,CHEK1/BRCA2/GINS1/NCAPG2,4,BP
GO:0010457,centriole-centriole cohesion,4/262,14/12185,0.000176426,0.001457296,0.001218369,NEK2/RTTN/CEP250/SGO1,4,BP
GO:0051299,centrosome separation,4/262,14/12185,0.000176426,0.001457296,0.001218369,NEK2/KIF11/CHEK1/AURKA,4,BP
GO:1902101,positive regulation of metaphase/anaphase transition of cell cycle,4/262,14/12185,0.000176426,0.001457296,0.001218369,CDC20/ESPL1/DLGAP5/UBE2C,4,BP
GO:0044380,protein localization to cytoskeleton,7/262,56/12185,0.000184965,0.001521005,0.001271633,STIL/KIF20B/SPAG5/CEP250/FAM83D/AURKA/TTK,7,BP
GO:0007140,male meiotic nuclear division,5/262,27/12185,0.000242337,0.001975153,0.001651322,KIF18A/BRCA2/FANCA/TRIP13/FIGNL1,5,BP
GO:0010165,response to X-ray,5/262,27/12185,0.000242337,0.001975153,0.001651322,BRCA2/BLM/MSH2/CDKN1A/XRCC2,5,BP
GO:0045859,regulation of protein kinase activity,20/262,389/12185,0.000283505,0.002300508,0.001923335,CLSPN/CDKN2C/PSRC1/FIRRM/KIF14/BORA/CDKN3/CCNB2/BLM/CCNF/PKMYT1/PLK1/CDC6/TPX2/ECT2/CENPE/CCNA2/CCNB1/CDC25C/CDKN1A,20,BP
GO:0007096,regulation of exit from mitosis,4/262,16/12185,0.000310071,0.002494106,0.002085192,CDCA5/KNTC1/UBE2C/ANLN,4,BP
GO:0031573,mitotic intra-S DNA damage checkpoint signaling,4/262,16/12185,0.000310071,0.002494106,0.002085192,TIPIN/EME1/MSH2/FANCD2,4,BP
GO:0010824,regulation of centrosome duplication,6/262,44/12185,0.000331807,0.002657345,0.002221668,STIL/SASS6/CENPJ/CCNF/BRCA1/PLK4,6,BP
GO:0006978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",4/262,17/12185,0.000398661,0.003178937,0.002657743,FOXM1/BRCA2/RPS27L/CDKN1A,4,BP
GO:0010458,exit from mitosis,5/262,30/12185,0.000405839,0.003194679,0.002670904,CDCA5/KNTC1/UBE2S/UBE2C/ANLN,5,BP
GO:0051642,centrosome localization,5/262,30/12185,0.000405839,0.003194679,0.002670904,GPSM2/ASPM/DLGAP5/AURKA/MAD2L1,5,BP
GO:0061842,microtubule organizing center localization,5/262,30/12185,0.000405839,0.003194679,0.002670904,GPSM2/ASPM/DLGAP5/AURKA/MAD2L1,5,BP
GO:0000729,DNA double-strand break processing,4/262,18/12185,0.000503955,0.003933412,0.00328852,DNA2/BLM/BRIP1/RBBP8,4,BP
GO:0042772,"DNA damage response, signal transduction resulting in transcription",4/262,18/12185,0.000503955,0.003933412,0.00328852,FOXM1/BRCA2/RPS27L/CDKN1A,4,BP
GO:0001832,blastocyst growth,4/262,19/12185,0.000627628,0.004857524,0.004061122,CHEK1/BRCA2/GINS1/NCAPG2,4,BP
GO:0051443,positive regulation of ubiquitin-protein transferase activity,4/262,19/12185,0.000627628,0.004857524,0.004061122,CDC20/PLK1/UBE2S/UBE2C,4,BP
GO:0043549,regulation of kinase activity,21/262,450/12185,0.000721749,0.0055626,0.004650599,CLSPN/CDKN2C/PSRC1/FIRRM/KIF14/BORA/CDKN3/CCNB2/BLM/CCNF/PKMYT1/PLK1/CDC6/TPX2/RBL1/ECT2/CENPE/CCNA2/CCNB1/CDC25C/CDKN1A,21,BP
GO:0045740,positive regulation of DNA replication,5/262,34/12185,0.00073881,0.005670365,0.004740696,CDC7/CDK1/DNA2/CDT1/DBF4,5,BP
GO:0051438,regulation of ubiquitin-protein transferase activity,5/262,35/12185,0.000846995,0.006473716,0.005412336,CDC20/PLK1/UBE2S/UBE2C/MAD2L1,5,BP
GO:0001824,blastocyst development,8/262,94/12185,0.000926996,0.007055898,0.005899068,NASP/NEK2/CHEK1/BRCA2/RBBP8/RRM2/GINS1/NCAPG2,8,BP
GO:0045910,negative regulation of DNA recombination,5/262,36/12185,0.000966557,0.007326739,0.006125504,PARPBP/BLM/RMI2/MSH2/POLQ,5,BP
GO:0035561,regulation of chromatin binding,3/262,10/12185,0.001054414,0.007863285,0.006574082,DDX11/CDT1/GMNN,3,BP
GO:0051447,negative regulation of meiotic cell cycle,3/262,10/12185,0.001054414,0.007863285,0.006574082,PKMYT1/TRIP13/TTK,3,BP
GO:0070601,centromeric sister chromatid cohesion,3/262,10/12185,0.001054414,0.007863285,0.006574082,BUB1B/BUB1/SGO1,3,BP
GO:0072697,protein localization to cell cortex,3/262,10/12185,0.001054414,0.007863285,0.006574082,GPSM2/PLK1/SAPCD2,3,BP
GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,7/262,75/12185,0.001119894,0.008317924,0.006954181,E2F2/BRCA2/RPS27L/MSH2/E2F1/CDKN1A/EDA2R,7,BP
GO:0031145,anaphase-promoting complex-dependent catabolic process,4/262,22/12185,0.001125923,0.008329114,0.006963537,CDC20/PLK1/UBE2S/UBE2C,4,BP
GO:1902117,positive regulation of organelle assembly,7/262,76/12185,0.001211308,0.008924921,0.00746166,STIL/SASS6/GPSM2/CENPJ/SPAG5/PLK4/WDR45,7,BP
GO:0008584,male gonad development,8/262,98/12185,0.001217587,0.008935442,0.007470456,NASP/ASPM/RRM1/KIF18A/FANCA/BRIP1/MSH2/HMGB2,8,BP
GO:0046546,development of primary male sexual characteristics,8/262,99/12185,0.001300514,0.009506136,0.007947583,NASP/ASPM/RRM1/KIF18A/FANCA/BRIP1/MSH2/HMGB2,8,BP
GO:0006312,mitotic recombination,4/262,23/12185,0.001340145,0.009718688,0.008125288,BRCA2/RAD51/MSH2/RAD54B,4,BP
GO:2000001,regulation of DNA damage checkpoint,4/262,23/12185,0.001340145,0.009718688,0.008125288,BRCA2/RAD51/WDR76/BRCA1,4,BP
GO:0031109,microtubule polymerization or depolymerization,9/262,124/12185,0.001413036,0.010108809,0.008451447,KIF2C/PSRC1/KIF18A/SKA3/CENPJ/KIF18B/SKA1/TPX2/KIF24,9,BP
GO:2000241,regulation of reproductive process,9/262,124/12185,0.001413036,0.010108809,0.008451447,CDC20/ASPM/RAD51AP1/PKMYT1/FANCA/AURKA/TRIP13/CDC25C/TTK,9,BP
GO:0071900,regulation of protein serine/threonine kinase activity,13/262,230/12185,0.001422653,0.010108809,0.008451447,CDKN2C/PSRC1/CDKN3/CCNB2/BLM/CCNF/PKMYT1/PLK1/CDC6/CCNA2/CCNB1/CDC25C/CDKN1A,13,BP
GO:0016446,somatic hypermutation of immunoglobulin genes,3/262,11/12185,0.001426868,0.010108809,0.008451447,EXO1/MSH2/POLQ,3,BP
GO:0051177,meiotic sister chromatid cohesion,3/262,11/12185,0.001426868,0.010108809,0.008451447,BUB1B/BUB1/SGO2,3,BP
GO:0085020,protein K6-linked ubiquitination,3/262,11/12185,0.001426868,0.010108809,0.008451447,UBE2T/BRCA1/UBE2S,3,BP
GO:0045814,"negative regulation of gene expression, epigenetic",8/262,103/12185,0.001678246,0.011844174,0.009902296,HELLS/CHEK1/BRCA1/LMNB2/UHRF1/DNMT1/LMNB1/PHF19,8,BP
GO:0007019,microtubule depolymerization,5/262,41/12185,0.001760737,0.012331854,0.010310019,KIF2C/KIF18A/KIF18B/TPX2/KIF24,5,BP
GO:0048146,positive regulation of fibroblast proliferation,5/262,41/12185,0.001760737,0.012331854,0.010310019,CDC6/E2F1/CCNA2/CCNB1/CDKN1A,5,BP
GO:0019985,translesion synthesis,4/262,25/12185,0.001851005,0.012914964,0.010797527,DTL/POLD3/POLE2/PCLAF,4,BP
GO:0002566,somatic diversification of immune receptors via somatic mutation,3/262,12/12185,0.001872404,0.013014973,0.010881139,EXO1/MSH2/POLQ,3,BP
GO:0071168,protein localization to chromatin,5/262,42/12185,0.001964135,0.013601266,0.011371308,PLK1/CENPA/MSH2/MMS22L/ESCO2,5,BP
GO:0008406,gonad development,10/262,156/12185,0.001994081,0.01375692,0.011501442,NASP/ASPM/RRM1/KIF18A/BRCA2/FANCA/BRIP1/MSH2/HMGB2/FANCG,10,BP
GO:0034728,nucleosome organization,7/262,83/12185,0.002026182,0.01392622,0.011642986,NASP/H2AX/CHD2/CHAF1A/CHAF1B/MCM2/HMGB2,7,BP
GO:0007129,homologous chromosome pairing at meiosis,4/262,26/12185,0.002151013,0.014674688,0.01226874,BRIP1/FANCD2/MND1/TRIP13,4,BP
GO:1902410,mitotic cytokinetic process,4/262,26/12185,0.002151013,0.014674688,0.01226874,IQGAP3/KIF20B/CEP55/KIF20A,4,BP
GO:0007018,microtubule-based movement,15/262,302/12185,0.00227015,0.015430315,0.012900481,KIF2C/KIF14/KIF20B/KIF11/KIF18A/DLG2/DLGAP5/KIF23/KIF18B/KIF15/CENPE/KIF20A/KIFC1/KIF24/KIF4A,15,BP
GO:0045137,development of primary sexual characteristics,10/262,159/12185,0.00229428,0.015537,0.012989674,NASP/ASPM/RRM1/KIF18A/BRCA2/FANCA/BRIP1/MSH2/HMGB2/FANCG,10,BP
GO:0090435,protein localization to nuclear envelope,3/262,13/12185,0.002395672,0.016105208,0.013464723,PLK1/LMNB2/LMNB1,3,BP
GO:2000105,positive regulation of DNA-templated DNA replication,3/262,13/12185,0.002395672,0.016105208,0.013464723,CDC7/CDT1/DBF4,3,BP
GO:0030010,establishment of cell polarity,9/262,134/12185,0.002414025,0.016169581,0.013518543,GPSM2/KIF20B/PLK1/SPAG5/NDC80/CENPA/MAD2L1/SPDL1/SAPCD2,9,BP
GO:0007548,sex differentiation,11/262,189/12185,0.002595088,0.017319392,0.014479839,NASP/ASPM/RRM1/KIF18A/BRCA2/FANCA/BRIP1/MSH2/HMGB2/FANCG/CENPI,11,BP
GO:0006334,nucleosome assembly,6/262,65/12185,0.002667366,0.0177375,0.014829397,NASP/H2AX/CHAF1A/CHAF1B/MCM2/HMGB2,6,BP
GO:0010332,response to gamma radiation,5/262,46/12185,0.002952081,0.019560193,0.016353256,H2AX/BRCA2/FANCD2/CDKN1A/XRCC2,5,BP
GO:0001325,formation of extrachromosomal circular DNA,3/262,14/12185,0.00300092,0.019564801,0.016357108,EXO1/DNA2/BLM,3,BP
GO:0051782,negative regulation of cell division,3/262,14/12185,0.00300092,0.019564801,0.016357108,ASPM/BLM/AURKB,3,BP
GO:0090656,t-circle formation,3/262,14/12185,0.00300092,0.019564801,0.016357108,EXO1/DNA2/BLM,3,BP
GO:0090737,telomere maintenance via telomere trimming,3/262,14/12185,0.00300092,0.019564801,0.016357108,EXO1/DNA2/BLM,3,BP
GO:0046661,male sex differentiation,8/262,113/12185,0.003007119,0.019564801,0.016357108,NASP/ASPM/RRM1/KIF18A/FANCA/BRIP1/MSH2/HMGB2,8,BP
GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,7/262,89/12185,0.003016506,0.019564801,0.016357108,DDIAS/BRCA2/RPS27L/BRCA1/MSH2/E2F1/CDKN1A,7,BP
GO:0007163,establishment or maintenance of cell polarity,11/262,195/12185,0.003301342,0.021337092,0.017838828,KIF2C/GPSM2/KIF20B/DLG2/PLK1/SPAG5/NDC80/CENPA/MAD2L1/SPDL1/SAPCD2,11,BP
GO:0009411,response to UV,9/262,143/12185,0.003734806,0.024054242,0.020110495,DTL/POLD3/BRCA2/PCLAF/TIPIN/AURKB/MSH2/CDKN1A/PBK,9,BP
GO:0071214,cellular response to abiotic stimulus,13/262,262/12185,0.004410353,0.028207882,0.023583137,POLD3/H2AX/CHEK1/RAD51AP1/BRCA2/RAD51/BLM/AURKB/BRCA1/ECT2/CDKN1A/FIGNL1/PBK,13,BP
GO:0104004,cellular response to environmental stimulus,13/262,262/12185,0.004410353,0.028207882,0.023583137,POLD3/H2AX/CHEK1/RAD51AP1/BRCA2/RAD51/BLM/AURKB/BRCA1/ECT2/CDKN1A/FIGNL1/PBK,13,BP
GO:0071312,cellular response to alkaloid,4/262,32/12185,0.004677818,0.029712208,0.024840826,CHEK1/RAD51/BLM/CCNA2,4,BP
GO:2000780,negative regulation of double-strand break repair,4/262,32/12185,0.004677818,0.029712208,0.024840826,AUNIP/PARPBP/RMI2/POLQ,4,BP
GO:0001701,in utero embryonic development,15/262,330/12185,0.005197382,0.032898895,0.027505048,NASP/STIL/NEK2/CHEK1/BRCA2/CCNB2/RBBP8/RRM2/MSH2/GINS1/SLC25A20/PLK4/CCNB1/XRCC2/NCAPG2,15,BP
GO:0071539,protein localization to centrosome,4/262,33/12185,0.00523458,0.03302088,0.027607034,STIL/SPAG5/CEP250/AURKA,4,BP
GO:0007063,regulation of sister chromatid cohesion,3/262,17/12185,0.005345425,0.033605027,0.028095408,DDX11/ESPL1/BUB1,3,BP
GO:0097193,intrinsic apoptotic signaling pathway,13/262,269/12185,0.005488769,0.034388815,0.028750692,E2F2/RTKN2/HELLS/DDIAS/BRCA2/RPS27L/BRCA1/MSH2/E2F1/CDKN1A/FIGNL1/MELK/EDA2R,13,BP
GO:0045738,negative regulation of DNA repair,4/262,34/12185,0.005834016,0.036304927,0.030352653,AUNIP/PARPBP/RMI2/POLQ,4,BP
GO:1905508,protein localization to microtubule organizing center,4/262,34/12185,0.005834016,0.036304927,0.030352653,STIL/SPAG5/CEP250/AURKA,4,BP
GO:0040020,regulation of meiotic nuclear division,3/262,19/12185,0.007379861,0.045770047,0.038265946,CDC20/RAD51AP1/TRIP13,3,BP
GO:0030866,cortical actin cytoskeleton organization,4/262,37/12185,0.007901905,0.048843319,0.040835348,IQGAP3/RACGAP1/ECT2/ANLN,4,BP
GO:0048232,male gamete generation,15/262,348/12185,0.008334463,0.051344753,0.042926666,ASPM/KIF18A/H2AX/RACGAP1/BRCA2/KNL1/FANCA/BRIP1/HMGB2/TRIP13/CDC25C/PTTG1/FIGNL1/DPY19L2P2/FANCG,15,BP
GO:2000042,negative regulation of double-strand break repair via homologous recombination,3/262,20/12185,0.008546064,0.052472836,0.043869798,PARPBP/RMI2/POLQ,3,BP
GO:1902115,regulation of organelle assembly,10/262,192/12185,0.008617843,0.052737762,0.044091288,STIL/SASS6/GPSM2/CENPJ/PLK1/SPAG5/BRCA1/PLK4/KIF24/WDR45,10,BP
GO:0042771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,4/262,39/12185,0.009517859,0.058052634,0.048534775,BRCA2/RPS27L/MSH2/CDKN1A,4,BP
GO:0032147,activation of protein kinase activity,5/262,61/12185,0.009881126,0.060069418,0.050220904,CLSPN/KIF14/BORA/TPX2/ECT2,5,BP
GO:0006303,double-strand break repair via nonhomologous end joining,5/262,62/12185,0.010564193,0.064010669,0.053515977,AUNIP/POLQ/NSD2/HMGB2/DEK,5,BP
GO:0002200,somatic diversification of immune receptors,5/262,63/12185,0.011278889,0.068117092,0.056949143,EXO1/MSH2/POLQ/NSD2/HMGB2,5,BP
GO:0048144,fibroblast proliferation,6/262,88/12185,0.011644519,0.070095438,0.058603135,CDK1/CDC6/E2F1/CCNA2/CCNB1/CDKN1A,6,BP
GO:0007281,germ cell development,10/262,203/12185,0.012436768,0.074620606,0.062386392,ASPM/BRCA2/KNL1/BRIP1/MSH2/AURKA/HMGB2/TRIP13/DPY19L2P2/FANCG,10,BP
GO:0001556,oocyte maturation,3/262,23/12185,0.012662994,0.075731281,0.063314969,BRCA2/AURKA/TRIP13,3,BP
GO:0000723,telomere maintenance,8/262,145/12185,0.013061267,0.07786037,0.065094989,NEK2/EXO1/DNA2/BRCA2/RAD51/PIF1/BLM/AURKB,8,BP
GO:0051493,regulation of cytoskeleton organization,17/262,436/12185,0.013205723,0.078467557,0.065602626,STIL/SASS6/GPSM2/PSRC1/KIF18A/SKA3/CENPJ/BORA/CCNF/PLK1/SPAG5/BRCA1/SKA1/TPX2/ECT2/TACC3/PLK4,17,BP
GO:0048608,reproductive structure development,10/262,207/12185,0.014102646,0.08352757,0.069833039,NASP/ASPM/RRM1/KIF18A/BRCA2/FANCA/BRIP1/MSH2/HMGB2/FANCG,10,BP
GO:0061351,neural precursor cell proliferation,7/262,119/12185,0.014296916,0.084406795,0.070568113,ASPM/KIF14/RRM1/RACGAP1/SHCBP1/WDR62/MELK,7,BP
GO:0006284,base-excision repair,4/262,44/12185,0.014454579,0.084864772,0.070951004,DNA2/POLE/POLQ/NEIL3,4,BP
GO:0030330,"DNA damage response, signal transduction by p53 class mediator",5/262,67/12185,0.014466633,0.084864772,0.070951004,FOXM1/BRCA2/RPS27L/GTSE1/CDKN1A,5,BP
GO:0061458,reproductive system development,10/262,210/12185,0.015457809,0.090391381,0.075571513,NASP/ASPM/RRM1/KIF18A/BRCA2/FANCA/BRIP1/MSH2/HMGB2/FANCG,10,BP
GO:0030865,cortical cytoskeleton organization,4/262,45/12185,0.015603574,0.090668088,0.075802853,IQGAP3/RACGAP1/ECT2/ANLN,4,BP
GO:0031100,animal organ regeneration,4/262,45/12185,0.015603574,0.090668088,0.075802853,CDK1/AURKA/CCNA2/CDKN1A,4,BP
GO:2001032,regulation of double-strand break repair via nonhomologous end joining,3/262,25/12185,0.015936336,0.092310477,0.077175969,AUNIP/NSD2/DEK,3,BP
GO:0031398,positive regulation of protein ubiquitination,6/262,96/12185,0.017304843,0.099923265,0.083540623,CDC20/FANCI/PLK1/BRCA1/UBE2S/UBE2C,6,BP
GO:0008340,determination of adult lifespan,3/262,26/12185,0.017734422,0.102083767,0.085346906,RAD54L/MSH2/RAD54B,3,BP
GO:0006997,nucleus organization,7/262,125/12185,0.018282621,0.104911487,0.087711015,CDK1/CHEK1/DDX11/PLK1/LMNB2/HMGB2/LMNB1,7,BP
GO:0035066,positive regulation of histone acetylation,2/262,10/12185,0.018495259,0.105802071,0.088455586,BRCA1/DEK,2,BP
GO:0048145,regulation of fibroblast proliferation,5/262,72/12185,0.019235557,0.109696272,0.091711324,CDC6/E2F1/CCNA2/CCNB1/CDKN1A,5,BP
GO:0009185,ribonucleoside diphosphate metabolic process,3/262,27/12185,0.019640855,0.110976857,0.092781955,RRM1/DLG2/RRM2,3,BP
GO:0031571,mitotic G1 DNA damage checkpoint signaling,3/262,27/12185,0.019640855,0.110976857,0.092781955,RPS27L/GTSE1/CDKN1A,3,BP
GO:0044819,mitotic G1/S transition checkpoint signaling,3/262,27/12185,0.019640855,0.110976857,0.092781955,RPS27L/GTSE1/CDKN1A,3,BP
GO:0032200,telomere organization,8/262,157/12185,0.020162704,0.113577065,0.094955853,NEK2/EXO1/DNA2/BRCA2/RAD51/PIF1/BLM/AURKB,8,BP
GO:0021987,cerebral cortex development,6/262,101/12185,0.021671133,0.12170191,0.101748611,ASPM/KIF14/H2AX/ARHGAP11B/WDR62/TACC3,6,BP
GO:0023035,CD40 signaling pathway,2/262,11/12185,0.022288235,0.124408874,0.104011762,FANCA/FANCD2,2,BP
GO:0042276,error-prone translesion synthesis,2/262,11/12185,0.022288235,0.124408874,0.104011762,POLD3/POLE2,2,BP
GO:0051098,regulation of binding,10/262,223/12185,0.022472078,0.125056096,0.104552871,DDX11/PLK1/CDT1/AURKB/HJURP/E2F1/AURKA/HMGB2/GMNN/CDKN1A,10,BP
GO:0070979,protein K11-linked ubiquitination,3/262,29/12185,0.023779802,0.131934924,0.1103039,UBE2T/UBE2S/UBE2C,3,BP
GO:0031507,heterochromatin formation,5/262,77/12185,0.024936477,0.137936908,0.115321845,HELLS/LMNB2/UHRF1/DNMT1/LMNB1,5,BP
GO:0000002,mitochondrial genome maintenance,3/262,30/12185,0.026012381,0.141209653,0.118058016,DNA2/RRM1/PIF1,3,BP
GO:0006298,mismatch repair,3/262,30/12185,0.026012381,0.141209653,0.118058016,EXO1/POLD3/MSH2,3,BP
GO:0009263,deoxyribonucleotide biosynthetic process,2/262,12/12185,0.026371401,0.141209653,0.118058016,RRM1/RRM2,2,BP
GO:0009265,2'-deoxyribonucleotide biosynthetic process,2/262,12/12185,0.026371401,0.141209653,0.118058016,RRM1/RRM2,2,BP
GO:0010826,negative regulation of centrosome duplication,2/262,12/12185,0.026371401,0.141209653,0.118058016,CCNF/BRCA1,2,BP
GO:0010992,ubiquitin recycling,2/262,12/12185,0.026371401,0.141209653,0.118058016,UBE2S/UBE2C,2,BP
GO:0046385,deoxyribose phosphate biosynthetic process,2/262,12/12185,0.026371401,0.141209653,0.118058016,RRM1/RRM2,2,BP
GO:0046606,negative regulation of centrosome cycle,2/262,12/12185,0.026371401,0.141209653,0.118058016,CCNF/BRCA1,2,BP
GO:0051290,protein heterotetramerization,2/262,12/12185,0.026371401,0.141209653,0.118058016,RRM1/RRM2,2,BP
GO:0051657,maintenance of organelle location,2/262,12/12185,0.026371401,0.141209653,0.118058016,GPSM2/ASPM,2,BP
GO:1903429,regulation of cell maturation,2/262,12/12185,0.026371401,0.141209653,0.118058016,KIF14/AURKA,2,BP
GO:0009132,nucleoside diphosphate metabolic process,3/262,31/12185,0.02835346,0.151382824,0.126563273,RRM1/DLG2/RRM2,3,BP
GO:0016445,somatic diversification of immunoglobulins,4/262,54/12185,0.02854017,0.151939285,0.127028501,EXO1/MSH2/POLQ/NSD2,4,BP
GO:0000712,resolution of meiotic recombination intermediates,2/262,13/12185,0.030730625,0.160278273,0.134000293,TOP2A/EME1,2,BP
GO:0006264,mitochondrial DNA replication,2/262,13/12185,0.030730625,0.160278273,0.134000293,DNA2/RRM1,2,BP
GO:0014841,skeletal muscle satellite cell proliferation,2/262,13/12185,0.030730625,0.160278273,0.134000293,NDC80/DSN1,2,BP
GO:0017121,plasma membrane phospholipid scrambling,2/262,13/12185,0.030730625,0.160278273,0.134000293,ANO7/XKR5,2,BP
GO:0033599,regulation of mammary gland epithelial cell proliferation,2/262,13/12185,0.030730625,0.160278273,0.134000293,IQGAP3/BRCA2,2,BP
GO:0034086,maintenance of sister chromatid cohesion,2/262,13/12185,0.030730625,0.160278273,0.134000293,BUB1/DSCC1,2,BP
GO:0034088,maintenance of mitotic sister chromatid cohesion,2/262,13/12185,0.030730625,0.160278273,0.134000293,BUB1/DSCC1,2,BP
GO:2000279,negative regulation of DNA biosynthetic process,3/262,32/12185,0.030802665,0.160278273,0.134000293,CHEK1/PIF1/CDKN1A,3,BP
GO:0007286,spermatid development,6/262,110/12185,0.031295061,0.162381698,0.135758857,KNL1/BRIP1/HMGB2/TRIP13/DPY19L2P2/FANCG,6,BP
GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,4/262,57/12185,0.033931017,0.174583611,0.145960239,EXO1/MSH2/NSD2/HMGB2,4,BP
GO:0016444,somatic cell DNA recombination,4/262,57/12185,0.033931017,0.174583611,0.145960239,EXO1/MSH2/NSD2/HMGB2,4,BP
GO:0045911,positive regulation of DNA recombination,4/262,57/12185,0.033931017,0.174583611,0.145960239,RAD51AP1/TIMELESS/MSH2/NSD2,4,BP
GO:0070828,heterochromatin organization,5/262,84/12185,0.034582556,0.177440299,0.148348567,HELLS/LMNB2/UHRF1/DNMT1/LMNB1,5,BP
GO:1901875,positive regulation of post-translational protein modification,7/262,143/12185,0.034793714,0.178027836,0.148839776,CDC20/FANCI/PLK1/BRCA1/UBE2S/UBE2C/DEK,7,BP
GO:0000722,telomere maintenance via recombination,2/262,14/12185,0.035352242,0.178897883,0.149567177,BRCA2/RAD51,2,BP
GO:0070193,synaptonemal complex organization,2/262,14/12185,0.035352242,0.178897883,0.149567177,PLK1/TRIP13,2,BP
GO:0072520,seminiferous tubule development,2/262,14/12185,0.035352242,0.178897883,0.149567177,KIF18A/BRIP1,2,BP
GO:0090399,replicative senescence,2/262,14/12185,0.035352242,0.178897883,0.149567177,CHEK1/CDKN1A,2,BP
GO:0045332,phospholipid translocation,3/262,34/12185,0.036023227,0.18179393,0.151988411,ATP8B3/ANO7/XKR5,3,BP
GO:0009416,response to light stimulus,10/262,244/12185,0.038285201,0.192681257,0.161090736,DTL/POLD3/BRCA2/PCLAF/TIPIN/AURKB/MSH2/CEP250/CDKN1A/PBK,10,BP
GO:0048515,spermatid differentiation,6/262,116/12185,0.039054643,0.196018125,0.163880517,KNL1/BRIP1/HMGB2/TRIP13/DPY19L2P2/FANCG,6,BP
GO:0007141,male meiosis I,2/262,15/12185,0.040223046,0.199705795,0.166963586,BRCA2/TRIP13,2,BP
GO:0016078,tRNA catabolic process,2/262,15/12185,0.040223046,0.199705795,0.166963586,EXOSC8/SLFN13,2,BP
GO:0048308,organelle inheritance,2/262,15/12185,0.040223046,0.199705795,0.166963586,CDK1/PLK1,2,BP
GO:0048313,Golgi inheritance,2/262,15/12185,0.040223046,0.199705795,0.166963586,CDK1/PLK1,2,BP
GO:1903322,positive regulation of protein modification by small protein conjugation or removal,6/262,118/12185,0.041890023,0.206757026,0.172858752,CDC20/FANCI/PLK1/BRCA1/UBE2S/UBE2C,6,BP
GO:0032091,negative regulation of protein binding,4/262,61/12185,0.041979983,0.206757026,0.172858752,DDX11/AURKB/AURKA/CDKN1A,4,BP
GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,4/262,61/12185,0.041979983,0.206757026,0.172858752,RPS27L/RBL1/GTSE1/CDKN1A,4,BP
GO:0045739,positive regulation of DNA repair,6/262,119/12185,0.043355144,0.212960466,0.178045124,H2AX/FOXM1/RAD51AP1/DDX11/TIMELESS/BRCA1,6,BP
GO:0006266,DNA ligation,2/262,16/12185,0.045330271,0.220312294,0.184191603,RAD51/TOP2A,2,BP
GO:0006977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",2/262,16/12185,0.045330271,0.220312294,0.184191603,GTSE1/CDKN1A,2,BP
GO:0021846,cell proliferation in forebrain,2/262,16/12185,0.045330271,0.220312294,0.184191603,KIF14/RRM1,2,BP
GO:2000758,positive regulation of peptidyl-lysine acetylation,2/262,16/12185,0.045330271,0.220312294,0.184191603,BRCA1/DEK,2,BP
GO:0014856,skeletal muscle cell proliferation,2/262,17/12185,0.050661584,0.243017286,0.203174061,NDC80/DSN1,2,BP
GO:0032069,regulation of nuclease activity,2/262,17/12185,0.050661584,0.243017286,0.203174061,DDX11/HMGB2,2,BP
GO:0051446,positive regulation of meiotic cell cycle,2/262,17/12185,0.050661584,0.243017286,0.203174061,RAD51AP1/CDC25C,2,BP
GO:0061952,midbody abscission,2/262,17/12185,0.050661584,0.243017286,0.203174061,CEP55/KIF20A,2,BP
GO:1904355,positive regulation of telomere capping,2/262,17/12185,0.050661584,0.243017286,0.203174061,NEK2/AURKB,2,BP
GO:0034204,lipid translocation,3/262,39/12185,0.050914534,0.243450655,0.203536378,ATP8B3/ANO7/XKR5,3,BP
GO:1902807,negative regulation of cell cycle G1/S phase transition,4/262,65/12185,0.051016261,0.243450655,0.203536378,RPS27L/RBL1/GTSE1/CDKN1A,4,BP
GO:0040029,epigenetic regulation of gene expression,8/262,190/12185,0.052946344,0.251401728,0.210183855,HELLS/CHEK1/BRCA1/LMNB2/UHRF1/DNMT1/LMNB1/PHF19,8,BP
GO:0071241,cellular response to inorganic substance,7/262,157/12185,0.052955413,0.251401728,0.210183855,DLG2/DDX11/TIMELESS/RAD51/BLM/ECT2/CCNA2,7,BP
GO:0048477,oogenesis,4/262,67/12185,0.055902779,0.264106463,0.220805621,ASPM/BRCA2/AURKA/TRIP13,4,BP
GO:0010224,response to UV-B,2/262,18/12185,0.056205067,0.264106463,0.220805621,MSH2/CDKN1A,2,BP
GO:0035065,regulation of histone acetylation,2/262,18/12185,0.056205067,0.264106463,0.220805621,BRCA1/DEK,2,BP
GO:2001224,positive regulation of neuron migration,2/262,18/12185,0.056205067,0.264106463,0.220805621,KIF20B/WDR62,2,BP
GO:0002204,somatic recombination of immunoglobulin genes involved in immune response,3/262,41/12185,0.057583512,0.26852868,0.224502806,EXO1/MSH2/NSD2,3,BP
GO:0002208,somatic diversification of immunoglobulins involved in immune response,3/262,41/12185,0.057583512,0.26852868,0.224502806,EXO1/MSH2/NSD2,3,BP
GO:0045190,isotype switching,3/262,41/12185,0.057583512,0.26852868,0.224502806,EXO1/MSH2/NSD2,3,BP
GO:0051495,positive regulation of cytoskeleton organization,7/262,161/12185,0.059063177,0.274733264,0.229690134,STIL/SASS6/GPSM2/PSRC1/CENPJ/SPAG5/PLK4,7,BP
GO:0007283,spermatogenesis,12/262,337/12185,0.060479734,0.280613776,0.234606523,ASPM/H2AX/RACGAP1/BRCA2/KNL1/BRIP1/HMGB2/TRIP13/CDC25C/PTTG1/DPY19L2P2/FANCG,12,BP
GO:0048599,oocyte development,3/262,42/12185,0.061065243,0.28191022,0.235690412,BRCA2/AURKA/TRIP13,3,BP
GO:2000242,negative regulation of reproductive process,3/262,42/12185,0.061065243,0.28191022,0.235690412,PKMYT1/TRIP13/TTK,3,BP
GO:0016075,rRNA catabolic process,2/262,19/12185,0.061949209,0.284564696,0.23790968,EXOSC8/SLFN13,2,BP
GO:0045589,regulation of regulatory T cell differentiation,2/262,19/12185,0.061949209,0.284564696,0.23790968,FANCA/FANCD2,2,BP
GO:0002377,immunoglobulin production,4/262,70/12185,0.063687879,0.291823563,0.24397844,EXO1/MSH2/POLQ/NSD2,4,BP
GO:0051100,negative regulation of binding,5/262,100/12185,0.064342409,0.293282176,0.245197911,DDX11/AURKB/E2F1/AURKA/CDKN1A,5,BP
GO:0002381,immunoglobulin production involved in immunoglobulin-mediated immune response,3/262,43/12185,0.064643086,0.293282176,0.245197911,EXO1/MSH2/NSD2,3,BP
GO:0006513,protein monoubiquitination,3/262,43/12185,0.064643086,0.293282176,0.245197911,UBE2T/DTL/UHRF1,3,BP
GO:0009994,oocyte differentiation,3/262,43/12185,0.064643086,0.293282176,0.245197911,BRCA2/AURKA/TRIP13,3,BP
GO:0043279,response to alkaloid,4/262,71/12185,0.066403027,0.300520814,0.251249758,CHEK1/RAD51/BLM/CCNA2,4,BP
GO:0051261,protein depolymerization,5/262,101/12185,0.066564871,0.300520814,0.251249758,KIF2C/KIF18A/KIF18B/TPX2/KIF24,5,BP
GO:0000083,regulation of transcription involved in G1/S transition of mitotic cell cycle,2/262,20/12185,0.067882892,0.304234274,0.254354388,E2F2/E2F1,2,BP
GO:0045736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,2/262,20/12185,0.067882892,0.304234274,0.254354388,PLK1/CDKN1A,2,BP
GO:1904030,negative regulation of cyclin-dependent protein kinase activity,2/262,20/12185,0.067882892,0.304234274,0.254354388,PLK1/CDKN1A,2,BP
GO:0097035,regulation of membrane lipid distribution,3/262,44/12185,0.068315415,0.3054296,0.255353737,ATP8B3/ANO7/XKR5,3,BP
GO:0001934,positive regulation of protein phosphorylation,14/262,420/12185,0.069700268,0.31086657,0.259899304,CLSPN/CDCA8/PSRC1/IQGAP3/KIF14/INCENP/BORA/PLK1/AURKB/BIRC5/TPX2/ECT2/CENPE/CDKN1A,14,BP
GO:0051972,regulation of telomerase activity,3/262,45/12185,0.072080547,0.320706201,0.268125706,NEK2/PIF1/AURKB,3,BP
GO:0045066,regulatory T cell differentiation,2/262,21/12185,0.073995379,0.326857288,0.273268308,FANCA/FANCD2,2,BP
GO:0045830,positive regulation of isotype switching,2/262,21/12185,0.073995379,0.326857288,0.273268308,MSH2/NSD2,2,BP
GO:0097150,neuronal stem cell population maintenance,2/262,21/12185,0.073995379,0.326857288,0.273268308,ASPM/FANCD2,2,BP
GO:0051101,regulation of DNA binding,4/262,74/12185,0.074903125,0.330075493,0.275958881,CDT1/HJURP/E2F1/HMGB2,4,BP
GO:0045860,positive regulation of protein kinase activity,8/262,206/12185,0.076944807,0.338263329,0.282804303,CLSPN/PSRC1/KIF14/BORA/TPX2/ECT2/CENPE/CDKN1A,8,BP
GO:0032042,mitochondrial DNA metabolic process,2/262,22/12185,0.080276307,0.350400375,0.292951454,DNA2/RRM1,2,BP
GO:0033598,mammary gland epithelial cell proliferation,2/262,22/12185,0.080276307,0.350400375,0.292951454,IQGAP3/BRCA2,2,BP
GO:0051291,protein heterooligomerization,2/262,22/12185,0.080276307,0.350400375,0.292951454,RRM1/RRM2,2,BP
GO:0048469,cell maturation,5/262,107/12185,0.080785645,0.351285821,0.293691729,KIF14/BRCA2/AURKA/TRIP13/CDKN1A,5,BP
GO:0010833,telomere maintenance via telomere lengthening,4/262,76/12185,0.08086058,0.351285821,0.293691729,NEK2/RAD51/PIF1/AURKB,4,BP
GO:0007097,nuclear migration,2/262,23/12185,0.086715671,0.374075563,0.312745041,LMNB2/LMNB1,2,BP
GO:1901985,positive regulation of protein acetylation,2/262,23/12185,0.086715671,0.374075563,0.312745041,BRCA1/DEK,2,BP
GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,2/262,23/12185,0.086715671,0.374075563,0.312745041,BRCA1/HMGB2,2,BP
GO:0016447,somatic recombination of immunoglobulin gene segments,3/262,49/12185,0.088033494,0.378772946,0.316672278,EXO1/MSH2/NSD2,3,BP
GO:0002520,immune system development,6/262,143/12185,0.088215849,0.378772946,0.316672278,EXO1/CCNB2/MSH2/POLQ/NSD2/HMGB2,6,BP
GO:0031396,regulation of protein ubiquitination,7/262,178/12185,0.089697839,0.384240509,0.321243422,CDC20/FANCI/PLK1/BRCA1/UBE2S/UBE2C/MAD2L1,7,BP
GO:0006289,nucleotide-excision repair,4/262,79/12185,0.090221822,0.384695824,0.321624087,POLD3/POLE/BRCA2/BRIP1,4,BP
GO:2000781,positive regulation of double-strand break repair,4/262,79/12185,0.090221822,0.384695824,0.321624087,FOXM1/RAD51AP1/DDX11/TIMELESS,4,BP
GO:0021543,pallium development,6/262,145/12185,0.092794199,0.394750379,0.330030176,ASPM/KIF14/H2AX/ARHGAP11B/WDR62/TACC3,6,BP
GO:0006346,DNA methylation-dependent heterochromatin formation,2/262,24/12185,0.093303814,0.39509339,0.33031695,HELLS/DNMT1,2,BP
GO:0006541,glutamine metabolic process,2/262,24/12185,0.093303814,0.39509339,0.33031695,PHGDH/ARHGAP11B,2,BP
GO:0002052,positive regulation of neuroblast proliferation,2/262,25/12185,0.10003142,0.422609808,0.353321989,ASPM/WDR62,2,BP
GO:0032210,regulation of telomere maintenance via telomerase,3/262,52/12185,0.100882614,0.424259762,0.354701429,NEK2/PIF1/AURKB,3,BP
GO:2000243,positive regulation of reproductive process,3/262,52/12185,0.100882614,0.424259762,0.354701429,RAD51AP1/AURKA/CDC25C,3,BP
GO:0006998,nuclear envelope organization,3/262,53/12185,0.105323659,0.440923137,0.368632807,PLK1/LMNB2/LMNB1,3,BP
GO:0050871,positive regulation of B cell activation,3/262,53/12185,0.105323659,0.440923137,0.368632807,MSH2/NSD2/CDKN1A,3,BP
GO:0002714,positive regulation of B cell mediated immunity,2/262,26/12185,0.106889504,0.442450484,0.369909743,MSH2/NSD2,2,BP
GO:0002891,positive regulation of immunoglobulin mediated immune response,2/262,26/12185,0.106889504,0.442450484,0.369909743,MSH2/NSD2,2,BP
GO:0071392,cellular response to estradiol stimulus,2/262,26/12185,0.106889504,0.442450484,0.369909743,KIF18A/CCNA2,2,BP
GO:0071480,cellular response to gamma radiation,2/262,26/12185,0.106889504,0.442450484,0.369909743,H2AX/CDKN1A,2,BP
GO:1904353,regulation of telomere capping,2/262,26/12185,0.106889504,0.442450484,0.369909743,NEK2/AURKB,2,BP
GO:0090398,cellular senescence,4/262,85/12185,0.110410443,0.456000079,0.381237851,H2AX/BRCA2/RBL1/CDKN1A,4,BP
GO:0043393,regulation of protein binding,5/262,119/12185,0.113635231,0.46818622,0.391426047,DDX11/PLK1/AURKB/AURKA/CDKN1A,5,BP
GO:1904385,cellular response to angiotensin,2/262,27/12185,0.113869395,0.46818622,0.391426047,CDC6/BRIP1,2,BP
GO:0007405,neuroblast proliferation,3/262,55/12185,0.114430588,0.469445753,0.392479077,ASPM/RACGAP1/WDR62,3,BP
GO:0034644,cellular response to UV,4/262,87/12185,0.117553126,0.481184129,0.40229292,POLD3/AURKB/CDKN1A/PBK,4,BP
GO:1990776,response to angiotensin,2/262,28/12185,0.120962738,0.492949919,0.412129683,CDC6/BRIP1,2,BP
GO:2000756,regulation of peptidyl-lysine acetylation,2/262,28/12185,0.120962738,0.492949919,0.412129683,BRCA1/DEK,2,BP
GO:0042327,positive regulation of phosphorylation,14/262,461/12185,0.122585531,0.49846037,0.416736683,CLSPN/CDCA8/PSRC1/IQGAP3/KIF14/INCENP/BORA/PLK1/AURKB/BIRC5/TPX2/ECT2/CENPE/CDKN1A,14,BP
GO:0031110,regulation of microtubule polymerization or depolymerization,4/262,89/12185,0.124891814,0.506719652,0.423641837,PSRC1/SKA3/SKA1/TPX2,4,BP
GO:0045191,regulation of isotype switching,2/262,29/12185,0.128161474,0.517704902,0.432826031,MSH2/NSD2,2,BP
GO:1902742,apoptotic process involved in development,2/262,29/12185,0.128161474,0.517704902,0.432826031,CHEK1/XKR5,2,BP
GO:0014855,striated muscle cell proliferation,3/262,58/12185,0.128622051,0.518428485,0.433430981,CDK1/NDC80/DSN1,3,BP
GO:0002312,B cell activation involved in immune response,3/262,59/12185,0.1334858,0.535688112,0.447860854,EXO1/MSH2/NSD2,3,BP
GO:1904356,regulation of telomere maintenance via telomere lengthening,3/262,59/12185,0.1334858,0.535688112,0.447860854,NEK2/PIF1/AURKB,3,BP
GO:0051647,nucleus localization,2/262,30/12185,0.135457838,0.542420298,0.453489283,LMNB2/LMNB1,2,BP
GO:0002639,positive regulation of immunoglobulin production,2/262,31/12185,0.142844347,0.570757671,0.477180681,MSH2/NSD2,2,BP
GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,4/262,95/12185,0.148015104,0.590138143,0.493383681,RTKN2/HELLS/DDIAS/FIGNL1,4,BP
GO:0051262,protein tetramerization,3/262,62/12185,0.148447388,0.590583344,0.49375589,RRM1/TK1/RRM2,3,BP
GO:0006473,protein acetylation,4/262,96/12185,0.152021032,0.603497288,0.504552564,BRCA1/DEK/ESCO2/DSCC1,4,BP
GO:0051865,protein autoubiquitination,3/262,63/12185,0.153551012,0.608260137,0.508534533,UBE2T/BRCA1/UHRF1,3,BP
GO:0018209,peptidyl-serine modification,8/262,244/12185,0.156092414,0.613452965,0.512875986,CLSPN/CDC7/CDK1/POGLUT3/PLK1/AURKA/TTK/PBK,8,BP
GO:0009394,2'-deoxyribonucleotide metabolic process,2/262,33/12185,0.157859232,0.613452965,0.512875986,RRM1/RRM2,2,BP
GO:0042307,positive regulation of protein import into nucleus,2/262,33/12185,0.157859232,0.613452965,0.512875986,CDK1/ECT2,2,BP
GO:0045943,positive regulation of transcription by RNA polymerase I,2/262,33/12185,0.157859232,0.613452965,0.512875986,DDX11/DEK,2,BP
GO:0051973,positive regulation of telomerase activity,2/262,33/12185,0.157859232,0.613452965,0.512875986,NEK2/AURKB,2,BP
GO:0070316,regulation of G0 to G1 transition,2/262,33/12185,0.157859232,0.613452965,0.512875986,RRM1/CHEK1,2,BP
GO:0090102,cochlea development,2/262,33/12185,0.157859232,0.613452965,0.512875986,MCM2/CCNA2,2,BP
GO:1902692,regulation of neuroblast proliferation,2/262,33/12185,0.157859232,0.613452965,0.512875986,ASPM/WDR62,2,BP
GO:1905168,positive regulation of double-strand break repair via homologous recombination,2/262,33/12185,0.157859232,0.613452965,0.512875986,RAD51AP1/TIMELESS,2,BP
GO:0071482,cellular response to light stimulus,4/262,98/12185,0.160154858,0.621063679,0.519238907,POLD3/AURKB/CDKN1A/PBK,4,BP
GO:0033674,positive regulation of kinase activity,8/262,246/12185,0.161069501,0.623298362,0.521107208,CLSPN/PSRC1/KIF14/BORA/TPX2/ECT2/CENPE/CDKN1A,8,BP
GO:0009262,deoxyribonucleotide metabolic process,2/262,34/12185,0.165473982,0.635006407,0.530895693,RRM1/RRM2,2,BP
GO:0019692,deoxyribose phosphate metabolic process,2/262,34/12185,0.165473982,0.635006407,0.530895693,RRM1/RRM2,2,BP
GO:0032212,positive regulation of telomere maintenance via telomerase,2/262,34/12185,0.165473982,0.635006407,0.530895693,NEK2/AURKB,2,BP
GO:0045023,G0 to G1 transition,2/262,34/12185,0.165473982,0.635006407,0.530895693,RRM1/CHEK1,2,BP
GO:0007004,telomere maintenance via telomerase,3/262,66/12185,0.169181795,0.647885378,0.541663128,NEK2/PIF1/AURKB,3,BP
GO:0072337,modified amino acid transport,2/262,35/12185,0.173151609,0.661712166,0.553222984,SLC7A1/SLC25A20,2,BP
GO:0006278,RNA-templated DNA biosynthetic process,3/262,67/12185,0.174491749,0.665453006,0.556350504,NEK2/PIF1/AURKB,3,BP
GO:0030900,forebrain development,9/262,291/12185,0.175875048,0.66934264,0.559602424,STIL/ASPM/KIF14/RRM1/H2AX/ARHGAP11B/WDR62/E2F1/TACC3,9,BP
GO:2000177,regulation of neural precursor cell proliferation,3/262,68/12185,0.179848104,0.683051973,0.571064082,ASPM/SHCBP1/WDR62,3,BP
GO:0097306,cellular response to alcohol,3/262,69/12185,0.185248811,0.701462898,0.586456495,RAD51/BLM/BRCA1,3,BP
GO:0016233,telomere capping,2/262,37/12185,0.188670963,0.701462898,0.586456495,NEK2/AURKB,2,BP
GO:0031056,regulation of histone modification,2/262,37/12185,0.188670963,0.701462898,0.586456495,BRCA1/DEK,2,BP
GO:0140718,facultative heterochromatin formation,2/262,37/12185,0.188670963,0.701462898,0.586456495,HELLS/DNMT1,2,BP
GO:1904358,positive regulation of telomere maintenance via telomere lengthening,2/262,37/12185,0.188670963,0.701462898,0.586456495,NEK2/AURKB,2,BP
GO:0006606,protein import into nucleus,5/262,142/12185,0.191010323,0.701462898,0.586456495,CDK1/POLA2/KPNA2/ECT2/CDKN1A,5,BP
GO:1901873,regulation of post-translational protein modification,8/262,258/12185,0.192433304,0.701462898,0.586456495,CDC20/FANCI/PLK1/BRCA1/UBE2S/UBE2C/MAD2L1/DEK,8,BP
GO:0002244,hematopoietic progenitor cell differentiation,4/262,106/12185,0.194175239,0.701462898,0.586456495,CHD2/TOP2A/ANLN/ESCO2,4,BP
GO:0006544,glycine metabolic process,1/262,10/12185,0.195428135,0.701462898,0.586456495,PHGDH,1,BP
GO:0015801,aromatic amino acid transport,1/262,10/12185,0.195428135,0.701462898,0.586456495,SLC7A1,1,BP
GO:0021681,cerebellar granular layer development,1/262,10/12185,0.195428135,0.701462898,0.586456495,KIF14,1,BP
GO:0030953,astral microtubule organization,1/262,10/12185,0.195428135,0.701462898,0.586456495,CENPJ,1,BP
GO:0031125,rRNA 3'-end processing,1/262,10/12185,0.195428135,0.701462898,0.586456495,EXOSC8,1,BP
GO:0043652,engulfment of apoptotic cell,1/262,10/12185,0.195428135,0.701462898,0.586456495,XKR5,1,BP
GO:0046710,GDP metabolic process,1/262,10/12185,0.195428135,0.701462898,0.586456495,DLG2,1,BP
GO:0051081,nuclear membrane disassembly,1/262,10/12185,0.195428135,0.701462898,0.586456495,PLK1,1,BP
GO:0051764,actin crosslink formation,1/262,10/12185,0.195428135,0.701462898,0.586456495,GAS2L3,1,BP
GO:0055015,ventricular cardiac muscle cell development,1/262,10/12185,0.195428135,0.701462898,0.586456495,CDK1,1,BP
GO:0071028,nuclear mRNA surveillance,1/262,10/12185,0.195428135,0.701462898,0.586456495,EXOSC8,1,BP
GO:0071313,cellular response to caffeine,1/262,10/12185,0.195428135,0.701462898,0.586456495,CHEK1,1,BP
GO:0090657,telomeric loop disassembly,1/262,10/12185,0.195428135,0.701462898,0.586456495,BLM,1,BP
GO:1901838,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,1/262,10/12185,0.195428135,0.701462898,0.586456495,DDX11,1,BP
GO:1902855,regulation of non-motile cilium assembly,1/262,10/12185,0.195428135,0.701462898,0.586456495,CENPJ,1,BP
GO:1903671,negative regulation of sprouting angiogenesis,1/262,10/12185,0.195428135,0.701462898,0.586456495,E2F2,1,BP
GO:1990700,nucleolar chromatin organization,1/262,10/12185,0.195428135,0.701462898,0.586456495,DDX11,1,BP
GO:1903320,regulation of protein modification by small protein conjugation or removal,7/262,220/12185,0.196011901,0.701462898,0.586456495,CDC20/FANCI/PLK1/BRCA1/UBE2S/UBE2C/MAD2L1,7,BP
GO:0002712,regulation of B cell mediated immunity,2/262,38/12185,0.196501007,0.701462898,0.586456495,MSH2/NSD2,2,BP
GO:0002889,regulation of immunoglobulin mediated immune response,2/262,38/12185,0.196501007,0.701462898,0.586456495,MSH2/NSD2,2,BP
GO:0032781,positive regulation of ATP-dependent activity,2/262,38/12185,0.196501007,0.701462898,0.586456495,UHRF1/MSH2,2,BP
GO:1901983,regulation of protein acetylation,2/262,38/12185,0.196501007,0.701462898,0.586456495,BRCA1/DEK,2,BP
GO:2001222,regulation of neuron migration,2/262,38/12185,0.196501007,0.701462898,0.586456495,KIF20B/WDR62,2,BP
GO:0006305,DNA alkylation,2/262,39/12185,0.204370546,0.722033749,0.603654709,HELLS/DNMT1,2,BP
GO:0006306,DNA methylation,2/262,39/12185,0.204370546,0.722033749,0.603654709,HELLS/DNMT1,2,BP
GO:0099024,plasma membrane invagination,2/262,39/12185,0.204370546,0.722033749,0.603654709,AURKB/XKR5,2,BP
GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,2/262,39/12185,0.204370546,0.722033749,0.603654709,BRCA1/HMGB2,2,BP
GO:2000179,positive regulation of neural precursor cell proliferation,2/262,39/12185,0.204370546,0.722033749,0.603654709,ASPM/WDR62,2,BP
GO:0051099,positive regulation of binding,4/262,109/12185,0.207475425,0.722033749,0.603654709,DDX11/CDT1/HMGB2/GMNN,4,BP
GO:0051259,protein complex oligomerization,6/262,185/12185,0.20841946,0.722033749,0.603654709,RRM1/BLM/TK1/RRM2/POLQ/ECT2,6,BP
GO:0051170,import into nucleus,5/262,147/12185,0.209880653,0.722033749,0.603654709,CDK1/POLA2/KPNA2/ECT2/CDKN1A,5,BP
GO:0009116,nucleoside metabolic process,2/262,40/12185,0.212274288,0.722033749,0.603654709,TK1/MACROD2,2,BP
GO:1902116,negative regulation of organelle assembly,2/262,40/12185,0.212274288,0.722033749,0.603654709,BRCA1/KIF24,2,BP
GO:0006563,L-serine metabolic process,1/262,11/12185,0.212742125,0.722033749,0.603654709,PHGDH,1,BP
GO:0007130,synaptonemal complex assembly,1/262,11/12185,0.212742125,0.722033749,0.603654709,TRIP13,1,BP
GO:0008272,sulfate transport,1/262,11/12185,0.212742125,0.722033749,0.603654709,RACGAP1,1,BP
GO:0010561,negative regulation of glycoprotein biosynthetic process,1/262,11/12185,0.212742125,0.722033749,0.603654709,ITM2B,1,BP
GO:0030397,membrane disassembly,1/262,11/12185,0.212742125,0.722033749,0.603654709,PLK1,1,BP
GO:0032688,negative regulation of interferon-beta production,1/262,11/12185,0.212742125,0.722033749,0.603654709,TRAIP,1,BP
GO:0033623,regulation of integrin activation,1/262,11/12185,0.212742125,0.722033749,0.603654709,KIF14,1,BP
GO:0034085,establishment of sister chromatid cohesion,1/262,11/12185,0.212742125,0.722033749,0.603654709,DDX11,1,BP
GO:0051095,regulation of helicase activity,1/262,11/12185,0.212742125,0.722033749,0.603654709,MSH2,1,BP
GO:0060576,intestinal epithelial cell development,1/262,11/12185,0.212742125,0.722033749,0.603654709,CDKN1A,1,BP
GO:0070341,fat cell proliferation,1/262,11/12185,0.212742125,0.722033749,0.603654709,E2F1,1,BP
GO:0071371,cellular response to gonadotropin stimulus,1/262,11/12185,0.212742125,0.722033749,0.603654709,CCNA2,1,BP
GO:0071415,cellular response to purine-containing compound,1/262,11/12185,0.212742125,0.722033749,0.603654709,CHEK1,1,BP
GO:1903826,L-arginine transmembrane transport,1/262,11/12185,0.212742125,0.722033749,0.603654709,SLC7A1,1,BP
GO:1905383,protein localization to presynapse,1/262,11/12185,0.212742125,0.722033749,0.603654709,DLG2,1,BP
GO:0008585,female gonad development,3/262,74/12185,0.212847082,0.722033749,0.603654709,BRCA2/FANCA/FANCG,3,BP
GO:0015914,phospholipid transport,3/262,74/12185,0.212847082,0.722033749,0.603654709,ATP8B3/ANO7/XKR5,3,BP
GO:0046545,development of primary female sexual characteristics,3/262,76/12185,0.224127087,0.751473569,0.628267805,BRCA2/FANCA/FANCG,3,BP
GO:0033002,muscle cell proliferation,5/262,152/12185,0.229326706,0.751473569,0.628267805,CDK1/NDC80/DNMT1/DSN1/CDKN1A,5,BP
GO:0002903,negative regulation of B cell apoptotic process,1/262,12/12185,0.229684918,0.751473569,0.628267805,AURKB,1,BP
GO:0006285,"base-excision repair, AP site formation",1/262,12/12185,0.229684918,0.751473569,0.628267805,NEIL3,1,BP
GO:0017062,respiratory chain complex III assembly,1/262,12/12185,0.229684918,0.751473569,0.628267805,UQCC1,1,BP
GO:0030214,hyaluronan catabolic process,1/262,12/12185,0.229684918,0.751473569,0.628267805,HMMR,1,BP
GO:0033147,negative regulation of intracellular estrogen receptor signaling pathway,1/262,12/12185,0.229684918,0.751473569,0.628267805,BRCA1,1,BP
GO:0034427,"nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'",1/262,12/12185,0.229684918,0.751473569,0.628267805,EXOSC8,1,BP
GO:0034551,mitochondrial respiratory chain complex III assembly,1/262,12/12185,0.229684918,0.751473569,0.628267805,UQCC1,1,BP
GO:0035331,negative regulation of hippo signaling,1/262,12/12185,0.229684918,0.751473569,0.628267805,CIT,1,BP
GO:0035864,response to potassium ion,1/262,12/12185,0.229684918,0.751473569,0.628267805,DLG2,1,BP
GO:0043045,post-fertilization epigenetic regulation of gene expression,1/262,12/12185,0.229684918,0.751473569,0.628267805,DNMT1,1,BP
GO:0044320,cellular response to leptin stimulus,1/262,12/12185,0.229684918,0.751473569,0.628267805,CCNA2,1,BP
GO:0048532,anatomical structure arrangement,1/262,12/12185,0.229684918,0.751473569,0.628267805,KIF14,1,BP
GO:0055057,neuroblast division,1/262,12/12185,0.229684918,0.751473569,0.628267805,ASPM,1,BP
GO:0071493,cellular response to UV-B,1/262,12/12185,0.229684918,0.751473569,0.628267805,CDKN1A,1,BP
GO:0071732,cellular response to nitric oxide,1/262,12/12185,0.229684918,0.751473569,0.628267805,CCNA2,1,BP
GO:0140719,constitutive heterochromatin formation,1/262,12/12185,0.229684918,0.751473569,0.628267805,HELLS,1,BP
GO:1904044,response to aldosterone,1/262,12/12185,0.229684918,0.751473569,0.628267805,CDKN1A,1,BP
GO:1904779,regulation of protein localization to centrosome,1/262,12/12185,0.229684918,0.751473569,0.628267805,CEP250,1,BP
GO:0016570,histone modification,4/262,114/12185,0.230194442,0.751805251,0.628545107,AURKB/BRCA1/UHRF1/DEK,4,BP
GO:0071695,anatomical structure maturation,5/262,153/12185,0.233278394,0.760528853,0.635838455,KIF14/BRCA2/AURKA/TRIP13/CDKN1A,5,BP
GO:0001578,microtubule bundle formation,3/262,78/12185,0.235521576,0.763107916,0.637994674,PSRC1/PLK1/KIF20A,3,BP
GO:0016064,immunoglobulin mediated immune response,3/262,78/12185,0.235521576,0.763107916,0.637994674,EXO1/MSH2/NSD2,3,BP
GO:0050864,regulation of B cell activation,3/262,78/12185,0.235521576,0.763107916,0.637994674,MSH2/NSD2/CDKN1A,3,BP
GO:0032873,negative regulation of stress-activated MAPK cascade,2/262,43/12185,0.236140886,0.763107916,0.637994674,FOXM1/PBK,2,BP
GO:0070303,negative regulation of stress-activated protein kinase signaling cascade,2/262,43/12185,0.236140886,0.763107916,0.637994674,FOXM1/PBK,2,BP
GO:2001234,negative regulation of apoptotic signaling pathway,6/262,194/12185,0.239591324,0.772775304,0.646077073,RTKN2/HELLS/DDIAS/BRCA1/HMGB2/FIGNL1,6,BP
GO:0019724,B cell mediated immunity,3/262,79/12185,0.241257093,0.772775304,0.646077073,EXO1/MSH2/NSD2,3,BP
GO:0018105,peptidyl-serine phosphorylation,7/262,235/12185,0.242648032,0.772775304,0.646077073,CLSPN/CDC7/CDK1/PLK1/AURKA/TTK/PBK,7,BP
GO:0002637,regulation of immunoglobulin production,2/262,44/12185,0.244132575,0.772775304,0.646077073,MSH2/NSD2,2,BP
GO:0001682,tRNA 5'-leader removal,1/262,13/12185,0.246264443,0.772775304,0.646077073,RPP25L,1,BP
GO:0001956,positive regulation of neurotransmitter secretion,1/262,13/12185,0.246264443,0.772775304,0.646077073,SLC4A8,1,BP
GO:0014821,phasic smooth muscle contraction,1/262,13/12185,0.246264443,0.772775304,0.646077073,EDN2,1,BP
GO:0016202,regulation of striated muscle tissue development,1/262,13/12185,0.246264443,0.772775304,0.646077073,CENPF,1,BP
GO:0031000,response to caffeine,1/262,13/12185,0.246264443,0.772775304,0.646077073,CHEK1,1,BP
GO:0032486,Rap protein signal transduction,1/262,13/12185,0.246264443,0.772775304,0.646077073,KIF14,1,BP
GO:0043928,exonucleolytic catabolism of deadenylated mRNA,1/262,13/12185,0.246264443,0.772775304,0.646077073,EXOSC8,1,BP
GO:0045039,protein insertion into mitochondrial inner membrane,1/262,13/12185,0.246264443,0.772775304,0.646077073,TIMM8B,1,BP
GO:0070914,UV-damage excision repair,1/262,13/12185,0.246264443,0.772775304,0.646077073,POLD3,1,BP
GO:0098840,protein transport along microtubule,1/262,13/12185,0.246264443,0.772775304,0.646077073,DLG2,1,BP
GO:0099118,microtubule-based protein transport,1/262,13/12185,0.246264443,0.772775304,0.646077073,DLG2,1,BP
GO:1903019,negative regulation of glycoprotein metabolic process,1/262,13/12185,0.246264443,0.772775304,0.646077073,ITM2B,1,BP
GO:1990822,basic amino acid transmembrane transport,1/262,13/12185,0.246264443,0.772775304,0.646077073,SLC7A1,1,BP
GO:0034504,protein localization to nucleus,8/262,277/12185,0.246721668,0.77289339,0.646175798,CDK1/POLA2/PLK1/KPNA2/LMNB2/ECT2/LMNB1/CDKN1A,8,BP
GO:0097305,response to alcohol,5/262,157/12185,0.249273199,0.779560666,0.65174996,CDK1/RAD51/BLM/BRCA1/CDKN1A,5,BP
GO:0007020,microtubule nucleation,2/262,45/12185,0.252134995,0.783191671,0.654785653,CENPJ/TPX2,2,BP
GO:0031146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,2/262,45/12185,0.252134995,0.783191671,0.654785653,KIF14/CCNF,2,BP
GO:0032608,interferon-beta production,2/262,45/12185,0.252134995,0.783191671,0.654785653,TRAIP/HMGB2,2,BP
GO:0032648,regulation of interferon-beta production,2/262,45/12185,0.252134995,0.783191671,0.654785653,TRAIP/HMGB2,2,BP
GO:1900182,positive regulation of protein localization to nucleus,3/262,81/12185,0.252795571,0.783636531,0.655157578,CDK1/PLK1/ECT2,3,BP
GO:0042773,ATP synthesis coupled electron transport,3/262,82/12185,0.25859497,0.783636531,0.655157578,CDK1/NDUFAF1/CCNB1,3,BP
GO:0042775,mitochondrial ATP synthesis coupled electron transport,3/262,82/12185,0.25859497,0.783636531,0.655157578,CDK1/NDUFAF1/CCNB1,3,BP
GO:0006356,regulation of transcription by RNA polymerase I,2/262,46/12185,0.260144007,0.783636531,0.655157578,DDX11/DEK,2,BP
GO:0008089,anterograde axonal transport,2/262,46/12185,0.260144007,0.783636531,0.655157578,DLG2/KIF4A,2,BP
GO:0010324,membrane invagination,2/262,46/12185,0.260144007,0.783636531,0.655157578,AURKB/XKR5,2,BP
GO:0006206,pyrimidine nucleobase metabolic process,1/262,14/12185,0.262488458,0.783636531,0.655157578,RRM1,1,BP
GO:0006287,"base-excision repair, gap-filling",1/262,14/12185,0.262488458,0.783636531,0.655157578,POLE,1,BP
GO:0008356,asymmetric cell division,1/262,14/12185,0.262488458,0.783636531,0.655157578,ASPM,1,BP
GO:0010225,response to UV-C,1/262,14/12185,0.262488458,0.783636531,0.655157578,BRCA2,1,BP
GO:0034391,regulation of smooth muscle cell apoptotic process,1/262,14/12185,0.262488458,0.783636531,0.655157578,DNMT1,1,BP
GO:0042983,amyloid precursor protein biosynthetic process,1/262,14/12185,0.262488458,0.783636531,0.655157578,ITM2B,1,BP
GO:0042984,regulation of amyloid precursor protein biosynthetic process,1/262,14/12185,0.262488458,0.783636531,0.655157578,ITM2B,1,BP
GO:0045717,negative regulation of fatty acid biosynthetic process,1/262,14/12185,0.262488458,0.783636531,0.655157578,BRCA1,1,BP
GO:0045737,positive regulation of cyclin-dependent protein serine/threonine kinase activity,1/262,14/12185,0.262488458,0.783636531,0.655157578,PSRC1,1,BP
GO:0046655,folic acid metabolic process,1/262,14/12185,0.262488458,0.783636531,0.655157578,MTHFD2,1,BP
GO:0048634,regulation of muscle organ development,1/262,14/12185,0.262488458,0.783636531,0.655157578,CENPF,1,BP
GO:0051151,negative regulation of smooth muscle cell differentiation,1/262,14/12185,0.262488458,0.783636531,0.655157578,DNMT1,1,BP
GO:0051444,negative regulation of ubiquitin-protein transferase activity,1/262,14/12185,0.262488458,0.783636531,0.655157578,MAD2L1,1,BP
GO:0055012,ventricular cardiac muscle cell differentiation,1/262,14/12185,0.262488458,0.783636531,0.655157578,CDK1,1,BP
GO:0071027,nuclear RNA surveillance,1/262,14/12185,0.262488458,0.783636531,0.655157578,EXOSC8,1,BP
GO:0071731,response to nitric oxide,1/262,14/12185,0.262488458,0.783636531,0.655157578,CCNA2,1,BP
GO:1902170,cellular response to reactive nitrogen species,1/262,14/12185,0.262488458,0.783636531,0.655157578,CCNA2,1,BP
GO:1905063,regulation of vascular associated smooth muscle cell differentiation,1/262,14/12185,0.262488458,0.783636531,0.655157578,DNMT1,1,BP
GO:0006304,DNA modification,3/262,83/12185,0.264412147,0.788102224,0.65889111,HELLS/DNMT1/NEIL3,3,BP
GO:0006119,oxidative phosphorylation,4/262,122/12185,0.26770724,0.796634469,0.666024475,CDK1/NDUFAF1/MSH2/CCNB1,4,BP
GO:0001675,acrosome assembly,1/262,15/12185,0.278364559,0.815178883,0.681528491,KNL1,1,BP
GO:0033762,response to glucagon,1/262,15/12185,0.278364559,0.815178883,0.681528491,CCNA2,1,BP
GO:0034390,smooth muscle cell apoptotic process,1/262,15/12185,0.278364559,0.815178883,0.681528491,DNMT1,1,BP
GO:0045091,regulation of single stranded viral RNA replication via double stranded DNA intermediate,1/262,15/12185,0.278364559,0.815178883,0.681528491,TOP2A,1,BP
GO:0046597,negative regulation of viral entry into host cell,1/262,15/12185,0.278364559,0.815178883,0.681528491,TRIM59,1,BP
GO:0046653,tetrahydrofolate metabolic process,1/262,15/12185,0.278364559,0.815178883,0.681528491,MTHFD2,1,BP
GO:0060413,atrial septum morphogenesis,1/262,15/12185,0.278364559,0.815178883,0.681528491,NSD2,1,BP
GO:0070314,G1 to G0 transition,1/262,15/12185,0.278364559,0.815178883,0.681528491,PHGDH,1,BP
GO:1901836,regulation of transcription of nucleolar large rRNA by RNA polymerase I,1/262,15/12185,0.278364559,0.815178883,0.681528491,DDX11,1,BP
GO:2000269,regulation of fibroblast apoptotic process,1/262,15/12185,0.278364559,0.815178883,0.681528491,XRCC2,1,BP
GO:0016573,histone acetylation,2/262,49/12185,0.284171745,0.823804857,0.688740217,BRCA1/DEK,2,BP
GO:0034661,ncRNA catabolic process,2/262,49/12185,0.284171745,0.823804857,0.688740217,EXOSC8/SLFN13,2,BP
GO:0042306,regulation of protein import into nucleus,2/262,49/12185,0.284171745,0.823804857,0.688740217,CDK1/ECT2,2,BP
GO:1904705,regulation of vascular associated smooth muscle cell proliferation,2/262,49/12185,0.284171745,0.823804857,0.688740217,DNMT1/CDKN1A,2,BP
GO:0018107,peptidyl-threonine phosphorylation,3/262,87/12185,0.287824787,0.823804857,0.688740217,CDK1/CHEK1/PLK1,3,BP
GO:0072089,stem cell proliferation,3/262,87/12185,0.287824787,0.823804857,0.688740217,CDKN2C/BRCA2/HMGB2,3,BP
GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,3/262,88/12185,0.293705718,0.823804857,0.688740217,CDC20/PLK1/AURKA,3,BP
GO:0046660,female sex differentiation,3/262,88/12185,0.293705718,0.823804857,0.688740217,BRCA2/FANCA/FANCG,3,BP
GO:0002070,epithelial cell maturation,1/262,16/12185,0.293900178,0.823804857,0.688740217,CDKN1A,1,BP
GO:0002902,regulation of B cell apoptotic process,1/262,16/12185,0.293900178,0.823804857,0.688740217,AURKB,1,BP
GO:0006213,pyrimidine nucleoside metabolic process,1/262,16/12185,0.293900178,0.823804857,0.688740217,TK1,1,BP
GO:0007289,spermatid nucleus differentiation,1/262,16/12185,0.293900178,0.823804857,0.688740217,HMGB2,1,BP
GO:0007398,ectoderm development,1/262,16/12185,0.293900178,0.823804857,0.688740217,EDA2R,1,BP
GO:0009163,nucleoside biosynthetic process,1/262,16/12185,0.293900178,0.823804857,0.688740217,TK1,1,BP
GO:0015802,basic amino acid transport,1/262,16/12185,0.293900178,0.823804857,0.688740217,SLC7A1,1,BP
GO:0021692,cerebellar Purkinje cell layer morphogenesis,1/262,16/12185,0.293900178,0.823804857,0.688740217,KIF14,1,BP
GO:0030903,notochord development,1/262,16/12185,0.293900178,0.823804857,0.688740217,STIL,1,BP
GO:0033151,V(D)J recombination,1/262,16/12185,0.293900178,0.823804857,0.688740217,HMGB2,1,BP
GO:0034404,nucleobase-containing small molecule biosynthetic process,1/262,16/12185,0.293900178,0.823804857,0.688740217,TK1,1,BP
GO:0034497,protein localization to phagophore assembly site,1/262,16/12185,0.293900178,0.823804857,0.688740217,WDR45,1,BP
GO:0035795,negative regulation of mitochondrial membrane permeability,1/262,16/12185,0.293900178,0.823804857,0.688740217,ARHGAP11B,1,BP
GO:0039692,single stranded viral RNA replication via double stranded DNA intermediate,1/262,16/12185,0.293900178,0.823804857,0.688740217,TOP2A,1,BP
GO:0044321,response to leptin,1/262,16/12185,0.293900178,0.823804857,0.688740217,CCNA2,1,BP
GO:0070200,establishment of protein localization to telomere,1/262,16/12185,0.293900178,0.823804857,0.688740217,BRCA2,1,BP
GO:0090128,regulation of synapse maturation,1/262,16/12185,0.293900178,0.823804857,0.688740217,CDC20,1,BP
GO:0099116,tRNA 5'-end processing,1/262,16/12185,0.293900178,0.823804857,0.688740217,RPP25L,1,BP
GO:1902001,fatty acid transmembrane transport,1/262,16/12185,0.293900178,0.823804857,0.688740217,SLC25A20,1,BP
GO:1904031,positive regulation of cyclin-dependent protein kinase activity,1/262,16/12185,0.293900178,0.823804857,0.688740217,PSRC1,1,BP
GO:0021700,developmental maturation,6/262,209/12185,0.294279911,0.823804857,0.688740217,CDC20/KIF14/BRCA2/AURKA/TRIP13/CDKN1A,6,BP
GO:0021537,telencephalon development,6/262,210/12185,0.298019408,0.833007206,0.696433821,ASPM/KIF14/H2AX/ARHGAP11B/WDR62/TACC3,6,BP
GO:0046785,microtubule polymerization,3/262,89/12185,0.299594575,0.836141224,0.699054009,PSRC1/CENPJ/TPX2,3,BP
GO:1990874,vascular associated smooth muscle cell proliferation,2/262,51/12185,0.300154796,0.836437418,0.699301642,DNMT1/CDKN1A,2,BP
GO:0018393,internal peptidyl-lysine acetylation,2/262,52/12185,0.308125683,0.838537513,0.701057421,BRCA1/DEK,2,BP
GO:0048524,positive regulation of viral process,2/262,52/12185,0.308125683,0.838537513,0.701057421,TOP2A/KPNA2,2,BP
GO:0061180,mammary gland epithelium development,2/262,52/12185,0.308125683,0.838537513,0.701057421,IQGAP3/BRCA2,2,BP
GO:0070534,protein K63-linked ubiquitination,2/262,52/12185,0.308125683,0.838537513,0.701057421,UBE2T/UBE2S,2,BP
GO:0001516,prostaglandin biosynthetic process,1/262,17/12185,0.30910259,0.838537513,0.701057421,EDN2,1,BP
GO:0007000,nucleolus organization,1/262,17/12185,0.30910259,0.838537513,0.701057421,DDX11,1,BP
GO:0009070,serine family amino acid biosynthetic process,1/262,17/12185,0.30910259,0.838537513,0.701057421,PHGDH,1,BP
GO:0009135,purine nucleoside diphosphate metabolic process,1/262,17/12185,0.30910259,0.838537513,0.701057421,DLG2,1,BP
GO:0009162,deoxyribonucleoside monophosphate metabolic process,1/262,17/12185,0.30910259,0.838537513,0.701057421,TK1,1,BP
GO:0009179,purine ribonucleoside diphosphate metabolic process,1/262,17/12185,0.30910259,0.838537513,0.701057421,DLG2,1,BP
GO:0010804,negative regulation of tumor necrosis factor-mediated signaling pathway,1/262,17/12185,0.30910259,0.838537513,0.701057421,TRAIP,1,BP
GO:0034698,response to gonadotropin,1/262,17/12185,0.30910259,0.838537513,0.701057421,CCNA2,1,BP
GO:0046457,prostanoid biosynthetic process,1/262,17/12185,0.30910259,0.838537513,0.701057421,EDN2,1,BP
GO:0051590,positive regulation of neurotransmitter transport,1/262,17/12185,0.30910259,0.838537513,0.701057421,SLC4A8,1,BP
GO:0060706,cell differentiation involved in embryonic placenta development,1/262,17/12185,0.30910259,0.838537513,0.701057421,PLK4,1,BP
GO:0071025,RNA surveillance,1/262,17/12185,0.30910259,0.838537513,0.701057421,EXOSC8,1,BP
GO:1902018,negative regulation of cilium assembly,1/262,17/12185,0.30910259,0.838537513,0.701057421,KIF24,1,BP
GO:1903902,positive regulation of viral life cycle,1/262,17/12185,0.30910259,0.838537513,0.701057421,KPNA2,1,BP
GO:0046824,positive regulation of nucleocytoplasmic transport,2/262,53/12185,0.316078703,0.856196789,0.71582142,CDK1/ECT2,2,BP
GO:0015698,inorganic anion transport,3/262,92/12185,0.317293443,0.856196789,0.71582142,RACGAP1/SLC4A8/ANO7,3,BP
GO:0042752,regulation of circadian rhythm,3/262,92/12185,0.317293443,0.856196789,0.71582142,CDK1/TIMELESS/TOP2A,3,BP
GO:0022411,cellular component disassembly,11/262,430/12185,0.320781415,0.856196789,0.71582142,KIF2C/CDK1/KIF18A/PLK1/TOP2A/KIF18B/TPX2/AURKA/SPATA18/KIF24/WDR45,11,BP
GO:0002440,production of molecular mediator of immune response,4/262,133/12185,0.320825874,0.856196789,0.71582142,EXO1/MSH2/POLQ/NSD2,4,BP
GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,4/262,133/12185,0.320825874,0.856196789,0.71582142,CDC20/PLK1/AURKA/PBK,4,BP
GO:0043543,protein acylation,4/262,133/12185,0.320825874,0.856196789,0.71582142,BRCA1/DEK/ESCO2/DSCC1,4,BP
GO:0006027,glycosaminoglycan catabolic process,1/262,18/12185,0.323978915,0.856196789,0.71582142,HMMR,1,BP
GO:0007339,binding of sperm to zona pellucida,1/262,18/12185,0.323978915,0.856196789,0.71582142,ATP8B3,1,BP
GO:0015697,quaternary ammonium group transport,1/262,18/12185,0.323978915,0.856196789,0.71582142,SLC25A20,1,BP
GO:0035372,protein localization to microtubule,1/262,18/12185,0.323978915,0.856196789,0.71582142,KIF20B,1,BP
GO:0045945,positive regulation of transcription by RNA polymerase III,1/262,18/12185,0.323978915,0.856196789,0.71582142,DEK,1,BP
GO:0046794,transport of virus,1/262,18/12185,0.323978915,0.856196789,0.71582142,KPNA2,1,BP
GO:0055093,response to hyperoxia,1/262,18/12185,0.323978915,0.856196789,0.71582142,CDKN1A,1,BP
GO:0060575,intestinal epithelial cell differentiation,1/262,18/12185,0.323978915,0.856196789,0.71582142,CDKN1A,1,BP
GO:1903901,negative regulation of viral life cycle,1/262,18/12185,0.323978915,0.856196789,0.71582142,TRIM59,1,BP
GO:1905709,negative regulation of membrane permeability,1/262,18/12185,0.323978915,0.856196789,0.71582142,ARHGAP11B,1,BP
GO:2000773,negative regulation of cellular senescence,1/262,18/12185,0.323978915,0.856196789,0.71582142,RBL1,1,BP
GO:0018210,peptidyl-threonine modification,3/262,94/12185,0.329104866,0.868497367,0.726105291,CDK1/CHEK1/PLK1,3,BP
GO:0006475,internal protein amino acid acetylation,2/262,55/12185,0.331919641,0.874591213,0.731200037,BRCA1/DEK,2,BP
GO:0051260,protein homooligomerization,4/262,136/12185,0.335482227,0.874591213,0.731200037,BLM/TK1/POLQ/ECT2,4,BP
GO:0000028,ribosomal small subunit assembly,1/262,19/12185,0.338536121,0.874591213,0.731200037,RPS27L,1,BP
GO:0006607,NLS-bearing protein import into nucleus,1/262,19/12185,0.338536121,0.874591213,0.731200037,KPNA2,1,BP
GO:0010460,positive regulation of heart rate,1/262,19/12185,0.338536121,0.874591213,0.731200037,EDN2,1,BP
GO:0010575,positive regulation of vascular endothelial growth factor production,1/262,19/12185,0.338536121,0.874591213,0.731200037,BRCA1,1,BP
GO:0014829,vascular associated smooth muscle contraction,1/262,19/12185,0.338536121,0.874591213,0.731200037,EDN2,1,BP
GO:0032211,negative regulation of telomere maintenance via telomerase,1/262,19/12185,0.338536121,0.874591213,0.731200037,PIF1,1,BP
GO:0033622,integrin activation,1/262,19/12185,0.338536121,0.874591213,0.731200037,KIF14,1,BP
GO:0044804,nucleophagy,1/262,19/12185,0.338536121,0.874591213,0.731200037,WDR45,1,BP
GO:0045987,positive regulation of smooth muscle contraction,1/262,19/12185,0.338536121,0.874591213,0.731200037,EDN2,1,BP
GO:0071295,cellular response to vitamin,1/262,19/12185,0.338536121,0.874591213,0.731200037,BRIP1,1,BP
GO:0090305,nucleic acid phosphodiester bond hydrolysis,1/262,19/12185,0.338536121,0.874591213,0.731200037,DNA2,1,BP
GO:2000647,negative regulation of stem cell proliferation,1/262,19/12185,0.338536121,0.874591213,0.731200037,CDKN2C,1,BP
GO:2000786,positive regulation of autophagosome assembly,1/262,19/12185,0.338536121,0.874591213,0.731200037,WDR45,1,BP
GO:1902476,chloride transmembrane transport,2/262,56/12185,0.339802134,0.876632395,0.732906562,SLC4A8/ANO7,2,BP
GO:0031099,regeneration,4/262,138/12185,0.345270674,0.88949452,0.743659913,CDK1/AURKA/CCNA2/CDKN1A,4,BP
GO:0043462,regulation of ATP-dependent activity,2/262,57/12185,0.347655901,0.893141101,0.746708629,UHRF1/MSH2,2,BP
GO:0070301,cellular response to hydrogen peroxide,2/262,57/12185,0.347655901,0.893141101,0.746708629,CDK1/ECT2,2,BP
GO:0000291,"nuclear-transcribed mRNA catabolic process, exonucleolytic",1/262,20/12185,0.352781028,0.893841339,0.747294062,EXOSC8,1,BP
GO:0006026,aminoglycan catabolic process,1/262,20/12185,0.352781028,0.893841339,0.747294062,HMMR,1,BP
GO:0008090,retrograde axonal transport,1/262,20/12185,0.352781028,0.893841339,0.747294062,DLG2,1,BP
GO:0009065,glutamine family amino acid catabolic process,1/262,20/12185,0.352781028,0.893841339,0.747294062,ARHGAP11B,1,BP
GO:0009584,detection of visible light,1/262,20/12185,0.352781028,0.893841339,0.747294062,CEP250,1,BP
GO:0021772,olfactory bulb development,1/262,20/12185,0.352781028,0.893841339,0.747294062,KIF14,1,BP
GO:0035036,sperm-egg recognition,1/262,20/12185,0.352781028,0.893841339,0.747294062,ATP8B3,1,BP
GO:0036120,cellular response to platelet-derived growth factor stimulus,1/262,20/12185,0.352781028,0.893841339,0.747294062,CCNA2,1,BP
GO:0042278,purine nucleoside metabolic process,1/262,20/12185,0.352781028,0.893841339,0.747294062,MACROD2,1,BP
GO:1904706,negative regulation of vascular associated smooth muscle cell proliferation,1/262,20/12185,0.352781028,0.893841339,0.747294062,CDKN1A,1,BP
GO:0022900,electron transport chain,4/262,140/12185,0.355065598,0.896974613,0.749913629,PHGDH/CDK1/NDUFAF1/CCNB1,4,BP
GO:1903008,organelle disassembly,4/262,140/12185,0.355065598,0.896974613,0.749913629,CDK1/AURKA/SPATA18/WDR45,4,BP
GO:1905515,non-motile cilium assembly,2/262,58/12185,0.355478538,0.896974613,0.749913629,CENPJ/CEP250,2,BP
GO:1903900,regulation of viral life cycle,3/262,99/12185,0.358594885,0.903600244,0.755452973,TOP2A/KPNA2/TRIM59,3,BP
GO:0032204,regulation of telomere maintenance,3/262,100/12185,0.364475811,0.905494386,0.757036566,NEK2/PIF1/AURKB,3,BP
GO:1901796,regulation of signal transduction by p53 class mediator,3/262,100/12185,0.364475811,0.905494386,0.757036566,CHEK1/AURKB/AURKA,3,BP
GO:0001990,regulation of systemic arterial blood pressure by hormone,1/262,21/12185,0.36672031,0.905494386,0.757036566,EDN2,1,BP
GO:0010574,regulation of vascular endothelial growth factor production,1/262,21/12185,0.36672031,0.905494386,0.757036566,BRCA1,1,BP
GO:0034471,ncRNA 5'-end processing,1/262,21/12185,0.36672031,0.905494386,0.757036566,RPP25L,1,BP
GO:0034472,snRNA 3'-end processing,1/262,21/12185,0.36672031,0.905494386,0.757036566,EXOSC8,1,BP
GO:0035268,protein mannosylation,1/262,21/12185,0.36672031,0.905494386,0.757036566,DPY19L2P2,1,BP
GO:0042790,nucleolar large rRNA transcription by RNA polymerase I,1/262,21/12185,0.36672031,0.905494386,0.757036566,DDX11,1,BP
GO:0044346,fibroblast apoptotic process,1/262,21/12185,0.36672031,0.905494386,0.757036566,XRCC2,1,BP
GO:0046688,response to copper ion,1/262,21/12185,0.36672031,0.905494386,0.757036566,CDK1,1,BP
GO:0051131,chaperone-mediated protein complex assembly,1/262,21/12185,0.36672031,0.905494386,0.757036566,NDUFAF1,1,BP
GO:0060045,positive regulation of cardiac muscle cell proliferation,1/262,21/12185,0.36672031,0.905494386,0.757036566,CDK1,1,BP
GO:0090141,positive regulation of mitochondrial fission,1/262,21/12185,0.36672031,0.905494386,0.757036566,AURKA,1,BP
GO:1901673,regulation of mitotic spindle assembly,1/262,21/12185,0.36672031,0.905494386,0.757036566,PLK1,1,BP
GO:2000114,regulation of establishment of cell polarity,1/262,21/12185,0.36672031,0.905494386,0.757036566,KIF20B,1,BP
GO:0009064,glutamine family amino acid metabolic process,2/262,60/12185,0.371021381,0.908721197,0.759734334,PHGDH/ARHGAP11B,2,BP
GO:0072091,regulation of stem cell proliferation,2/262,60/12185,0.371021381,0.908721197,0.759734334,CDKN2C/HMGB2,2,BP
GO:0098930,axonal transport,2/262,60/12185,0.371021381,0.908721197,0.759734334,DLG2/KIF4A,2,BP
GO:1901657,glycosyl compound metabolic process,2/262,60/12185,0.371021381,0.908721197,0.759734334,TK1/MACROD2,2,BP
GO:1902017,regulation of cilium assembly,2/262,60/12185,0.371021381,0.908721197,0.759734334,CENPJ/KIF24,2,BP
GO:2000377,regulation of reactive oxygen species metabolic process,3/262,102/12185,0.376210708,0.908721197,0.759734334,FOXM1/BRCA1/CDKN1A,3,BP
GO:0009123,nucleoside monophosphate metabolic process,2/262,61/12185,0.37873734,0.908721197,0.759734334,DLG2/TK1,2,BP
GO:0097194,execution phase of apoptosis,2/262,61/12185,0.37873734,0.908721197,0.759734334,TOP2A/XKR5,2,BP
GO:0009410,response to xenobiotic stimulus,7/262,275/12185,0.379359304,0.908721197,0.759734334,RAD54L/CENPF/CDK1/E2F1/CDKN1A/MCM7/RAD54B,7,BP
GO:0000966,RNA 5'-end processing,1/262,22/12185,0.380360501,0.908721197,0.759734334,RPP25L,1,BP
GO:0001783,B cell apoptotic process,1/262,22/12185,0.380360501,0.908721197,0.759734334,AURKB,1,BP
GO:0001835,blastocyst hatching,1/262,22/12185,0.380360501,0.908721197,0.759734334,RBBP8,1,BP
GO:0002455,humoral immune response mediated by circulating immunoglobulin,1/262,22/12185,0.380360501,0.908721197,0.759734334,EXO1,1,BP
GO:0015701,bicarbonate transport,1/262,22/12185,0.380360501,0.908721197,0.759734334,SLC4A8,1,BP
GO:0021988,olfactory lobe development,1/262,22/12185,0.380360501,0.908721197,0.759734334,KIF14,1,BP
GO:0030262,apoptotic nuclear changes,1/262,22/12185,0.380360501,0.908721197,0.759734334,TOP2A,1,BP
GO:0035188,hatching,1/262,22/12185,0.380360501,0.908721197,0.759734334,RBBP8,1,BP
GO:0035330,regulation of hippo signaling,1/262,22/12185,0.380360501,0.908721197,0.759734334,CIT,1,BP
GO:0036119,response to platelet-derived growth factor,1/262,22/12185,0.380360501,0.908721197,0.759734334,CCNA2,1,BP
GO:0048246,macrophage chemotaxis,1/262,22/12185,0.380360501,0.908721197,0.759734334,EDN2,1,BP
GO:0050829,defense response to Gram-negative bacterium,1/262,22/12185,0.380360501,0.908721197,0.759734334,HMGB2,1,BP
GO:0071684,organism emergence from protective structure,1/262,22/12185,0.380360501,0.908721197,0.759734334,RBBP8,1,BP
GO:0097421,liver regeneration,1/262,22/12185,0.380360501,0.908721197,0.759734334,AURKA,1,BP
GO:0097502,mannosylation,1/262,22/12185,0.380360501,0.908721197,0.759734334,DPY19L2P2,1,BP
GO:1901659,glycosyl compound biosynthetic process,1/262,22/12185,0.380360501,0.908721197,0.759734334,TK1,1,BP
GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,3/262,103/12185,0.382062344,0.911604711,0.76214509,CDC20/PLK1/AURKA,3,BP
GO:0070936,protein K48-linked ubiquitination,2/262,62/12185,0.386413672,0.920794287,0.769828014,UBE2T/UBE2C,2,BP
GO:0022904,respiratory electron transport chain,3/262,104/12185,0.387901929,0.92314645,0.771794535,CDK1/NDUFAF1/CCNB1,3,BP
GO:0002026,regulation of the force of heart contraction,1/262,23/12185,0.393707993,0.928180769,0.776003466,EDN2,1,BP
GO:0003283,atrial septum development,1/262,23/12185,0.393707993,0.928180769,0.776003466,NSD2,1,BP
GO:0010800,positive regulation of peptidyl-threonine phosphorylation,1/262,23/12185,0.393707993,0.928180769,0.776003466,PLK1,1,BP
GO:0044090,positive regulation of vacuole organization,1/262,23/12185,0.393707993,0.928180769,0.776003466,WDR45,1,BP
GO:0045652,regulation of megakaryocyte differentiation,1/262,23/12185,0.393707993,0.928180769,0.776003466,HMGB2,1,BP
GO:0046037,GMP metabolic process,1/262,23/12185,0.393707993,0.928180769,0.776003466,DLG2,1,BP
GO:0051385,response to mineralocorticoid,1/262,23/12185,0.393707993,0.928180769,0.776003466,CDKN1A,1,BP
GO:0006821,chloride transport,2/262,63/12185,0.394048513,0.928180769,0.776003466,SLC4A8/ANO7,2,BP
GO:0030218,erythrocyte differentiation,3/262,106/12185,0.399540595,0.939915422,0.785814197,RACGAP1/HMGB2/NCAPG2,3,BP
GO:0015748,organophosphate ester transport,3/262,107/12185,0.405337572,0.943663199,0.788947517,ATP8B3/ANO7/XKR5,3,BP
GO:0006921,cellular component disassembly involved in execution phase of apoptosis,1/262,24/12185,0.406769045,0.943663199,0.788947517,TOP2A,1,BP
GO:0010573,vascular endothelial growth factor production,1/262,24/12185,0.406769045,0.943663199,0.788947517,BRCA1,1,BP
GO:0021680,cerebellar Purkinje cell layer development,1/262,24/12185,0.406769045,0.943663199,0.788947517,KIF14,1,BP
GO:0030212,hyaluronan metabolic process,1/262,24/12185,0.406769045,0.943663199,0.788947517,HMMR,1,BP
GO:0032878,regulation of establishment or maintenance of cell polarity,1/262,24/12185,0.406769045,0.943663199,0.788947517,KIF20B,1,BP
GO:0045922,negative regulation of fatty acid metabolic process,1/262,24/12185,0.406769045,0.943663199,0.788947517,BRCA1,1,BP
GO:0046427,positive regulation of receptor signaling pathway via JAK-STAT,1/262,24/12185,0.406769045,0.943663199,0.788947517,CENPJ,1,BP
GO:0055023,positive regulation of cardiac muscle tissue growth,1/262,24/12185,0.406769045,0.943663199,0.788947517,CDK1,1,BP
GO:0070199,establishment of protein localization to chromosome,1/262,24/12185,0.406769045,0.943663199,0.788947517,BRCA2,1,BP
GO:0071353,cellular response to interleukin-4,1/262,24/12185,0.406769045,0.943663199,0.788947517,MCM2,1,BP
GO:0018394,peptidyl-lysine acetylation,2/262,65/12185,0.409186759,0.948078001,0.792638502,BRCA1/DEK,2,BP
GO:1901800,positive regulation of proteasomal protein catabolic process,3/262,108/12185,0.41111829,0.951356646,0.795379606,CDC20/PLK1/AURKA,3,BP
GO:0002708,positive regulation of lymphocyte mediated immunity,2/262,66/12185,0.416686914,0.955401425,0.798761235,MSH2/NSD2,2,BP
GO:0009798,axis specification,2/262,66/12185,0.416686914,0.955401425,0.798761235,STIL/AURKA,2,BP
GO:0046718,viral entry into host cell,3/262,109/12185,0.416881767,0.955401425,0.798761235,CDK1/SLC7A1/TRIM59,3,BP
GO:0000466,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",1/262,25/12185,0.419549779,0.955401425,0.798761235,EXOSC8,1,BP
GO:0003209,cardiac atrium morphogenesis,1/262,25/12185,0.419549779,0.955401425,0.798761235,NSD2,1,BP
GO:0006760,folic acid-containing compound metabolic process,1/262,25/12185,0.419549779,0.955401425,0.798761235,MTHFD2,1,BP
GO:0007026,negative regulation of microtubule depolymerization,1/262,25/12185,0.419549779,0.955401425,0.798761235,TPX2,1,BP
GO:0030890,positive regulation of B cell proliferation,1/262,25/12185,0.419549779,0.955401425,0.798761235,CDKN1A,1,BP
GO:0036296,response to increased oxygen levels,1/262,25/12185,0.419549779,0.955401425,0.798761235,CDKN1A,1,BP
GO:0045724,positive regulation of cilium assembly,1/262,25/12185,0.419549779,0.955401425,0.798761235,CENPJ,1,BP
GO:0070670,response to interleukin-4,1/262,25/12185,0.419549779,0.955401425,0.798761235,MCM2,1,BP
GO:1904357,negative regulation of telomere maintenance via telomere lengthening,1/262,25/12185,0.419549779,0.955401425,0.798761235,PIF1,1,BP
GO:0007264,small GTPase mediated signal transduction,10/262,421/12185,0.419608986,0.955401425,0.798761235,GPSM2/IQGAP3/KIF14/FOXM1/RACGAP1/ARHGAP11B/ARHGAP11A/ECT2/CCNA2/CDKN1A,10,BP
GO:2001242,regulation of intrinsic apoptotic signaling pathway,4/262,154/12185,0.423305943,0.962147997,0.804401691,RTKN2/HELLS/DDIAS/FIGNL1,4,BP
GO:0003281,ventricular septum development,2/262,67/12185,0.424139073,0.962147997,0.804401691,NSD2/CNTRL,2,BP
GO:0072527,pyrimidine-containing compound metabolic process,2/262,67/12185,0.424139073,0.962147997,0.804401691,RRM1/TK1,2,BP
GO:0019058,viral life cycle,6/262,244/12185,0.428059083,0.963495765,0.80552849,CDK1/SLC7A1/TOP2A/KPNA2/TRIM59/DEK,6,BP
GO:0009582,detection of abiotic stimulus,2/262,68/12185,0.43154183,0.963495765,0.80552849,TIMELESS/CEP250,2,BP
GO:0032206,positive regulation of telomere maintenance,2/262,68/12185,0.43154183,0.963495765,0.80552849,NEK2/AURKB,2,BP
GO:0000578,embryonic axis specification,1/262,26/12185,0.43205619,0.963495765,0.80552849,STIL,1,BP
GO:0016180,snRNA processing,1/262,26/12185,0.43205619,0.963495765,0.80552849,EXOSC8,1,BP
GO:0019755,one-carbon compound transport,1/262,26/12185,0.43205619,0.963495765,0.80552849,SLC4A8,1,BP
GO:0033687,osteoblast proliferation,1/262,26/12185,0.43205619,0.963495765,0.80552849,FIGNL1,1,BP
GO:0035886,vascular associated smooth muscle cell differentiation,1/262,26/12185,0.43205619,0.963495765,0.80552849,DNMT1,1,BP
GO:0039694,viral RNA genome replication,1/262,26/12185,0.43205619,0.963495765,0.80552849,TOP2A,1,BP
GO:0045070,positive regulation of viral genome replication,1/262,26/12185,0.43205619,0.963495765,0.80552849,TOP2A,1,BP
GO:0045648,positive regulation of erythrocyte differentiation,1/262,26/12185,0.43205619,0.963495765,0.80552849,HMGB2,1,BP
GO:0048854,brain morphogenesis,1/262,26/12185,0.43205619,0.963495765,0.80552849,FANCD2,1,BP
GO:0060074,synapse maturation,1/262,26/12185,0.43205619,0.963495765,0.80552849,CDC20,1,BP
GO:1904894,positive regulation of receptor signaling pathway via STAT,1/262,26/12185,0.43205619,0.963495765,0.80552849,CENPJ,1,BP
GO:0098661,inorganic anion transmembrane transport,2/262,69/12185,0.438893861,0.977560449,0.817287237,SLC4A8/ANO7,2,BP
GO:0034101,erythrocyte homeostasis,3/262,113/12185,0.439744611,0.978272433,0.81788249,RACGAP1/HMGB2/NCAPG2,3,BP
GO:0051056,regulation of small GTPase mediated signal transduction,6/262,248/12185,0.443350286,0.978760853,0.818290832,KIF14/FOXM1/RACGAP1/ARHGAP11B/ARHGAP11A/ECT2,6,BP
GO:0003044,regulation of systemic arterial blood pressure mediated by a chemical signal,1/262,27/12185,0.444294144,0.978760853,0.818290832,EDN2,1,BP
GO:0009583,detection of light stimulus,1/262,27/12185,0.444294144,0.978760853,0.818290832,CEP250,1,BP
GO:0046456,icosanoid biosynthetic process,1/262,27/12185,0.444294144,0.978760853,0.818290832,EDN2,1,BP
GO:0060421,positive regulation of heart growth,1/262,27/12185,0.444294144,0.978760853,0.818290832,CDK1,1,BP
GO:1903670,regulation of sprouting angiogenesis,1/262,27/12185,0.444294144,0.978760853,0.818290832,E2F2,1,BP
GO:1904376,negative regulation of protein localization to cell periphery,1/262,27/12185,0.444294144,0.978760853,0.818290832,SAPCD2,1,BP
GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,2/262,70/12185,0.44619392,0.978760853,0.818290832,MSH2/NSD2,2,BP
GO:0006360,transcription by RNA polymerase I,2/262,70/12185,0.44619392,0.978760853,0.818290832,DDX11/DEK,2,BP
GO:0007338,single fertilization,2/262,70/12185,0.44619392,0.978760853,0.818290832,CDK1/ATP8B3,2,BP
GO:0050671,positive regulation of lymphocyte proliferation,2/262,70/12185,0.44619392,0.978760853,0.818290832,SLC7A1/CDKN1A,2,BP
GO:0007265,Ras protein signal transduction,7/262,294/12185,0.446340454,0.978760853,0.818290832,GPSM2/IQGAP3/KIF14/FOXM1/RACGAP1/CCNA2/CDKN1A,7,BP
GO:0000209,protein polyubiquitination,5/262,204/12185,0.447602324,0.980360857,0.819628513,UBE2T/DTL/BRCA1/UBE2S/UBE2C,5,BP
GO:0002285,lymphocyte activation involved in immune response,3/262,115/12185,0.451049093,0.985566346,0.82398055,EXO1/MSH2/NSD2,3,BP
GO:0044409,entry into host,3/262,115/12185,0.451049093,0.985566346,0.82398055,CDK1/SLC7A1/TRIM59,3,BP
GO:0030308,negative regulation of cell growth,4/262,160/12185,0.452077666,0.986441549,0.824712261,CDKN2C/PSRC1/BRCA1/CDKN1A,4,BP
GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,2/262,71/12185,0.45344084,0.986441549,0.824712261,BRCA1/HMGB2,2,BP
GO:0009112,nucleobase metabolic process,1/262,28/12185,0.456269381,0.986441549,0.824712261,RRM1,1,BP
GO:0043029,T cell homeostasis,1/262,28/12185,0.456269381,0.986441549,0.824712261,CCNB2,1,BP
GO:0043550,regulation of lipid kinase activity,1/262,28/12185,0.456269381,0.986441549,0.824712261,RBL1,1,BP
GO:0070229,negative regulation of lymphocyte apoptotic process,1/262,28/12185,0.456269381,0.986441549,0.824712261,AURKB,1,BP
GO:0090140,regulation of mitochondrial fission,1/262,28/12185,0.456269381,0.986441549,0.824712261,AURKA,1,BP
GO:1902230,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,1/262,28/12185,0.456269381,0.986441549,0.824712261,DDIAS,1,BP
GO:1903307,positive regulation of regulated secretory pathway,1/262,28/12185,0.456269381,0.986441549,0.824712261,SLC4A8,1,BP
GO:0008088,axo-dendritic transport,2/262,72/12185,0.460633527,0.990842543,0.828391703,DLG2/KIF4A,2,BP
GO:2000058,regulation of ubiquitin-dependent protein catabolic process,4/262,162/12185,0.461569111,0.990842543,0.828391703,CDC20/PLK1/AURKA/PBK,4,BP
GO:0010232,vascular transport,2/262,73/12185,0.467770957,0.990842543,0.828391703,SLC4A8/SLC7A1,2,BP
GO:0032946,positive regulation of mononuclear cell proliferation,2/262,73/12185,0.467770957,0.990842543,0.828391703,SLC7A1/CDKN1A,2,BP
GO:0150104,transport across blood-brain barrier,2/262,73/12185,0.467770957,0.990842543,0.828391703,SLC4A8/SLC7A1,2,BP
GO:0006693,prostaglandin metabolic process,1/262,29/12185,0.46798752,0.990842543,0.828391703,EDN2,1,BP
GO:0006730,one-carbon metabolic process,1/262,29/12185,0.46798752,0.990842543,0.828391703,MTHFD2,1,BP
GO:0009048,dosage compensation by inactivation of X chromosome,1/262,29/12185,0.46798752,0.990842543,0.828391703,BRCA1,1,BP
GO:0021591,ventricular system development,1/262,29/12185,0.46798752,0.990842543,0.828391703,CENPF,1,BP
GO:0021696,cerebellar cortex morphogenesis,1/262,29/12185,0.46798752,0.990842543,0.828391703,KIF14,1,BP
GO:0031114,regulation of microtubule depolymerization,1/262,29/12185,0.46798752,0.990842543,0.828391703,TPX2,1,BP
GO:0033146,regulation of intracellular estrogen receptor signaling pathway,1/262,29/12185,0.46798752,0.990842543,0.828391703,BRCA1,1,BP
GO:0045823,positive regulation of heart contraction,1/262,29/12185,0.46798752,0.990842543,0.828391703,EDN2,1,BP
GO:0051150,regulation of smooth muscle cell differentiation,1/262,29/12185,0.46798752,0.990842543,0.828391703,DNMT1,1,BP
GO:0070198,"protein localization to chromosome, telomeric region",1/262,29/12185,0.46798752,0.990842543,0.828391703,BRCA2,1,BP
GO:0120033,negative regulation of plasma membrane bounded cell projection assembly,1/262,29/12185,0.46798752,0.990842543,0.828391703,KIF24,1,BP
GO:1903524,positive regulation of blood circulation,1/262,29/12185,0.46798752,0.990842543,0.828391703,EDN2,1,BP
GO:1904707,positive regulation of vascular associated smooth muscle cell proliferation,1/262,29/12185,0.46798752,0.990842543,0.828391703,DNMT1,1,BP
GO:1904375,regulation of protein localization to cell periphery,3/262,119/12185,0.473371935,0.9934245,0.830550342,GPSM2/PLK1/SAPCD2,3,BP
GO:0002821,positive regulation of adaptive immune response,2/262,74/12185,0.474852176,0.9934245,0.830550342,MSH2/NSD2,2,BP
GO:0050792,regulation of viral process,3/262,120/12185,0.478888746,0.9934245,0.830550342,TOP2A/KPNA2/TRIM59,3,BP
GO:0006359,regulation of transcription by RNA polymerase III,1/262,30/12185,0.479454061,0.9934245,0.830550342,DEK,1,BP
GO:0006692,prostanoid metabolic process,1/262,30/12185,0.479454061,0.9934245,0.830550342,EDN2,1,BP
GO:0006911,"phagocytosis, engulfment",1/262,30/12185,0.479454061,0.9934245,0.830550342,XKR5,1,BP
GO:0009069,serine family amino acid metabolic process,1/262,30/12185,0.479454061,0.9934245,0.830550342,PHGDH,1,BP
GO:0009988,cell-cell recognition,1/262,30/12185,0.479454061,0.9934245,0.830550342,ATP8B3,1,BP
GO:0010656,negative regulation of muscle cell apoptotic process,1/262,30/12185,0.479454061,0.9934245,0.830550342,DNMT1,1,BP
GO:0016242,negative regulation of macroautophagy,1/262,30/12185,0.479454061,0.9934245,0.830550342,LZTS1,1,BP
GO:0021872,forebrain generation of neurons,1/262,30/12185,0.479454061,0.9934245,0.830550342,ASPM,1,BP
GO:0032480,negative regulation of type I interferon production,1/262,30/12185,0.479454061,0.9934245,0.830550342,TRAIP,1,BP
GO:0032728,positive regulation of interferon-beta production,1/262,30/12185,0.479454061,0.9934245,0.830550342,HMGB2,1,BP
GO:0042304,regulation of fatty acid biosynthetic process,1/262,30/12185,0.479454061,0.9934245,0.830550342,BRCA1,1,BP
GO:0042558,pteridine-containing compound metabolic process,1/262,30/12185,0.479454061,0.9934245,0.830550342,MTHFD2,1,BP
GO:0046596,regulation of viral entry into host cell,1/262,30/12185,0.479454061,0.9934245,0.830550342,TRIM59,1,BP
GO:0051353,positive regulation of oxidoreductase activity,1/262,30/12185,0.479454061,0.9934245,0.830550342,EDN2,1,BP
GO:0060043,regulation of cardiac muscle cell proliferation,1/262,30/12185,0.479454061,0.9934245,0.830550342,CDK1,1,BP
GO:0060218,hematopoietic stem cell differentiation,1/262,30/12185,0.479454061,0.9934245,0.830550342,CHD2,1,BP
GO:0031503,protein-containing complex localization,4/262,166/12185,0.480377629,0.994219767,0.831215223,DLG2/BIRC5/LMNB2/LMNB1,4,BP
GO:0051402,neuron apoptotic process,5/262,212/12185,0.480983431,0.994356318,0.831329386,KIF14/CIT/MSH2/MYBL2/XRCC2,5,BP
GO:0046777,protein autophosphorylation,4/262,167/12185,0.485040534,0.999969493,0.836022269,NEK2/AURKB/AURKA/MELK,4,BP
GO:0002705,positive regulation of leukocyte mediated immunity,2/262,76/12185,0.48884249,0.999969493,0.836022269,MSH2/NSD2,2,BP
GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,2/262,76/12185,0.48884249,0.999969493,0.836022269,BRCA1/HMGB2,2,BP
GO:0009060,aerobic respiration,4/262,168/12185,0.489686803,0.999969493,0.836022269,CDK1/NDUFAF1/MSH2/CCNB1,4,BP
GO:0007549,dosage compensation,1/262,31/12185,0.490674385,0.999969493,0.836022269,BRCA1,1,BP
GO:0031116,positive regulation of microtubule polymerization,1/262,31/12185,0.490674385,0.999969493,0.836022269,PSRC1,1,BP
GO:0033144,negative regulation of intracellular steroid hormone receptor signaling pathway,1/262,31/12185,0.490674385,0.999969493,0.836022269,BRCA1,1,BP
GO:0033574,response to testosterone,1/262,31/12185,0.490674385,0.999969493,0.836022269,NASP,1,BP
GO:0043276,anoikis,1/262,31/12185,0.490674385,0.999969493,0.836022269,E2F1,1,BP
GO:0050830,defense response to Gram-positive bacterium,1/262,31/12185,0.490674385,0.999969493,0.836022269,HMGB2,1,BP
GO:0071425,hematopoietic stem cell proliferation,1/262,31/12185,0.490674385,0.999969493,0.836022269,BRCA2,1,BP
GO:0099068,postsynapse assembly,1/262,31/12185,0.490674385,0.999969493,0.836022269,LZTS1,1,BP
GO:0043524,negative regulation of neuron apoptotic process,3/262,124/12185,0.500680354,0.999969493,0.836022269,KIF14/MSH2/XRCC2,3,BP
GO:1900180,regulation of protein localization to nucleus,3/262,124/12185,0.500680354,0.999969493,0.836022269,CDK1/PLK1/ECT2,3,BP
GO:0010559,regulation of glycoprotein biosynthetic process,1/262,32/12185,0.501653759,0.999969493,0.836022269,ITM2B,1,BP
GO:0043388,positive regulation of DNA binding,1/262,32/12185,0.501653759,0.999969493,0.836022269,HMGB2,1,BP
GO:0043392,negative regulation of DNA binding,1/262,32/12185,0.501653759,0.999969493,0.836022269,E2F1,1,BP
GO:0046685,response to arsenic-containing substance,1/262,32/12185,0.501653759,0.999969493,0.836022269,CDKN1A,1,BP
GO:0002702,positive regulation of production of molecular mediator of immune response,2/262,78/12185,0.502598114,0.999969493,0.836022269,MSH2/NSD2,2,BP
GO:0033209,tumor necrosis factor-mediated signaling pathway,2/262,78/12185,0.502598114,0.999969493,0.836022269,TRAIP/EDA2R,2,BP
GO:0042113,B cell activation,4/262,171/12185,0.503521317,0.999969493,0.836022269,EXO1/MSH2/NSD2/CDKN1A,4,BP
GO:1903052,positive regulation of proteolysis involved in protein catabolic process,3/262,125/12185,0.506056304,0.999969493,0.836022269,CDC20/PLK1/AURKA,3,BP
GO:0043523,regulation of neuron apoptotic process,4/262,172/12185,0.508096622,0.999969493,0.836022269,KIF14/MSH2/MYBL2/XRCC2,4,BP
GO:0032355,response to estradiol,2/262,79/12185,0.509386192,0.999969493,0.836022269,KIF18A/CCNA2,2,BP
GO:0003230,cardiac atrium development,1/262,33/12185,0.512397338,0.999969493,0.836022269,NSD2,1,BP
GO:0006636,unsaturated fatty acid biosynthetic process,1/262,33/12185,0.512397338,0.999969493,0.836022269,EDN2,1,BP
GO:0009948,anterior/posterior axis specification,1/262,33/12185,0.512397338,0.999969493,0.836022269,AURKA,1,BP
GO:0032205,negative regulation of telomere maintenance,1/262,33/12185,0.512397338,0.999969493,0.836022269,PIF1,1,BP
GO:0035307,positive regulation of protein dephosphorylation,1/262,33/12185,0.512397338,0.999969493,0.836022269,CDCA2,1,BP
GO:0043277,apoptotic cell clearance,1/262,33/12185,0.512397338,0.999969493,0.836022269,XKR5,1,BP
GO:0045933,positive regulation of muscle contraction,1/262,33/12185,0.512397338,0.999969493,0.836022269,EDN2,1,BP
GO:1901861,regulation of muscle tissue development,1/262,33/12185,0.512397338,0.999969493,0.836022269,CENPF,1,BP
GO:2000378,negative regulation of reactive oxygen species metabolic process,1/262,33/12185,0.512397338,0.999969493,0.836022269,BRCA1,1,BP
GO:0032388,positive regulation of intracellular transport,4/262,173/12185,0.51265314,0.999969493,0.836022269,CDK1/KIF20B/SPAG5/ECT2,4,BP
GO:0070665,positive regulation of leukocyte proliferation,2/262,80/12185,0.516113641,0.999969493,0.836022269,SLC7A1/CDKN1A,2,BP
GO:0044782,cilium organization,7/262,316/12185,0.522150834,0.999969493,0.836022269,CENPJ/RTTN/CEP250/AURKA/POC1A/PLK4/KIF24,7,BP
GO:0071901,negative regulation of protein serine/threonine kinase activity,2/262,81/12185,0.522779921,0.999969493,0.836022269,PLK1/CDKN1A,2,BP
GO:0030888,regulation of B cell proliferation,1/262,34/12185,0.522910167,0.999969493,0.836022269,CDKN1A,1,BP
GO:0031670,cellular response to nutrient,1/262,34/12185,0.522910167,0.999969493,0.836022269,BRIP1,1,BP
GO:0046622,positive regulation of organ growth,1/262,34/12185,0.522910167,0.999969493,0.836022269,CDK1,1,BP
GO:0051204,protein insertion into mitochondrial membrane,1/262,34/12185,0.522910167,0.999969493,0.836022269,TIMM8B,1,BP
GO:1905517,macrophage migration,1/262,34/12185,0.522910167,0.999969493,0.836022269,EDN2,1,BP
GO:0032984,protein-containing complex disassembly,5/262,223/12185,0.525706324,0.999969493,0.836022269,KIF2C/KIF18A/KIF18B/TPX2/KIF24,5,BP
GO:0045995,regulation of embryonic development,2/262,82/12185,0.529384545,0.999969493,0.836022269,CDK1/RACGAP1,2,BP
GO:0009167,purine ribonucleoside monophosphate metabolic process,1/262,35/12185,0.533197183,0.999969493,0.836022269,DLG2,1,BP
GO:0010799,regulation of peptidyl-threonine phosphorylation,1/262,35/12185,0.533197183,0.999969493,0.836022269,PLK1,1,BP
GO:0014037,Schwann cell differentiation,1/262,35/12185,0.533197183,0.999969493,0.836022269,CDK1,1,BP
GO:0014075,response to amine,1/262,35/12185,0.533197183,0.999969493,0.836022269,CDK1,1,BP
GO:0031112,positive regulation of microtubule polymerization or depolymerization,1/262,35/12185,0.533197183,0.999969493,0.836022269,PSRC1,1,BP
GO:0032435,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,1/262,35/12185,0.533197183,0.999969493,0.836022269,PBK,1,BP
GO:0042220,response to cocaine,1/262,35/12185,0.533197183,0.999969493,0.836022269,CCNA2,1,BP
GO:0072528,pyrimidine-containing compound biosynthetic process,1/262,35/12185,0.533197183,0.999969493,0.836022269,TK1,1,BP
GO:2000300,regulation of synaptic vesicle exocytosis,1/262,35/12185,0.533197183,0.999969493,0.836022269,SLC4A8,1,BP
GO:0045664,regulation of neuron differentiation,3/262,132/12185,0.542822151,0.999969493,0.836022269,ASPM/WDR62/ECT2,3,BP
GO:0000460,maturation of 5.8S rRNA,1/262,36/12185,0.543263219,0.999969493,0.836022269,EXOSC8,1,BP
GO:0009303,rRNA transcription,1/262,36/12185,0.543263219,0.999969493,0.836022269,DDX11,1,BP
GO:0015695,organic cation transport,1/262,36/12185,0.543263219,0.999969493,0.836022269,SLC25A20,1,BP
GO:0021587,cerebellum morphogenesis,1/262,36/12185,0.543263219,0.999969493,0.836022269,KIF14,1,BP
GO:0031111,negative regulation of microtubule polymerization or depolymerization,1/262,36/12185,0.543263219,0.999969493,0.836022269,TPX2,1,BP
GO:0031641,regulation of myelination,1/262,36/12185,0.543263219,0.999969493,0.836022269,KIF14,1,BP
GO:0036260,RNA capping,1/262,36/12185,0.543263219,0.999969493,0.836022269,RPP25L,1,BP
GO:0043124,negative regulation of canonical NF-kappaB signal transduction,1/262,36/12185,0.543263219,0.999969493,0.836022269,TRIM59,1,BP
GO:0048538,thymus development,1/262,36/12185,0.543263219,0.999969493,0.836022269,CCNB2,1,BP
GO:0048662,negative regulation of smooth muscle cell proliferation,1/262,36/12185,0.543263219,0.999969493,0.836022269,CDKN1A,1,BP
GO:0052372,modulation by symbiont of entry into host,1/262,36/12185,0.543263219,0.999969493,0.836022269,TRIM59,1,BP
GO:1902229,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,1/262,36/12185,0.543263219,0.999969493,0.836022269,DDIAS,1,BP
GO:1903018,regulation of glycoprotein metabolic process,1/262,36/12185,0.543263219,0.999969493,0.836022269,ITM2B,1,BP
GO:0061136,regulation of proteasomal protein catabolic process,4/262,180/12185,0.543990739,0.999969493,0.836022269,CDC20/PLK1/AURKA/PBK,4,BP
GO:0001764,neuron migration,3/262,133/12185,0.547945142,0.999969493,0.836022269,ASPM/KIF20B/WDR62,3,BP
GO:0042542,response to hydrogen peroxide,2/262,85/12185,0.548824322,0.999969493,0.836022269,CDK1/ECT2,2,BP
GO:0098656,monoatomic anion transmembrane transport,2/262,85/12185,0.548824322,0.999969493,0.836022269,SLC4A8/ANO7,2,BP
GO:1901874,negative regulation of post-translational protein modification,2/262,85/12185,0.548824322,0.999969493,0.836022269,BRCA1/MAD2L1,2,BP
GO:0090316,positive regulation of intracellular protein transport,3/262,134/12185,0.553034572,0.999969493,0.836022269,CDK1/KIF20B/ECT2,3,BP
GO:0002066,columnar/cuboidal epithelial cell development,1/262,37/12185,0.553113004,0.999969493,0.836022269,CDKN1A,1,BP
GO:0002437,inflammatory response to antigenic stimulus,1/262,37/12185,0.553113004,0.999969493,0.836022269,HMGB2,1,BP
GO:0009124,nucleoside monophosphate biosynthetic process,1/262,37/12185,0.553113004,0.999969493,0.836022269,TK1,1,BP
GO:0009126,purine nucleoside monophosphate metabolic process,1/262,37/12185,0.553113004,0.999969493,0.836022269,DLG2,1,BP
GO:0045646,regulation of erythrocyte differentiation,1/262,37/12185,0.553113004,0.999969493,0.836022269,HMGB2,1,BP
GO:0046686,response to cadmium ion,1/262,37/12185,0.553113004,0.999969493,0.836022269,CDK1,1,BP
GO:0090151,establishment of protein localization to mitochondrial membrane,1/262,37/12185,0.553113004,0.999969493,0.836022269,TIMM8B,1,BP
GO:2000772,regulation of cellular senescence,1/262,37/12185,0.553113004,0.999969493,0.836022269,RBL1,1,BP
GO:0044089,positive regulation of cellular component biogenesis,9/262,421/12185,0.55512066,0.999969493,0.836022269,STIL/SASS6/GPSM2/PSRC1/CENPJ/SPAG5/PLK4/ANLN/WDR45,9,BP
GO:1990830,cellular response to leukemia inhibitory factor,2/262,86/12185,0.555178393,0.999969493,0.836022269,HELLS/MYBL2,2,BP
GO:0042176,regulation of protein catabolic process,7/262,326/12185,0.555372375,0.999969493,0.836022269,CDC20/DTL/PLK1/FAM83D/AURKA/MAD2L1/PBK,7,BP
GO:0000266,mitochondrial fission,1/262,38/12185,0.562751166,0.999969493,0.836022269,AURKA,1,BP
GO:0015909,long-chain fatty acid transport,1/262,38/12185,0.562751166,0.999969493,0.836022269,SLC25A20,1,BP
GO:0021575,hindbrain morphogenesis,1/262,38/12185,0.562751166,0.999969493,0.836022269,KIF14,1,BP
GO:0043903,regulation of biological process involved in symbiotic interaction,1/262,38/12185,0.562751166,0.999969493,0.836022269,TRIM59,1,BP
GO:0072348,sulfur compound transport,1/262,38/12185,0.562751166,0.999969493,0.836022269,RACGAP1,1,BP
GO:0089718,amino acid import across plasma membrane,1/262,38/12185,0.562751166,0.999969493,0.836022269,SLC7A1,1,BP
GO:2000107,negative regulation of leukocyte apoptotic process,1/262,38/12185,0.562751166,0.999969493,0.836022269,AURKB,1,BP
GO:0007030,Golgi organization,3/262,136/12185,0.563111304,0.999969493,0.836022269,CDK1/PLK1/ATP8B3,3,BP
GO:0051494,negative regulation of cytoskeleton organization,3/262,136/12185,0.563111304,0.999969493,0.836022269,CCNF/BRCA1/TPX2,3,BP
GO:0001843,neural tube closure,2/262,88/12185,0.56769612,0.999969493,0.836022269,STIL/KIF20B,2,BP
GO:0032479,regulation of type I interferon production,2/262,88/12185,0.56769612,0.999969493,0.836022269,TRAIP/HMGB2,2,BP
GO:0032606,type I interferon production,2/262,88/12185,0.56769612,0.999969493,0.836022269,TRAIP/HMGB2,2,BP
GO:1990823,response to leukemia inhibitory factor,2/262,88/12185,0.56769612,0.999969493,0.836022269,HELLS/MYBL2,2,BP
GO:0031032,actomyosin structure organization,4/262,186/12185,0.570012399,0.999969493,0.836022269,IQGAP3/RACGAP1/ECT2/ANLN,4,BP
GO:0051348,negative regulation of transferase activity,4/262,186/12185,0.570012399,0.999969493,0.836022269,PIF1/PLK1/MAD2L1/CDKN1A,4,BP
GO:0017004,cytochrome complex assembly,1/262,39/12185,0.572182235,0.999969493,0.836022269,UQCC1,1,BP
GO:0019229,regulation of vasoconstriction,1/262,39/12185,0.572182235,0.999969493,0.836022269,EDN2,1,BP
GO:0035306,positive regulation of dephosphorylation,1/262,39/12185,0.572182235,0.999969493,0.836022269,CDCA2,1,BP
GO:0043616,keratinocyte proliferation,1/262,39/12185,0.572182235,0.999969493,0.836022269,CDKN1A,1,BP
GO:0050906,detection of stimulus involved in sensory perception,1/262,39/12185,0.572182235,0.999969493,0.836022269,CEP250,1,BP
GO:0050918,positive chemotaxis,1/262,39/12185,0.572182235,0.999969493,0.836022269,HMGB2,1,BP
GO:0002262,myeloid cell homeostasis,3/262,138/12185,0.573049649,0.999969493,0.836022269,RACGAP1/HMGB2/NCAPG2,3,BP
GO:0060606,tube closure,2/262,89/12185,0.573859374,0.999969493,0.836022269,STIL/KIF20B,2,BP
GO:0044000,movement in host,3/262,139/12185,0.577966162,0.999969493,0.836022269,CDK1/SLC7A1/TRIM59,3,BP
GO:0002706,regulation of lymphocyte mediated immunity,2/262,90/12185,0.579958682,0.999969493,0.836022269,MSH2/NSD2,2,BP
GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,9/262,430/12185,0.580846332,0.999969493,0.836022269,CDC20/KIF14/DTL/CCNF/PLK1/UBE2S/UBE2C/AURKA/PBK,9,BP
GO:0001541,ovarian follicle development,1/262,40/12185,0.581410644,0.999969493,0.836022269,FANCG,1,BP
GO:0007007,inner mitochondrial membrane organization,1/262,40/12185,0.581410644,0.999969493,0.836022269,TIMM8B,1,BP
GO:0009066,aspartate family amino acid metabolic process,1/262,40/12185,0.581410644,0.999969493,0.836022269,PHGDH,1,BP
GO:0030593,neutrophil chemotaxis,1/262,40/12185,0.581410644,0.999969493,0.836022269,EDN2,1,BP
GO:0035329,hippo signaling,1/262,40/12185,0.581410644,0.999969493,0.836022269,CIT,1,BP
GO:0043525,positive regulation of neuron apoptotic process,1/262,40/12185,0.581410644,0.999969493,0.836022269,MYBL2,1,BP
GO:0048286,lung alveolus development,1/262,40/12185,0.581410644,0.999969493,0.836022269,EDN2,1,BP
GO:0071364,cellular response to epidermal growth factor stimulus,1/262,40/12185,0.581410644,0.999969493,0.836022269,KNSTRN,1,BP
GO:0045732,positive regulation of protein catabolic process,4/262,189/12185,0.582711438,0.999969493,0.836022269,CDC20/DTL/PLK1/AURKA,4,BP
GO:0071417,cellular response to organonitrogen compound,10/262,479/12185,0.583776756,0.999969493,0.836022269,CHEK1/DDX11/TIMELESS/RAD51/BLM/CDC6/BRCA1/BRIP1/DNMT1/CCNA2,10,BP
GO:0010035,response to inorganic substance,8/262,383/12185,0.583831843,0.999969493,0.836022269,CDK1/DLG2/DDX11/TIMELESS/RAD51/BLM/ECT2/CCNA2,8,BP
GO:0060412,ventricular septum morphogenesis,1/262,41/12185,0.590440731,0.999969493,0.836022269,NSD2,1,BP
GO:0070228,regulation of lymphocyte apoptotic process,1/262,41/12185,0.590440731,0.999969493,0.836022269,AURKB,1,BP
GO:0051258,protein polymerization,5/262,240/12185,0.591278702,0.999969493,0.836022269,PSRC1/CENPJ/UBE2S/TPX2/UBE2C,5,BP
GO:0014020,primary neural tube formation,2/262,92/12185,0.591965057,0.999969493,0.836022269,STIL/KIF20B,2,BP
GO:0021915,neural tube development,3/262,142/12185,0.592501813,0.999969493,0.836022269,STIL/PHGDH/KIF20B,3,BP
GO:1902075,cellular response to salt,3/262,142/12185,0.592501813,0.999969493,0.836022269,DLG2/ECT2/CCNA2,3,BP
GO:0000422,autophagy of mitochondrion,2/262,93/12185,0.597872006,0.999969493,0.836022269,SPATA18/WDR45,2,BP
GO:0061726,mitochondrion disassembly,2/262,93/12185,0.597872006,0.999969493,0.836022269,SPATA18/WDR45,2,BP
GO:0006120,"mitochondrial electron transport, NADH to ubiquinone",1/262,42/12185,0.599276743,0.999969493,0.836022269,NDUFAF1,1,BP
GO:0021695,cerebellar cortex development,1/262,42/12185,0.599276743,0.999969493,0.836022269,KIF14,1,BP
GO:0030520,intracellular estrogen receptor signaling pathway,1/262,42/12185,0.599276743,0.999969493,0.836022269,BRCA1,1,BP
GO:0045665,negative regulation of neuron differentiation,1/262,42/12185,0.599276743,0.999969493,0.836022269,ASPM,1,BP
GO:0051289,protein homotetramerization,1/262,42/12185,0.599276743,0.999969493,0.836022269,TK1,1,BP
GO:0060038,cardiac muscle cell proliferation,1/262,42/12185,0.599276743,0.999969493,0.836022269,CDK1,1,BP
GO:0060976,coronary vasculature development,1/262,42/12185,0.599276743,0.999969493,0.836022269,CNTRL,1,BP
GO:1901224,positive regulation of non-canonical NF-kappaB signal transduction,1/262,42/12185,0.599276743,0.999969493,0.836022269,RTKN2,1,BP
GO:0009566,fertilization,2/262,94/12185,0.60371477,0.999969493,0.836022269,CDK1/ATP8B3,2,BP
GO:0120034,positive regulation of plasma membrane bounded cell projection assembly,2/262,94/12185,0.60371477,0.999969493,0.836022269,CENPJ/ANLN,2,BP
GO:0032872,regulation of stress-activated MAPK cascade,3/262,145/12185,0.606711727,0.999969493,0.836022269,FOXM1/PBK/EDA2R,3,BP
GO:0006940,regulation of smooth muscle contraction,1/262,43/12185,0.607922835,0.999969493,0.836022269,EDN2,1,BP
GO:0044458,motile cilium assembly,1/262,43/12185,0.607922835,0.999969493,0.836022269,CENPJ,1,BP
GO:0045599,negative regulation of fat cell differentiation,1/262,43/12185,0.607922835,0.999969493,0.836022269,E2F1,1,BP
GO:0051055,negative regulation of lipid biosynthetic process,1/262,43/12185,0.607922835,0.999969493,0.836022269,BRCA1,1,BP
GO:0070830,bicellular tight junction assembly,1/262,43/12185,0.607922835,0.999969493,0.836022269,ECT2,1,BP
GO:0070849,response to epidermal growth factor,1/262,43/12185,0.607922835,0.999969493,0.836022269,KNSTRN,1,BP
GO:0071763,nuclear membrane organization,1/262,43/12185,0.607922835,0.999969493,0.836022269,PLK1,1,BP
GO:2000785,regulation of autophagosome assembly,1/262,43/12185,0.607922835,0.999969493,0.836022269,WDR45,1,BP
GO:0006913,nucleocytoplasmic transport,6/262,294/12185,0.609095855,0.999969493,0.836022269,CDK1/NUP160/POLA2/KPNA2/ECT2/CDKN1A,6,BP
GO:0051169,nuclear transport,6/262,294/12185,0.609095855,0.999969493,0.836022269,CDK1/NUP160/POLA2/KPNA2/ECT2/CDKN1A,6,BP
GO:0007368,determination of left/right symmetry,2/262,96/12185,0.615207847,0.999969493,0.836022269,STIL/RTTN,2,BP
GO:0033108,mitochondrial respiratory chain complex assembly,2/262,96/12185,0.615207847,0.999969493,0.836022269,NDUFAF1/UQCC1,2,BP
GO:0046822,regulation of nucleocytoplasmic transport,2/262,96/12185,0.615207847,0.999969493,0.836022269,CDK1/ECT2,2,BP
GO:0051251,positive regulation of lymphocyte activation,4/262,197/12185,0.615500158,0.999969493,0.836022269,SLC7A1/MSH2/NSD2/CDKN1A,4,BP
GO:0051249,regulation of lymphocyte activation,6/262,296/12185,0.615692964,0.999969493,0.836022269,SLC7A1/FANCA/MSH2/FANCD2/NSD2/CDKN1A,6,BP
GO:0010803,regulation of tumor necrosis factor-mediated signaling pathway,1/262,44/12185,0.616383074,0.999969493,0.836022269,TRAIP,1,BP
GO:0032365,intracellular lipid transport,1/262,44/12185,0.616383074,0.999969493,0.836022269,SLC25A20,1,BP
GO:0043113,receptor clustering,1/262,44/12185,0.616383074,0.999969493,0.836022269,DLG2,1,BP
GO:0055021,regulation of cardiac muscle tissue growth,1/262,44/12185,0.616383074,0.999969493,0.836022269,CDK1,1,BP
GO:2000379,positive regulation of reactive oxygen species metabolic process,1/262,44/12185,0.616383074,0.999969493,0.836022269,CDKN1A,1,BP
GO:0045926,negative regulation of growth,4/262,198/12185,0.619485239,0.999969493,0.836022269,CDKN2C/PSRC1/BRCA1/CDKN1A,4,BP
GO:0070302,regulation of stress-activated protein kinase signaling cascade,3/262,148/12185,0.620590664,0.999969493,0.836022269,FOXM1/PBK/EDA2R,3,BP
GO:0001841,neural tube formation,2/262,97/12185,0.620858283,0.999969493,0.836022269,STIL/KIF20B,2,BP
GO:0030219,megakaryocyte differentiation,1/262,45/12185,0.624661439,0.999969493,0.836022269,HMGB2,1,BP
GO:0042100,B cell proliferation,1/262,45/12185,0.624661439,0.999969493,0.836022269,CDKN1A,1,BP
GO:1902275,regulation of chromatin organization,1/262,45/12185,0.624661439,0.999969493,0.836022269,MKI67,1,BP
GO:0006820,monoatomic anion transport,2/262,98/12185,0.626444777,0.999969493,0.836022269,SLC4A8/ANO7,2,BP
GO:0007605,sensory perception of sound,2/262,98/12185,0.626444777,0.999969493,0.836022269,TIMM8B/BIRC5,2,BP
GO:0042177,negative regulation of protein catabolic process,2/262,98/12185,0.626444777,0.999969493,0.836022269,MAD2L1/PBK,2,BP
GO:0048660,regulation of smooth muscle cell proliferation,2/262,98/12185,0.626444777,0.999969493,0.836022269,DNMT1/CDKN1A,2,BP
GO:0002449,lymphocyte mediated immunity,3/262,150/12185,0.629657371,0.999969493,0.836022269,EXO1/MSH2/NSD2,3,BP
GO:0003279,cardiac septum development,2/262,99/12185,0.631967455,0.999969493,0.836022269,NSD2/CNTRL,2,BP
GO:0001756,somitogenesis,1/262,46/12185,0.632761827,0.999969493,0.836022269,XRCC2,1,BP
GO:0042102,positive regulation of T cell proliferation,1/262,46/12185,0.632761827,0.999969493,0.836022269,SLC7A1,1,BP
GO:0045197,establishment or maintenance of epithelial cell apical/basal polarity,1/262,46/12185,0.632761827,0.999969493,0.836022269,DLG2,1,BP
GO:0051341,regulation of oxidoreductase activity,1/262,46/12185,0.632761827,0.999969493,0.836022269,EDN2,1,BP
GO:0019827,stem cell population maintenance,3/262,151/12185,0.634134585,0.999969493,0.836022269,ASPM/FANCD2/PHF19,3,BP
GO:0009799,specification of symmetry,2/262,100/12185,0.637426468,0.999969493,0.836022269,STIL/RTTN,2,BP
GO:0009855,determination of bilateral symmetry,2/262,100/12185,0.637426468,0.999969493,0.836022269,STIL/RTTN,2,BP
GO:1904019,epithelial cell apoptotic process,2/262,100/12185,0.637426468,0.999969493,0.836022269,E2F2/E2F1,2,BP
GO:0051701,biological process involved in interaction with host,3/262,152/12185,0.638574242,0.999969493,0.836022269,CDK1/SLC7A1/TRIM59,3,BP
GO:0001655,urogenital system development,1/262,47/12185,0.640688048,0.999969493,0.836022269,HELLS,1,BP
GO:0031648,protein destabilization,1/262,47/12185,0.640688048,0.999969493,0.836022269,PLK1,1,BP
GO:0043627,response to estrogen,1/262,47/12185,0.640688048,0.999969493,0.836022269,BRCA1,1,BP
GO:0045685,regulation of glial cell differentiation,1/262,47/12185,0.640688048,0.999969493,0.836022269,CDK1,1,BP
GO:1901799,negative regulation of proteasomal protein catabolic process,1/262,47/12185,0.640688048,0.999969493,0.836022269,PBK,1,BP
GO:0071407,cellular response to organic cyclic compound,8/262,403/12185,0.641258238,0.999969493,0.836022269,CDK1/KIF18A/CHEK1/RAD51/BLM/BRCA1/DNMT1/CCNA2,8,BP
GO:0006633,fatty acid biosynthetic process,2/262,101/12185,0.64282199,0.999969493,0.836022269,EDN2/BRCA1,2,BP
GO:0060972,left/right pattern formation,2/262,101/12185,0.64282199,0.999969493,0.836022269,STIL/RTTN,2,BP
GO:0098727,maintenance of cell number,3/262,153/12185,0.64297626,0.999969493,0.836022269,ASPM/FANCD2/PHF19,3,BP
GO:0072593,reactive oxygen species metabolic process,3/262,154/12185,0.647340571,0.999969493,0.836022269,FOXM1/BRCA1/CDKN1A,3,BP
GO:0019079,viral genome replication,2/262,102/12185,0.648154215,0.999969493,0.836022269,TOP2A/DEK,2,BP
GO:0030879,mammary gland development,2/262,102/12185,0.648154215,0.999969493,0.836022269,IQGAP3/BRCA2,2,BP
GO:0048659,smooth muscle cell proliferation,2/262,102/12185,0.648154215,0.999969493,0.836022269,DNMT1/CDKN1A,2,BP
GO:0009880,embryonic pattern specification,1/262,48/12185,0.648443834,0.999969493,0.836022269,STIL,1,BP
GO:0035088,establishment or maintenance of apical/basal cell polarity,1/262,48/12185,0.648443834,0.999969493,0.836022269,DLG2,1,BP
GO:0061245,establishment or maintenance of bipolar cell polarity,1/262,48/12185,0.648443834,0.999969493,0.836022269,DLG2,1,BP
GO:0120192,tight junction assembly,1/262,48/12185,0.648443834,0.999969493,0.836022269,ECT2,1,BP
GO:2000059,negative regulation of ubiquitin-dependent protein catabolic process,1/262,48/12185,0.648443834,0.999969493,0.836022269,PBK,1,BP
GO:0046651,lymphocyte proliferation,3/262,156/12185,0.655955854,0.999969493,0.836022269,HELLS/SLC7A1/CDKN1A,3,BP
GO:0001947,heart looping,1/262,49/12185,0.656032836,0.999969493,0.836022269,STIL,1,BP
GO:0009161,ribonucleoside monophosphate metabolic process,1/262,49/12185,0.656032836,0.999969493,0.836022269,DLG2,1,BP
GO:0014823,response to activity,1/262,49/12185,0.656032836,0.999969493,0.836022269,CDK1,1,BP
GO:0060420,regulation of heart growth,1/262,49/12185,0.656032836,0.999969493,0.836022269,CDK1,1,BP
GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,2/262,104/12185,0.658629664,0.999969493,0.836022269,MSH2/NSD2,2,BP
GO:0002260,lymphocyte homeostasis,1/262,50/12185,0.663458627,0.999969493,0.836022269,CCNB2,1,BP
GO:0006767,water-soluble vitamin metabolic process,1/262,50/12185,0.663458627,0.999969493,0.836022269,MTHFD2,1,BP
GO:0010660,regulation of muscle cell apoptotic process,1/262,50/12185,0.663458627,0.999969493,0.836022269,DNMT1,1,BP
GO:0033363,secretory granule organization,1/262,50/12185,0.663458627,0.999969493,0.836022269,KNL1,1,BP
GO:0034198,cellular response to amino acid starvation,1/262,50/12185,0.663458627,0.999969493,0.836022269,CDKN1A,1,BP
GO:0035904,aorta development,1/262,50/12185,0.663458627,0.999969493,0.836022269,CNTRL,1,BP
GO:0048255,mRNA stabilization,1/262,50/12185,0.663458627,0.999969493,0.836022269,E2F1,1,BP
GO:0090175,regulation of establishment of planar polarity,1/262,50/12185,0.663458627,0.999969493,0.836022269,SAPCD2,1,BP
GO:0097120,receptor localization to synapse,1/262,50/12185,0.663458627,0.999969493,0.836022269,DLG2,1,BP
GO:1904888,cranial skeletal system development,1/262,50/12185,0.663458627,0.999969493,0.836022269,CEP55,1,BP
GO:0002366,leukocyte activation involved in immune response,3/262,158/12185,0.664419774,0.999969493,0.836022269,EXO1/MSH2/NSD2,3,BP
GO:0007623,circadian rhythm,3/262,158/12185,0.664419774,0.999969493,0.836022269,CDK1/TIMELESS/TOP2A,3,BP
GO:0071356,cellular response to tumor necrosis factor,3/262,158/12185,0.664419774,0.999969493,0.836022269,BRCA1/TRAIP/EDA2R,3,BP
GO:0045333,cellular respiration,4/262,210/12185,0.665259436,0.999969493,0.836022269,CDK1/NDUFAF1/MSH2/CCNB1,4,BP
GO:0001960,negative regulation of cytokine-mediated signaling pathway,1/262,51/12185,0.670724703,0.999969493,0.836022269,TRAIP,1,BP
GO:0034605,cellular response to heat,1/262,51/12185,0.670724703,0.999969493,0.836022269,CDKN1A,1,BP
GO:0043297,apical junction assembly,1/262,51/12185,0.670724703,0.999969493,0.836022269,ECT2,1,BP
GO:0061371,determination of heart left/right asymmetry,1/262,51/12185,0.670724703,0.999969493,0.836022269,STIL,1,BP
GO:1902475,L-alpha-amino acid transmembrane transport,1/262,51/12185,0.670724703,0.999969493,0.836022269,SLC7A1,1,BP
GO:2001233,regulation of apoptotic signaling pathway,6/262,314/12185,0.672168474,0.999969493,0.836022269,RTKN2/HELLS/DDIAS/BRCA1/HMGB2/FIGNL1,6,BP
GO:0002700,regulation of production of molecular mediator of immune response,2/262,107/12185,0.673874153,0.999969493,0.836022269,MSH2/NSD2,2,BP
GO:1903050,regulation of proteolysis involved in protein catabolic process,4/262,213/12185,0.676100743,0.999969493,0.836022269,CDC20/PLK1/AURKA/PBK,4,BP
GO:0002263,cell activation involved in immune response,3/262,161/12185,0.676831601,0.999969493,0.836022269,EXO1/MSH2/NSD2,3,BP
GO:0009636,response to toxic substance,3/262,161/12185,0.676831601,0.999969493,0.836022269,CDK1/BRIP1/CDKN1A,3,BP
GO:0002690,positive regulation of leukocyte chemotaxis,1/262,52/12185,0.677834488,0.999969493,0.836022269,EDN2,1,BP
GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress,1/262,52/12185,0.677834488,0.999969493,0.836022269,MELK,1,BP
GO:0032481,positive regulation of type I interferon production,1/262,52/12185,0.677834488,0.999969493,0.836022269,HMGB2,1,BP
GO:0042246,tissue regeneration,1/262,52/12185,0.677834488,0.999969493,0.836022269,CDKN1A,1,BP
GO:0046902,regulation of mitochondrial membrane permeability,1/262,52/12185,0.677834488,0.999969493,0.836022269,ARHGAP11B,1,BP
GO:0051148,negative regulation of muscle cell differentiation,1/262,52/12185,0.677834488,0.999969493,0.836022269,DNMT1,1,BP
GO:1990266,neutrophil migration,1/262,52/12185,0.677834488,0.999969493,0.836022269,EDN2,1,BP
GO:0045580,regulation of T cell differentiation,2/262,108/12185,0.678831811,0.999969493,0.836022269,FANCA/FANCD2,2,BP
GO:0051092,positive regulation of NF-kappaB transcription factor activity,2/262,108/12185,0.678831811,0.999969493,0.836022269,RTKN2/EDA2R,2,BP
GO:0051606,detection of stimulus,2/262,108/12185,0.678831811,0.999969493,0.836022269,TIMELESS/CEP250,2,BP
GO:0032943,mononuclear cell proliferation,3/262,162/12185,0.680893157,0.999969493,0.836022269,HELLS/SLC7A1/CDKN1A,3,BP
GO:0001838,embryonic epithelial tube formation,2/262,109/12185,0.683728074,0.999969493,0.836022269,STIL/KIF20B,2,BP
GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,1/262,53/12185,0.68479133,0.999969493,0.836022269,RPS27L,1,BP
GO:0042310,vasoconstriction,1/262,53/12185,0.68479133,0.999969493,0.836022269,EDN2,1,BP
GO:0044088,regulation of vacuole organization,1/262,53/12185,0.68479133,0.999969493,0.836022269,WDR45,1,BP
GO:0070527,platelet aggregation,1/262,53/12185,0.68479133,0.999969493,0.836022269,MYL12A,1,BP
GO:0071621,granulocyte chemotaxis,1/262,53/12185,0.68479133,0.999969493,0.836022269,EDN2,1,BP
GO:0120193,tight junction organization,1/262,53/12185,0.68479133,0.999969493,0.836022269,ECT2,1,BP
GO:1990928,response to amino acid starvation,1/262,53/12185,0.68479133,0.999969493,0.836022269,CDKN1A,1,BP
GO:0002696,positive regulation of leukocyte activation,4/262,216/12185,0.686697651,0.999969493,0.836022269,SLC7A1/MSH2/NSD2/CDKN1A,4,BP
GO:0071466,cellular response to xenobiotic stimulus,2/262,110/12185,0.688563278,0.999969493,0.836022269,E2F1/MCM7,2,BP
GO:0016073,snRNA metabolic process,1/262,54/12185,0.691598507,0.999969493,0.836022269,EXOSC8,1,BP
GO:0042116,macrophage activation,1/262,54/12185,0.691598507,0.999969493,0.836022269,EDN2,1,BP
GO:0051145,smooth muscle cell differentiation,1/262,54/12185,0.691598507,0.999969493,0.836022269,DNMT1,1,BP
GO:0071260,cellular response to mechanical stimulus,1/262,54/12185,0.691598507,0.999969493,0.836022269,CHEK1,1,BP
GO:0001890,placenta development,2/262,111/12185,0.693337774,0.999969493,0.836022269,CCNF/PLK4,2,BP
GO:0007006,mitochondrial membrane organization,2/262,111/12185,0.693337774,0.999969493,0.836022269,TIMM8B/ARHGAP11B,2,BP
GO:0003231,cardiac ventricle development,2/262,112/12185,0.698051927,0.999969493,0.836022269,NSD2/CNTRL,2,BP
GO:0050954,sensory perception of mechanical stimulus,2/262,112/12185,0.698051927,0.999969493,0.836022269,TIMM8B/BIRC5,2,BP
GO:0003143,embryonic heart tube morphogenesis,1/262,55/12185,0.698259227,0.999969493,0.836022269,STIL,1,BP
GO:0010257,NADH dehydrogenase complex assembly,1/262,55/12185,0.698259227,0.999969493,0.836022269,NDUFAF1,1,BP
GO:0010657,muscle cell apoptotic process,1/262,55/12185,0.698259227,0.999969493,0.836022269,DNMT1,1,BP
GO:0032981,mitochondrial respiratory chain complex I assembly,1/262,55/12185,0.698259227,0.999969493,0.836022269,NDUFAF1,1,BP
GO:0048814,regulation of dendrite morphogenesis,1/262,55/12185,0.698259227,0.999969493,0.836022269,LZTS1,1,BP
GO:0060761,negative regulation of response to cytokine stimulus,1/262,55/12185,0.698259227,0.999969493,0.836022269,TRAIP,1,BP
GO:1905039,carboxylic acid transmembrane transport,2/262,113/12185,0.702706113,0.999969493,0.836022269,SLC7A1/SLC25A20,2,BP
GO:0033273,response to vitamin,1/262,56/12185,0.704776629,0.999969493,0.836022269,BRIP1,1,BP
GO:0046425,regulation of receptor signaling pathway via JAK-STAT,1/262,56/12185,0.704776629,0.999969493,0.836022269,CENPJ,1,BP
GO:0050886,endocrine process,1/262,56/12185,0.704776629,0.999969493,0.836022269,EDN2,1,BP
GO:0043467,regulation of generation of precursor metabolites and energy,2/262,114/12185,0.70730072,0.999969493,0.836022269,CDK1/CCNB1,2,BP
GO:1903825,organic acid transmembrane transport,2/262,114/12185,0.70730072,0.999969493,0.836022269,SLC7A1/SLC25A20,2,BP
GO:0120032,regulation of plasma membrane bounded cell projection assembly,3/262,169/12185,0.708267961,0.999969493,0.836022269,CENPJ/ANLN/KIF24,3,BP
GO:0050867,positive regulation of cell activation,4/262,223/12185,0.710469584,0.999969493,0.836022269,SLC7A1/MSH2/NSD2/CDKN1A,4,BP
GO:0008543,fibroblast growth factor receptor signaling pathway,1/262,57/12185,0.711153784,0.999969493,0.836022269,SHCBP1,1,BP
GO:0015908,fatty acid transport,1/262,57/12185,0.711153784,0.999969493,0.836022269,SLC25A20,1,BP
GO:0031122,cytoplasmic microtubule organization,1/262,57/12185,0.711153784,0.999969493,0.836022269,CENPJ,1,BP
GO:0045921,positive regulation of exocytosis,1/262,57/12185,0.711153784,0.999969493,0.836022269,SLC4A8,1,BP
GO:1902373,negative regulation of mRNA catabolic process,1/262,57/12185,0.711153784,0.999969493,0.836022269,E2F1,1,BP
GO:1990542,mitochondrial transmembrane transport,1/262,57/12185,0.711153784,0.999969493,0.836022269,SLC25A20,1,BP
GO:0002819,regulation of adaptive immune response,2/262,115/12185,0.711836147,0.999969493,0.836022269,MSH2/NSD2,2,BP
GO:0060491,regulation of cell projection assembly,3/262,171/12185,0.71575191,0.999969493,0.836022269,CENPJ/ANLN/KIF24,3,BP
GO:0035264,multicellular organism growth,2/262,116/12185,0.716312804,0.999969493,0.836022269,STIL/XRCC2,2,BP
GO:0003073,regulation of systemic arterial blood pressure,1/262,58/12185,0.717393701,0.999969493,0.836022269,EDN2,1,BP
GO:0031113,regulation of microtubule polymerization,1/262,58/12185,0.717393701,0.999969493,0.836022269,PSRC1,1,BP
GO:0097009,energy homeostasis,1/262,58/12185,0.717393701,0.999969493,0.836022269,EDN2,1,BP
GO:1901607,alpha-amino acid biosynthetic process,1/262,58/12185,0.717393701,0.999969493,0.836022269,PHGDH,1,BP
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,3/262,172/12185,0.719438098,0.999969493,0.836022269,EXO1/MSH2/NSD2,3,BP
GO:0006839,mitochondrial transport,3/262,172/12185,0.719438098,0.999969493,0.836022269,TIMM8B/ARHGAP11B/SLC25A20,3,BP
GO:0007009,plasma membrane organization,2/262,117/12185,0.72073111,0.999969493,0.836022269,ANO7/XKR5,2,BP
GO:0006690,icosanoid metabolic process,1/262,59/12185,0.723499321,0.999969493,0.836022269,EDN2,1,BP
GO:0043489,RNA stabilization,1/262,59/12185,0.723499321,0.999969493,0.836022269,E2F1,1,BP
GO:1904892,regulation of receptor signaling pathway via STAT,1/262,59/12185,0.723499321,0.999969493,0.836022269,CENPJ,1,BP
GO:0071456,cellular response to hypoxia,2/262,118/12185,0.725091494,0.999969493,0.836022269,BRIP1/CCNA2,2,BP
GO:0015980,energy derivation by oxidation of organic compounds,5/262,281/12185,0.726589431,0.999969493,0.836022269,CDK1/NDUFAF1/MSH2/CCNB1/PHKA1,5,BP
GO:0034612,response to tumor necrosis factor,3/262,174/12185,0.726699469,0.999969493,0.836022269,BRCA1/TRAIP/EDA2R,3,BP
GO:0072175,epithelial tube formation,2/262,119/12185,0.729394392,0.999969493,0.836022269,STIL/KIF20B,2,BP
GO:1901653,cellular response to peptide,5/262,282/12185,0.72944719,0.999969493,0.836022269,DDX11/TIMELESS/CDC6/BRIP1/CCNA2,5,BP
GO:0045666,positive regulation of neuron differentiation,1/262,60/12185,0.729473523,0.999969493,0.836022269,ECT2,1,BP
GO:0070227,lymphocyte apoptotic process,1/262,60/12185,0.729473523,0.999969493,0.836022269,AURKB,1,BP
GO:0048511,rhythmic process,4/262,229/12185,0.729782777,0.999969493,0.836022269,DTL/CDK1/TIMELESS/TOP2A,4,BP
GO:1903829,positive regulation of protein localization,7/262,387/12185,0.731290596,0.999969493,0.836022269,GPSM2/CDK1/KIF20B/CENPJ/PLK1/CEP250/ECT2,7,BP
GO:0007224,smoothened signaling pathway,2/262,120/12185,0.73364025,0.999969493,0.836022269,STIL/CENPJ,2,BP
GO:0050670,regulation of lymphocyte proliferation,2/262,120/12185,0.73364025,0.999969493,0.836022269,SLC7A1/CDKN1A,2,BP
GO:0005977,glycogen metabolic process,1/262,61/12185,0.735319126,0.999969493,0.836022269,PHKA1,1,BP
GO:0006383,transcription by RNA polymerase III,1/262,61/12185,0.735319126,0.999969493,0.836022269,DEK,1,BP
GO:0006406,mRNA export from nucleus,1/262,61/12185,0.735319126,0.999969493,0.836022269,NUP160,1,BP
GO:0021510,spinal cord development,1/262,61/12185,0.735319126,0.999969493,0.836022269,PHGDH,1,BP
GO:0042255,ribosome assembly,1/262,61/12185,0.735319126,0.999969493,0.836022269,RPS27L,1,BP
GO:0048661,positive regulation of smooth muscle cell proliferation,1/262,61/12185,0.735319126,0.999969493,0.836022269,DNMT1,1,BP
GO:0061053,somite development,1/262,61/12185,0.735319126,0.999969493,0.836022269,XRCC2,1,BP
GO:0090559,regulation of membrane permeability,1/262,61/12185,0.735319126,0.999969493,0.836022269,ARHGAP11B,1,BP
GO:1901880,negative regulation of protein depolymerization,1/262,61/12185,0.735319126,0.999969493,0.836022269,TPX2,1,BP
GO:1904377,positive regulation of protein localization to cell periphery,1/262,61/12185,0.735319126,0.999969493,0.836022269,GPSM2,1,BP
GO:2000106,regulation of leukocyte apoptotic process,1/262,61/12185,0.735319126,0.999969493,0.836022269,AURKB,1,BP
GO:0010498,proteasomal protein catabolic process,9/262,492/12185,0.736507706,0.999969493,0.836022269,CDC20/KIF14/DTL/CCNF/PLK1/UBE2S/UBE2C/AURKA/PBK,9,BP
GO:0030177,positive regulation of Wnt signaling pathway,2/262,121/12185,0.737829521,0.999969493,0.836022269,ASPM/DEPDC1B,2,BP
GO:0033143,regulation of intracellular steroid hormone receptor signaling pathway,1/262,62/12185,0.741038888,0.999969493,0.836022269,BRCA1,1,BP
GO:0044042,glucan metabolic process,1/262,62/12185,0.741038888,0.999969493,0.836022269,PHKA1,1,BP
GO:0048678,response to axon injury,1/262,62/12185,0.741038888,0.999969493,0.836022269,CDK1,1,BP
GO:1903051,negative regulation of proteolysis involved in protein catabolic process,1/262,62/12185,0.741038888,0.999969493,0.836022269,PBK,1,BP
GO:2001236,regulation of extrinsic apoptotic signaling pathway,2/262,122/12185,0.741962665,0.999969493,0.836022269,BRCA1/HMGB2,2,BP
GO:0010001,glial cell differentiation,3/262,179/12185,0.744211413,0.999969493,0.836022269,CDKN2C/PHGDH/CDK1,3,BP
GO:0048872,homeostasis of number of cells,4/262,234/12185,0.74513255,0.999969493,0.836022269,RACGAP1/CCNB2/HMGB2/NCAPG2,4,BP
GO:0002703,regulation of leukocyte mediated immunity,2/262,123/12185,0.746040146,0.999969493,0.836022269,MSH2/NSD2,2,BP
GO:0032944,regulation of mononuclear cell proliferation,2/262,123/12185,0.746040146,0.999969493,0.836022269,SLC7A1/CDKN1A,2,BP
GO:0034614,cellular response to reactive oxygen species,2/262,123/12185,0.746040146,0.999969493,0.836022269,CDK1/ECT2,2,BP
GO:0008652,amino acid biosynthetic process,1/262,63/12185,0.746635507,0.999969493,0.836022269,PHGDH,1,BP
GO:0035304,regulation of protein dephosphorylation,1/262,63/12185,0.746635507,0.999969493,0.836022269,CDCA2,1,BP
GO:0045069,regulation of viral genome replication,1/262,63/12185,0.746635507,0.999969493,0.836022269,TOP2A,1,BP
GO:0046928,regulation of neurotransmitter secretion,1/262,63/12185,0.746635507,0.999969493,0.836022269,SLC4A8,1,BP
GO:0048525,negative regulation of viral process,1/262,63/12185,0.746635507,0.999969493,0.836022269,TRIM59,1,BP
GO:0071277,cellular response to calcium ion,1/262,63/12185,0.746635507,0.999969493,0.836022269,ECT2,1,BP
GO:0051403,stress-activated MAPK cascade,3/262,180/12185,0.747604983,0.999969493,0.836022269,FOXM1/PBK/EDA2R,3,BP
GO:0016032,viral process,6/262,342/12185,0.748927412,0.999969493,0.836022269,CDK1/SLC7A1/TOP2A/KPNA2/TRIM59/DEK,6,BP
GO:1902532,negative regulation of intracellular signal transduction,8/262,447/12185,0.750473023,0.999969493,0.836022269,RTKN2/HELLS/DDIAS/FOXM1/CIT/TRIM59/FIGNL1/PBK,8,BP
GO:0070661,leukocyte proliferation,3/262,181/12185,0.750962647,0.999969493,0.836022269,HELLS/SLC7A1/CDKN1A,3,BP
GO:0002694,regulation of leukocyte activation,6/262,343/12185,0.751411578,0.999969493,0.836022269,SLC7A1/FANCA/MSH2/FANCD2/NSD2/CDKN1A,6,BP
GO:0000288,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",1/262,64/12185,0.752111624,0.999969493,0.836022269,EXOSC8,1,BP
GO:0015807,L-amino acid transport,1/262,64/12185,0.752111624,0.999969493,0.836022269,SLC7A1,1,BP
GO:0019217,regulation of fatty acid metabolic process,1/262,64/12185,0.752111624,0.999969493,0.836022269,BRCA1,1,BP
GO:0035418,protein localization to synapse,1/262,64/12185,0.752111624,0.999969493,0.836022269,DLG2,1,BP
GO:0045824,negative regulation of innate immune response,1/262,64/12185,0.752111624,0.999969493,0.836022269,AURKB,1,BP
GO:0055017,cardiac muscle tissue growth,1/262,64/12185,0.752111624,0.999969493,0.836022269,CDK1,1,BP
GO:1901606,alpha-amino acid catabolic process,1/262,64/12185,0.752111624,0.999969493,0.836022269,ARHGAP11B,1,BP
GO:0001736,establishment of planar polarity,1/262,65/12185,0.757469825,0.999969493,0.836022269,SAPCD2,1,BP
GO:0007164,establishment of tissue polarity,1/262,65/12185,0.757469825,0.999969493,0.836022269,SAPCD2,1,BP
GO:0007422,peripheral nervous system development,1/262,65/12185,0.757469825,0.999969493,0.836022269,CDK1,1,BP
GO:0033559,unsaturated fatty acid metabolic process,1/262,65/12185,0.757469825,0.999969493,0.836022269,EDN2,1,BP
GO:0051453,regulation of intracellular pH,1/262,65/12185,0.757469825,0.999969493,0.836022269,SLC4A8,1,BP
GO:0097530,granulocyte migration,1/262,65/12185,0.757469825,0.999969493,0.836022269,EDN2,1,BP
GO:1901222,regulation of non-canonical NF-kappaB signal transduction,1/262,65/12185,0.757469825,0.999969493,0.836022269,RTKN2,1,BP
GO:0009952,anterior/posterior pattern specification,2/262,126/12185,0.757943367,0.999969493,0.836022269,AURKA/XRCC2,2,BP
GO:0016331,morphogenesis of embryonic epithelium,2/262,126/12185,0.757943367,0.999969493,0.836022269,STIL/KIF20B,2,BP
GO:0048839,inner ear development,2/262,126/12185,0.757943367,0.999969493,0.836022269,MCM2/CCNA2,2,BP
GO:0010822,positive regulation of mitochondrion organization,1/262,66/12185,0.762712639,0.999969493,0.836022269,AURKA,1,BP
GO:0045833,negative regulation of lipid metabolic process,1/262,66/12185,0.762712639,0.999969493,0.836022269,BRCA1,1,BP
GO:0046330,positive regulation of JNK cascade,1/262,66/12185,0.762712639,0.999969493,0.836022269,EDA2R,1,BP
GO:0060271,cilium assembly,5/262,295/12185,0.764651931,0.999969493,0.836022269,CENPJ/CEP250/POC1A/PLK4/KIF24,5,BP
GO:0001822,kidney development,4/262,241/12185,0.765499524,0.999969493,0.836022269,CENPF/HELLS/NUP160/CNTRL,4,BP
GO:0036294,cellular response to decreased oxygen levels,2/262,128/12185,0.76560933,0.999969493,0.836022269,BRIP1/CCNA2,2,BP
GO:0045619,regulation of lymphocyte differentiation,2/262,128/12185,0.76560933,0.999969493,0.836022269,FANCA/FANCD2,2,BP
GO:0006112,energy reserve metabolic process,1/262,67/12185,0.767842542,0.999969493,0.836022269,PHKA1,1,BP
GO:0009581,detection of external stimulus,1/262,67/12185,0.767842542,0.999969493,0.836022269,CEP250,1,BP
GO:0045639,positive regulation of myeloid cell differentiation,1/262,67/12185,0.767842542,0.999969493,0.836022269,HMGB2,1,BP
GO:0035148,tube formation,2/262,129/12185,0.769362929,0.999969493,0.836022269,STIL/KIF20B,2,BP
GO:0031098,stress-activated protein kinase signaling cascade,3/262,187/12185,0.770364317,0.999969493,0.836022269,FOXM1/PBK/EDA2R,3,BP
GO:0050769,positive regulation of neurogenesis,3/262,187/12185,0.770364317,0.999969493,0.836022269,ASPM/WDR62/XRCC2,3,BP
GO:0002688,regulation of leukocyte chemotaxis,1/262,68/12185,0.772861955,0.999969493,0.836022269,EDN2,1,BP
GO:0030641,regulation of cellular pH,1/262,68/12185,0.772861955,0.999969493,0.836022269,SLC4A8,1,BP
GO:0035050,embryonic heart tube development,1/262,68/12185,0.772861955,0.999969493,0.836022269,STIL,1,BP
GO:0042982,amyloid precursor protein metabolic process,1/262,68/12185,0.772861955,0.999969493,0.836022269,ITM2B,1,BP
GO:0060411,cardiac septum morphogenesis,1/262,68/12185,0.772861955,0.999969493,0.836022269,NSD2,1,BP
GO:0016049,cell growth,7/262,406/12185,0.775008909,0.999969493,0.836022269,EDN2/CDKN2C/PSRC1/KIF14/BRCA1/AURKA/CDKN1A,7,BP
GO:0001892,embryonic placenta development,1/262,69/12185,0.777773251,0.999969493,0.836022269,PLK4,1,BP
GO:0003333,amino acid transmembrane transport,1/262,69/12185,0.777773251,0.999969493,0.836022269,SLC7A1,1,BP
GO:0043242,negative regulation of protein-containing complex disassembly,1/262,69/12185,0.777773251,0.999969493,0.836022269,TPX2,1,BP
GO:1902369,negative regulation of RNA catabolic process,1/262,69/12185,0.777773251,0.999969493,0.836022269,E2F1,1,BP
GO:0016239,positive regulation of macroautophagy,1/262,70/12185,0.782578748,0.999969493,0.836022269,WDR45,1,BP
GO:0016525,negative regulation of angiogenesis,1/262,70/12185,0.782578748,0.999969493,0.836022269,E2F2,1,BP
GO:0021766,hippocampus development,1/262,70/12185,0.782578748,0.999969493,0.836022269,KIF14,1,BP
GO:0031397,negative regulation of protein ubiquitination,1/262,70/12185,0.782578748,0.999969493,0.836022269,MAD2L1,1,BP
GO:0045471,response to ethanol,1/262,70/12185,0.782578748,0.999969493,0.836022269,CDK1,1,BP
GO:0048534,hematopoietic or lymphoid organ development,1/262,70/12185,0.782578748,0.999969493,0.836022269,CCNB2,1,BP
GO:0051205,protein insertion into membrane,1/262,70/12185,0.782578748,0.999969493,0.836022269,TIMM8B,1,BP
GO:0060419,heart growth,1/262,70/12185,0.782578748,0.999969493,0.836022269,CDK1,1,BP
GO:0071230,cellular response to amino acid stimulus,1/262,70/12185,0.782578748,0.999969493,0.836022269,DNMT1,1,BP
GO:0072001,renal system development,4/262,248/12185,0.784581843,0.999969493,0.836022269,CENPF/HELLS/NUP160/CNTRL,4,BP
GO:0006399,tRNA metabolic process,3/262,192/12185,0.785578384,0.999969493,0.836022269,EXOSC8/SLFN13/RPP25L,3,BP
GO:0034109,homotypic cell-cell adhesion,1/262,71/12185,0.787280718,0.999969493,0.836022269,MYL12A,1,BP
GO:0035282,segmentation,1/262,71/12185,0.787280718,0.999969493,0.836022269,XRCC2,1,BP
GO:0046620,regulation of organ growth,1/262,71/12185,0.787280718,0.999969493,0.836022269,CDK1,1,BP
GO:0048709,oligodendrocyte differentiation,1/262,71/12185,0.787280718,0.999969493,0.836022269,CDKN2C,1,BP
GO:1901343,negative regulation of vasculature development,1/262,71/12185,0.787280718,0.999969493,0.836022269,E2F2,1,BP
GO:2000181,negative regulation of blood vessel morphogenesis,1/262,71/12185,0.787280718,0.999969493,0.836022269,E2F2,1,BP
GO:0043409,negative regulation of MAPK cascade,2/262,134/12185,0.787357131,0.999969493,0.836022269,FOXM1/PBK,2,BP
GO:0070663,regulation of leukocyte proliferation,2/262,134/12185,0.787357131,0.999969493,0.836022269,SLC7A1/CDKN1A,2,BP
GO:0072594,establishment of protein localization to organelle,7/262,412/12185,0.787678307,0.999969493,0.836022269,CDK1/POLA2/TIMM8B/BRCA2/KPNA2/ECT2/CDKN1A,7,BP
GO:0033157,regulation of intracellular protein transport,3/262,193/12185,0.78851954,0.999969493,0.836022269,CDK1/KIF20B/ECT2,3,BP
GO:0071248,cellular response to metal ion,2/262,135/12185,0.790804756,0.999969493,0.836022269,DLG2/ECT2,2,BP
GO:0006885,regulation of pH,1/262,72/12185,0.791881383,0.999969493,0.836022269,SLC4A8,1,BP
GO:0062014,negative regulation of small molecule metabolic process,1/262,72/12185,0.791881383,0.999969493,0.836022269,BRCA1,1,BP
GO:0002699,positive regulation of immune effector process,2/262,136/12185,0.794203166,0.999969493,0.836022269,MSH2/NSD2,2,BP
GO:0001776,leukocyte homeostasis,1/262,73/12185,0.796382917,0.999969493,0.836022269,CCNB2,1,BP
GO:0001938,positive regulation of endothelial cell proliferation,1/262,73/12185,0.796382917,0.999969493,0.836022269,HMGB2,1,BP
GO:0006493,protein O-linked glycosylation,1/262,73/12185,0.796382917,0.999969493,0.836022269,POGLUT3,1,BP
GO:0006766,vitamin metabolic process,1/262,73/12185,0.796382917,0.999969493,0.836022269,MTHFD2,1,BP
GO:0003018,vascular process in circulatory system,3/262,196/12185,0.797143545,0.999969493,0.836022269,EDN2/SLC4A8/SLC7A1,3,BP
GO:0046649,lymphocyte activation,8/262,471/12185,0.799288166,0.999969493,0.836022269,EXO1/HELLS/SLC7A1/FANCA/MSH2/FANCD2/NSD2/CDKN1A,8,BP
GO:1904951,positive regulation of establishment of protein localization,4/262,254/12185,0.799941935,0.999969493,0.836022269,CDK1/KIF20B/CENPJ/ECT2,4,BP
GO:0010507,negative regulation of autophagy,1/262,74/12185,0.800787448,0.999969493,0.836022269,LZTS1,1,BP
GO:0019646,aerobic electron transport chain,1/262,74/12185,0.800787448,0.999969493,0.836022269,NDUFAF1,1,BP
GO:0043648,dicarboxylic acid metabolic process,1/262,74/12185,0.800787448,0.999969493,0.836022269,MTHFD2,1,BP
GO:0050673,epithelial cell proliferation,5/262,311/12185,0.803113146,0.999969493,0.836022269,IQGAP3/BRCA2/UHRF1/HMGB2/CDKN1A,5,BP
GO:0006959,humoral immune response,1/262,75/12185,0.805097058,0.999969493,0.836022269,EXO1,1,BP
GO:0016079,synaptic vesicle exocytosis,1/262,75/12185,0.805097058,0.999969493,0.836022269,SLC4A8,1,BP
GO:0030216,keratinocyte differentiation,1/262,75/12185,0.805097058,0.999969493,0.836022269,CDKN1A,1,BP
GO:0055013,cardiac muscle cell development,1/262,75/12185,0.805097058,0.999969493,0.836022269,CDK1,1,BP
GO:1901879,regulation of protein depolymerization,1/262,75/12185,0.805097058,0.999969493,0.836022269,TPX2,1,BP
GO:0002443,leukocyte mediated immunity,3/262,200/12185,0.808185138,0.999969493,0.836022269,EXO1/MSH2/NSD2,3,BP
GO:0070371,ERK1 and ERK2 cascade,3/262,200/12185,0.808185138,0.999969493,0.836022269,IQGAP3/CDK1/FAM83D,3,BP
GO:0006939,smooth muscle contraction,1/262,76/12185,0.809313785,0.999969493,0.836022269,EDN2,1,BP
GO:0021549,cerebellum development,1/262,76/12185,0.809313785,0.999969493,0.836022269,KIF14,1,BP
GO:0051588,regulation of neurotransmitter transport,1/262,76/12185,0.809313785,0.999969493,0.836022269,SLC4A8,1,BP
GO:0071229,cellular response to acid chemical,1/262,76/12185,0.809313785,0.999969493,0.836022269,DNMT1,1,BP
GO:1903510,mucopolysaccharide metabolic process,1/262,76/12185,0.809313785,0.999969493,0.836022269,HMMR,1,BP
GO:0071216,cellular response to biotic stimulus,2/262,141/12185,0.81047495,0.999969493,0.836022269,EME1/HMGB2,2,BP
GO:0071453,cellular response to oxygen levels,2/262,141/12185,0.81047495,0.999969493,0.836022269,BRIP1/CCNA2,2,BP
GO:0072330,monocarboxylic acid biosynthetic process,2/262,141/12185,0.81047495,0.999969493,0.836022269,EDN2/BRCA1,2,BP
GO:0032273,positive regulation of protein polymerization,1/262,77/12185,0.813439625,0.999969493,0.836022269,PSRC1,1,BP
GO:1901654,response to ketone,2/262,142/12185,0.813588852,0.999969493,0.836022269,NASP/CDKN1A,2,BP
GO:0043122,regulation of canonical NF-kappaB signal transduction,3/262,203/12185,0.816131566,0.999969493,0.836022269,TRIM59/ECT2/EDA2R,3,BP
GO:0050678,regulation of epithelial cell proliferation,4/262,261/12185,0.816735895,0.999969493,0.836022269,IQGAP3/BRCA2/UHRF1/HMGB2,4,BP
GO:0031669,cellular response to nutrient levels,3/262,205/12185,0.821273309,0.999969493,0.836022269,BRIP1/CDKN1A/WDR45,3,BP
GO:0009408,response to heat,1/262,79/12185,0.821426403,0.999969493,0.836022269,CDKN1A,1,BP
GO:0044344,cellular response to fibroblast growth factor stimulus,1/262,79/12185,0.821426403,0.999969493,0.836022269,SHCBP1,1,BP
GO:0140747,regulation of ncRNA transcription,1/262,79/12185,0.821426403,0.999969493,0.836022269,DDX11,1,BP
GO:1903321,negative regulation of protein modification by small protein conjugation or removal,1/262,79/12185,0.821426403,0.999969493,0.836022269,MAD2L1,1,BP
GO:0006469,negative regulation of protein kinase activity,2/262,145/12185,0.822658893,0.999969493,0.836022269,PLK1/CDKN1A,2,BP
GO:0006401,RNA catabolic process,4/262,264/12185,0.823572541,0.999969493,0.836022269,DNA2/EXOSC8/SLFN13/E2F1,4,BP
GO:0042326,negative regulation of phosphorylation,4/262,264/12185,0.823572541,0.999969493,0.836022269,CDKN2C/PLK1/CDKN1A/PBK,4,BP
GO:0005976,polysaccharide metabolic process,1/262,80/12185,0.825291122,0.999969493,0.836022269,PHKA1,1,BP
GO:0006405,RNA export from nucleus,1/262,80/12185,0.825291122,0.999969493,0.836022269,NUP160,1,BP
GO:0009063,amino acid catabolic process,1/262,80/12185,0.825291122,0.999969493,0.836022269,ARHGAP11B,1,BP
GO:0050865,regulation of cell activation,6/262,377/12185,0.825520592,0.999969493,0.836022269,SLC7A1/FANCA/MSH2/FANCD2/NSD2/CDKN1A,6,BP
GO:0043488,regulation of mRNA stability,2/262,146/12185,0.825593391,0.999969493,0.836022269,EXOSC8/E2F1,2,BP
GO:0043583,ear development,2/262,146/12185,0.825593391,0.999969493,0.836022269,MCM2/CCNA2,2,BP
GO:1990138,neuron projection extension,2/262,146/12185,0.825593391,0.999969493,0.836022269,EDN2/AURKA,2,BP
GO:0003205,cardiac chamber development,2/262,147/12185,0.828484315,0.999969493,0.836022269,NSD2/CNTRL,2,BP
GO:0007204,positive regulation of cytosolic calcium ion concentration,1/262,81/12185,0.829072512,0.999969493,0.836022269,EDN2,1,BP
GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,1/262,81/12185,0.829072512,0.999969493,0.836022269,RPS27L,1,BP
GO:0055006,cardiac cell development,1/262,81/12185,0.829072512,0.999969493,0.836022269,CDK1,1,BP
GO:1903312,negative regulation of mRNA metabolic process,1/262,81/12185,0.829072512,0.999969493,0.836022269,E2F1,1,BP
GO:0006869,lipid transport,4/262,267/12185,0.830198167,0.999969493,0.836022269,ATP8B3/ANO7/SLC25A20/XKR5,4,BP
GO:0030324,lung development,2/262,148/12185,0.831332173,0.999969493,0.836022269,EDN2/TIMELESS,2,BP
GO:0048167,regulation of synaptic plasticity,2/262,148/12185,0.831332173,0.999969493,0.836022269,CDC20/LZTS1,2,BP
GO:0002027,regulation of heart rate,1/262,82/12185,0.832772363,0.999969493,0.836022269,EDN2,1,BP
GO:0008037,cell recognition,1/262,82/12185,0.832772363,0.999969493,0.836022269,ATP8B3,1,BP
GO:0022037,metencephalon development,1/262,82/12185,0.832772363,0.999969493,0.836022269,KIF14,1,BP
GO:0051384,response to glucocorticoid,1/262,82/12185,0.832772363,0.999969493,0.836022269,CDKN1A,1,BP
GO:0060840,artery development,1/262,82/12185,0.832772363,0.999969493,0.836022269,CNTRL,1,BP
GO:0099175,regulation of postsynapse organization,1/262,82/12185,0.832772363,0.999969493,0.836022269,LZTS1,1,BP
GO:0050727,regulation of inflammatory response,3/262,210/12185,0.833596181,0.999969493,0.836022269,FANCA/FANCD2/PBK,3,BP
GO:0016241,regulation of macroautophagy,2/262,149/12185,0.834137472,0.999969493,0.836022269,LZTS1/WDR45,2,BP
GO:0050679,positive regulation of epithelial cell proliferation,2/262,149/12185,0.834137472,0.999969493,0.836022269,IQGAP3/HMGB2,2,BP
GO:0001738,morphogenesis of a polarized epithelium,1/262,83/12185,0.836392428,0.999969493,0.836022269,SAPCD2,1,BP
GO:0002065,columnar/cuboidal epithelial cell differentiation,1/262,83/12185,0.836392428,0.999969493,0.836022269,CDKN1A,1,BP
GO:0006497,protein lipidation,1/262,83/12185,0.836392428,0.999969493,0.836022269,WDR45,1,BP
GO:0071774,response to fibroblast growth factor,1/262,83/12185,0.836392428,0.999969493,0.836022269,SHCBP1,1,BP
GO:0003002,regionalization,4/262,271/12185,0.838710865,0.999969493,0.836022269,STIL/RTTN/AURKA/XRCC2,4,BP
GO:1901605,alpha-amino acid metabolic process,2/262,151/12185,0.83962241,0.999969493,0.836022269,PHGDH/ARHGAP11B,2,BP
GO:0002687,positive regulation of leukocyte migration,1/262,84/12185,0.83993442,0.999969493,0.836022269,EDN2,1,BP
GO:0021782,glial cell development,1/262,84/12185,0.83993442,0.999969493,0.836022269,PHGDH,1,BP
GO:0035303,regulation of dephosphorylation,1/262,84/12185,0.83993442,0.999969493,0.836022269,CDCA2,1,BP
GO:0050773,regulation of dendrite development,1/262,84/12185,0.83993442,0.999969493,0.836022269,LZTS1,1,BP
GO:0051963,regulation of synapse assembly,1/262,84/12185,0.83993442,0.999969493,0.836022269,LZTS1,1,BP
GO:0034599,cellular response to oxidative stress,3/262,213/12185,0.840635271,0.999969493,0.836022269,CDK1/FANCD2/ECT2,3,BP
GO:0009267,cellular response to starvation,2/262,152/12185,0.842303052,0.999969493,0.836022269,CDKN1A/WDR45,2,BP
GO:0030323,respiratory tube development,2/262,152/12185,0.842303052,0.999969493,0.836022269,EDN2/TIMELESS,2,BP
GO:0043123,positive regulation of canonical NF-kappaB signal transduction,2/262,152/12185,0.842303052,0.999969493,0.836022269,ECT2/EDA2R,2,BP
GO:0050863,regulation of T cell activation,3/262,214/12185,0.842924015,0.999969493,0.836022269,SLC7A1/FANCA/FANCD2,3,BP
GO:0071887,leukocyte apoptotic process,1/262,85/12185,0.843400016,0.999969493,0.836022269,AURKB,1,BP
GO:1903305,regulation of regulated secretory pathway,1/262,86/12185,0.846790859,0.999969493,0.836022269,SLC4A8,1,BP
GO:0046578,regulation of Ras protein signal transduction,2/262,154/12185,0.847543176,0.999969493,0.836022269,KIF14/FOXM1,2,BP
GO:0042158,lipoprotein biosynthetic process,1/262,87/12185,0.850108554,0.999969493,0.836022269,WDR45,1,BP
GO:0071496,cellular response to external stimulus,4/262,277/12185,0.850810544,0.999969493,0.836022269,CHEK1/BRIP1/CDKN1A/WDR45,4,BP
GO:0007259,receptor signaling pathway via JAK-STAT,1/262,88/12185,0.853354674,0.999969493,0.836022269,CENPJ,1,BP
GO:0021761,limbic system development,1/262,88/12185,0.853354674,0.999969493,0.836022269,KIF14,1,BP
GO:0030203,glycosaminoglycan metabolic process,1/262,88/12185,0.853354674,0.999969493,0.836022269,HMMR,1,BP
GO:0050921,positive regulation of chemotaxis,1/262,88/12185,0.853354674,0.999969493,0.836022269,EDN2,1,BP
GO:0110020,regulation of actomyosin structure organization,1/262,88/12185,0.853354674,0.999969493,0.836022269,ECT2,1,BP
GO:0046394,carboxylic acid biosynthetic process,3/262,219/12185,0.853946841,0.999969493,0.836022269,EDN2/PHGDH/BRCA1,3,BP
GO:0006486,protein glycosylation,2/262,157/12185,0.855107864,0.999969493,0.836022269,POGLUT3/DPY19L2P2,2,BP
GO:0033673,negative regulation of kinase activity,2/262,157/12185,0.855107864,0.999969493,0.836022269,PLK1/CDKN1A,2,BP
GO:0043413,macromolecule glycosylation,2/262,157/12185,0.855107864,0.999969493,0.836022269,POGLUT3/DPY19L2P2,2,BP
GO:0043487,regulation of RNA stability,2/262,157/12185,0.855107864,0.999969493,0.836022269,EXOSC8/E2F1,2,BP
GO:0016053,organic acid biosynthetic process,3/262,220/12185,0.856068981,0.999969493,0.836022269,EDN2/PHGDH/BRCA1,3,BP
GO:0051962,positive regulation of nervous system development,3/262,220/12185,0.856068981,0.999969493,0.836022269,ASPM/WDR62/XRCC2,3,BP
GO:0045862,positive regulation of proteolysis,4/262,280/12185,0.856568151,0.999969493,0.836022269,CDC20/RPS27L/PLK1/AURKA,4,BP
GO:0009895,negative regulation of catabolic process,4/262,281/12185,0.8584451,0.999969493,0.836022269,E2F1/MAD2L1/LZTS1/PBK,4,BP
GO:0032874,positive regulation of stress-activated MAPK cascade,1/262,90/12185,0.859638308,0.999969493,0.836022269,EDA2R,1,BP
GO:0034446,substrate adhesion-dependent cell spreading,1/262,90/12185,0.859638308,0.999969493,0.836022269,KIF14,1,BP
GO:0042129,regulation of T cell proliferation,1/262,90/12185,0.859638308,0.999969493,0.836022269,SLC7A1,1,BP
GO:0046683,response to organophosphorus,1/262,90/12185,0.859638308,0.999969493,0.836022269,RFC3,1,BP
GO:0048565,digestive tract development,1/262,90/12185,0.859638308,0.999969493,0.836022269,CDKN1A,1,BP
GO:0090630,activation of GTPase activity,1/262,90/12185,0.859638308,0.999969493,0.836022269,ECT2,1,BP
GO:1902414,protein localization to cell junction,1/262,90/12185,0.859638308,0.999969493,0.836022269,DLG2,1,BP
GO:0044403,biological process involved in symbiotic interaction,3/262,222/12185,0.860232847,0.999969493,0.836022269,CDK1/SLC7A1/TRIM59,3,BP
GO:0061013,regulation of mRNA catabolic process,2/262,160/12185,0.862329655,0.999969493,0.836022269,EXOSC8/E2F1,2,BP
GO:0015718,monocarboxylic acid transport,1/262,91/12185,0.862678801,0.999969493,0.836022269,SLC25A20,1,BP
GO:0031123,RNA 3'-end processing,1/262,91/12185,0.862678801,0.999969493,0.836022269,EXOSC8,1,BP
GO:0038061,non-canonical NF-kappaB signal transduction,1/262,91/12185,0.862678801,0.999969493,0.836022269,RTKN2,1,BP
GO:0050728,negative regulation of inflammatory response,1/262,91/12185,0.862678801,0.999969493,0.836022269,PBK,1,BP
GO:0001558,regulation of cell growth,5/262,342/12185,0.863402033,0.999969493,0.836022269,CDKN2C/PSRC1/KIF14/BRCA1/CDKN1A,5,BP
GO:0000302,response to reactive oxygen species,2/262,161/12185,0.864662964,0.999969493,0.836022269,CDK1/ECT2,2,BP
GO:0030183,B cell differentiation,1/262,92/12185,0.865653678,0.999969493,0.836022269,MSH2,1,BP
GO:0061157,mRNA destabilization,1/262,92/12185,0.865653678,0.999969493,0.836022269,EXOSC8,1,BP
GO:0070304,positive regulation of stress-activated protein kinase signaling cascade,1/262,92/12185,0.865653678,0.999969493,0.836022269,EDA2R,1,BP
GO:0090263,positive regulation of canonical Wnt signaling pathway,1/262,92/12185,0.865653678,0.999969493,0.836022269,ASPM,1,BP
GO:0097696,receptor signaling pathway via STAT,1/262,92/12185,0.865653678,0.999969493,0.836022269,CENPJ,1,BP
GO:2001056,positive regulation of cysteine-type endopeptidase activity,1/262,92/12185,0.865653678,0.999969493,0.836022269,RPS27L,1,BP
GO:0006022,aminoglycan metabolic process,1/262,93/12185,0.868564348,0.999969493,0.836022269,HMMR,1,BP
GO:0048640,negative regulation of developmental growth,1/262,93/12185,0.868564348,0.999969493,0.836022269,CDKN1A,1,BP
GO:0060326,cell chemotaxis,2/262,163/12185,0.869221493,0.999969493,0.836022269,EDN2/HMGB2,2,BP
GO:0043068,positive regulation of programmed cell death,6/262,403/12185,0.869469053,0.999969493,0.836022269,TOP2A/E2F1/MYBL2/ECT2/CDKN1A/MELK,6,BP
GO:0030168,platelet activation,1/262,94/12185,0.871412193,0.999969493,0.836022269,MYL12A,1,BP
GO:0031330,negative regulation of cellular catabolic process,2/262,164/12185,0.871447649,0.999969493,0.836022269,E2F1/LZTS1,2,BP
GO:0010970,transport along microtubule,2/262,165/12185,0.873639017,0.999969493,0.836022269,DLG2/KIF4A,2,BP
GO:0002250,adaptive immune response,3/262,229/12185,0.873988315,0.999969493,0.836022269,EXO1/MSH2/NSD2,3,BP
GO:0007249,canonical NF-kappaB signal transduction,3/262,229/12185,0.873988315,0.999969493,0.836022269,TRIM59/ECT2/EDA2R,3,BP
GO:0031960,response to corticosteroid,1/262,95/12185,0.874198563,0.999969493,0.836022269,CDKN1A,1,BP
GO:0050779,RNA destabilization,1/262,95/12185,0.874198563,0.999969493,0.836022269,EXOSC8,1,BP
GO:0032386,regulation of intracellular transport,4/262,290/12185,0.874417823,0.999969493,0.836022269,CDK1/KIF20B/SPAG5/ECT2,4,BP
GO:0060541,respiratory system development,2/262,166/12185,0.875796059,0.999969493,0.836022269,EDN2/TIMELESS,2,BP
GO:0006367,transcription initiation at RNA polymerase II promoter,1/262,96/12185,0.876924781,0.999969493,0.836022269,E2F2,1,BP
GO:0010565,regulation of cellular ketone metabolic process,1/262,96/12185,0.876924781,0.999969493,0.836022269,BRCA1,1,BP
GO:0061014,positive regulation of mRNA catabolic process,1/262,96/12185,0.876924781,0.999969493,0.836022269,EXOSC8,1,BP
GO:2000027,regulation of animal organ morphogenesis,1/262,96/12185,0.876924781,0.999969493,0.836022269,SAPCD2,1,BP
GO:0031668,cellular response to extracellular stimulus,3/262,231/12185,0.877692952,0.999969493,0.836022269,BRIP1/CDKN1A/WDR45,3,BP
GO:0009101,glycoprotein biosynthetic process,3/262,232/12185,0.879508928,0.999969493,0.836022269,POGLUT3/ITM2B/DPY19L2P2,3,BP
GO:0006575,cellular modified amino acid metabolic process,1/262,97/12185,0.879592141,0.999969493,0.836022269,MTHFD2,1,BP
GO:0002040,sprouting angiogenesis,1/262,98/12185,0.882201907,0.999969493,0.836022269,E2F2,1,BP
GO:0035150,regulation of tube size,1/262,98/12185,0.882201907,0.999969493,0.836022269,EDN2,1,BP
GO:0035296,regulation of tube diameter,1/262,98/12185,0.882201907,0.999969493,0.836022269,EDN2,1,BP
GO:0055123,digestive system development,1/262,98/12185,0.882201907,0.999969493,0.836022269,CDKN1A,1,BP
GO:0097746,blood vessel diameter maintenance,1/262,98/12185,0.882201907,0.999969493,0.836022269,EDN2,1,BP
GO:0051345,positive regulation of hydrolase activity,5/262,355/12185,0.883658248,0.999969493,0.836022269,DDX11/ARHGAP11A/RPS27L/ECT2/HMGB2,5,BP
GO:0043200,response to amino acid,1/262,99/12185,0.88475532,0.999969493,0.836022269,DNMT1,1,BP
GO:0006091,generation of precursor metabolites and energy,6/262,415/12185,0.886431027,0.999969493,0.836022269,PHGDH/CDK1/NDUFAF1/MSH2/CCNB1/PHKA1,6,BP
GO:0051960,regulation of nervous system development,5/262,357/12185,0.886536332,0.999969493,0.836022269,ASPM/KIF14/WDR62/HMGB2/XRCC2,5,BP
GO:0001936,regulation of endothelial cell proliferation,1/262,100/12185,0.887253591,0.999969493,0.836022269,HMGB2,1,BP
GO:0006626,protein targeting to mitochondrion,1/262,100/12185,0.887253591,0.999969493,0.836022269,TIMM8B,1,BP
GO:0007601,visual perception,1/262,100/12185,0.887253591,0.999969493,0.836022269,CEP250,1,BP
GO:0071375,cellular response to peptide hormone stimulus,3/262,237/12185,0.888235202,0.999969493,0.836022269,CDC6/BRIP1/CCNA2,3,BP
GO:0030518,intracellular steroid hormone receptor signaling pathway,1/262,101/12185,0.889697907,0.999969493,0.836022269,BRCA1,1,BP
GO:0050680,negative regulation of epithelial cell proliferation,1/262,101/12185,0.889697907,0.999969493,0.836022269,BRCA2,1,BP
GO:0051222,positive regulation of protein transport,3/262,238/12185,0.88991144,0.999969493,0.836022269,CDK1/KIF20B/ECT2,3,BP
GO:0040008,regulation of growth,7/262,476/12185,0.89135482,0.999969493,0.836022269,CDKN2C/PSRC1/KIF14/CDK1/CCNB2/BRCA1/CDKN1A,7,BP
GO:0045936,negative regulation of phosphate metabolic process,4/262,301/12185,0.891814555,0.999969493,0.836022269,CDKN2C/PLK1/CDKN1A/PBK,4,BP
GO:0050767,regulation of neurogenesis,4/262,301/12185,0.891814555,0.999969493,0.836022269,ASPM/WDR62/HMGB2/XRCC2,4,BP
GO:1990778,protein localization to cell periphery,4/262,301/12185,0.891814555,0.999969493,0.836022269,GPSM2/PLK1/MYL12A/SAPCD2,4,BP
GO:0007584,response to nutrient,1/262,102/12185,0.892089429,0.999969493,0.836022269,BRIP1,1,BP
GO:0042742,defense response to bacterium,1/262,102/12185,0.892089429,0.999969493,0.836022269,HMGB2,1,BP
GO:0050953,sensory perception of light stimulus,1/262,102/12185,0.892089429,0.999969493,0.836022269,CEP250,1,BP
GO:0031400,negative regulation of protein modification process,5/262,361/12185,0.892110616,0.999969493,0.836022269,PLK1/BRCA1/MAD2L1/CDKN1A/PBK,5,BP
GO:0042063,gliogenesis,3/262,240/12185,0.893196829,0.999969493,0.836022269,CDKN2C/PHGDH/CDK1,3,BP
GO:0048545,response to steroid hormone,3/262,240/12185,0.893196829,0.999969493,0.836022269,BRCA1/HMGB2/CDKN1A,3,BP
GO:1901293,nucleoside phosphate biosynthetic process,3/262,240/12185,0.893196829,0.999969493,0.836022269,RRM1/TK1/RRM2,3,BP
GO:0010563,negative regulation of phosphorus metabolic process,4/262,302/12185,0.893286852,0.999969493,0.836022269,CDKN2C/PLK1/CDKN1A/PBK,4,BP
GO:0051651,maintenance of location in cell,2/262,175/12185,0.893738673,0.999969493,0.836022269,GPSM2/ASPM,2,BP
GO:0070085,glycosylation,2/262,176/12185,0.895576891,0.999969493,0.836022269,POGLUT3/DPY19L2P2,2,BP
GO:0000045,autophagosome assembly,1/262,104/12185,0.896718609,0.999969493,0.836022269,WDR45,1,BP
GO:0002832,negative regulation of response to biotic stimulus,1/262,104/12185,0.896718609,0.999969493,0.836022269,AURKB,1,BP
GO:0014074,response to purine-containing compound,1/262,104/12185,0.896718609,0.999969493,0.836022269,CHEK1,1,BP
GO:0042274,ribosomal small subunit biogenesis,1/262,104/12185,0.896718609,0.999969493,0.836022269,RPS27L,1,BP
GO:0045598,regulation of fat cell differentiation,1/262,104/12185,0.896718609,0.999969493,0.836022269,E2F1,1,BP
GO:0048675,axon extension,1/262,104/12185,0.896718609,0.999969493,0.836022269,EDN2,1,BP
GO:0010876,lipid localization,4/262,305/12185,0.89759929,0.999969493,0.836022269,ATP8B3/ANO7/SLC25A20/XKR5,4,BP
GO:0006865,amino acid transport,1/262,105/12185,0.898958467,0.999969493,0.836022269,SLC7A1,1,BP
GO:0046328,regulation of JNK cascade,1/262,105/12185,0.898958467,0.999969493,0.836022269,EDA2R,1,BP
GO:0051592,response to calcium ion,1/262,105/12185,0.898958467,0.999969493,0.836022269,ECT2,1,BP
GO:0060041,retina development in camera-type eye,1/262,105/12185,0.898958467,0.999969493,0.836022269,RRM1,1,BP
GO:0007389,pattern specification process,4/262,306/12185,0.899002477,0.999969493,0.836022269,STIL/RTTN/AURKA/XRCC2,4,BP
GO:0051091,positive regulation of DNA-binding transcription factor activity,2/262,178/12185,0.899165177,0.999969493,0.836022269,RTKN2/EDA2R,2,BP
GO:0097191,extrinsic apoptotic signaling pathway,2/262,178/12185,0.899165177,0.999969493,0.836022269,BRCA1/HMGB2,2,BP
GO:0001933,negative regulation of protein phosphorylation,3/262,244/12185,0.899505934,0.999969493,0.836022269,PLK1/CDKN1A/PBK,3,BP
GO:0031348,negative regulation of defense response,2/262,180/12185,0.902638664,0.999969493,0.836022269,AURKB/PBK,2,BP
GO:0042594,response to starvation,2/262,180/12185,0.902638664,0.999969493,0.836022269,CDKN1A/WDR45,2,BP
GO:0001889,liver development,1/262,107/12185,0.903294042,0.999969493,0.836022269,AURKA,1,BP
GO:0007043,cell-cell junction assembly,1/262,107/12185,0.903294042,0.999969493,0.836022269,ECT2,1,BP
GO:0010927,cellular component assembly involved in morphogenesis,1/262,107/12185,0.903294042,0.999969493,0.836022269,KNL1,1,BP
GO:0071902,positive regulation of protein serine/threonine kinase activity,1/262,107/12185,0.903294042,0.999969493,0.836022269,PSRC1,1,BP
GO:0001101,response to acid chemical,1/262,108/12185,0.90539182,0.999969493,0.836022269,DNMT1,1,BP
GO:0042157,lipoprotein metabolic process,1/262,108/12185,0.90539182,0.999969493,0.836022269,WDR45,1,BP
GO:0043547,positive regulation of GTPase activity,2/262,182/12185,0.906000577,0.999969493,0.836022269,ARHGAP11A/ECT2,2,BP
GO:0007269,neurotransmitter secretion,1/262,109/12185,0.907444262,0.999969493,0.836022269,SLC4A8,1,BP
GO:0099643,signal release from synapse,1/262,109/12185,0.907444262,0.999969493,0.836022269,SLC4A8,1,BP
GO:1901652,response to peptide,5/262,373/12185,0.907444644,0.999969493,0.836022269,DDX11/TIMELESS/CDC6/BRIP1/CCNA2,5,BP
GO:0032259,methylation,3/262,250/12185,0.908343521,0.999969493,0.836022269,HELLS/DNMT1/NSD2,3,BP
GO:0010720,positive regulation of cell development,4/262,313/12185,0.90836074,0.999969493,0.836022269,ASPM/WDR62/AURKA/XRCC2,4,BP
GO:0010950,positive regulation of endopeptidase activity,1/262,110/12185,0.909452344,0.999969493,0.836022269,RPS27L,1,BP
GO:0035725,sodium ion transmembrane transport,1/262,110/12185,0.909452344,0.999969493,0.836022269,SLC4A8,1,BP
GO:0043244,regulation of protein-containing complex disassembly,1/262,110/12185,0.909452344,0.999969493,0.836022269,TPX2,1,BP
GO:0055007,cardiac muscle cell differentiation,1/262,110/12185,0.909452344,0.999969493,0.836022269,CDK1,1,BP
GO:0061008,hepaticobiliary system development,1/262,110/12185,0.909452344,0.999969493,0.836022269,AURKA,1,BP
GO:0048732,gland development,4/262,314/12185,0.909633202,0.999969493,0.836022269,IQGAP3/BRCA2/CCNB2/AURKA,4,BP
GO:0050807,regulation of synapse organization,2/262,185/12185,0.910841141,0.999969493,0.836022269,CDC20/LZTS1,2,BP
GO:0003206,cardiac chamber morphogenesis,1/262,111/12185,0.911417022,0.999969493,0.836022269,NSD2,1,BP
GO:1905037,autophagosome organization,1/262,111/12185,0.911417022,0.999969493,0.836022269,WDR45,1,BP
GO:0010038,response to metal ion,3/262,253/12185,0.912494007,0.999969493,0.836022269,CDK1/DLG2/ECT2,3,BP
GO:0030902,hindbrain development,1/262,112/12185,0.91333923,0.999969493,0.836022269,KIF14,1,BP
GO:0050803,regulation of synapse structure or activity,2/262,187/12185,0.913937803,0.999969493,0.836022269,CDC20/LZTS1,2,BP
GO:0008360,regulation of cell shape,1/262,113/12185,0.915219883,0.999969493,0.836022269,MYL12A,1,BP
GO:0030595,leukocyte chemotaxis,1/262,113/12185,0.915219883,0.999969493,0.836022269,EDN2,1,BP
GO:0051028,mRNA transport,1/262,113/12185,0.915219883,0.999969493,0.836022269,NUP160,1,BP
GO:0030217,T cell differentiation,2/262,188/12185,0.915448149,0.999969493,0.836022269,FANCA/FANCD2,2,BP
GO:0008217,regulation of blood pressure,1/262,114/12185,0.917059876,0.999969493,0.836022269,EDN2,1,BP
GO:0042098,T cell proliferation,1/262,114/12185,0.917059876,0.999969493,0.836022269,SLC7A1,1,BP
GO:0042552,myelination,1/262,114/12185,0.917059876,0.999969493,0.836022269,KIF14,1,BP
GO:0043401,steroid hormone mediated signaling pathway,1/262,114/12185,0.917059876,0.999969493,0.836022269,BRCA1,1,BP
GO:0050806,positive regulation of synaptic transmission,1/262,114/12185,0.917059876,0.999969493,0.836022269,SLC4A8,1,BP
GO:0071222,cellular response to lipopolysaccharide,1/262,114/12185,0.917059876,0.999969493,0.836022269,HMGB2,1,BP
GO:0043414,macromolecule methylation,2/262,190/12185,0.918394714,0.999969493,0.836022269,HELLS/DNMT1,2,BP
GO:0007266,Rho protein signal transduction,1/262,115/12185,0.918860084,0.999969493,0.836022269,RACGAP1,1,BP
GO:0045766,positive regulation of angiogenesis,1/262,115/12185,0.918860084,0.999969493,0.836022269,BRCA1,1,BP
GO:0048813,dendrite morphogenesis,1/262,115/12185,0.918860084,0.999969493,0.836022269,LZTS1,1,BP
GO:0072006,nephron development,1/262,115/12185,0.918860084,0.999969493,0.836022269,NUP160,1,BP
GO:1904018,positive regulation of vasculature development,1/262,115/12185,0.918860084,0.999969493,0.836022269,BRCA1,1,BP
GO:1902074,response to salt,3/262,258/12185,0.919034823,0.999969493,0.836022269,DLG2/ECT2/CCNA2,3,BP
GO:0030098,lymphocyte differentiation,3/262,259/12185,0.920288446,0.999969493,0.836022269,FANCA/MSH2/FANCD2,3,BP
GO:0001959,regulation of cytokine-mediated signaling pathway,1/262,116/12185,0.920621365,0.999969493,0.836022269,TRAIP,1,BP
GO:0007272,ensheathment of neurons,1/262,116/12185,0.920621365,0.999969493,0.836022269,KIF14,1,BP
GO:0008366,axon ensheathment,1/262,116/12185,0.920621365,0.999969493,0.836022269,KIF14,1,BP
GO:0009913,epidermal cell differentiation,1/262,116/12185,0.920621365,0.999969493,0.836022269,CDKN1A,1,BP
GO:0016072,rRNA metabolic process,3/262,260/12185,0.921524388,0.999969493,0.836022269,DDX11/EXOSC8/SLFN13,3,BP
GO:0001935,endothelial cell proliferation,1/262,117/12185,0.922344557,0.999969493,0.836022269,HMGB2,1,BP
GO:0046034,ATP metabolic process,1/262,117/12185,0.922344557,0.999969493,0.836022269,FIGNL1,1,BP
GO:0051147,regulation of muscle cell differentiation,1/262,117/12185,0.922344557,0.999969493,0.836022269,DNMT1,1,BP
GO:0072655,establishment of protein localization to mitochondrion,1/262,117/12185,0.922344557,0.999969493,0.836022269,TIMM8B,1,BP
GO:0048588,developmental cell growth,2/262,193/12185,0.922634643,0.999969493,0.836022269,EDN2/AURKA,2,BP
GO:0002697,regulation of immune effector process,2/262,194/12185,0.924001386,0.999969493,0.836022269,MSH2/NSD2,2,BP
GO:0099111,microtubule-based transport,2/262,194/12185,0.924001386,0.999969493,0.836022269,DLG2/KIF4A,2,BP
GO:0002274,myeloid leukocyte activation,1/262,118/12185,0.92403048,0.999969493,0.836022269,EDN2,1,BP
GO:0048754,branching morphogenesis of an epithelial tube,1/262,118/12185,0.92403048,0.999969493,0.836022269,TIMELESS,1,BP
GO:0071219,cellular response to molecule of bacterial origin,1/262,118/12185,0.92403048,0.999969493,0.836022269,HMGB2,1,BP
GO:0097529,myeloid leukocyte migration,1/262,118/12185,0.92403048,0.999969493,0.836022269,EDN2,1,BP
GO:0048863,stem cell differentiation,2/262,195/12185,0.925345422,0.999969493,0.836022269,CHD2/PHF19,2,BP
GO:1902105,regulation of leukocyte differentiation,2/262,195/12185,0.925345422,0.999969493,0.836022269,FANCA/FANCD2,2,BP
GO:0098781,ncRNA transcription,1/262,119/12185,0.925679939,0.999969493,0.836022269,DDX11,1,BP
GO:1903706,regulation of hemopoiesis,3/262,264/12185,0.926295529,0.999969493,0.836022269,FANCA/FANCD2/HMGB2,3,BP
GO:0050777,negative regulation of immune response,1/262,120/12185,0.927293717,0.999969493,0.836022269,AURKB,1,BP
GO:0030705,cytoskeleton-dependent intracellular transport,2/262,197/12185,0.927966728,0.999969493,0.836022269,DLG2/KIF4A,2,BP
GO:0007600,sensory perception,3/262,266/12185,0.928580413,0.999969493,0.836022269,TIMM8B/BIRC5/CEP250,3,BP
GO:0062197,cellular response to chemical stress,3/262,266/12185,0.928580413,0.999969493,0.836022269,CDK1/FANCD2/ECT2,3,BP
GO:0043065,positive regulation of apoptotic process,5/262,393/12185,0.928807748,0.999969493,0.836022269,TOP2A/E2F1/MYBL2/ECT2/MELK,5,BP
GO:0000956,nuclear-transcribed mRNA catabolic process,1/262,121/12185,0.928872586,0.999969493,0.836022269,EXOSC8,1,BP
GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,1/262,121/12185,0.928872586,0.999969493,0.836022269,RPS27L,1,BP
GO:0048639,positive regulation of developmental growth,1/262,121/12185,0.928872586,0.999969493,0.836022269,CDK1,1,BP
GO:1903313,positive regulation of mRNA metabolic process,1/262,121/12185,0.928872586,0.999969493,0.836022269,EXOSC8,1,BP
GO:0010952,positive regulation of peptidase activity,1/262,122/12185,0.930417296,0.999969493,0.836022269,RPS27L,1,BP
GO:0045765,regulation of angiogenesis,2/262,199/12185,0.93050123,0.999969493,0.836022269,E2F2/BRCA1,2,BP
GO:0060562,epithelial tube morphogenesis,3/262,269/12185,0.931886426,0.999969493,0.836022269,STIL/KIF20B/TIMELESS,3,BP
GO:0031333,negative regulation of protein-containing complex assembly,1/262,123/12185,0.931928584,0.999969493,0.836022269,KIF14,1,BP
GO:0045727,positive regulation of translation,1/262,123/12185,0.931928584,0.999969493,0.836022269,RPS27L,1,BP
GO:0070585,protein localization to mitochondrion,1/262,123/12185,0.931928584,0.999969493,0.836022269,TIMM8B,1,BP
GO:0060560,developmental growth involved in morphogenesis,2/262,201/12185,0.932951533,0.999969493,0.836022269,EDN2/AURKA,2,BP
GO:1901342,regulation of vasculature development,2/262,201/12185,0.932951533,0.999969493,0.836022269,E2F2/BRCA1,2,BP
GO:0070482,response to oxygen levels,3/262,270/12185,0.932956872,0.999969493,0.836022269,BRIP1/CCNA2/CDKN1A,3,BP
GO:0009266,response to temperature stimulus,1/262,124/12185,0.93340717,0.999969493,0.836022269,CDKN1A,1,BP
GO:0046890,regulation of lipid biosynthetic process,1/262,124/12185,0.93340717,0.999969493,0.836022269,BRCA1,1,BP
GO:0006631,fatty acid metabolic process,3/262,271/12185,0.934011865,0.999969493,0.836022269,EDN2/ACBD7/BRCA1,3,BP
GO:0018205,peptidyl-lysine modification,2/262,202/12185,0.934145907,0.999969493,0.836022269,BRCA1/DEK,2,BP
GO:0060759,regulation of response to cytokine stimulus,1/262,125/12185,0.93485376,0.999969493,0.836022269,TRAIP,1,BP
GO:0015711,organic anion transport,3/262,272/12185,0.935051596,0.999969493,0.836022269,SLC4A8/SLC7A1/SLC25A20,3,BP
GO:0120031,plasma membrane bounded cell projection assembly,6/262,463/12185,0.936866442,0.999969493,0.836022269,CENPJ/CEP250/POC1A/PLK4/ANLN/KIF24,6,BP
GO:0043086,negative regulation of catalytic activity,4/262,340/12185,0.937657366,0.999969493,0.836022269,PIF1/PLK1/MAD2L1/CDKN1A,4,BP
GO:0007254,JNK cascade,1/262,128/12185,0.939008375,0.999969493,0.836022269,EDA2R,1,BP
GO:0019722,calcium-mediated signaling,1/262,128/12185,0.939008375,0.999969493,0.836022269,EDN2,1,BP
GO:0032543,mitochondrial translation,1/262,129/12185,0.94033373,0.999969493,0.836022269,MRPL32,1,BP
GO:0019221,cytokine-mediated signaling pathway,3/262,279/12185,0.941918216,0.999969493,0.836022269,EDN2/TRAIP/EDA2R,3,BP
GO:0002685,regulation of leukocyte migration,1/262,131/12185,0.942898981,0.999969493,0.836022269,EDN2,1,BP
GO:0008033,tRNA processing,1/262,131/12185,0.942898981,0.999969493,0.836022269,RPP25L,1,BP
GO:0032006,regulation of TOR signaling,1/262,131/12185,0.942898981,0.999969493,0.836022269,FAM83D,1,BP
GO:0035265,organ growth,1/262,131/12185,0.942898981,0.999969493,0.836022269,CDK1,1,BP
GO:0008544,epidermis development,2/262,210/12185,0.943002615,0.999969493,0.836022269,CDKN1A/EDA2R,2,BP
GO:0009896,positive regulation of catabolic process,6/262,471/12185,0.943003511,0.999969493,0.836022269,CDC20/DTL/EXOSC8/PLK1/AURKA/WDR45,6,BP
GO:0006937,regulation of muscle contraction,1/262,132/12185,0.944140102,0.999969493,0.836022269,EDN2,1,BP
GO:0010821,regulation of mitochondrion organization,1/262,132/12185,0.944140102,0.999969493,0.836022269,AURKA,1,BP
GO:0030031,cell projection assembly,6/262,473/12185,0.944452493,0.999969493,0.836022269,CENPJ/CEP250/POC1A/PLK4/ANLN/KIF24,6,BP
GO:0070201,regulation of establishment of protein localization,5/262,413/12185,0.945683381,0.999969493,0.836022269,CDK1/KIF20B/CENPJ/ECT2/NSD2,5,BP
GO:0001659,temperature homeostasis,1/262,134/12185,0.946542296,0.999969493,0.836022269,EDN2,1,BP
GO:0006352,DNA-templated transcription initiation,1/262,134/12185,0.946542296,0.999969493,0.836022269,E2F2,1,BP
GO:0010508,positive regulation of autophagy,1/262,134/12185,0.946542296,0.999969493,0.836022269,WDR45,1,BP
GO:0046942,carboxylic acid transport,2/262,214/12185,0.946995778,0.999969493,0.836022269,SLC7A1/SLC25A20,2,BP
GO:0015849,organic acid transport,2/262,215/12185,0.947951754,0.999969493,0.836022269,SLC7A1/SLC25A20,2,BP
GO:0048284,organelle fusion,1/262,136/12185,0.948841563,0.999969493,0.836022269,CDK1,1,BP
GO:0098739,import across plasma membrane,1/262,136/12185,0.948841563,0.999969493,0.836022269,SLC7A1,1,BP
GO:1901136,carbohydrate derivative catabolic process,1/262,136/12185,0.948841563,0.999969493,0.836022269,HMMR,1,BP
GO:1902904,negative regulation of supramolecular fiber organization,1/262,136/12185,0.948841563,0.999969493,0.836022269,TPX2,1,BP
GO:0031647,regulation of protein stability,3/262,287/12185,0.94894195,0.999969493,0.836022269,PLK1/NDC80/AURKA,3,BP
GO:0003007,heart morphogenesis,2/262,217/12185,0.949814781,0.999969493,0.836022269,STIL/NSD2,2,BP
GO:0006402,mRNA catabolic process,2/262,217/12185,0.949814781,0.999969493,0.836022269,EXOSC8/E2F1,2,BP
GO:0009205,purine ribonucleoside triphosphate metabolic process,1/262,137/12185,0.94995398,0.999969493,0.836022269,FIGNL1,1,BP
GO:0035051,cardiocyte differentiation,1/262,137/12185,0.94995398,0.999969493,0.836022269,CDK1,1,BP
GO:0045637,regulation of myeloid cell differentiation,1/262,137/12185,0.94995398,0.999969493,0.836022269,HMGB2,1,BP
GO:2000116,regulation of cysteine-type endopeptidase activity,1/262,137/12185,0.94995398,0.999969493,0.836022269,RPS27L,1,BP
GO:0014706,striated muscle tissue development,2/262,218/12185,0.950722348,0.999969493,0.836022269,CENPF/CDK1,2,BP
GO:0001505,regulation of neurotransmitter levels,1/262,138/12185,0.951042298,0.999969493,0.836022269,SLC4A8,1,BP
GO:1903131,mononuclear cell differentiation,3/262,290/12185,0.951366428,0.999969493,0.836022269,FANCA/MSH2/FANCD2,3,BP
GO:0009755,hormone-mediated signaling pathway,1/262,139/12185,0.952107038,0.999969493,0.836022269,BRCA1,1,BP
GO:0050657,nucleic acid transport,1/262,139/12185,0.952107038,0.999969493,0.836022269,NUP160,1,BP
GO:0050658,RNA transport,1/262,139/12185,0.952107038,0.999969493,0.836022269,NUP160,1,BP
GO:0009100,glycoprotein metabolic process,3/262,291/12185,0.952150523,0.999969493,0.836022269,POGLUT3/ITM2B/DPY19L2P2,3,BP
GO:0055086,nucleobase-containing small molecule metabolic process,6/262,485/12185,0.952477246,0.999969493,0.836022269,RRM1/DLG2/TK1/RRM2/MACROD2/FIGNL1,6,BP
GO:0017157,regulation of exocytosis,1/262,140/12185,0.953148708,0.999969493,0.836022269,SLC4A8,1,BP
GO:0061138,morphogenesis of a branching epithelium,1/262,140/12185,0.953148708,0.999969493,0.836022269,TIMELESS,1,BP
GO:0006520,amino acid metabolic process,2/262,223/12185,0.95503071,0.999969493,0.836022269,PHGDH/ARHGAP11B,2,BP
GO:0001837,epithelial to mesenchymal transition,1/262,142/12185,0.95516482,0.999969493,0.836022269,FAM83D,1,BP
GO:0006909,phagocytosis,1/262,142/12185,0.95516482,0.999969493,0.836022269,XKR5,1,BP
GO:0051236,establishment of RNA localization,1/262,142/12185,0.95516482,0.999969493,0.836022269,NUP160,1,BP
GO:0006753,nucleoside phosphate metabolic process,5/262,427/12185,0.955258539,0.999969493,0.836022269,RRM1/DLG2/TK1/RRM2/FIGNL1,5,BP
GO:0009144,purine nucleoside triphosphate metabolic process,1/262,143/12185,0.956140226,0.999969493,0.836022269,FIGNL1,1,BP
GO:0050870,positive regulation of T cell activation,1/262,143/12185,0.956140226,0.999969493,0.836022269,SLC7A1,1,BP
GO:0050920,regulation of chemotaxis,1/262,143/12185,0.956140226,0.999969493,0.836022269,EDN2,1,BP
GO:0009199,ribonucleoside triphosphate metabolic process,1/262,144/12185,0.957094491,0.999969493,0.836022269,FIGNL1,1,BP
GO:0034250,positive regulation of amide metabolic process,1/262,145/12185,0.958028072,0.999969493,0.836022269,RPS27L,1,BP
GO:0034655,nucleobase-containing compound catabolic process,4/262,367/12185,0.958210783,0.999969493,0.836022269,DNA2/EXOSC8/SLFN13/E2F1,4,BP
GO:0030099,myeloid cell differentiation,3/262,300/12185,0.958696413,0.999969493,0.836022269,RACGAP1/HMGB2/NCAPG2,3,BP
GO:0019216,regulation of lipid metabolic process,2/262,228/12185,0.958978515,0.999969493,0.836022269,LACTB/BRCA1,2,BP
GO:0006836,neurotransmitter transport,1/262,148/12185,0.960709125,0.999969493,0.836022269,SLC4A8,1,BP
GO:0031929,TOR signaling,1/262,148/12185,0.960709125,0.999969493,0.836022269,FAM83D,1,BP
GO:0001666,response to hypoxia,2/262,233/12185,0.96259398,0.999969493,0.836022269,BRIP1/CCNA2,2,BP
GO:0001763,morphogenesis of a branching structure,1/262,151/12185,0.963219531,0.999969493,0.836022269,TIMELESS,1,BP
GO:0051168,nuclear export,1/262,151/12185,0.963219531,0.999969493,0.836022269,NUP160,1,BP
GO:0002064,epithelial cell development,1/262,153/12185,0.964803705,0.999969493,0.836022269,CDKN1A,1,BP
GO:0009612,response to mechanical stimulus,1/262,153/12185,0.964803705,0.999969493,0.836022269,CHEK1,1,BP
GO:0042180,cellular ketone metabolic process,1/262,153/12185,0.964803705,0.999969493,0.836022269,BRCA1,1,BP
GO:1902905,positive regulation of supramolecular fiber organization,1/262,153/12185,0.964803705,0.999969493,0.836022269,PSRC1,1,BP
GO:0043087,regulation of GTPase activity,2/262,237/12185,0.965264777,0.999969493,0.836022269,ARHGAP11A/ECT2,2,BP
GO:0009743,response to carbohydrate,1/262,154/12185,0.965570114,0.999969493,0.836022269,CDT1,1,BP
GO:0031345,negative regulation of cell projection organization,1/262,154/12185,0.965570114,0.999969493,0.836022269,KIF24,1,BP
GO:0045055,regulated exocytosis,1/262,154/12185,0.965570114,0.999969493,0.836022269,SLC4A8,1,BP
GO:0048568,embryonic organ development,3/262,312/12185,0.966128609,0.999969493,0.836022269,STIL/POLE/PLK4,3,BP
GO:0043408,regulation of MAPK cascade,5/262,447/12185,0.966291419,0.999969493,0.836022269,IQGAP3/FOXM1/FAM83D/PBK/EDA2R,5,BP
GO:0007596,blood coagulation,1/262,155/12185,0.966319896,0.999969493,0.836022269,MYL12A,1,BP
GO:0009165,nucleotide biosynthetic process,2/262,239/12185,0.966530691,0.999969493,0.836022269,RRM1/RRM2,2,BP
GO:0007416,synapse assembly,1/262,156/12185,0.967053411,0.999969493,0.836022269,LZTS1,1,BP
GO:0045216,cell-cell junction organization,1/262,156/12185,0.967053411,0.999969493,0.836022269,ECT2,1,BP
GO:0060348,bone development,1/262,156/12185,0.967053411,0.999969493,0.836022269,NSD2,1,BP
GO:0099173,postsynapse organization,1/262,156/12185,0.967053411,0.999969493,0.836022269,LZTS1,1,BP
GO:0006814,sodium ion transport,1/262,157/12185,0.967771011,0.999969493,0.836022269,SLC4A8,1,BP
GO:0009141,nucleoside triphosphate metabolic process,1/262,157/12185,0.967771011,0.999969493,0.836022269,FIGNL1,1,BP
GO:0050817,coagulation,1/262,157/12185,0.967771011,0.999969493,0.836022269,MYL12A,1,BP
GO:1903039,positive regulation of leukocyte cell-cell adhesion,1/262,157/12185,0.967771011,0.999969493,0.836022269,SLC7A1,1,BP
GO:0008361,regulation of cell size,1/262,158/12185,0.968473039,0.999969493,0.836022269,IQGAP3,1,BP
GO:0044270,cellular nitrogen compound catabolic process,4/262,386/12185,0.968715305,0.999969493,0.836022269,DNA2/EXOSC8/SLFN13/E2F1,4,BP
GO:0043434,response to peptide hormone,3/262,317/12185,0.968838253,0.999969493,0.836022269,CDC6/BRIP1/CCNA2,3,BP
GO:0007599,hemostasis,1/262,159/12185,0.969159832,0.999969493,0.836022269,MYL12A,1,BP
GO:0045861,negative regulation of proteolysis,1/262,159/12185,0.969159832,0.999969493,0.836022269,PBK,1,BP
GO:0046700,heterocycle catabolic process,4/262,388/12185,0.969665296,0.999969493,0.836022269,DNA2/EXOSC8/SLFN13/E2F1,4,BP
GO:0042110,T cell activation,3/262,319/12185,0.96986389,0.999969493,0.836022269,SLC7A1/FANCA/FANCD2,3,BP
GO:0016311,dephosphorylation,2/262,246/12185,0.970621974,0.999969493,0.836022269,CDKN3/CDCA2,2,BP
GO:0031334,positive regulation of protein-containing complex assembly,1/262,162/12185,0.971132062,0.999969493,0.836022269,PSRC1,1,BP
GO:0099504,synaptic vesicle cycle,1/262,162/12185,0.971132062,0.999969493,0.836022269,SLC4A8,1,BP
GO:0140053,mitochondrial gene expression,1/262,162/12185,0.971132062,0.999969493,0.836022269,MRPL32,1,BP
GO:0036293,response to decreased oxygen levels,2/262,247/12185,0.971165694,0.999969493,0.836022269,BRIP1/CCNA2,2,BP
GO:0009617,response to bacterium,3/262,322/12185,0.971342887,0.999969493,0.836022269,MACROD2/NAALADL2/HMGB2,3,BP
GO:0071383,cellular response to steroid hormone stimulus,1/262,163/12185,0.971761139,0.999969493,0.836022269,BRCA1,1,BP
GO:0006979,response to oxidative stress,3/262,323/12185,0.971820483,0.999969493,0.836022269,CDK1/FANCD2/ECT2,3,BP
GO:0071396,cellular response to lipid,4/262,393/12185,0.97192417,0.999969493,0.836022269,KIF18A/BRCA1/CCNA2/HMGB2,4,BP
GO:0048638,regulation of developmental growth,2/262,249/12185,0.972224259,0.999969493,0.836022269,CDK1/CDKN1A,2,BP
GO:0019439,aromatic compound catabolic process,4/262,394/12185,0.972356714,0.999969493,0.836022269,DNA2/EXOSC8/SLFN13/E2F1,4,BP
GO:0002252,immune effector process,3/262,325/12185,0.972753231,0.999969493,0.836022269,EXO1/MSH2/NSD2,3,BP
GO:0009611,response to wounding,4/262,395/12185,0.97278304,0.999969493,0.836022269,CDK1/MYL12A/AURKA/CDKN1A,4,BP
GO:0001818,negative regulation of cytokine production,1/262,165/12185,0.972978618,0.999969493,0.836022269,TRAIP,1,BP
GO:0010631,epithelial cell migration,2/262,251/12185,0.973245395,0.999969493,0.836022269,EDN2/ANLN,2,BP
GO:0090132,epithelium migration,2/262,251/12185,0.973245395,0.999969493,0.836022269,EDN2/ANLN,2,BP
GO:0055001,muscle cell development,1/262,166/12185,0.973567603,0.999969493,0.836022269,CDK1,1,BP
GO:0006470,protein dephosphorylation,1/262,167/12185,0.974143798,0.999969493,0.836022269,CDCA2,1,BP
GO:0008016,regulation of heart contraction,1/262,167/12185,0.974143798,0.999969493,0.836022269,EDN2,1,BP
GO:1901888,regulation of cell junction assembly,1/262,167/12185,0.974143798,0.999969493,0.836022269,LZTS1,1,BP
GO:1903311,regulation of mRNA metabolic process,2/262,253/12185,0.974230354,0.999969493,0.836022269,EXOSC8/E2F1,2,BP
GO:0090130,tissue migration,2/262,255/12185,0.975180351,0.999969493,0.836022269,EDN2/ANLN,2,BP
GO:0032271,regulation of protein polymerization,1/262,170/12185,0.975798379,0.999969493,0.836022269,PSRC1,1,BP
GO:0002009,morphogenesis of an epithelium,4/262,403/12185,0.975979258,0.999969493,0.836022269,STIL/KIF20B/TIMELESS/SAPCD2,4,BP
GO:0030162,regulation of proteolysis,5/262,471/12185,0.976214672,0.999969493,0.836022269,CDC20/RPS27L/PLK1/AURKA/PBK,5,BP
GO:0051235,maintenance of location,2/262,258/12185,0.976542358,0.999969493,0.836022269,GPSM2/ASPM,2,BP
GO:0030335,positive regulation of cell migration,4/262,405/12185,0.976721562,0.999969493,0.836022269,EDN2/KIF20B/WDR62/ARHGEF39,4,BP
GO:1903828,negative regulation of protein localization,1/262,172/12185,0.976842399,0.999969493,0.836022269,SAPCD2,1,BP
GO:0031347,regulation of defense response,5/262,476/12185,0.977906901,0.999969493,0.836022269,FANCA/AURKB/FANCD2/HMGB2/PBK,5,BP
GO:0017148,negative regulation of translation,1/262,176/12185,0.978797741,0.999969493,0.836022269,EXOSC8,1,BP
GO:0006403,RNA localization,1/262,177/12185,0.97926031,0.999969493,0.836022269,NUP160,1,BP
GO:0043588,skin development,1/262,177/12185,0.97926031,0.999969493,0.836022269,CDKN1A,1,BP
GO:1901361,organic cyclic compound catabolic process,4/262,413/12185,0.979481186,0.999969493,0.836022269,DNA2/EXOSC8/SLFN13/E2F1,4,BP
GO:0006935,chemotaxis,2/262,266/12185,0.979831199,0.999969493,0.836022269,EDN2/HMGB2,2,BP
GO:0042330,taxis,2/262,266/12185,0.979831199,0.999969493,0.836022269,EDN2/HMGB2,2,BP
GO:0099003,vesicle-mediated transport in synapse,1/262,179/12185,0.980155504,0.999969493,0.836022269,SLC4A8,1,BP
GO:0001649,osteoblast differentiation,1/262,180/12185,0.980588559,0.999969493,0.836022269,FIGNL1,1,BP
GO:0032496,response to lipopolysaccharide,1/262,181/12185,0.981012199,0.999969493,0.836022269,HMGB2,1,BP
GO:0070372,regulation of ERK1 and ERK2 cascade,1/262,181/12185,0.981012199,0.999969493,0.836022269,FAM83D,1,BP
GO:0043254,regulation of protein-containing complex assembly,3/262,347/12185,0.981260837,0.999969493,0.836022269,PSRC1/KIF14/HJURP,3,BP
GO:2000147,positive regulation of cell motility,4/262,419/12185,0.981346016,0.999969493,0.836022269,EDN2/KIF20B/WDR62/ARHGEF39,4,BP
GO:0043542,endothelial cell migration,1/262,182/12185,0.981426628,0.999969493,0.836022269,EDN2,1,BP
GO:0050804,modulation of chemical synaptic transmission,3/262,348/12185,0.981580115,0.999969493,0.836022269,CDC20/SLC4A8/LZTS1,3,BP
GO:0099177,regulation of trans-synaptic signaling,3/262,349/12185,0.981894212,0.999969493,0.836022269,CDC20/SLC4A8/LZTS1,3,BP
GO:0009117,nucleotide metabolic process,4/262,421/12185,0.981931345,0.999969493,0.836022269,RRM1/DLG2/RRM2/FIGNL1,4,BP
GO:0048562,embryonic organ morphogenesis,1/262,184/12185,0.982228646,0.999969493,0.836022269,STIL,1,BP
GO:0090257,regulation of muscle system process,1/262,184/12185,0.982228646,0.999969493,0.836022269,EDN2,1,BP
GO:0045088,regulation of innate immune response,2/262,273/12185,0.982339693,0.999969493,0.836022269,AURKB/HMGB2,2,BP
GO:0022409,positive regulation of cell-cell adhesion,1/262,186/12185,0.982996158,0.999969493,0.836022269,SLC7A1,1,BP
GO:0030111,regulation of Wnt signaling pathway,2/262,275/12185,0.982999117,0.999969493,0.836022269,ASPM/DEPDC1B,2,BP
GO:0040017,positive regulation of locomotion,4/262,426/12185,0.983319894,0.999969493,0.836022269,EDN2/KIF20B/WDR62/ARHGEF39,4,BP
GO:0045444,fat cell differentiation,1/262,187/12185,0.98336744,0.999969493,0.836022269,E2F1,1,BP
GO:0032787,monocarboxylic acid metabolic process,4/262,427/12185,0.983585249,0.999969493,0.836022269,EDN2/PHGDH/ACBD7/BRCA1,4,BP
GO:0045927,positive regulation of growth,1/262,188/12185,0.983730645,0.999969493,0.836022269,CDK1,1,BP
GO:0007517,muscle organ development,2/262,278/12185,0.983943769,0.999969493,0.836022269,CENPF/CHD2,2,BP
GO:0031667,response to nutrient levels,3/262,356/12185,0.98395428,0.999969493,0.836022269,BRIP1/CDKN1A/WDR45,3,BP
GO:0052548,regulation of endopeptidase activity,1/262,189/12185,0.984085948,0.999969493,0.836022269,RPS27L,1,BP
GO:0002237,response to molecule of bacterial origin,1/262,190/12185,0.98443352,0.999969493,0.836022269,HMGB2,1,BP
GO:0016054,organic acid catabolic process,1/262,190/12185,0.98443352,0.999969493,0.836022269,ARHGAP11B,1,BP
GO:0019932,second-messenger-mediated signaling,1/262,190/12185,0.98443352,0.999969493,0.836022269,EDN2,1,BP
GO:0046395,carboxylic acid catabolic process,1/262,190/12185,0.98443352,0.999969493,0.836022269,ARHGAP11B,1,BP
GO:0016358,dendrite development,1/262,191/12185,0.98477353,0.999969493,0.836022269,LZTS1,1,BP
GO:0001819,positive regulation of cytokine production,2/262,281/12185,0.984837491,0.999969493,0.836022269,BRCA1/HMGB2,2,BP
GO:0044283,small molecule biosynthetic process,4/262,433/12185,0.985095578,0.999969493,0.836022269,EDN2/PHGDH/BRCA1/TK1,4,BP
GO:0006898,receptor-mediated endocytosis,1/262,192/12185,0.985106141,0.999969493,0.836022269,HMMR,1,BP
GO:0015931,nucleobase-containing compound transport,1/262,192/12185,0.985106141,0.999969493,0.836022269,NUP160,1,BP
GO:1903532,positive regulation of secretion by cell,1/262,193/12185,0.985431514,0.999969493,0.836022269,SLC4A8,1,BP
GO:0007162,negative regulation of cell adhesion,1/262,194/12185,0.985749804,0.999969493,0.836022269,ADAM22,1,BP
GO:1903522,regulation of blood circulation,1/262,194/12185,0.985749804,0.999969493,0.836022269,EDN2,1,BP
GO:0051090,regulation of DNA-binding transcription factor activity,2/262,285/12185,0.98595443,0.999969493,0.836022269,RTKN2/EDA2R,2,BP
GO:0030855,epithelial cell differentiation,4/262,438/12185,0.986252873,0.999969493,0.836022269,CDK1/CEP152/PLK4/CDKN1A,4,BP
GO:0034249,negative regulation of amide metabolic process,1/262,196/12185,0.986365752,0.999969493,0.836022269,EXOSC8,1,BP
GO:0031331,positive regulation of cellular catabolic process,2/262,287/12185,0.986482553,0.999969493,0.836022269,EXOSC8/WDR45,2,BP
GO:0032102,negative regulation of response to external stimulus,2/262,288/12185,0.986739338,0.999969493,0.836022269,AURKB/PBK,2,BP
GO:0022618,protein-RNA complex assembly,1/262,198/12185,0.986955174,0.999969493,0.836022269,RPS27L,1,BP
GO:0060047,heart contraction,1/262,198/12185,0.986955174,0.999969493,0.836022269,EDN2,1,BP
GO:0032870,cellular response to hormone stimulus,4/262,444/12185,0.987529403,0.999969493,0.836022269,CDC6/BRCA1/BRIP1/CCNA2,4,BP
GO:0009150,purine ribonucleotide metabolic process,2/262,293/12185,0.98795387,0.999969493,0.836022269,DLG2/FIGNL1,2,BP
GO:0006874,intracellular calcium ion homeostasis,1/262,203/12185,0.988320024,0.999969493,0.836022269,EDN2,1,BP
GO:0051047,positive regulation of secretion,1/262,204/12185,0.98857542,0.999969493,0.836022269,SLC4A8,1,BP
GO:0043410,positive regulation of MAPK cascade,2/262,296/12185,0.988629973,0.999969493,0.836022269,IQGAP3/EDA2R,2,BP
GO:0050900,leukocyte migration,1/262,205/12185,0.988825252,0.999969493,0.836022269,EDN2,1,BP
GO:0022604,regulation of cell morphogenesis,1/262,206/12185,0.989069642,0.999969493,0.836022269,MYL12A,1,BP
GO:0048738,cardiac muscle tissue development,1/262,206/12185,0.989069642,0.999969493,0.836022269,CDK1,1,BP
GO:0048762,mesenchymal cell differentiation,1/262,206/12185,0.989069642,0.999969493,0.836022269,FAM83D,1,BP
GO:0071826,protein-RNA complex organization,1/262,206/12185,0.989069642,0.999969493,0.836022269,RPS27L,1,BP
GO:0031346,positive regulation of cell projection organization,2/262,299/12185,0.989269139,0.999969493,0.836022269,CENPJ/ANLN,2,BP
GO:0007033,vacuole organization,1/262,207/12185,0.989308706,0.999969493,0.836022269,WDR45,1,BP
GO:0052547,regulation of peptidase activity,1/262,207/12185,0.989308706,0.999969493,0.836022269,RPS27L,1,BP
GO:0009991,response to extracellular stimulus,3/262,380/12185,0.98944845,0.999969493,0.836022269,BRIP1/CDKN1A/WDR45,3,BP
GO:0002521,leukocyte differentiation,3/262,381/12185,0.989632817,0.999969493,0.836022269,FANCA/MSH2/FANCD2,3,BP
GO:0003015,heart process,1/262,209/12185,0.989771321,0.999969493,0.836022269,EDN2,1,BP
GO:0006954,inflammatory response,4/262,457/12185,0.989920207,0.999969493,0.836022269,FANCA/FANCD2/HMGB2/PBK,4,BP
GO:1903037,regulation of leukocyte cell-cell adhesion,1/262,211/12185,0.990213991,0.999969493,0.836022269,SLC7A1,1,BP
GO:0042060,wound healing,2/262,305/12185,0.990444345,0.999969493,0.836022269,MYL12A/CDKN1A,2,BP
GO:0007423,sensory organ development,3/262,387/12185,0.990675748,0.999969493,0.836022269,RRM1/MCM2/CCNA2,3,BP
GO:0060828,regulation of canonical Wnt signaling pathway,1/262,214/12185,0.990842465,0.999969493,0.836022269,ASPM,1,BP
GO:0051223,regulation of protein transport,3/262,389/12185,0.991000419,0.999969493,0.836022269,CDK1/KIF20B/ECT2,3,BP
GO:0045089,positive regulation of innate immune response,1/262,215/12185,0.991042888,0.999969493,0.836022269,HMGB2,1,BP
GO:0009259,ribonucleotide metabolic process,2/262,309/12185,0.991157188,0.999969493,0.836022269,DLG2/FIGNL1,2,BP
GO:0072521,purine-containing compound metabolic process,3/262,390/12185,0.991158651,0.999969493,0.836022269,DLG2/MACROD2/FIGNL1,3,BP
GO:0055074,calcium ion homeostasis,1/262,216/12185,0.991238942,0.999969493,0.836022269,EDN2,1,BP
GO:0001525,angiogenesis,3/262,392/12185,0.991467129,0.999969493,0.836022269,E2F2/EDN2/BRCA1,3,BP
GO:0016236,macroautophagy,2/262,313/12185,0.991818142,0.999969493,0.836022269,LZTS1/WDR45,2,BP
GO:0019693,ribose phosphate metabolic process,2/262,316/12185,0.992282014,0.999969493,0.836022269,DLG2/FIGNL1,2,BP
GO:0051607,defense response to virus,1/262,222/12185,0.992328666,0.999969493,0.836022269,SLFN13,1,BP
GO:0140546,defense response to symbiont,1/262,222/12185,0.992328666,0.999969493,0.836022269,SLFN13,1,BP
GO:0010506,regulation of autophagy,2/262,317/12185,0.992430864,0.999969493,0.836022269,LZTS1/WDR45,2,BP
GO:0006364,rRNA processing,1/262,224/12185,0.992661018,0.999969493,0.836022269,EXOSC8,1,BP
GO:0002833,positive regulation of response to biotic stimulus,1/262,225/12185,0.992821775,0.999969493,0.836022269,HMGB2,1,BP
GO:0042254,ribosome biogenesis,2/262,320/12185,0.992860813,0.999969493,0.836022269,EXOSC8/RPS27L,2,BP
GO:0002831,regulation of response to biotic stimulus,2/262,328/12185,0.99389418,0.999969493,0.836022269,AURKB/HMGB2,2,BP
GO:1902903,regulation of supramolecular fiber organization,2/262,328/12185,0.99389418,0.999969493,0.836022269,PSRC1/TPX2,2,BP
GO:0048729,tissue morphogenesis,4/262,489/12185,0.994086121,0.999969493,0.836022269,STIL/KIF20B/TIMELESS/SAPCD2,4,BP
GO:0042692,muscle cell differentiation,2/262,331/12185,0.99424276,0.999969493,0.836022269,CDK1/DNMT1,2,BP
GO:0007159,leukocyte cell-cell adhesion,1/262,235/12185,0.994248451,0.999969493,0.836022269,SLC7A1,1,BP
GO:0043010,camera-type eye development,1/262,235/12185,0.994248451,0.999969493,0.836022269,RRM1,1,BP
GO:0050778,positive regulation of immune response,3/262,417/12185,0.994547595,0.999969493,0.836022269,MSH2/NSD2/HMGB2,3,BP
GO:0048812,neuron projection morphogenesis,4/262,497/12185,0.994834335,0.999969493,0.836022269,EDN2/KIF20B/AURKA/LZTS1,4,BP
GO:0050878,regulation of body fluid levels,1/262,240/12185,0.994852005,0.999969493,0.836022269,MYL12A,1,BP
GO:0062012,regulation of small molecule metabolic process,1/262,241/12185,0.99496492,0.999969493,0.836022269,BRCA1,1,BP
GO:0051146,striated muscle cell differentiation,1/262,242/12185,0.995075368,0.999969493,0.836022269,CDK1,1,BP
GO:0034329,cell junction assembly,2/262,346/12185,0.995714022,0.999969493,0.836022269,ECT2/LZTS1,2,BP
GO:0006790,sulfur compound metabolic process,1/262,249/12185,0.995783785,0.999969493,0.836022269,PHGDH,1,BP
GO:0060485,mesenchyme development,1/262,250/12185,0.995876332,0.999969493,0.836022269,FAM83D,1,BP
GO:0060537,muscle tissue development,2/262,349/12185,0.995960601,0.999969493,0.836022269,CENPF/CDK1,2,BP
GO:0090150,establishment of protein localization to membrane,1/262,251/12185,0.995966856,0.999969493,0.836022269,TIMM8B,1,BP
GO:0072659,protein localization to plasma membrane,1/262,253/12185,0.996142007,0.999969493,0.836022269,MYL12A,1,BP
GO:0009306,protein secretion,1/262,254/12185,0.99622672,0.999969493,0.836022269,SLC4A8,1,BP
GO:0035592,establishment of protein localization to extracellular region,1/262,254/12185,0.99622672,0.999969493,0.836022269,SLC4A8,1,BP
GO:0060070,canonical Wnt signaling pathway,1/262,254/12185,0.99622672,0.999969493,0.836022269,ASPM,1,BP
GO:0001667,ameboidal-type cell migration,2/262,354/12185,0.996341055,0.999969493,0.836022269,EDN2/ANLN,2,BP
GO:0003013,circulatory system process,3/262,440/12185,0.996410824,0.999969493,0.836022269,EDN2/SLC4A8/SLC7A1,3,BP
GO:0006887,exocytosis,1/262,257/12185,0.9964699,0.999969493,0.836022269,SLC4A8,1,BP
GO:0071692,protein localization to extracellular region,1/262,258/12185,0.99654744,0.999969493,0.836022269,SLC4A8,1,BP
GO:0030003,intracellular monoatomic cation homeostasis,2/262,357/12185,0.996552243,0.999969493,0.836022269,EDN2/SLC4A8,2,BP
GO:0006873,intracellular monoatomic ion homeostasis,2/262,362/12185,0.996877987,0.999969493,0.836022269,EDN2/SLC4A8,2,BP
GO:0030522,intracellular receptor signaling pathway,1/262,264/12185,0.996978308,0.999969493,0.836022269,BRCA1,1,BP
GO:0032103,positive regulation of response to external stimulus,2/262,364/12185,0.996999665,0.999969493,0.836022269,EDN2/HMGB2,2,BP
GO:0006417,regulation of translation,2/262,368/12185,0.997229239,0.999969493,0.836022269,EXOSC8/RPS27L,2,BP
GO:0006163,purine nucleotide metabolic process,2/262,370/12185,0.997337477,0.999969493,0.836022269,DLG2/FIGNL1,2,BP
GO:0001654,eye development,1/262,270/12185,0.997355585,0.999969493,0.836022269,RRM1,1,BP
GO:0150063,visual system development,1/262,270/12185,0.997355585,0.999969493,0.836022269,RRM1,1,BP
GO:0031589,cell-substrate adhesion,1/262,271/12185,0.997413734,0.999969493,0.836022269,KIF14,1,BP
GO:0032956,regulation of actin cytoskeleton organization,1/262,271/12185,0.997413734,0.999969493,0.836022269,ECT2,1,BP
GO:0006936,muscle contraction,1/262,272/12185,0.997470608,0.999969493,0.836022269,EDN2,1,BP
GO:0044282,small molecule catabolic process,1/262,272/12185,0.997470608,0.999969493,0.836022269,ARHGAP11B,1,BP
GO:0048514,blood vessel morphogenesis,3/262,460/12185,0.997515859,0.999969493,0.836022269,E2F2/EDN2/BRCA1,3,BP
GO:0048880,sensory system development,1/262,273/12185,0.997526236,0.999969493,0.836022269,RRM1,1,BP
GO:0050808,synapse organization,2/262,374/12185,0.99754166,0.999969493,0.836022269,CDC20/LZTS1,2,BP
GO:0016055,Wnt signaling pathway,2/262,376/12185,0.99763791,0.999969493,0.836022269,ASPM/DEPDC1B,2,BP
GO:0198738,cell-cell signaling by wnt,2/262,377/12185,0.997684638,0.999969493,0.836022269,ASPM/DEPDC1B,2,BP
GO:0031349,positive regulation of defense response,1/262,276/12185,0.997685914,0.999969493,0.836022269,HMGB2,1,BP
GO:0007015,actin filament organization,2/262,380/12185,0.997819449,0.999969493,0.836022269,IQGAP3/GAS2L3,2,BP
GO:0010608,post-transcriptional regulation of gene expression,3/262,468/12185,0.997858209,0.999969493,0.836022269,EXOSC8/RPS27L/E2F1,3,BP
GO:0045596,negative regulation of cell differentiation,3/262,471/12185,0.99797437,0.999969493,0.836022269,ASPM/DNMT1/E2F1,3,BP
GO:0001817,regulation of cytokine production,3/262,473/12185,0.99804838,0.999969493,0.836022269,BRCA1/TRAIP/HMGB2,3,BP
GO:0001816,cytokine production,3/262,482/12185,0.998350102,0.999969493,0.836022269,BRCA1/TRAIP/HMGB2,3,BP
GO:0090066,regulation of anatomical structure size,2/262,395/12185,0.998386111,0.999969493,0.836022269,EDN2/IQGAP3,2,BP
GO:0009615,response to virus,1/262,293/12185,0.998415008,0.999969493,0.836022269,SLFN13,1,BP
GO:0022407,regulation of cell-cell adhesion,1/262,294/12185,0.998449928,0.999969493,0.836022269,SLC7A1,1,BP
GO:0042391,regulation of membrane potential,1/262,297/12185,0.998550156,0.999969493,0.836022269,SLC4A8,1,BP
GO:0055080,monoatomic cation homeostasis,2/262,404/12185,0.998653754,0.999969493,0.836022269,EDN2/SLC4A8,2,BP
GO:0006605,protein targeting,1/262,302/12185,0.998703057,0.999969493,0.836022269,TIMM8B,1,BP
GO:0050801,monoatomic ion homeostasis,2/262,409/12185,0.998783058,0.999969493,0.836022269,EDN2/SLC4A8,2,BP
GO:0002683,negative regulation of immune system process,1/262,305/12185,0.998786973,0.999969493,0.836022269,AURKB,1,BP
GO:0032535,regulation of cellular component size,1/262,307/12185,0.998839889,0.999969493,0.836022269,IQGAP3,1,BP
GO:0034470,ncRNA processing,2/262,412/12185,0.998854693,0.999969493,0.836022269,EXOSC8/RPP25L,2,BP
GO:0032970,regulation of actin filament-based process,1/262,310/12185,0.998914982,0.999969493,0.836022269,ECT2,1,BP
GO:0001503,ossification,1/262,314/12185,0.999007626,0.999969493,0.836022269,FIGNL1,1,BP
GO:0034248,regulation of amide metabolic process,2/262,420/12185,0.999026058,0.999969493,0.836022269,EXOSC8/RPS27L,2,BP
GO:0045785,positive regulation of cell adhesion,1/262,315/12185,0.999029529,0.999969493,0.836022269,SLC7A1,1,BP
GO:0016050,vesicle organization,1/262,319/12185,0.999112426,0.999969493,0.836022269,KNL1,1,BP
GO:0023061,signal release,1/262,325/12185,0.999223731,0.999969493,0.836022269,SLC4A8,1,BP
GO:0048598,embryonic morphogenesis,2/262,434/12185,0.999267314,0.999969493,0.836022269,STIL/KIF20B,2,BP
GO:0048667,cell morphogenesis involved in neuron differentiation,2/262,449/12185,0.999460638,0.999969493,0.836022269,EDN2/LZTS1,2,BP
GO:0003012,muscle system process,1/262,342/12185,0.999469149,0.999969493,0.836022269,EDN2,1,BP
GO:0007409,axonogenesis,1/262,348/12185,0.999535841,0.999969493,0.836022269,EDN2,1,BP
GO:0098771,inorganic ion homeostasis,1/262,351/12185,0.999565988,0.999969493,0.836022269,EDN2,1,BP
GO:0022613,ribonucleoprotein complex biogenesis,2/262,464/12185,0.99960349,0.999969493,0.836022269,EXOSC8/RPS27L,2,BP
GO:0010975,regulation of neuron projection development,1/262,365/12185,0.999682823,0.999969493,0.836022269,LZTS1,1,BP
GO:0008015,blood circulation,1/262,366/12185,0.999689853,0.999969493,0.836022269,EDN2,1,BP
GO:0001501,skeletal system development,1/262,367/12185,0.999696728,0.999969493,0.836022269,NSD2,1,BP
GO:0055082,intracellular chemical homeostasis,2/262,486/12185,0.999748087,0.999969493,0.836022269,EDN2/SLC4A8,2,BP
GO:1903530,regulation of secretion by cell,1/262,376/12185,0.999752159,0.999969493,0.836022269,SLC4A8,1,BP
GO:0061564,axon development,1/262,388/12185,0.999810682,0.999969493,0.836022269,EDN2,1,BP
GO:0007186,G protein-coupled receptor signaling pathway,1/262,389/12185,0.999814887,0.999969493,0.836022269,GPSM2,1,BP
GO:0044057,regulation of system process,1/262,393/12185,0.999830795,0.999969493,0.836022269,EDN2,1,BP
GO:0060627,regulation of vesicle-mediated transport,1/262,398/12185,0.999848778,0.999969493,0.836022269,SLC4A8,1,BP
GO:0051046,regulation of secretion,1/262,408/12185,0.999879232,0.999969493,0.836022269,SLC4A8,1,BP
GO:0005975,carbohydrate metabolic process,1/262,439/12185,0.999939928,0.999969493,0.836022269,PHKA1,1,BP
GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,1/262,469/12185,0.999969493,0.999969493,0.836022269,SHCBP1,1,BP
GO:0017116,single-stranded DNA helicase activity,16/259,23/12494,1.58E-22,5.28E-20,4.63E-20,DNA2/RFC5/RFC3/RAD51/PIF1/CHTF18/MCM6/MCM5/POLQ/MCM2/RFC4/MCM3/RFC2/MCM7/MCM4/DSCC1,16,MF
GO:0008094,"ATP-dependent activity, acting on DNA",27/259,116/12494,3.35E-21,5.61E-19,4.92E-19,RAD54L/DNA2/HELLS/DDX11/RFC5/RFC3/RAD51/PIF1/BLM/CHD2/CHTF18/TOP2A/BRIP1/MSH2/MCM6/MCM5/POLQ/MCM2/RFC4/MCM3/RFC2/MCM7/XRCC2/MCM4/RAD54B/DSCC1/ERCC6L,27,MF
GO:0140097,"catalytic activity, acting on DNA",35/259,226/12494,5.73E-21,6.39E-19,5.61E-19,RAD54L/EXO1/DNA2/HELLS/POLD3/DDX11/RFC5/POLE/RFC3/POLE2/RAD51/PIF1/BLM/CHD2/CHTF18/TOP2A/EME1/BRIP1/RBBP8/DNMT1/MSH2/MCM6/MCM5/POLQ/MCM2/RFC4/NEIL3/MCM3/RFC2/MCM7/XRCC2/MCM4/RAD54B/DSCC1/ERCC6L,35,MF
GO:0140657,ATP-dependent activity,48/259,470/12494,1.54E-20,1.29E-18,1.13E-18,KIF2C/RAD54L/ORC1/KIF14/DNA2/KIF20B/KIF11/HELLS/KIF18A/DDX11/RFC5/RFC3/RAD51/PIF1/KIF23/BLM/CHD2/CHTF18/CDC6/TOP2A/KIF18B/BRIP1/ATP8B3/MSH2/MCM6/MCM5/KIF15/POLQ/MCM2/SMC4/RFC4/CENPE/ZGRF1/TRIP13/KIF20A/KIFC1/MCM3/FIGNL1/RFC2/MCM7/XRCC2/MCM4/RAD54B/DSCC1/ATAD2/KIF24/KIF4A/ERCC6L,48,MF
GO:0003678,DNA helicase activity,20/259,57/12494,6.29E-20,4.21E-18,3.69E-18,DNA2/DDX11/RFC5/RFC3/RAD51/PIF1/BLM/CHTF18/BRIP1/MCM6/MCM5/POLQ/MCM2/RFC4/MCM3/RFC2/MCM7/MCM4/RAD54B/DSCC1,20,MF
GO:0004386,helicase activity,25/259,140/12494,9.25E-17,5.16E-15,4.53E-15,RAD54L/DNA2/HELLS/DDX11/RFC5/RFC3/RAD51/PIF1/BLM/CHD2/CHTF18/BRIP1/MCM6/MCM5/POLQ/MCM2/RFC4/ZGRF1/MCM3/RFC2/MCM7/MCM4/RAD54B/DSCC1/ERCC6L,25,MF
GO:0016887,ATP hydrolysis activity,37/259,346/12494,1.35E-16,6.47E-15,5.68E-15,KIF2C/RAD54L/ORC1/KIF14/DNA2/KIF20B/KIF18A/DDX11/RFC5/RFC3/RAD51/PIF1/KIF23/BLM/CHD2/CHTF18/CDC6/KIF18B/BRIP1/ATP8B3/MSH2/MCM6/MCM5/KIF15/MCM2/SMC4/RFC4/TRIP13/KIF20A/KIFC1/MCM3/FIGNL1/RFC2/MCM7/MCM4/ATAD2/ERCC6L,37,MF
GO:0008017,microtubule binding,28/259,237/12494,7.25E-14,3.03E-12,2.66E-12,KIF2C/PSRC1/KIF14/CENPF/KIF20B/KIF11/KIF18A/RACGAP1/GAS2L3/DLGAP5/KNSTRN/NUSAP1/KIF23/PRC1/PLK1/SPAG5/KIF18B/BIRC5/SKA1/SPC24/FAM83D/GTSE1/KIF15/CENPE/KIF20A/KIFC1/KIF24/KIF4A,28,MF
GO:0003697,single-stranded DNA binding,19/259,112/12494,1.34E-12,5.01E-11,4.39E-11,RAD54L/MCM10/RAD51AP1/DDX11/BRCA2/RAD51/BLM/MSH2/MCM6/CDC45/MCM5/MCM2/SMC4/HMGB2/NEIL3/MCM3/MMS22L/MCM7/MCM4,19,MF
GO:0015631,tubulin binding,31/259,330/12494,1.60E-12,5.35E-11,4.69E-11,KIF2C/PSRC1/KIF14/CENPF/KIF20B/KIF11/KIF18A/RACGAP1/GAS2L3/CENPJ/BRCA2/DLGAP5/KNSTRN/NUSAP1/KIF23/PRC1/PLK1/SPAG5/BRCA1/KIF18B/BIRC5/SKA1/SPC24/FAM83D/GTSE1/KIF15/CENPE/KIF20A/KIFC1/KIF24/KIF4A,31,MF
GO:0003777,microtubule motor activity,13/259,53/12494,3.89E-11,1.18E-09,1.04E-09,KIF2C/KIF14/KIF20B/KIF11/KIF18A/KIF23/KIF18B/KIF15/CENPE/KIF20A/KIFC1/KIF24/KIF4A,13,MF
GO:0003774,cytoskeletal motor activity,13/259,80/12494,8.85E-09,2.47E-07,2.17E-07,KIF2C/KIF14/KIF20B/KIF11/KIF18A/KIF23/KIF18B/KIF15/CENPE/KIF20A/KIFC1/KIF24/KIF4A,13,MF
GO:0003688,DNA replication origin binding,7/259,16/12494,1.48E-08,3.81E-07,3.34E-07,ORC1/MCM10/DDX11/CDC6/CDC45/MCM5/MCM2,7,MF
GO:0003682,chromatin binding,31/259,484/12494,2.21E-08,5.28E-07,4.63E-07,ORC1/UBE2T/CENPF/EXO1/CDK1/HELLS/CDCA5/DDX11/POLE/WDHD1/RAD51/PCLAF/TICRR/CHD2/CDT1/TOP2A/BRIP1/CHAF1A/DNMT1/CENPA/MSH2/NCAPH/RBL1/CHAF1B/CDC45/POLQ/SMC4/NSD2/GMNN/ATAD2/PHF19,31,MF
GO:0003684,damaged DNA binding,10/259,68/12494,1.24E-06,2.78E-05,2.44E-05,AUNIP/H2AX/BLM/BRCA1/RBBP8/MSH2/POLQ/HMGB2/NEIL3/FANCG,10,MF
GO:0000217,DNA secondary structure binding,7/259,37/12494,9.18E-06,0.000183879,0.000161201,CLSPN/RAD51AP1/BLM/MSH2/HMGB2/NEIL3/XRCC2,7,MF
GO:0008574,plus-end-directed microtubule motor activity,5/259,15/12494,9.33E-06,0.000183879,0.000161201,KIF14/KIF20B/KIF11/KIF18A/KIF18B,5,MF
GO:0043138,3'-5' DNA helicase activity,4/259,14/12494,0.000153326,0.002853563,0.002501631,BLM/MCM6/MCM5/MCM2,4,MF
GO:0016538,cyclin-dependent protein serine/threonine kinase regulator activity,6/259,43/12494,0.000239867,0.004229239,0.003707644,CDKN2C/CCNB2/CCNF/CCNA2/CCNB1/CDKN1A,6,MF
GO:0000400,four-way junction DNA binding,4/259,18/12494,0.000439043,0.00735397,0.006446999,BLM/MSH2/HMGB2/XRCC2,4,MF
GO:0035173,histone kinase activity,4/259,20/12494,0.000672837,0.010733358,0.009409606,CDK1/CHEK1/BUB1/AURKA,4,MF
GO:0140658,ATP-dependent chromatin remodeler activity,5/259,35/12494,0.000718778,0.010945031,0.009595173,RAD54L/HELLS/CHD2/RAD54B/ERCC6L,5,MF
GO:0070182,DNA polymerase binding,4/259,21/12494,0.000817717,0.011413967,0.010006275,RAD51/FANCI/CDT1/FANCD2,4,MF
GO:0140612,DNA damage sensor activity,4/259,21/12494,0.000817717,0.011413967,0.010006275,RAD51/UHRF1/MSH2/XRCC2,4,MF
GO:0051880,G-quadruplex DNA binding,3/259,10/12494,0.000948597,0.012711201,0.01114352,DDX11/PIF1/BLM,3,MF
GO:0003887,DNA-directed DNA polymerase activity,4/259,23/12494,0.001171081,0.015088934,0.013228005,POLD3/POLE/POLE2/POLQ,4,MF
GO:0034061,DNA polymerase activity,4/259,28/12494,0.002496646,0.030976903,0.027156499,POLD3/POLE/POLE2/POLQ,4,MF
GO:0106310,protein serine kinase activity,15/259,321/12494,0.002873973,0.03438503,0.0301443,CDC7/NEK2/CDK1/CHEK1/CIT/BUB1B/PKMYT1/PLK1/AURKB/BUB1/AURKA/PLK4/TTK/PBK/MELK,15,MF
GO:0042393,histone binding,12/259,230/12494,0.003083988,0.035625381,0.031231678,NASP/H2AX/NCAPD2/CHD2/UHRF1/HJURP/CHAF1B/MCM2/DEK/NCAPG2/ATAD2/PHF19,12,MF
GO:0140664,ATP-dependent DNA damage sensor activity,3/259,17/12494,0.004828253,0.053915487,0.047266052,RAD51/MSH2/XRCC2,3,MF
GO:0004536,DNA nuclease activity,5/259,54/12494,0.005090354,0.054901225,0.048130218,EXO1/DNA2/POLE/EME1/RBBP8,5,MF
GO:0004674,protein serine/threonine kinase activity,16/259,376/12494,0.005244296,0.054901225,0.048130218,CDC7/NEK2/CDK1/CHEK1/CIT/BUB1B/PKMYT1/PLK1/AURKB/BUB1/AURKA/PLK4/TTK/PBK/MELK/PHKA1,16,MF
GO:0140299,small molecule sensor activity,4/259,35/12494,0.00570125,0.057876323,0.050738394,RAD51/UHRF1/MSH2/XRCC2,4,MF
GO:0004520,DNA endonuclease activity,4/259,36/12494,0.006311312,0.062184981,0.054515663,EXO1/DNA2/EME1/RBBP8,4,MF
GO:0051010,microtubule plus-end binding,3/259,21/12494,0.00888476,0.085039848,0.074551823,KIF2C/KIF18A/KNSTRN,3,MF
GO:0051536,iron-sulfur cluster binding,5/259,63/12494,0.009738335,0.088171409,0.077297166,DNA2/DDX11/POLE/BRIP1/KIF4A,5,MF
GO:0051540,metal cluster binding,5/259,63/12494,0.009738335,0.088171409,0.077297166,DNA2/DDX11/POLE/BRIP1/KIF4A,5,MF
GO:0004712,protein serine/threonine/tyrosine kinase activity,4/259,41/12494,0.010011767,0.088261634,0.077376263,AURKB/AURKA/TTK/PBK,4,MF
GO:0051539,"4 iron, 4 sulfur cluster binding",4/259,42/12494,0.010889415,0.093537283,0.082001263,DNA2/DDX11/POLE/BRIP1,4,MF
GO:0004869,cysteine-type endopeptidase inhibitor activity,2/259,10/12494,0.01726105,0.141035409,0.123641411,BIRC5/PTTG1,2,MF
GO:0032356,oxidized DNA binding,2/259,10/12494,0.01726105,0.141035409,0.123641411,BLM/MSH2,2,MF
GO:0004672,protein kinase activity,17/259,472/12494,0.019303255,0.153966438,0.134977647,CDC7/NEK2/CDK1/CHEK1/CIT/BUB1B/PKMYT1/PLK1/AURKB/BUB1/AURKA/PLK4/CDKN1A/TTK/PBK/MELK/PHKA1,17,MF
GO:0140666,annealing activity,2/259,11/12494,0.020811414,0.158450541,0.138908722,RAD54L/BLM,2,MF
GO:0140996,histone H3 kinase activity,2/259,11/12494,0.020811414,0.158450541,0.138908722,CHEK1/AURKA,2,MF
GO:0004861,cyclin-dependent protein serine/threonine kinase inhibitor activity,2/259,12/12494,0.024636411,0.179417338,0.157289669,CDKN2C/CDKN1A,2,MF
GO:0016888,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters",2/259,12/12494,0.024636411,0.179417338,0.157289669,EXO1/DNA2,2,MF
GO:0030332,cyclin binding,3/259,31/12494,0.025811019,0.180139405,0.157922684,CDK1/NDC80/CDKN1A,3,MF
GO:0061631,ubiquitin conjugating enzyme activity,3/259,31/12494,0.025811019,0.180139405,0.157922684,UBE2T/UBE2S/UBE2C,3,MF
GO:0043015,gamma-tubulin binding,3/259,34/12494,0.032846822,0.221498175,0.194180647,RACGAP1/CENPJ/BRCA2,3,MF
GO:0008301,"DNA binding, bending",2/259,14/12494,0.033059429,0.221498175,0.194180647,TOP2A/HMGB2,2,MF
GO:0050699,WW domain binding,2/259,15/12494,0.03763303,0.245035706,0.214815277,KIF20B/CDC25C,2,MF
GO:0030291,protein serine/threonine kinase inhibitor activity,3/259,36/12494,0.038035393,0.245035706,0.214815277,CDKN2C/CIT/CDKN1A,3,MF
GO:0061650,ubiquitin-like protein conjugating enzyme activity,3/259,37/12494,0.040777056,0.257741771,0.225954294,UBE2T/UBE2S/UBE2C,3,MF
GO:0019887,protein kinase regulator activity,8/259,190/12494,0.044445606,0.275727372,0.241721718,CDKN2C/CIT/CCNB2/CCNF/CCNA2/CCNB1/CDKN1A/DBF4,8,MF
GO:0019894,kinesin binding,3/259,39/12494,0.046550715,0.283536171,0.248567453,PRC1/KIF18B/FAM83D,3,MF
GO:0000287,magnesium ion binding,8/259,194/12494,0.049162274,0.294095748,0.257824709,PRIM1/PIF1/PLK1/TOP2A/ATP8B3/MSH2/MTHFD2/FIGNL1,8,MF
GO:0008186,"ATP-dependent activity, acting on RNA",4/259,67/12494,0.050121322,0.294572684,0.258242825,DDX11/PIF1/BRIP1/RAD54B,4,MF
GO:0070840,dynein complex binding,2/259,18/12494,0.052663806,0.30417888,0.266664281,GPSM2/CENPF,2,MF
GO:0004519,endonuclease activity,5/259,101/12494,0.058774764,0.333721115,0.292563052,EXO1/DNA2/SLFN13/EME1/RBBP8,5,MF
GO:0008327,methyl-CpG binding,2/259,21/12494,0.069434668,0.381321539,0.334292881,UHRF1/DNMT1,2,MF
GO:0016895,"DNA exonuclease activity, producing 5'-phosphomonoesters",2/259,21/12494,0.069434668,0.381321539,0.334292881,EXO1/POLE,2,MF
GO:0019207,kinase regulator activity,8/259,211/12494,0.07276395,0.393160051,0.344671341,CDKN2C/CIT/CCNB2/CCNF/CCNA2/CCNB1/CDKN1A/DBF4,8,MF
GO:0004529,DNA exonuclease activity,2/259,22/12494,0.075364899,0.400749859,0.351325093,EXO1/POLE,2,MF
GO:0140993,histone modifying activity,7/259,189/12494,0.098525466,0.515719234,0.452115212,CDK1/CHEK1/BRCA2/UHRF1/BUB1/AURKA/NSD2,7,MF
GO:0016799,"hydrolase activity, hydrolyzing N-glycosyl compounds",2/259,28/12494,0.11388727,0.586957467,0.514567583,MACROD2/NEIL3,2,MF
GO:0016779,nucleotidyltransferase activity,5/259,129/12494,0.130189167,0.660808649,0.579310646,POLD3/PRIM1/POLE/POLE2/POLQ,5,MF
GO:0004518,nuclease activity,6/259,176/12494,0.159245966,0.794063153,0.696130776,EXO1/DNA2/POLE/SLFN13/EME1/RBBP8,6,MF
GO:0030527,structural constituent of chromatin,2/259,35/12494,0.163553306,0.794063153,0.696130776,H2AX/CENPA,2,MF
GO:0042162,telomeric DNA binding,2/259,35/12494,0.163553306,0.794063153,0.696130776,PIF1/BLM,2,MF
GO:0004860,protein kinase inhibitor activity,3/259,68/12494,0.166908517,0.795330538,0.697241854,CDKN2C/CIT/CDKN1A,3,MF
GO:0016893,"endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters",2/259,36/12494,0.170936713,0.795330538,0.697241854,EXO1/DNA2,2,MF
GO:0019205,nucleobase-containing compound kinase activity,2/259,36/12494,0.170936713,0.795330538,0.697241854,DLG2/TK1,2,MF
GO:0019210,kinase inhibitor activity,3/259,70/12494,0.177145855,0.811965456,0.711825176,CDKN2C/CIT/CDKN1A,3,MF
GO:0000014,single-stranded DNA endodeoxyribonuclease activity,1/259,10/12494,0.189054643,0.811965456,0.711825176,RBBP8,1,MF
GO:0008353,RNA polymerase II CTD heptapeptide repeat kinase activity,1/259,10/12494,0.189054643,0.811965456,0.711825176,CDK1,1,MF
GO:0035252,UDP-xylosyltransferase activity,1/259,10/12494,0.189054643,0.811965456,0.711825176,POGLUT3,1,MF
GO:0042285,xylosyltransferase activity,1/259,10/12494,0.189054643,0.811965456,0.711825176,POGLUT3,1,MF
GO:0061459,L-arginine transmembrane transporter activity,1/259,10/12494,0.189054643,0.811965456,0.711825176,SLC7A1,1,MF
GO:0035064,methylated histone binding,3/259,75/12494,0.203445195,0.820248256,0.719086452,UHRF1/NCAPG2/PHF19,3,MF
GO:0032404,mismatch repair complex binding,1/259,11/12494,0.205878966,0.820248256,0.719086452,MSH2,1,MF
GO:0035251,UDP-glucosyltransferase activity,1/259,11/12494,0.205878966,0.820248256,0.719086452,POGLUT3,1,MF
GO:0046975,histone H3K36 methyltransferase activity,1/259,11/12494,0.205878966,0.820248256,0.719086452,NSD2,1,MF
GO:0140852,histone ubiquitin ligase activity,1/259,11/12494,0.205878966,0.820248256,0.719086452,UHRF1,1,MF
GO:0005096,GTPase activator activity,7/259,234/12494,0.213041444,0.820248256,0.719086452,DEPDC1/IQGAP3/RACGAP1/ARHGAP11B/ARHGAP11A/ECT2/DEPDC1B,7,MF
GO:0140034,methylation-dependent protein binding,3/259,77/12494,0.214209583,0.820248256,0.719086452,UHRF1/NCAPG2/PHF19,3,MF
GO:0003906,DNA-(apurinic or apyrimidinic site) endonuclease activity,1/259,12/12494,0.222355562,0.820248256,0.719086452,NEIL3,1,MF
GO:0015651,quaternary ammonium group transmembrane transporter activity,1/259,12/12494,0.222355562,0.820248256,0.719086452,SLC25A20,1,MF
GO:0030983,mismatched DNA binding,1/259,12/12494,0.222355562,0.820248256,0.719086452,MSH2,1,MF
GO:0097027,ubiquitin-protein transferase activator activity,1/259,12/12494,0.222355562,0.820248256,0.719086452,CDC20,1,MF
GO:0061733,peptide-lysine-N-acetyltransferase activity,2/259,43/12494,0.22385211,0.820248256,0.719086452,BRCA2/ESCO2,2,MF
GO:0005521,lamin binding,1/259,13/12494,0.238491591,0.820248256,0.719086452,TMPO,1,MF
GO:0005540,hyaluronic acid binding,1/259,13/12494,0.238491591,0.820248256,0.719086452,HMMR,1,MF
GO:0008296,3'-5'-DNA exonuclease activity,1/259,13/12494,0.238491591,0.820248256,0.719086452,POLE,1,MF
GO:0015174,basic amino acid transmembrane transporter activity,1/259,13/12494,0.238491591,0.820248256,0.719086452,SLC7A1,1,MF
GO:0019104,DNA N-glycosylase activity,1/259,13/12494,0.238491591,0.820248256,0.719086452,NEIL3,1,MF
GO:0061575,cyclin-dependent protein serine/threonine kinase activator activity,1/259,13/12494,0.238491591,0.820248256,0.719086452,CCNB1,1,MF
GO:0071855,neuropeptide receptor binding,1/259,13/12494,0.238491591,0.820248256,0.719086452,EDN2,1,MF
GO:0004559,alpha-mannosidase activity,1/259,14/12494,0.254294065,0.820248256,0.719086452,MANEAL,1,MF
GO:0010484,histone H3 acetyltransferase activity,1/259,14/12494,0.254294065,0.820248256,0.719086452,BRCA2,1,MF
GO:0016894,"endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters",1/259,14/12494,0.254294065,0.820248256,0.719086452,EME1,1,MF
GO:0043274,phospholipase binding,1/259,14/12494,0.254294065,0.820248256,0.719086452,LMNB1,1,MF
GO:0140776,protein-containing complex destabilizing activity,1/259,14/12494,0.254294065,0.820248256,0.719086452,FIGNL1,1,MF
GO:0140939,histone H4 methyltransferase activity,1/259,14/12494,0.254294065,0.820248256,0.719086452,NSD2,1,MF
GO:0034212,peptide N-acetyltransferase activity,2/259,47/12494,0.254644235,0.820248256,0.719086452,BRCA2/ESCO2,2,MF
GO:0000062,fatty-acyl-CoA binding,1/259,15/12494,0.269769853,0.829109182,0.726854554,ACBD7,1,MF
GO:0015923,mannosidase activity,1/259,15/12494,0.269769853,0.829109182,0.726854554,MANEAL,1,MF
GO:0050145,nucleoside monophosphate kinase activity,1/259,15/12494,0.269769853,0.829109182,0.726854554,DLG2,1,MF
GO:0140328,floppase activity,1/259,15/12494,0.269769853,0.829109182,0.726854554,ATP8B3,1,MF
GO:1901567,fatty acid derivative binding,1/259,15/12494,0.269769853,0.829109182,0.726854554,ACBD7,1,MF
GO:0016798,"hydrolase activity, acting on glycosyl bonds",3/259,89/12494,0.280825808,0.831728182,0.729150551,MANEAL/MACROD2/NEIL3,3,MF
GO:0008047,enzyme activator activity,12/259,476/12494,0.284343406,0.831728182,0.729150551,CDC20/DEPDC1/IQGAP3/RACGAP1/ARHGAP11B/ARHGAP11A/RPS27L/ECT2/DEPDC1B/CCNB1/CDKN1A/DBF4,12,MF
GO:0004708,MAP kinase kinase activity,1/259,16/12494,0.284925684,0.831728182,0.729150551,PBK,1,MF
GO:0005092,GDP-dissociation inhibitor activity,1/259,16/12494,0.284925684,0.831728182,0.729150551,GPSM2,1,MF
GO:0016646,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor",1/259,16/12494,0.284925684,0.831728182,0.729150551,MTHFD2,1,MF
GO:0043539,protein serine/threonine kinase activator activity,2/259,51/12494,0.28551863,0.831728182,0.729150551,CCNB1/DBF4,2,MF
GO:0005452,solute:inorganic anion antiporter activity,1/259,17/12494,0.299768146,0.851036686,0.746077724,SLC4A8,1,MF
GO:0008656,cysteine-type endopeptidase activator activity involved in apoptotic process,1/259,17/12494,0.299768146,0.851036686,0.746077724,RPS27L,1,MF
GO:0140994,RNA polymerase II CTD heptapeptide repeat modifying activity,1/259,17/12494,0.299768146,0.851036686,0.746077724,CDK1,1,MF
GO:0001618,virus receptor activity,2/259,54/12494,0.308599952,0.85284018,0.747658791,CDK1/SLC7A1,2,MF
GO:0140272,exogenous protein binding,2/259,54/12494,0.308599952,0.85284018,0.747658791,CDK1/SLC7A1,2,MF
GO:0008409,5'-3' exonuclease activity,1/259,18/12494,0.314303696,0.85284018,0.747658791,EXO1,1,MF
GO:0046527,glucosyltransferase activity,1/259,18/12494,0.314303696,0.85284018,0.747658791,POGLUT3,1,MF
GO:0120227,acyl-CoA binding,1/259,18/12494,0.314303696,0.85284018,0.747658791,ACBD7,1,MF
GO:0016796,"exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters",2/259,56/12494,0.323908469,0.85284018,0.747658791,EXO1/POLE,2,MF
GO:0015106,bicarbonate transmembrane transporter activity,1/259,19/12494,0.328538654,0.85284018,0.747658791,SLC4A8,1,MF
GO:0016505,peptidase activator activity involved in apoptotic process,1/259,19/12494,0.328538654,0.85284018,0.747658791,RPS27L,1,MF
GO:0061608,nuclear import signal receptor activity,1/259,19/12494,0.328538654,0.85284018,0.747658791,KPNA2,1,MF
GO:0030295,protein kinase activator activity,3/259,98/12494,0.331948946,0.85284018,0.747658791,CCNB1/CDKN1A/DBF4,3,MF
GO:0008080,N-acetyltransferase activity,2/259,58/12494,0.339129753,0.85284018,0.747658791,BRCA2/ESCO2,2,MF
GO:1990841,promoter-specific chromatin binding,2/259,58/12494,0.339129753,0.85284018,0.747658791,DNMT1/RBL1,2,MF
GO:0008139,nuclear localization sequence binding,1/259,20/12494,0.342479214,0.85284018,0.747658791,KPNA2,1,MF
GO:0042056,chemoattractant activity,1/259,20/12494,0.342479214,0.85284018,0.747658791,HMGB2,1,MF
GO:0004521,RNA endonuclease activity,2/259,59/12494,0.346701813,0.85284018,0.747658791,EXO1/SLFN13,2,MF
GO:0015108,chloride transmembrane transporter activity,2/259,60/12494,0.354245232,0.85284018,0.747658791,SLC4A8/ANO7,2,MF
GO:0016835,carbon-oxygen lyase activity,2/259,60/12494,0.354245232,0.85284018,0.747658791,POLQ/NEIL3,2,MF
GO:0140311,protein sequestering activity,1/259,21/12494,0.356131442,0.85284018,0.747658791,CDKN1A,1,MF
GO:0051082,unfolded protein binding,3/259,103/12494,0.360362551,0.85284018,0.747658791,NDUFAF1/CHAF1A/CHAF1B,3,MF
GO:0002039,p53 binding,2/259,61/12494,0.361757947,0.85284018,0.747658791,BLM/BRCA1,2,MF
GO:0001965,G-protein alpha-subunit binding,1/259,22/12494,0.369501277,0.85284018,0.747658791,GPSM2,1,MF
GO:0004683,calmodulin-dependent protein kinase activity,1/259,22/12494,0.369501277,0.85284018,0.747658791,PHKA1,1,MF
GO:0008093,cytoskeletal anchor activity,1/259,22/12494,0.369501277,0.85284018,0.747658791,GAS2L3,1,MF
GO:0010485,histone H4 acetyltransferase activity,1/259,22/12494,0.369501277,0.85284018,0.747658791,BRCA2,1,MF
GO:0015101,organic cation transmembrane transporter activity,1/259,22/12494,0.369501277,0.85284018,0.747658791,SLC25A20,1,MF
GO:0017056,structural constituent of nuclear pore,1/259,22/12494,0.369501277,0.85284018,0.747658791,NUP160,1,MF
GO:0140326,ATPase-coupled intramembrane lipid transporter activity,1/259,22/12494,0.369501277,0.85284018,0.747658791,ATP8B3,1,MF
GO:0019209,kinase activator activity,3/259,105/12494,0.371685571,0.85284018,0.747658791,CCNB1/CDKN1A/DBF4,3,MF
GO:0016645,"oxidoreductase activity, acting on the CH-NH group of donors",1/259,23/12494,0.38259454,0.860160202,0.754076029,MTHFD2,1,MF
GO:0016814,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines",1/259,23/12494,0.38259454,0.860160202,0.754076029,MTHFD2,1,MF
GO:0004713,protein tyrosine kinase activity,3/259,108/12494,0.388597704,0.860160202,0.754076029,TTK/PBK/MELK,3,MF
GO:0004842,ubiquitin-protein transferase activity,9/259,380/12494,0.389831657,0.860160202,0.754076029,UBE2T/DTL/HERC2P3/BRCA1/UHRF1/UBE2S/UBE2C/TRAIP/TRIM59,9,MF
GO:0003724,RNA helicase activity,2/259,65/12494,0.391463839,0.860160202,0.754076029,BRIP1/RAD54B,2,MF
GO:0000030,mannosyltransferase activity,1/259,24/12494,0.395416929,0.860160202,0.754076029,DPY19L2P2,1,MF
GO:0043425,bHLH transcription factor binding,1/259,24/12494,0.395416929,0.860160202,0.754076029,NCAPG2,1,MF
GO:0080025,"phosphatidylinositol-3,5-bisphosphate binding",1/259,24/12494,0.395416929,0.860160202,0.754076029,WDR45,1,MF
GO:0035925,mRNA 3'-UTR AU-rich region binding,1/259,25/12494,0.407974027,0.867674858,0.760663897,EXOSC8,1,MF
GO:0097718,disordered domain specific binding,1/259,25/12494,0.407974027,0.867674858,0.760663897,RRM1,1,MF
GO:0140828,metal cation:monoatomic cation antiporter activity,1/259,25/12494,0.407974027,0.867674858,0.760663897,SLC4A8,1,MF
GO:0004857,enzyme inhibitor activity,6/259,248/12494,0.409231724,0.867674858,0.760663897,CDKN2C/CIT/PIF1/BIRC5/PTTG1/CDKN1A,6,MF
GO:0030165,PDZ domain binding,2/259,68/12494,0.413333564,0.869079545,0.761895343,KIF14/CIT,2,MF
GO:0004693,cyclin-dependent protein serine/threonine kinase activity,1/259,26/12494,0.420271302,0.869079545,0.761895343,CDK1,1,MF
GO:0055106,ubiquitin-protein transferase regulator activity,1/259,26/12494,0.420271302,0.869079545,0.761895343,CDC20,1,MF
GO:0097472,cyclin-dependent protein kinase activity,1/259,26/12494,0.420271302,0.869079545,0.761895343,CDK1,1,MF
GO:0004866,endopeptidase inhibitor activity,2/259,70/12494,0.427695971,0.879007057,0.770598488,BIRC5/PTTG1,2,MF
GO:0016410,N-acyltransferase activity,2/259,71/12494,0.434808066,0.883084755,0.774173281,BRCA2/ESCO2,2,MF
GO:0061134,peptidase regulator activity,3/259,118/12494,0.444034421,0.883084755,0.774173281,RPS27L/BIRC5/PTTG1,3,MF
GO:0000049,tRNA binding,2/259,73/12494,0.448888278,0.883084755,0.774173281,PSTK/SLFN13,2,MF
GO:0016776,"phosphotransferase activity, phosphate group as acceptor",1/259,29/12494,0.4556572,0.883084755,0.774173281,DLG2,1,MF
GO:0016891,"RNA endonuclease activity, producing 5'-phosphomonoesters",1/259,29/12494,0.4556572,0.883084755,0.774173281,EXO1,1,MF
GO:0072349,modified amino acid transmembrane transporter activity,1/259,29/12494,0.4556572,0.883084755,0.774173281,SLC7A1,1,MF
GO:0030414,peptidase inhibitor activity,2/259,74/12494,0.455854289,0.883084755,0.774173281,BIRC5/PTTG1,2,MF
GO:0004527,exonuclease activity,2/259,75/12494,0.462769607,0.883084755,0.774173281,EXO1/POLE,2,MF
GO:0003899,DNA-directed 5'-3' RNA polymerase activity,1/259,30/12494,0.466967652,0.883084755,0.774173281,PRIM1,1,MF
GO:0042169,SH2 domain binding,1/259,30/12494,0.466967652,0.883084755,0.774173281,SHCBP1,1,MF
GO:0043028,cysteine-type endopeptidase regulator activity involved in apoptotic process,1/259,30/12494,0.466967652,0.883084755,0.774173281,RPS27L,1,MF
GO:0019787,ubiquitin-like protein transferase activity,9/259,407/12494,0.469816792,0.883084755,0.774173281,UBE2T/DTL/HERC2P3/BRCA1/UHRF1/UBE2S/UBE2C/TRAIP/TRIM59,9,MF
GO:0008509,monoatomic anion transmembrane transporter activity,2/259,77/12494,0.476444634,0.883084755,0.774173281,SLC4A8/ANO7,2,MF
GO:0004715,non-membrane spanning protein tyrosine kinase activity,1/259,31/12494,0.478043983,0.883084755,0.774173281,MELK,1,MF
GO:0140142,nucleocytoplasmic carrier activity,1/259,31/12494,0.478043983,0.883084755,0.774173281,KPNA2,1,MF
GO:0005547,"phosphatidylinositol-3,4,5-trisphosphate binding",1/259,32/12494,0.488891018,0.883084755,0.774173281,RACGAP1,1,MF
GO:0034062,5'-3' RNA polymerase activity,1/259,32/12494,0.488891018,0.883084755,0.774173281,PRIM1,1,MF
GO:0043531,ADP binding,1/259,32/12494,0.488891018,0.883084755,0.774173281,MSH2,1,MF
GO:0097747,RNA polymerase activity,1/259,32/12494,0.488891018,0.883084755,0.774173281,PRIM1,1,MF
GO:0140303,intramembrane lipid transporter activity,1/259,32/12494,0.488891018,0.883084755,0.774173281,ATP8B3,1,MF
GO:0140313,molecular sequestering activity,1/259,32/12494,0.488891018,0.883084755,0.774173281,CDKN1A,1,MF
GO:0004725,protein tyrosine phosphatase activity,2/259,79/12494,0.489906881,0.883084755,0.774173281,CDKN3/CDC25C,2,MF
GO:0016755,aminoacyltransferase activity,9/259,414/12494,0.490309745,0.883084755,0.774173281,UBE2T/DTL/HERC2P3/BRCA1/UHRF1/UBE2S/UBE2C/TRAIP/TRIM59,9,MF
GO:0005200,structural constituent of cytoskeleton,2/259,80/12494,0.496556427,0.889552957,0.779843755,LMNB2/LMNB1,2,MF
GO:0046982,protein heterodimerization activity,5/259,227/12494,0.508983955,0.891278955,0.781356884,H2AX/TOP2A/CENPA/AURKA/CENPW,5,MF
GO:0016407,acetyltransferase activity,2/259,82/12494,0.509689245,0.891278955,0.781356884,BRCA2/ESCO2,2,MF
GO:0005179,hormone activity,1/259,34/12494,0.509916025,0.891278955,0.781356884,EDN2,1,MF
GO:0019213,deacetylase activity,1/259,34/12494,0.509916025,0.891278955,0.781356884,MACROD2,1,MF
GO:0030695,GTPase regulator activity,9/259,422/12494,0.513483099,0.891278955,0.781356884,DEPDC1/GPSM2/IQGAP3/RACGAP1/ARHGAP11B/ARHGAP11A/ECT2/DEPDC1B/ARHGEF39,9,MF
GO:0060589,nucleoside-triphosphatase regulator activity,9/259,422/12494,0.513483099,0.891278955,0.781356884,DEPDC1/GPSM2/IQGAP3/RACGAP1/ARHGAP11B/ARHGAP11A/ECT2/DEPDC1B/ARHGEF39,9,MF
GO:0015103,inorganic anion transmembrane transporter activity,2/259,83/12494,0.516171417,0.891326931,0.781398944,SLC4A8/ANO7,2,MF
GO:0061135,endopeptidase regulator activity,2/259,84/12494,0.522596774,0.897794457,0.787068825,BIRC5/PTTG1,2,MF
GO:0005254,chloride channel activity,1/259,36/12494,0.530079348,0.901403968,0.790233172,ANO7,1,MF
GO:0140318,protein transporter activity,1/259,36/12494,0.530079348,0.901403968,0.790233172,TIMM8B,1,MF
GO:0035254,glutamate receptor binding,1/259,37/12494,0.53984893,0.908790912,0.79670908,MYL12A,1,MF
GO:0048487,beta-tubulin binding,1/259,37/12494,0.53984893,0.908790912,0.79670908,RACGAP1,1,MF
GO:0001223,transcription coactivator binding,1/259,38/12494,0.549416172,0.915693619,0.802760471,CIT,1,MF
GO:0032266,phosphatidylinositol-3-phosphate binding,1/259,38/12494,0.549416172,0.915693619,0.802760471,WDR45,1,MF
GO:0004402,histone acetyltransferase activity,1/259,39/12494,0.558785248,0.923624674,0.809713383,BRCA2,1,MF
GO:0005048,signal sequence binding,1/259,40/12494,0.567960247,0.923624674,0.809713383,KPNA2,1,MF
GO:0008138,protein tyrosine/serine/threonine phosphatase activity,1/259,40/12494,0.567960247,0.923624674,0.809713383,CDKN3,1,MF
GO:0015370,solute:sodium symporter activity,1/259,40/12494,0.567960247,0.923624674,0.809713383,SLC4A8,1,MF
GO:0140938,histone H3 methyltransferase activity,1/259,40/12494,0.567960247,0.923624674,0.809713383,NSD2,1,MF
GO:0043014,alpha-tubulin binding,1/259,41/12494,0.576945176,0.933703545,0.818549219,RACGAP1,1,MF
GO:0044389,ubiquitin-like protein ligase binding,6/259,299/12494,0.589800665,0.943652811,0.827271435,UBE2T/BRCA1/UBE2C/AURKA/CCNB1/CDKN1A,6,MF
GO:0005080,protein kinase C binding,1/259,43/12494,0.594360427,0.943652811,0.827271435,TOP2A,1,MF
GO:0016504,peptidase activator activity,1/259,43/12494,0.594360427,0.943652811,0.827271435,RPS27L,1,MF
GO:0038024,cargo receptor activity,1/259,43/12494,0.594360427,0.943652811,0.827271435,HMMR,1,MF
GO:0016763,pentosyltransferase activity,1/259,44/12494,0.602798356,0.946812861,0.830041754,POGLUT3,1,MF
GO:0030544,Hsp70 protein binding,1/259,44/12494,0.602798356,0.946812861,0.830041754,CDK1,1,MF
GO:0005516,calmodulin binding,3/259,150/12494,0.604829708,0.946812861,0.830041754,IQGAP3/ASPM/PHKA1,3,MF
GO:0015179,L-amino acid transmembrane transporter activity,1/259,45/12494,0.611061426,0.951451092,0.834107949,SLC7A1,1,MF
GO:0140098,"catalytic activity, acting on RNA",7/259,358/12494,0.615934869,0.951451092,0.834107949,EXO1/PSTK/PRIM1/PIF1/SLFN13/BRIP1/RAD54B,7,MF
GO:0042826,histone deacetylase binding,2/259,100/12494,0.617435692,0.951451092,0.834107949,KPNA2/GMNN,2,MF
GO:0051287,NAD binding,1/259,46/12494,0.619153248,0.951451092,0.834107949,PHGDH,1,MF
GO:0005253,monoatomic anion channel activity,1/259,47/12494,0.627077357,0.959227921,0.840925656,ANO7,1,MF
GO:0004540,RNA nuclease activity,2/259,103/12494,0.633525934,0.960322118,0.841884904,EXO1/SLFN13,2,MF
GO:0017124,SH3 domain binding,2/259,103/12494,0.633525934,0.960322118,0.841884904,CIT/PTTG1,2,MF
GO:0008408,3'-5' exonuclease activity,1/259,52/12494,0.664300946,0.999974073,0.876646555,POLE,1,MF
GO:0005548,phospholipid transporter activity,1/259,53/12494,0.671289056,0.999974073,0.876646555,ATP8B3,1,MF
GO:0016279,protein-lysine N-methyltransferase activity,1/259,56/12494,0.691395786,0.999974073,0.876646555,NSD2,1,MF
GO:0043621,protein self-association,1/259,56/12494,0.691395786,0.999974073,0.876646555,GPSM2,1,MF
GO:0070063,RNA polymerase binding,1/259,56/12494,0.691395786,0.999974073,0.876646555,BRCA1,1,MF
GO:0140030,modification-dependent protein binding,3/259,171/12494,0.692217664,0.999974073,0.876646555,UHRF1/NCAPG2/PHF19,3,MF
GO:0051087,protein-folding chaperone binding,2/259,116/12494,0.697178181,0.999974073,0.876646555,CDK1/BIRC5,2,MF
GO:0016278,lysine N-methyltransferase activity,1/259,57/12494,0.697821939,0.999974073,0.876646555,NSD2,1,MF
GO:0140678,molecular function inhibitor activity,6/259,336/12494,0.700937091,0.999974073,0.876646555,CDKN2C/CIT/PIF1/BIRC5/PTTG1/CDKN1A,6,MF
GO:0015171,amino acid transmembrane transporter activity,1/259,58/12494,0.704114784,0.999974073,0.876646555,SLC7A1,1,MF
GO:0097110,scaffold protein binding,1/259,58/12494,0.704114784,0.999974073,0.876646555,CIT,1,MF
GO:0017022,myosin binding,1/259,59/12494,0.710277077,0.999974073,0.876646555,IQGAP3,1,MF
GO:0061630,ubiquitin protein ligase activity,5/259,287/12494,0.713978611,0.999974073,0.876646555,HERC2P3/UHRF1/UBE2C/TRAIP/TRIM59,5,MF
GO:0004553,"hydrolase activity, hydrolyzing O-glycosyl compounds",1/259,61/12494,0.722220741,0.999974073,0.876646555,MANEAL,1,MF
GO:0001540,amyloid-beta binding,1/259,62/12494,0.728007343,0.999974073,0.876646555,ITM2B,1,MF
GO:0042054,histone methyltransferase activity,1/259,62/12494,0.728007343,0.999974073,0.876646555,NSD2,1,MF
GO:0004197,cysteine-type endopeptidase activity,1/259,67/12494,0.755187918,0.999974073,0.876646555,ESPL1,1,MF
GO:0017018,myosin phosphatase activity,1/259,68/12494,0.760290222,0.999974073,0.876646555,CDKN3,1,MF
GO:0061659,ubiquitin-like protein ligase activity,5/259,305/12494,0.762133717,0.999974073,0.876646555,HERC2P3/UHRF1/UBE2C/TRAIP/TRIM59,5,MF
GO:0004222,metalloendopeptidase activity,1/259,70/12494,0.770179205,0.999974073,0.876646555,ADAM22,1,MF
GO:0015294,solute:monoatomic cation symporter activity,1/259,70/12494,0.770179205,0.999974073,0.876646555,SLC4A8,1,MF
GO:0003727,single-stranded RNA binding,1/259,71/12494,0.774970221,0.999974073,0.876646555,DDX11,1,MF
GO:0016758,hexosyltransferase activity,2/259,139/12494,0.787292679,0.999974073,0.876646555,POGLUT3/DPY19L2P2,2,MF
GO:0031267,small GTPase binding,4/259,259/12494,0.788954505,0.999974073,0.876646555,IQGAP3/KNTC1/BIRC5/ECT2,4,MF
GO:1901981,phosphatidylinositol phosphate binding,2/259,140/12494,0.790617336,0.999974073,0.876646555,RACGAP1/WDR45,2,MF
GO:1902936,phosphatidylinositol bisphosphate binding,1/259,79/12494,0.80988405,0.999974073,0.876646555,WDR45,1,MF
GO:0004721,phosphoprotein phosphatase activity,2/259,147/12494,0.812634895,0.999974073,0.876646555,CDKN3/CDC25C,2,MF
GO:0016616,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",1/259,81/12494,0.817733966,0.999974073,0.876646555,PHGDH,1,MF
GO:0016829,lyase activity,2/259,149/12494,0.818536015,0.999974073,0.876646555,POLQ/NEIL3,2,MF
GO:0140104,molecular carrier activity,1/259,82/12494,0.821536987,0.999974073,0.876646555,KPNA2,1,MF
GO:0005506,iron ion binding,1/259,83/12494,0.825260958,0.999974073,0.876646555,RRM2,1,MF
GO:0004722,protein serine/threonine phosphatase activity,1/259,84/12494,0.828907514,0.999974073,0.876646555,CDKN3,1,MF
GO:0008276,protein methyltransferase activity,1/259,86/12494,0.835974765,0.999974073,0.876646555,NSD2,1,MF
GO:0016614,"oxidoreductase activity, acting on CH-OH group of donors",1/259,86/12494,0.835974765,0.999974073,0.876646555,PHGDH,1,MF
GO:0003735,structural constituent of ribosome,2/259,157/12494,0.840512754,0.999974073,0.876646555,RPS27L/MRPL32,2,MF
GO:0031625,ubiquitin protein ligase binding,4/259,283/12494,0.842436389,0.999974073,0.876646555,UBE2T/BRCA1/AURKA/CDKN1A,4,MF
GO:0009055,electron transfer activity,1/259,88/12494,0.842751172,0.999974073,0.876646555,PHGDH,1,MF
GO:0015081,sodium ion transmembrane transporter activity,1/259,88/12494,0.842751172,0.999974073,0.876646555,SLC4A8,1,MF
GO:0008514,organic anion transmembrane transporter activity,2/259,158/12494,0.843084209,0.999974073,0.876646555,SLC4A8/SLC7A1,2,MF
GO:0003730,mRNA 3'-UTR binding,1/259,92/12494,0.855478668,0.999974073,0.876646555,EXOSC8,1,MF
GO:0008170,N-methyltransferase activity,1/259,92/12494,0.855478668,0.999974073,0.876646555,NSD2,1,MF
GO:0051020,GTPase binding,4/259,290/12494,0.855723279,0.999974073,0.876646555,IQGAP3/KNTC1/BIRC5/ECT2,4,MF
GO:0140297,DNA-binding transcription factor binding,6/259,409/12494,0.855878392,0.999974073,0.876646555,CENPF/RBBP8/E2F1/HMGB2/GMNN/NCAPG2,6,MF
GO:0015293,symporter activity,1/259,94/12494,0.861452164,0.999974073,0.876646555,SLC4A8,1,MF
GO:0043130,ubiquitin binding,1/259,96/12494,0.867179673,0.999974073,0.876646555,TOP2A,1,MF
GO:0008194,UDP-glycosyltransferase activity,1/259,98/12494,0.872671285,0.999974073,0.876646555,POGLUT3,1,MF
GO:0016810,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds",1/259,98/12494,0.872671285,0.999974073,0.876646555,MTHFD2,1,MF
GO:0045296,cadherin binding,4/259,301/12494,0.874681572,0.999974073,0.876646555,TMPO/CCNB2/CIP2A/ANLN,4,MF
GO:0001221,transcription coregulator binding,1/259,99/12494,0.87533167,0.999974073,0.876646555,CIT,1,MF
GO:0015297,antiporter activity,1/259,99/12494,0.87533167,0.999974073,0.876646555,SLC4A8,1,MF
GO:0090079,"translation regulator activity, nucleic acid binding",1/259,99/12494,0.87533167,0.999974073,0.876646555,RPS27L,1,MF
GO:0008757,S-adenosylmethionine-dependent methyltransferase activity,2/259,173/12494,0.877395912,0.999974073,0.876646555,DNMT1/NSD2,2,MF
GO:0051015,actin filament binding,2/259,173/12494,0.877395912,0.999974073,0.876646555,IQGAP3/GAS2L3,2,MF
GO:0016747,"acyltransferase activity, transferring groups other than amino-acyl groups",2/259,176/12494,0.883372308,0.999974073,0.876646555,BRCA2/ESCO2,2,MF
GO:0003713,transcription coactivator activity,3/259,244/12494,0.885162639,0.999974073,0.876646555,CENPJ/BRCA1/HMGB2,3,MF
GO:0002020,protease binding,1/259,103/12494,0.885430821,0.999974073,0.876646555,BRCA2,1,MF
GO:0003714,transcription corepressor activity,2/259,178/12494,0.887206147,0.999974073,0.876646555,RBBP8/GMNN,2,MF
GO:0046943,carboxylic acid transmembrane transporter activity,1/259,105/12494,0.890170466,0.999974073,0.876646555,SLC7A1,1,MF
GO:1901681,sulfur compound binding,2/259,180/12494,0.890923303,0.999974073,0.876646555,ACBD7/RRM2,2,MF
GO:0005342,organic acid transmembrane transporter activity,1/259,106/12494,0.892466523,0.999974073,0.876646555,SLC7A1,1,MF
GO:0005319,lipid transporter activity,1/259,107/12494,0.894714761,0.999974073,0.876646555,ATP8B3,1,MF
GO:0031072,heat shock protein binding,1/259,113/12494,0.907254134,0.999974073,0.876646555,CDK1,1,MF
GO:0003712,transcription coregulator activity,6/259,449/12494,0.908199824,0.999974073,0.876646555,CENPJ/BRCA1/RBBP8/HMGB2/TRIP13/GMNN,6,MF
GO:0033218,amide binding,3/259,261/12494,0.910561565,0.999974073,0.876646555,ACBD7/ITM2B/KPNA2,3,MF
GO:0042277,peptide binding,2/259,193/12494,0.912447708,0.999974073,0.876646555,ITM2B/KPNA2,2,MF
GO:0032182,ubiquitin-like protein binding,1/259,116/12494,0.912954168,0.999974073,0.876646555,TOP2A,1,MF
GO:0008168,methyltransferase activity,2/259,194/12494,0.913927505,0.999974073,0.876646555,DNMT1/NSD2,2,MF
GO:0005178,integrin binding,1/259,118/12494,0.916558934,0.999974073,0.876646555,ADAM22,1,MF
GO:0005085,guanyl-nucleotide exchange factor activity,2/259,196/12494,0.916817192,0.999974073,0.876646555,ECT2/ARHGEF39,2,MF
GO:0048018,receptor ligand activity,2/259,198/12494,0.919615851,0.999974073,0.876646555,EDN2/HMGB2,2,MF
GO:0019903,protein phosphatase binding,1/259,120/12494,0.920014971,0.999974073,0.876646555,NEK2,1,MF
GO:0016757,glycosyltransferase activity,2/259,201/12494,0.923648764,0.999974073,0.876646555,POGLUT3/DPY19L2P2,2,MF
GO:0045182,translation regulator activity,1/259,123/12494,0.924933464,0.999974073,0.876646555,RPS27L,1,MF
GO:0030546,signaling receptor activator activity,2/259,202/12494,0.924950301,0.999974073,0.876646555,EDN2/HMGB2,2,MF
GO:0016741,"transferase activity, transferring one-carbon groups",2/259,204/12494,0.927491058,0.999974073,0.876646555,DNMT1/NSD2,2,MF
GO:0008237,metallopeptidase activity,1/259,125/12494,0.92804388,0.999974073,0.876646555,ADAM22,1,MF
GO:0140101,"catalytic activity, acting on a tRNA",1/259,129/12494,0.933884781,0.999974073,0.876646555,PSTK,1,MF
GO:0005539,glycosaminoglycan binding,1/259,134/12494,0.940526065,0.999974073,0.876646555,HMMR,1,MF
GO:0008234,cysteine-type peptidase activity,1/259,136/12494,0.942992565,0.999974073,0.876646555,ESPL1,1,MF
GO:0016853,isomerase activity,1/259,136/12494,0.942992565,0.999974073,0.876646555,TOP2A,1,MF
GO:0004175,endopeptidase activity,2/259,219/12494,0.94411858,0.999974073,0.876646555,ESPL1/ADAM22,2,MF
GO:0003779,actin binding,4/259,361/12494,0.944539063,0.999974073,0.876646555,IQGAP3/KIF18A/GAS2L3/ANLN,4,MF
GO:0016791,phosphatase activity,2/259,220/12494,0.945087778,0.999974073,0.876646555,CDKN3/CDC25C,2,MF
GO:0001216,DNA-binding transcription activator activity,3/259,296/12494,0.94754011,0.999974073,0.876646555,E2F2/E2F1/MYBL2,3,MF
GO:0030545,signaling receptor regulator activity,2/259,223/12494,0.947900573,0.999974073,0.876646555,EDN2/HMGB2,2,MF
GO:0008233,peptidase activity,4/259,367/12494,0.949079396,0.999974073,0.876646555,FAM111B/ESPL1/LACTB/ADAM22,4,MF
GO:0035091,phosphatidylinositol binding,2/259,225/12494,0.949699149,0.999974073,0.876646555,RACGAP1/WDR45,2,MF
GO:0030674,protein-macromolecule adaptor activity,4/259,370/12494,0.95121998,0.999974073,0.876646555,DTL/POLD3/GAS2L3/NDC80,4,MF
GO:0001664,G protein-coupled receptor binding,1/259,145/12494,0.952889688,0.999974073,0.876646555,EDN2,1,MF
GO:0022853,active monoatomic ion transmembrane transporter activity,1/259,157/12494,0.963474149,0.999974073,0.876646555,SLC4A8,1,MF
GO:0019902,phosphatase binding,1/259,160/12494,0.965726815,0.999974073,0.876646555,NEK2,1,MF
GO:0050839,cell adhesion molecule binding,5/259,466/12494,0.967351008,0.999974073,0.876646555,TMPO/CCNB2/CIP2A/ANLN/ADAM22,5,MF
GO:1901702,salt transmembrane transporter activity,3/259,338/12494,0.973123433,0.999974073,0.876646555,SLC4A8/SLC7A1/ANO7,3,MF
GO:0015291,secondary active transmembrane transporter activity,1/259,191/12494,0.982262936,0.999974073,0.876646555,SLC4A8,1,MF
GO:0042578,phosphoric ester hydrolase activity,2/259,284/12494,0.982588422,0.999974073,0.876646555,CDKN3/CDC25C,2,MF
GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",2/259,292/12494,0.984969463,0.999974073,0.876646555,E2F2/MYBL2,2,MF
GO:0001227,"DNA-binding transcription repressor activity, RNA polymerase II-specific",1/259,236/12494,0.993203021,0.999974073,0.876646555,MXD3,1,MF
GO:0005216,monoatomic ion channel activity,1/259,237/12494,0.993346635,0.999974073,0.876646555,ANO7,1,MF
GO:0001217,DNA-binding transcription repressor activity,1/259,244/12494,0.994270747,0.999974073,0.876646555,MXD3,1,MF
GO:0015267,channel activity,1/259,261/12494,0.996016892,0.999974073,0.876646555,ANO7,1,MF
GO:0022803,passive transmembrane transporter activity,1/259,261/12494,0.996016892,0.999974073,0.876646555,ANO7,1,MF
GO:0005543,phospholipid binding,2/259,364/12494,0.996106861,0.999974073,0.876646555,RACGAP1/WDR45,2,MF
GO:0046873,metal ion transmembrane transporter activity,1/259,267/12494,0.996496935,0.999974073,0.876646555,SLC4A8,1,MF
GO:0003729,mRNA binding,1/259,283/12494,0.997513534,0.999974073,0.876646555,EXOSC8,1,MF
GO:0061629,RNA polymerase II-specific DNA-binding transcription factor binding,1/259,295/12494,0.998077776,0.999974073,0.876646555,RBBP8,1,MF
GO:0015318,inorganic molecular entity transmembrane transporter activity,2/259,415/12494,0.998541612,0.999974073,0.876646555,SLC4A8/ANO7,2,MF
GO:0022804,active transmembrane transporter activity,1/259,316/12494,0.998775599,0.999974073,0.876646555,SLC4A8,1,MF
GO:0015075,monoatomic ion transmembrane transporter activity,2/259,438/12494,0.9990687,0.999974073,0.876646555,SLC4A8/ANO7,2,MF
GO:0005509,calcium ion binding,2/259,443/12494,0.999155582,0.999974073,0.876646555,MYL12A/MELK,2,MF
GO:0022890,inorganic cation transmembrane transporter activity,1/259,353/12494,0.999447962,0.999974073,0.876646555,SLC4A8,1,MF
GO:0004888,transmembrane signaling receptor activity,1/259,357/12494,0.999493587,0.999974073,0.876646555,EDA2R,1,MF
GO:0008324,monoatomic cation transmembrane transporter activity,1/259,367/12494,0.999591879,0.999974073,0.876646555,SLC4A8,1,MF
GO:0038023,signaling receptor activity,1/259,494/12494,0.999974073,0.999974073,0.876646555,EDA2R,1,MF
GO:0060089,molecular transducer activity,1/259,494/12494,0.999974073,0.999974073,0.876646555,EDA2R,1,MF
GO:0098687,chromosomal region,75/264,358/12707,3.27E-55,8.19E-53,6.27E-53,CDCA8/CDC20/KIF2C/ORC1/NUF2/FIRRM/CENPL/NEK2/CENPF/ZWINT/CDK1/DNA2/HELLS/KIF18A/NUP160/INCENP/CDCA5/H2AX/CHEK1/RAD51AP1/NCAPD2/KNTC1/SKA3/BRCA2/MIS18BP1/BUB1B/KNSTRN/KNL1/RAD51/OIP5/PIF1/ZWILCH/BLM/PLK1/CDT1/AURKB/SPAG5/TOP2A/BIRC5/NDC80/SKA1/DNMT1/SPC24/CENPO/CENPA/MSH2/BUB1/MCM6/SPC25/SGO2/HJURP/DSN1/AURKA/MCM5/CENPM/SGO1/MCM2/SMC4/NCAPG/CENPE/MAD2L1/CENPU/CENPK/CCNB1/CENPH/SPDL1/MCM3/TTK/CENPW/MCM7/ESCO2/MCM4/DSCC1/ERCC6L/CENPI,75,CC
GO:0000793,condensed chromosome,62/264,247/12707,1.97E-50,2.46E-48,1.89E-48,CDC20/KIF2C/NUF2/FIRRM/CENPL/NEK2/CENPF/ZWINT/MKI67/KIF18A/NUP160/INCENP/H2AX/CHEK1/NCAPD2/KNTC1/SKA3/BRCA2/BUB1B/KNSTRN/KNL1/RAD51/ZWILCH/BLM/PLK1/CDT1/AURKB/SPAG5/TOP2A/BRCA1/BIRC5/NDC80/SKA1/SPC24/CENPO/CENPA/NCAPH/BUB1/SPC25/SGO2/HJURP/DSN1/AURKA/CENPM/FANCD2/SGO1/TOPBP1/SMC4/NCAPG/CENPE/MAD2L1/HMGB2/CENPU/CENPK/CCNB1/CENPH/SPDL1/TTK/CENPW/NCAPG2/ERCC6L/CENPI,62,CC
GO:0000775,"chromosome, centromeric region",58/264,233/12707,7.30E-47,6.08E-45,4.66E-45,CDCA8/CDC20/KIF2C/NUF2/FIRRM/CENPL/NEK2/CENPF/ZWINT/HELLS/KIF18A/NUP160/INCENP/CDCA5/NCAPD2/KNTC1/SKA3/MIS18BP1/BUB1B/KNSTRN/KNL1/OIP5/ZWILCH/PLK1/CDT1/AURKB/SPAG5/TOP2A/BIRC5/NDC80/SKA1/DNMT1/SPC24/CENPO/CENPA/BUB1/SPC25/SGO2/HJURP/DSN1/AURKA/CENPM/SGO1/SMC4/NCAPG/CENPE/MAD2L1/CENPU/CENPK/CCNB1/CENPH/SPDL1/TTK/CENPW/ESCO2/DSCC1/ERCC6L/CENPI,58,CC
GO:0000779,"condensed chromosome, centromeric region",48/264,175/12707,7.04E-41,4.40E-39,3.37E-39,CDC20/KIF2C/NUF2/FIRRM/CENPL/NEK2/CENPF/ZWINT/KIF18A/NUP160/INCENP/NCAPD2/KNTC1/SKA3/BUB1B/KNSTRN/KNL1/ZWILCH/PLK1/CDT1/AURKB/SPAG5/BIRC5/NDC80/SKA1/SPC24/CENPO/CENPA/BUB1/SPC25/SGO2/HJURP/DSN1/AURKA/CENPM/SGO1/NCAPG/CENPE/MAD2L1/CENPU/CENPK/CCNB1/CENPH/SPDL1/TTK/CENPW/ERCC6L/CENPI,48,CC
GO:0000776,kinetochore,45/264,165/12707,3.42E-38,1.71E-36,1.31E-36,CDC20/KIF2C/NUF2/FIRRM/CENPL/NEK2/CENPF/ZWINT/KIF18A/NUP160/INCENP/KNTC1/SKA3/BUB1B/KNSTRN/KNL1/ZWILCH/PLK1/CDT1/AURKB/SPAG5/BIRC5/NDC80/SKA1/SPC24/CENPO/BUB1/SPC25/SGO2/HJURP/DSN1/AURKA/CENPM/SGO1/CENPE/MAD2L1/CENPU/CENPK/CCNB1/CENPH/SPDL1/TTK/CENPW/ERCC6L/CENPI,45,CC
GO:0005819,spindle,61/264,390/12707,1.14E-36,4.75E-35,3.64E-35,AUNIP/CDCA8/CDC20/KIF2C/CDC7/GPSM2/PSRC1/FIRRM/ASPM/KIF14/NEK2/CENPF/CDK1/KIF20B/KIF11/KIF18A/INCENP/DDX11/RACGAP1/ESPL1/KNTC1/SKA3/BORA/DLGAP5/CEP128/BUB1B/KNSTRN/NUSAP1/ZWILCH/KIF23/PRC1/PLK1/SHCBP1/AURKB/SPAG5/CDC6/KIF18B/BIRC5/SKA1/WDR62/CKAP2L/TPX2/DSN1/FAM83D/AURKA/SGO1/KIF15/POC1A/TOPBP1/ECT2/TACC3/CENPE/MAD2L1/CCNB1/KIF20A/HMMR/SPDL1/KIFC1/TTK/CNTRL/KIF4A,61,CC
GO:0000228,nuclear chromosome,39/264,196/12707,1.81E-27,6.45E-26,4.95E-26,ORC1/NEK2/MCM10/INCENP/POLA2/POLD3/H2AX/CHEK1/NCAPD2/TIMELESS/PRIM1/POLE/BRCA2/POLE2/WDHD1/RAD51/TIPIN/BLM/PLK1/GINS2/TOP2A/BRCA1/EME1/BIRC5/NCAPH/MCM6/GINS1/CDC45/MCM5/MCM2/TOPBP1/SMC4/NCAPG/MCM3/MMS22L/FIGNL1/MCM7/NCAPG2/MCM4,39,CC
GO:0000922,spindle pole,33/264,162/12707,1.10E-23,3.44E-22,2.63E-22,AUNIP/CDC20/GPSM2/PSRC1/ASPM/NEK2/CENPF/KIF20B/KIF11/DDX11/KNTC1/DLGAP5/CEP128/KNSTRN/PRC1/PLK1/AURKB/SPAG5/CDC6/WDR62/CKAP2L/TPX2/DSN1/FAM83D/AURKA/SGO1/POC1A/TOPBP1/TACC3/MAD2L1/CCNB1/SPDL1/CNTRL,33,CC
GO:0072686,mitotic spindle,32/264,165/12707,2.70E-22,7.51E-21,5.75E-21,CDC7/GPSM2/ASPM/CDK1/KIF20B/KIF11/KIF18A/RACGAP1/ESPL1/SKA3/DLGAP5/KNSTRN/NUSAP1/KIF23/PRC1/PLK1/AURKB/SPAG5/CDC6/KIF18B/SKA1/WDR62/CKAP2L/TPX2/FAM83D/AURKA/ECT2/TACC3/CENPE/MAD2L1/KIFC1/CNTRL,32,CC
GO:0000940,outer kinetochore,15/264,20/12707,5.51E-22,1.38E-20,1.06E-20,NUF2/CENPF/ZWINT/SKA3/BUB1B/KNL1/PLK1/NDC80/SKA1/SPC24/BUB1/SPC25/DSN1/CCNB1/SPDL1,15,CC
GO:0005657,replication fork,21/264,66/12707,8.13E-20,1.85E-18,1.42E-18,MCM10/POLA2/POLD3/H2AX/CHEK1/TIMELESS/PRIM1/RFC5/RFC3/WDHD1/PIF1/TIPIN/BLM/EME1/UHRF1/DNMT1/RFC4/MCM3/MMS22L/RFC2/XRCC2,21,CC
GO:0030496,midbody,27/264,191/12707,2.52E-15,5.24E-14,4.02E-14,CDCA8/PSRC1/FIRRM/ASPM/KIF14/NEK2/CENPF/CDK1/KIF20B/CEP55/INCENP/DDX11/RACGAP1/KIF23/PRC1/PLK1/SHCBP1/AURKB/SPAG5/BIRC5/AURKA/ECT2/CENPE/KIF20A/ANLN/CNTRL/KIF4A,27,CC
GO:0051233,spindle midzone,14/264,35/12707,3.11E-15,5.98E-14,4.58E-14,CDCA8/FIRRM/KIF14/KIF20B/KIF18A/INCENP/RACGAP1/PRC1/PLK1/AURKB/CDC6/KIF18B/AURKA/CENPE,14,CC
GO:0071162,CMG complex,9/264,11/12707,3.34E-14,5.97E-13,4.57E-13,GINS2/MCM6/GINS1/CDC45/MCM5/MCM2/MCM3/MCM7/MCM4,9,CC
GO:0005874,microtubule,35/264,380/12707,1.01E-13,1.68E-12,1.29E-12,KIF2C/PSRC1/ASPM/KIF14/NEK2/CDK1/KIF20B/KIF11/KIF18A/INCENP/RACGAP1/GAS2L3/KNTC1/SKA3/CENPJ/KNSTRN/NUSAP1/ZWILCH/KIF23/PRC1/PLK1/AURKB/SPAG5/KIF18B/BIRC5/SKA1/TPX2/AURKA/GTSE1/KIF15/CENPE/KIF20A/KIFC1/KIF24/KIF4A,35,CC
GO:0031261,DNA replication preinitiation complex,9/264,12/12707,1.31E-13,2.05E-12,1.57E-12,GINS2/MCM6/GINS1/CDC45/MCM5/MCM2/MCM3/MCM7/MCM4,9,CC
GO:0000794,condensed nuclear chromosome,15/264,54/12707,1.64E-13,2.41E-12,1.84E-12,NEK2/INCENP/H2AX/CHEK1/NCAPD2/BRCA2/RAD51/BLM/PLK1/BRCA1/NCAPH/TOPBP1/SMC4/NCAPG/NCAPG2,15,CC
GO:0005876,spindle microtubule,15/264,77/12707,4.35E-11,6.05E-10,4.63E-10,PSRC1/CDK1/KIF11/KIF18A/KNTC1/SKA3/ZWILCH/PRC1/PLK1/AURKB/KIF18B/SKA1/AURKA/CENPE/KIF4A,15,CC
GO:0043596,nuclear replication fork,10/264,33/12707,7.68E-10,1.01E-08,7.75E-09,MCM10/POLA2/POLD3/TIMELESS/PRIM1/WDHD1/TIPIN/EME1/MCM3/MMS22L,10,CC
GO:0000939,inner kinetochore,8/264,19/12707,1.94E-09,2.42E-08,1.86E-08,CENPL/CENPO/CENPM/CENPU/CENPK/CENPH/CENPW/CENPI,8,CC
GO:0005814,centriole,17/264,142/12707,5.91E-09,7.03E-08,5.39E-08,STIL/SASS6/CEP55/CENPJ/CEP128/CEP152/CCNF/PLK1/TOP2A/RTTN/WDR62/CEP250/AURKA/POC1A/PLK4/LRRCC1/KIF24,17,CC
GO:0005871,kinesin complex,10/264,41/12707,8.04E-09,8.85E-08,6.79E-08,KIF2C/KIF14/KIF20B/KIF11/KIF18A/KIF23/KIF18B/KIF15/KIF20A/KIFC1,10,CC
GO:0000781,"chromosome, telomeric region",17/264,145/12707,8.15E-09,8.85E-08,6.79E-08,ORC1/CDK1/DNA2/H2AX/CHEK1/RAD51AP1/BRCA2/RAD51/PIF1/BLM/MSH2/MCM6/MCM5/MCM2/MCM3/MCM7/MCM4,17,CC
GO:0005875,microtubule associated complex,16/264,130/12707,1.12E-08,1.17E-07,8.94E-08,CDCA8/KIF2C/KIF14/KIF20B/KIF11/KIF18A/INCENP/KIF23/AURKB/KIF18B/BIRC5/AURKA/KIF15/KIF20A/KIFC1/KIF4A,16,CC
GO:0097431,mitotic spindle pole,9/264,37/12707,4.71E-08,4.71E-07,3.61E-07,GPSM2/ASPM/KIF20B/PLK1/AURKB/SPAG5/FAM83D/AURKA/CNTRL,9,CC
GO:1990023,mitotic spindle midzone,6/264,13/12707,1.15E-07,1.11E-06,8.50E-07,KIF20B/KIF18A/PRC1/AURKB/KIF18B/CENPE,6,CC
GO:0045171,intercellular bridge,11/264,74/12707,3.32E-07,3.07E-06,2.36E-06,CDCA8/CDC7/KIF20B/CEP55/PRC1/CDC6/SKA1/TPX2/FAM83D/CENPE/KIF20A,11,CC
GO:0072687,meiotic spindle,5/264,11/12707,1.55E-06,1.32E-05,1.02E-05,ASPM/INCENP/BORA/AURKA/CNTRL,5,CC
GO:0000795,synaptonemal complex,6/264,19/12707,1.64E-06,1.32E-05,1.02E-05,INCENP/BRCA2/RAD51/BLM/PLK1/BRCA1,6,CC
GO:0042575,DNA polymerase complex,6/264,19/12707,1.64E-06,1.32E-05,1.02E-05,POLA2/POLD3/PRIM1/POLE/POLE2/MCM3,6,CC
GO:0099086,synaptonemal structure,6/264,19/12707,1.64E-06,1.32E-05,1.02E-05,INCENP/BRCA2/RAD51/BLM/PLK1/BRCA1,6,CC
GO:0010369,chromocenter,5/264,12/12707,2.62E-06,2.05E-05,1.57E-05,CDCA8/INCENP/OIP5/AURKB/ESCO2,5,CC
GO:0043073,germ cell nucleus,8/264,48/12707,5.74E-06,4.35E-05,3.33E-05,H2AX/RAD51/TOP2A/BRCA1/DNMT1/AURKA/TOPBP1/TRIP13,8,CC
GO:0000152,nuclear ubiquitin ligase complex,7/264,43/12707,2.62E-05,0.000192867,0.000147797,CDC20/BRCA2/BUB1B/RAD51/BRCA1/UBE2S/UBE2C,7,CC
GO:0001741,XY body,4/264,11/12707,5.36E-05,0.000382672,0.000293247,H2AX/BRCA1/PLK4/ESCO2,4,CC
GO:0043601,nuclear replisome,4/264,12/12707,7.91E-05,0.000548966,0.000420681,POLA2/POLD3/PRIM1/MCM3,4,CC
GO:0000792,heterochromatin,8/264,72/12707,0.000118357,0.000799708,0.000612829,HELLS/INCENP/WDR76/EME1/UHRF1/DNMT1/CENPA/ESCO2,8,CC
GO:0001673,male germ cell nucleus,6/264,39/12707,0.000139361,0.000916847,0.000702594,H2AX/RAD51/TOP2A/BRCA1/TOPBP1/TRIP13,6,CC
GO:0030894,replisome,4/264,14/12707,0.000154694,0.000991631,0.000759903,POLA2/POLD3/PRIM1/MCM3,4,CC
GO:0005721,pericentric heterochromatin,5/264,27/12707,0.000206849,0.001292804,0.000990696,HELLS/INCENP/DNMT1/CENPA/ESCO2,5,CC
GO:0090543,Flemming body,5/264,29/12707,0.000294127,0.001793456,0.001374354,KIF14/CEP55/RACGAP1/KIF23/CNTRL,5,CC
GO:0090734,site of DNA damage,9/264,107/12707,0.000382637,0.002277603,0.001745363,AUNIP/H2AX/TIMELESS/RAD51/WDR76/TRAIP/ZGRF1/MMS22L/ESCO2,9,CC
GO:0000307,cyclin-dependent protein kinase holoenzyme complex,6/264,48/12707,0.000448385,0.00260689,0.001997701,CDK1/CCNB2/CCNF/CCNA2/CCNB1/CDKN1A,6,CC
GO:1990752,microtubule end,5/264,32/12707,0.00047404,0.002693407,0.002064,KIF2C/ASPM/KNSTRN/SPAG5/KIF18B,5,CC
GO:0005680,anaphase-promoting complex,4/264,20/12707,0.000678678,0.003688466,0.00282653,CDC20/BUB1B/UBE2S/UBE2C,4,CC
GO:0005828,kinetochore microtubule,4/264,20/12707,0.000678678,0.003688466,0.00282653,KIF18A/KNTC1/ZWILCH/CENPE,4,CC
GO:0070938,contractile ring,3/264,10/12707,0.000954881,0.005079152,0.003892234,KIF20B/PRC1/ANLN,3,CC
GO:1990391,DNA repair complex,4/264,22/12707,0.000991743,0.005165326,0.003958271,BRCA2/FANCI/BRCA1/FANCD2,4,CC
GO:0034451,centriolar satellite,8/264,100/12707,0.00111743,0.005701171,0.004368897,KNSTRN/PLK1/SPAG5/SKA1/WDR62/TACC3/CENPU/CNTRL,8,CC
GO:0061695,"transferase complex, transferring phosphorus-containing groups",14/264,262/12707,0.001169291,0.005789723,0.004436756,CDK1/POLA2/POLD3/PRIM1/POLE/POLE2/CCNB2/CCNF/CCNA2/CCNB1/CDKN1A/MCM3/DBF4/PHKA1,14,CC
GO:0035371,microtubule plus-end,4/264,23/12707,0.001181103,0.005789723,0.004436756,KIF2C/KNSTRN/SPAG5/KIF18B,4,CC
GO:0043240,Fanconi anaemia nuclear complex,3/264,11/12707,0.00129287,0.006098446,0.004673335,FANCA/FANCE/FANCG,3,CC
GO:0045120,pronucleus,3/264,11/12707,0.00129287,0.006098446,0.004673335,CENPF/AURKA/CCNA2,3,CC
GO:0031616,spindle pole centrosome,3/264,12/12707,0.001697477,0.007858689,0.006022238,DLGAP5/AURKB/AURKA,3,CC
GO:1902554,serine/threonine protein kinase complex,8/264,112/12707,0.002308029,0.01049104,0.00803945,CDK1/CCNB2/CCNF/CCNA2/CCNB1/CDKN1A/DBF4/PHKA1,8,CC
GO:0000803,sex chromosome,4/264,30/12707,0.003261899,0.014562049,0.011159128,H2AX/BRCA1/PLK4/ESCO2,4,CC
GO:1902911,protein kinase complex,8/264,128/12707,0.005230994,0.022657888,0.017363097,CDK1/CCNB2/CCNF/CCNA2/CCNB1/CDKN1A/DBF4/PHKA1,8,CC
GO:0035861,site of double-strand break,6/264,77/12707,0.00525663,0.022657888,0.017363097,H2AX/TIMELESS/RAD51/ZGRF1/MMS22L/ESCO2,6,CC
GO:0032153,cell division site,5/264,63/12707,0.009829631,0.041650978,0.031917802,CEP55/RACGAP1/ECT2/PLK4/ANLN,5,CC
GO:0036064,ciliary basal body,8/264,144/12707,0.010388319,0.043284661,0.033169719,CENPF/CENPJ/SPAG5/RTTN/CEP250/AURKA/CDC45/POC1A,8,CC
GO:0032154,cleavage furrow,4/264,45/12707,0.013920993,0.05705325,0.043720807,CEP55/RACGAP1/ECT2/PLK4,4,CC
GO:0000235,astral microtubule,2/264,10/12707,0.017334492,0.06771286,0.051889434,KIF18A/KIF18B,2,CC
GO:0005818,aster,2/264,10/12707,0.017334492,0.06771286,0.051889434,KIF18A/KIF18B,2,CC
GO:0120103,centriolar subdistal appendage,2/264,10/12707,0.017334492,0.06771286,0.051889434,CEP128/CNTRL,2,CC
GO:0005652,nuclear lamina,2/264,12/12707,0.024739661,0.095152542,0.072916896,LMNB2/LMNB1,2,CC
GO:0034399,nuclear periphery,7/264,140/12707,0.026874639,0.101797875,0.078009319,CENPF/BLM/LMNB2/UHRF1/LMNB1/CENPW/KIF4A,7,CC
GO:0016363,nuclear matrix,6/264,118/12707,0.036430961,0.135936421,0.104170226,CENPF/BLM/UHRF1/LMNB1/CENPW/KIF4A,6,CC
GO:0000930,gamma-tubulin complex,2/264,16/12707,0.042604881,0.156635593,0.120032328,CENPJ/BRCA1,2,CC
GO:0005881,cytoplasmic microtubule,4/264,74/12707,0.067863276,0.245881436,0.188422826,KIF2C/KIF18A/KIF18B/GTSE1,4,CC
GO:0031461,cullin-RING ubiquitin ligase complex,6/264,165/12707,0.12956502,0.462732216,0.354599003,CDC20/DTL/BUB1B/CCNF/UBE2S/UBE2C,6,CC
GO:0099738,cell cortex region,2/264,33/12707,0.149501328,0.526413128,0.403398692,GPSM2/SAPCD2,2,CC
GO:0017053,transcription repressor complex,3/264,65/12707,0.152616566,0.529918631,0.406085014,DEPDC1/RBBP8/GMNN,3,CC
GO:0000151,ubiquitin ligase complex,9/264,295/12707,0.161823733,0.554190866,0.424685211,CDC20/DTL/BRCA2/BUB1B/RAD51/CCNF/BRCA1/UBE2S/UBE2C,9,CC
GO:0005635,nuclear envelope,12/264,431/12707,0.187057781,0.599476564,0.459388357,DTL/CENPF/RRM1/NUP160/TMPO/CEP128/BRIP1/KPNA2/LMNB2/MAD2L1/LMNB1/DPY19L2P2,12,CC
GO:0001669,acrosomal vesicle,3/264,72/12707,0.188394174,0.599476564,0.459388357,RACGAP1/KNL1/ATP8B3,3,CC
GO:0000172,ribonuclease MRP complex,1/264,10/12707,0.189434594,0.599476564,0.459388357,RPP25L,1,CC
GO:0032300,mismatch repair complex,1/264,10/12707,0.189434594,0.599476564,0.459388357,MSH2,1,CC
GO:0101019,nucleolar exosome (RNase complex),1/264,10/12707,0.189434594,0.599476564,0.459388357,EXOSC8,1,CC
GO:1990531,phospholipid-translocating ATPase complex,1/264,10/12707,0.189434594,0.599476564,0.459388357,ATP8B3,1,CC
GO:1905348,endonuclease complex,2/264,39/12707,0.194045414,0.606391918,0.464687701,EME1/RPP25L,2,CC
GO:0031965,nuclear membrane,8/264,270/12707,0.200417469,0.618572434,0.474021823,DTL/CENPF/CEP128/BRIP1/KPNA2/LMNB2/LMNB1/DPY19L2P2,8,CC
GO:0031074,nucleocytoplasmic transport complex,1/264,11/12707,0.206288124,0.621349771,0.476150141,KPNA2,1,CC
GO:0099569,presynaptic cytoskeleton,1/264,11/12707,0.206288124,0.621349771,0.476150141,RAD51,1,CC
GO:0000176,nuclear exosome (RNase complex),1/264,12/12707,0.22279253,0.655272147,0.502145392,EXOSC8,1,CC
GO:0044615,nuclear pore nuclear basket,1/264,12/12707,0.22279253,0.655272147,0.502145392,MAD2L1,1,CC
GO:0045111,intermediate filament cytoskeleton,3/264,81/12707,0.237076814,0.666646431,0.510861686,RAD51/LMNB2/LMNB1,3,CC
GO:0031464,Cul4A-RING E3 ubiquitin ligase complex,1/264,13/12707,0.238955017,0.666646431,0.510861686,DTL,1,CC
GO:0032809,neuronal cell body membrane,1/264,13/12707,0.238955017,0.666646431,0.510861686,SLC4A8,1,CC
GO:0035253,ciliary rootlet,1/264,13/12707,0.238955017,0.666646431,0.510861686,SPAG5,1,CC
GO:0005637,nuclear inner membrane,2/264,45/12707,0.239992715,0.666646431,0.510861686,LMNB1/DPY19L2P2,2,CC
GO:0000177,cytoplasmic exosome (RNase complex),1/264,15/12707,0.270282318,0.73446282,0.562830456,EXOSC8,1,CC
GO:0044298,cell body membrane,1/264,15/12707,0.270282318,0.73446282,0.562830456,SLC4A8,1,CC
GO:0002080,acrosomal membrane,1/264,16/12707,0.285460813,0.761678342,0.58368614,ATP8B3,1,CC
GO:0005882,intermediate filament,2/264,51/12707,0.286391057,0.761678342,0.58368614,LMNB2/LMNB1,2,CC
GO:0016328,lateral plasma membrane,2/264,53/12707,0.301822956,0.794270937,0.60866236,GPSM2/IQGAP3,2,CC
GO:0000178,exosome (RNase complex),1/264,18/12707,0.314880652,0.811548071,0.621902101,EXOSC8,1,CC
GO:0016460,myosin II complex,1/264,18/12707,0.314880652,0.811548071,0.621902101,MYL12A,1,CC
GO:0055029,nuclear DNA-directed RNA polymerase complex,3/264,97/12707,0.327482561,0.831148608,0.636922302,POLA2/PRIM1/MCM3,3,CC
GO:1905354,exoribonuclease complex,1/264,19/12707,0.329134849,0.831148608,0.636922302,EXOSC8,1,CC
GO:1904115,axon cytoplasm,2/264,58/12707,0.340104531,0.844577972,0.647213435,DLG2/KIF4A,2,CC
GO:0000428,DNA-directed RNA polymerase complex,3/264,100/12707,0.344587813,0.844577972,0.647213435,POLA2/PRIM1/MCM3,3,CC
GO:0016605,PML body,3/264,100/12707,0.344587813,0.844577972,0.647213435,RAD51/BLM/TOPBP1,3,CC
GO:0000242,pericentriolar material,1/264,21/12707,0.356762951,0.849435598,0.650935911,CEP152,1,CC
GO:0034045,phagophore assembly site membrane,1/264,21/12707,0.356762951,0.849435598,0.650935911,WDR45,1,CC
GO:0097386,glial cell projection,1/264,21/12707,0.356762951,0.849435598,0.650935911,SLC4A8,1,CC
GO:0030880,RNA polymerase complex,3/264,103/12707,0.361656437,0.852963294,0.65363924,POLA2/PRIM1/MCM3,3,CC
GO:1990204,oxidoreductase complex,3/264,104/12707,0.367332503,0.858253511,0.657693217,RRM1/NDUFAF1/RRM2,3,CC
GO:0043195,terminal bouton,1/264,23/12707,0.383257384,0.88716987,0.679852279,SLC4A8,1,CC
GO:0000786,nucleosome,2/264,65/12707,0.39252083,0.900277133,0.689896582,H2AX/CENPA,2,CC
GO:0005732,sno(s)RNA-containing ribonucleoprotein complex,1/264,25/12707,0.408664495,0.928782943,0.711741034,RPP25L,1,CC
GO:0099568,cytoplasmic region,5/264,211/12707,0.447052662,0.999972865,0.766294996,GPSM2/CENPF/DLG2/SAPCD2/KIF4A,5,CC
GO:0005929,cilium,11/264,495/12707,0.45347541,0.999972865,0.766294996,CENPF/CENPJ/CEP128/SPAG5/RTTN/CEP250/AURKA/CDC45/POC1A/CEP15/CNTRL,11,CC
GO:0005758,mitochondrial intermembrane space,2/264,74/12707,0.456987698,0.999972865,0.766294996,TIMM8B/CDC25C,2,CC
GO:0005938,cell cortex,6/264,262/12707,0.462902834,0.999972865,0.766294996,GPSM2/IQGAP3/ECT2/ANLN/MELK/SAPCD2,6,CC
GO:0080008,Cul4-RING E3 ubiquitin ligase complex,1/264,31/12707,0.478797522,0.999972865,0.766294996,DTL,1,CC
GO:0120111,neuron projection cytoplasm,2/264,78/12707,0.484360018,0.999972865,0.766294996,DLG2/KIF4A,2,CC
GO:0016323,basolateral plasma membrane,4/264,176/12707,0.499138133,0.999972865,0.766294996,DLG2/SLC4A8/SLC7A1/AURKA,4,CC
GO:0031970,organelle envelope lumen,2/264,83/12707,0.517350417,0.999972865,0.766294996,TIMM8B/CDC25C,2,CC
GO:1902555,endoribonuclease complex,1/264,35/12707,0.520884474,0.999972865,0.766294996,RPP25L,1,CC
GO:0000407,phagophore assembly site,1/264,37/12707,0.540640443,0.999972865,0.766294996,WDR45,1,CC
GO:0016459,myosin complex,1/264,38/12707,0.550211944,0.999972865,0.766294996,MYL12A,1,CC
GO:0022627,cytosolic small ribosomal subunit,1/264,39/12707,0.559584748,0.999972865,0.766294996,RPS27L,1,CC
GO:0005643,nuclear pore,2/264,90/12707,0.561129514,0.999972865,0.766294996,NUP160/MAD2L1,2,CC
GO:0005747,mitochondrial respiratory chain complex I,1/264,40/12707,0.568762963,0.999972865,0.766294996,NDUFAF1,1,CC
GO:0030964,NADH dehydrogenase complex,1/264,40/12707,0.568762963,0.999972865,0.766294996,NDUFAF1,1,CC
GO:0045271,respiratory chain complex I,1/264,40/12707,0.568762963,0.999972865,0.766294996,NDUFAF1,1,CC
GO:0001917,photoreceptor inner segment,1/264,41/12707,0.577750614,0.999972865,0.766294996,CEP250,1,CC
GO:0009925,basal plasma membrane,4/264,199/12707,0.59626298,0.999972865,0.766294996,DLG2/SLC4A8/SLC7A1/AURKA,4,CC
GO:0009295,nucleoid,1/264,44/12707,0.603609199,0.999972865,0.766294996,DNA2,1,CC
GO:0042645,mitochondrial nucleoid,1/264,44/12707,0.603609199,0.999972865,0.766294996,DNA2,1,CC
GO:0005923,bicellular tight junction,2/264,98/12707,0.607607983,0.999972865,0.766294996,ECT2/SAPCD2,2,CC
GO:0044304,main axon,1/264,45/12707,0.61187321,0.999972865,0.766294996,DLG2,1,CC
GO:0070160,tight junction,2/264,103/12707,0.634714208,0.999972865,0.766294996,ECT2/SAPCD2,2,CC
GO:0000791,euchromatin,1/264,49/12707,0.643247908,0.999972865,0.766294996,UHRF1,1,CC
GO:0030660,Golgi-associated vesicle membrane,1/264,49/12707,0.643247908,0.999972865,0.766294996,ITM2B,1,CC
GO:0045178,basal part of cell,4/264,212/12707,0.645949891,0.999972865,0.766294996,DLG2/SLC4A8/SLC7A1/AURKA,4,CC
GO:0001750,photoreceptor outer segment,1/264,51/12707,0.657974412,0.999972865,0.766294996,CEP250,1,CC
GO:0000315,organellar large ribosomal subunit,1/264,56/12707,0.692194781,0.999972865,0.766294996,MRPL32,1,CC
GO:0005762,mitochondrial large ribosomal subunit,1/264,56/12707,0.692194781,0.999972865,0.766294996,MRPL32,1,CC
GO:0015030,Cajal body,1/264,57/12707,0.698618034,0.999972865,0.766294996,OIP5,1,CC
GO:0043296,apical junction complex,2/264,120/12707,0.715960662,0.999972865,0.766294996,ECT2/SAPCD2,2,CC
GO:0032838,plasma membrane bounded cell projection cytoplasm,3/264,178/12707,0.719282639,0.999972865,0.766294996,CENPF/DLG2/KIF4A,3,CC
GO:0019005,SCF ubiquitin ligase complex,1/264,61/12707,0.723002997,0.999972865,0.766294996,CCNF,1,CC
GO:0005667,transcription regulator complex,7/264,400/12707,0.729928023,0.999972865,0.766294996,E2F2/DEPDC1/RBBP8/E2F1/RBL1/MXD3/GMNN,7,CC
GO:0005759,mitochondrial matrix,8/264,456/12707,0.736040279,0.999972865,0.766294996,CDK1/DNA2/ARHGAP11B/RAD51/NDUFAF1/MTHFD2/CCNB1/MRPL32,8,CC
GO:0001725,stress fiber,1/264,64/12707,0.739992581,0.999972865,0.766294996,MYL12A,1,CC
GO:0030864,cortical actin cytoskeleton,1/264,64/12707,0.739992581,0.999972865,0.766294996,ANLN,1,CC
GO:0031594,neuromuscular junction,1/264,64/12707,0.739992581,0.999972865,0.766294996,DLG2,1,CC
GO:0097517,contractile actin filament bundle,1/264,64/12707,0.739992581,0.999972865,0.766294996,MYL12A,1,CC
GO:0005901,caveola,1/264,65/12707,0.745421827,0.999972865,0.766294996,KIF18A,1,CC
GO:0035578,azurophil granule lumen,1/264,65/12707,0.745421827,0.999972865,0.766294996,DSN1,1,CC
GO:0043679,axon terminus,1/264,65/12707,0.745421827,0.999972865,0.766294996,SLC4A8,1,CC
GO:0098803,respiratory chain complex,1/264,68/12707,0.761041192,0.999972865,0.766294996,NDUFAF1,1,CC
GO:0098839,postsynaptic density membrane,1/264,68/12707,0.761041192,0.999972865,0.766294996,DLG2,1,CC
GO:0032432,actin filament bundle,1/264,70/12707,0.770919935,0.999972865,0.766294996,MYL12A,1,CC
GO:0042641,actomyosin,1/264,70/12707,0.770919935,0.999972865,0.766294996,MYL12A,1,CC
GO:0016324,apical plasma membrane,4/264,252/12707,0.772313321,0.999972865,0.766294996,ASPM/SLC4A8/SLC7A1/SAPCD2,4,CC
GO:0097733,photoreceptor cell cilium,1/264,71/12707,0.775705654,0.999972865,0.766294996,CEP250,1,CC
GO:0005746,mitochondrial respirasome,1/264,72/12707,0.780391766,0.999972865,0.766294996,NDUFAF1,1,CC
GO:0001650,fibrillar center,2/264,138/12707,0.784934122,0.999972865,0.766294996,EXOSC8/DSN1,2,CC
GO:0015935,small ribosomal subunit,1/264,73/12707,0.784980335,0.999972865,0.766294996,RPS27L,1,CC
GO:0044306,neuron projection terminus,1/264,78/12707,0.8065294,0.999972865,0.766294996,SLC4A8,1,CC
GO:0044853,plasma membrane raft,1/264,79/12707,0.810573762,0.999972865,0.766294996,KIF18A,1,CC
GO:0070469,respirasome,1/264,79/12707,0.810573762,0.999972865,0.766294996,NDUFAF1,1,CC
GO:0097731,9+0 non-motile cilium,1/264,80/12707,0.814533892,0.999972865,0.766294996,CEP250,1,CC
GO:0099634,postsynaptic specialization membrane,1/264,80/12707,0.814533892,0.999972865,0.766294996,DLG2,1,CC
GO:0005798,Golgi-associated vesicle,1/264,81/12707,0.818411539,0.999972865,0.766294996,ITM2B,1,CC
GO:0032279,asymmetric synapse,4/264,272/12707,0.820777036,0.999972865,0.766294996,DLG2/SLC4A8/AURKA/LZTS1,4,CC
GO:0090575,RNA polymerase II transcription regulator complex,3/264,215/12707,0.82800135,0.999972865,0.766294996,E2F2/E2F1/MXD3,3,CC
GO:0070603,SWI/SNF superfamily-type complex,1/264,87/12707,0.84003869,0.999972865,0.766294996,DEK,1,CC
GO:0001726,ruffle,2/264,159/12707,0.846476017,0.999972865,0.766294996,KIF18A/KNSTRN,2,CC
GO:0000313,organellar ribosome,1/264,89/12707,0.846661467,0.999972865,0.766294996,MRPL32,1,CC
GO:0005761,mitochondrial ribosome,1/264,89/12707,0.846661467,0.999972865,0.766294996,MRPL32,1,CC
GO:0043025,neuronal cell body,5/264,346/12707,0.849978442,0.999972865,0.766294996,RRM1/DLG2/SLC4A8/TPX2/AURKA,5,CC
GO:0005912,adherens junction,2/264,161/12707,0.851417891,0.999972865,0.766294996,DLG2/CDCA3,2,CC
GO:0030672,synaptic vesicle membrane,1/264,91/12707,0.85301104,0.999972865,0.766294996,SLC4A8,1,CC
GO:0030863,cortical cytoskeleton,1/264,91/12707,0.85301104,0.999972865,0.766294996,ANLN,1,CC
GO:0099501,exocytic vesicle membrane,1/264,91/12707,0.85301104,0.999972865,0.766294996,SLC4A8,1,CC
GO:0098984,neuron to neuron synapse,4/264,297/12707,0.869110054,0.999972865,0.766294996,DLG2/SLC4A8/AURKA/LZTS1,4,CC
GO:0043204,perikaryon,1/264,98/12707,0.873241095,0.999972865,0.766294996,DLG2,1,CC
GO:0097730,non-motile cilium,1/264,98/12707,0.873241095,0.999972865,0.766294996,CEP250,1,CC
GO:0019866,organelle inner membrane,7/264,481/12707,0.87686572,0.999972865,0.766294996,TIMM8B/NDUFAF1/UQCC1/SLC25A20/LMNB1/MRPL32/DPY19L2P2,7,CC
GO:0005930,axoneme,1/264,100/12707,0.878493743,0.999972865,0.766294996,CENPF,1,CC
GO:0005884,actin filament,1/264,101/12707,0.881038175,0.999972865,0.766294996,GAS2L3,1,CC
GO:0097014,ciliary plasm,1/264,101/12707,0.881038175,0.999972865,0.766294996,CENPF,1,CC
GO:0045177,apical part of cell,4/264,305/12707,0.882017562,0.999972865,0.766294996,ASPM/SLC4A8/SLC7A1/SAPCD2,4,CC
GO:0030424,axon,7/264,488/12707,0.885688011,0.999972865,0.766294996,KIF20B/DLG2/SLC4A8/TPX2/AURKA/ADAM22/KIF4A,7,CC
GO:0044391,ribosomal subunit,2/264,181/12707,0.893433007,0.999972865,0.766294996,RPS27L/MRPL32,2,CC
GO:0016607,nuclear speck,5/264,377/12707,0.896381901,0.999972865,0.766294996,H2AX/OIP5/RMI2/SMC4/NCAPG2,5,CC
GO:0022626,cytosolic ribosome,1/264,110/12707,0.901676975,0.999972865,0.766294996,RPS27L,1,CC
GO:0015934,large ribosomal subunit,1/264,112/12707,0.905755135,0.999972865,0.766294996,MRPL32,1,CC
GO:1990351,transporter complex,3/264,258/12707,0.907236154,0.999972865,0.766294996,TIMM8B/NDUFAF1/ATP8B3,3,CC
GO:0014069,postsynaptic density,3/264,259/12707,0.908606063,0.999972865,0.766294996,DLG2/AURKA/LZTS1,3,CC
GO:0005766,primary lysosome,1/264,114/12707,0.909664758,0.999972865,0.766294996,DSN1,1,CC
GO:0042582,azurophil granule,1/264,114/12707,0.909664758,0.999972865,0.766294996,DSN1,1,CC
GO:0042734,presynaptic membrane,1/264,117/12707,0.91522829,0.999972865,0.766294996,SLC4A8,1,CC
GO:0044297,cell body,5/264,396/12707,0.918243428,0.999972865,0.766294996,RRM1/DLG2/SLC4A8/TPX2/AURKA,5,CC
GO:0005911,cell-cell junction,5/264,398/12707,0.920291111,0.999972865,0.766294996,IQGAP3/DLG2/CDCA3/ECT2/SAPCD2,5,CC
GO:0098798,mitochondrial protein-containing complex,3/264,273/12707,0.925954856,0.999972865,0.766294996,TIMM8B/NDUFAF1/MRPL32,3,CC
GO:0009898,cytoplasmic side of plasma membrane,1/264,125/12707,0.928451306,0.999972865,0.766294996,RACGAP1,1,CC
GO:0030018,Z disc,1/264,125/12707,0.928451306,0.999972865,0.766294996,MYL12A,1,CC
GO:0099572,postsynaptic specialization,3/264,276/12707,0.929257512,0.999972865,0.766294996,DLG2/AURKA/LZTS1,3,CC
GO:0150034,distal axon,2/264,206/12707,0.930476166,0.999972865,0.766294996,KIF20B/SLC4A8,2,CC
GO:0005775,vacuolar lumen,1/264,131/12707,0.93700099,0.999972865,0.766294996,DSN1,1,CC
GO:0015629,actin cytoskeleton,5/264,421/12707,0.94078337,0.999972865,0.766294996,GAS2L3/KNTC1/MYL12A/TOPBP1/ANLN,5,CC
GO:0098800,inner mitochondrial membrane protein complex,1/264,134/12707,0.940886083,0.999972865,0.766294996,NDUFAF1,1,CC
GO:1904949,ATPase complex,1/264,134/12707,0.940886083,0.999972865,0.766294996,DEK,1,CC
GO:0043292,contractile fiber,2/264,216/12707,0.941578636,0.999972865,0.766294996,MYL12A/DEK,2,CC
GO:0031674,I band,1/264,136/12707,0.943342591,0.999972865,0.766294996,MYL12A,1,CC
GO:0005840,ribosome,2/264,222/12707,0.947411023,0.999972865,0.766294996,RPS27L/MRPL32,2,CC
GO:0043197,dendritic spine,1/264,143/12707,0.95116651,0.999972865,0.766294996,LZTS1,1,CC
GO:0005743,mitochondrial inner membrane,5/264,437/12707,0.952115542,0.999972865,0.766294996,TIMM8B/NDUFAF1/UQCC1/SLC25A20/MRPL32,5,CC
GO:0030426,growth cone,1/264,145/12707,0.953197248,0.999972865,0.766294996,KIF20B,1,CC
GO:0044309,neuron spine,1/264,145/12707,0.953197248,0.999972865,0.766294996,LZTS1,1,CC
GO:0030427,site of polarized growth,1/264,149/12707,0.957009774,0.999972865,0.766294996,KIF20B,1,CC
GO:0019898,extrinsic component of membrane,1/264,151/12707,0.958798365,0.999972865,0.766294996,WDR45,1,CC
GO:0098562,cytoplasmic side of membrane,1/264,158/12707,0.964494343,0.999972865,0.766294996,RACGAP1,1,CC
GO:0008021,synaptic vesicle,1/264,163/12707,0.968075778,0.999972865,0.766294996,SLC4A8,1,CC
GO:0098978,glutamatergic synapse,3/264,333/12707,0.97117425,0.999972865,0.766294996,SLC4A8/AURKA/LZTS1,3,CC
GO:0030658,transport vesicle membrane,1/264,177/12707,0.976301272,0.999972865,0.766294996,SLC4A8,1,CC
GO:0045211,postsynaptic membrane,1/264,179/12707,0.977289428,0.999972865,0.766294996,DLG2,1,CC
GO:0097060,synaptic membrane,2/264,270/12707,0.977743478,0.999972865,0.766294996,DLG2/SLC4A8,2,CC
GO:0070382,exocytic vesicle,1/264,180/12707,0.977768003,0.999972865,0.766294996,SLC4A8,1,CC
GO:0005741,mitochondrial outer membrane,1/264,189/12707,0.981647364,0.999972865,0.766294996,SPATA18,1,CC
GO:0030017,sarcomere,1/264,193/12707,0.983147448,0.999972865,0.766294996,MYL12A,1,CC
GO:0030667,secretory granule membrane,1/264,204/12707,0.986672035,0.999972865,0.766294996,ATP8B3,1,CC
GO:0030016,myofibril,1/264,209/12707,0.988021157,0.999972865,0.766294996,MYL12A,1,CC
GO:0045121,membrane raft,1/264,209/12707,0.988021157,0.999972865,0.766294996,KIF18A,1,CC
GO:0031968,organelle outer membrane,1/264,210/12707,0.988274191,0.999972865,0.766294996,SPATA18,1,CC
GO:0098857,membrane microdomain,1/264,210/12707,0.988274191,0.999972865,0.766294996,KIF18A,1,CC
GO:0019867,outer membrane,1/264,212/12707,0.988764395,0.999972865,0.766294996,SPATA18,1,CC
GO:0005802,trans-Golgi network,1/264,220/12707,0.990529321,0.999972865,0.766294996,ATP8B3,1,CC
GO:0034774,secretory granule lumen,1/264,223/12707,0.991117444,0.999972865,0.766294996,DSN1,1,CC
GO:0060205,cytoplasmic vesicle lumen,1/264,225/12707,0.991489166,0.999972865,0.766294996,DSN1,1,CC
GO:0031983,vesicle lumen,1/264,226/12707,0.991669174,0.999972865,0.766294996,DSN1,1,CC
GO:1902495,transmembrane transporter complex,1/264,235/12707,0.99312777,0.999972865,0.766294996,NDUFAF1,1,CC
GO:0005788,endoplasmic reticulum lumen,1/264,237/12707,0.993415637,0.999972865,0.766294996,POGLUT3,1,CC
GO:0031252,cell leading edge,2/264,359/12707,0.995775912,0.999972865,0.766294996,KIF18A/KNSTRN,2,CC
GO:0030425,dendrite,3/264,471/12707,0.997271127,0.999972865,0.766294996,ZWINT/SLC4A8/LZTS1,3,CC
GO:0097447,dendritic tree,3/264,471/12707,0.997271127,0.999972865,0.766294996,ZWINT/SLC4A8/LZTS1,3,CC
GO:0098794,postsynapse,3/264,497/12707,0.998287886,0.999972865,0.766294996,DLG2/AURKA/LZTS1,3,CC
GO:0098793,presynapse,2/264,427/12707,0.998863972,0.999972865,0.766294996,SLC4A8/RAD51,2,CC
GO:0098791,Golgi apparatus subcompartment,1/264,319/12707,0.998867683,0.999972865,0.766294996,ATP8B3,1,CC
GO:0030133,transport vesicle,1/264,334/12707,0.999180482,0.999972865,0.766294996,SLC4A8,1,CC
GO:0005769,early endosome,1/264,361/12707,0.999542503,0.999972865,0.766294996,KIFC1,1,CC
GO:0098552,side of membrane,1/264,387/12707,0.999739346,0.999972865,0.766294996,RACGAP1,1,CC
GO:0005925,focal adhesion,1/264,395/12707,0.999780829,0.999972865,0.766294996,KIF23,1,CC
GO:0030055,cell-substrate junction,1/264,404/12707,0.999819685,0.999972865,0.766294996,KIF23,1,CC
GO:0010008,endosome membrane,1/264,468/12707,0.999955172,0.999972865,0.766294996,ITM2B,1,CC
GO:0009986,cell surface,1/264,491/12707,0.999972865,0.999972865,0.766294996,HMMR,1,CC
